data_2jqi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -59.01 -39.08 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -39.11 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.81 -31.98 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.99 -35.53 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.38 -45.34 84.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -67.07 -23.78 65.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.581 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -47.62 79.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -76.4 136.09 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.533 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -92.32 -60.0 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.803 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.97 165.27 29.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.281 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.44 122.79 34.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.386 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -90.35 122.86 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.922 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 146' ' ' PHE . 20.4 mt -126.34 120.46 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.444 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.3 t -80.83 121.31 25.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.399 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -26.17 19.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.379 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.445 HG21 ' HB3' ' A' ' 142' ' ' SER . 40.2 p -79.87 -2.18 42.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.579 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.32 76.49 0.29 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.807 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -146.32 -42.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -117.72 141.26 28.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.8 141.06 36.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.152 1.902 . . . . 0.0 112.167 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.7 mt -55.9 133.56 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.82 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -127.1 164.05 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.137 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.85 119.78 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -87.18 130.45 34.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.463 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.627 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.91 155.99 48.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.287 1.041 . . . . 0.0 113.497 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.226 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 16.4 ttpt . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 92' ' ' LEU . 11.9 p -111.35 140.08 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.575 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.6 m-90 -100.67 139.34 36.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.107 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 131.41 55.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -120.2 145.58 46.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.659 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.45 -169.18 36.18 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.768 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -81.95 3.75 25.26 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.82 132.65 45.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.572 0.225 . . . . 0.0 111.007 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.88 -13.3 39.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.514 2.143 . . . . 0.0 111.63 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -42.92 17.41 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.914 0.864 . . . . 0.0 108.847 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.54 137.52 3.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.805 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -18.09 11.01 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.226 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.457 ' CE2' HG22 ' A' ' 43' ' ' ILE . 9.8 t80 -129.06 119.43 24.19 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.031 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.97 111.41 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HA ' HG12 ' A' ' 43' ' ' ILE . 1.7 mt -88.07 -65.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.06 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.169 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.4 p30 178.78 54.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 111.007 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.1 mm -75.06 126.66 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 p -54.94 -40.83 70.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.277 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -68.81 -44.9 72.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -72.99 150.07 42.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -95.69 166.83 11.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.78 -53.15 6.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 109.805 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 9.7 ptmt -120.9 81.83 1.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.7 t60 -60.4 -46.15 91.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.829 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.8 p90 -142.45 160.2 40.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.077 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HG3' ' HA ' ' A' ' 67' ' ' THR . 3.8 tt0 -135.99 143.87 45.05 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 69.9 mt -120.03 125.68 74.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.632 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.9 pt? -114.17 137.3 51.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.307 179.442 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' CB ' HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.8 mp -133.14 147.13 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.224 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mp -112.62 125.66 54.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 90' ' ' GLN . 41.1 t30 -116.69 115.63 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.8 p30 -80.44 132.6 35.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.808 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -139.57 41.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.95 157.76 16.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.018 0.437 . . . . 0.0 111.473 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -68.84 -36.35 78.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.445 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -19.84 17.34 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.46 161.45 11.25 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.489 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.0 m -117.6 137.99 52.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.821 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.6 148.38 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -124.33 113.54 18.37 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 45.78 42.75 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.37 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.84 -5.5 84.87 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.493 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.39 118.72 37.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.108 0.454 . . . . 0.0 110.868 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.821 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.4 tptm -75.11 126.91 32.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.327 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 m -101.52 165.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.256 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tt0 -69.86 125.92 28.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 47.9 tttm -52.12 161.82 0.56 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.91 0.386 . . . . 0.0 110.558 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.63 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.281 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.23 145.07 40.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.251 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.67 130.13 34.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.8 mm-40 -129.39 147.89 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.477 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -72.8 135.99 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.331 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.421 ' CD2' HG12 ' A' ' 147' ' ' ILE . 63.4 tp -65.62 155.23 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.463 0.649 . . . . 0.0 111.733 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.95 153.12 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.515 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 123.13 21.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.139 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.38 46.15 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.063 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.5 t70 -52.14 170.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 mt-10 -145.02 135.56 24.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 11.3 mt -113.52 126.68 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.48 138.57 40.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.745 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.8 m -140.27 158.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.84 31.49 23.62 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.6 t -73.41 140.36 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.604 0.716 . . . . 0.0 112.217 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.01 -39.33 0.88 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 21.6 t -126.23 128.31 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.017 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.4 -35.42 28.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.38 6.55 47.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.423 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.92 27.32 8.16 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.47 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -107.12 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.172 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -124.35 134.48 53.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.434 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.445 ' HB3' HG21 ' A' ' 40' ' ' THR . 41.6 t -112.61 150.41 31.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.671 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.2 mm? -135.91 152.4 50.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.379 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.403 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 18.9 t -119.82 140.08 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.34 . . . . 0.0 111.334 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 145' ' ' ILE . 47.7 mt -106.32 121.0 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -109.11 114.38 28.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.512 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.3 mt -84.86 132.76 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.551 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.8 179.768 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -38.88 86.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -35.45 77.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.843 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -42.17 88.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.22 -35.14 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.22 -43.35 82.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.853 0.359 . . . . 0.0 110.377 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.428 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.47 79.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.827 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -75.35 135.04 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.561 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -92.26 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.838 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.7 p -146.49 147.21 30.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.326 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 128.17 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.265 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.472 ' CG2' ' CE1' ' A' ' 76' ' ' TYR . 34.5 m -94.58 122.9 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.798 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.15 111.38 29.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.655 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.04 106.42 18.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -97.76 -10.76 24.29 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.678 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.1 p -79.94 -2.59 44.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.408 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.45 84.26 0.69 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.432 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 141' ' ' LEU . 15.1 pt20 -161.72 -47.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.422 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.6 mt -134.16 142.79 44.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.711 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 63.4 Cg_endo -75.92 146.01 29.03 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.255 1.97 . . . . 0.0 111.794 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mt -52.24 136.77 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.969 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -132.08 161.89 32.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -117.77 120.02 36.68 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.1 mt -96.04 136.96 35.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.56 159.07 43.91 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -178.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.709 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.7 ttpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.848 0.356 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG13 ' HG2' ' A' ' 90' ' ' GLN . 19.5 t -132.55 139.48 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.22 0.533 . . . . 0.0 111.761 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.523 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.4 m-90 -100.88 137.67 38.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.69 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.01 127.48 56.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -115.25 145.53 42.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.66 -173.06 35.63 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.663 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 14.3 mtm105 -77.79 4.87 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -84.97 131.91 47.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 0.0 111.043 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 Cg_exo -66.07 -14.21 43.35 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.362 2.041 . . . . 0.0 111.573 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.01 -42.61 17.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.946 0.879 . . . . 0.0 109.014 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.65 138.19 1.44 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.096 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.39 -18.21 10.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CZ ' HG23 ' A' ' 43' ' ' ILE . 6.6 t80 -128.48 112.22 14.12 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.79 0.328 . . . . 0.0 111.222 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -90.46 118.28 29.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.415 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -126.95 172.4 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.33 137.09 45.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.577 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -71.51 81.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.9 127.31 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.955 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -55.04 -24.93 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -46.07 15.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.157 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.3 mt -72.7 152.18 41.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.036 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.4 p -95.88 166.03 11.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.693 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.608 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.14 -53.77 6.17 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 109.614 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.36 81.85 1.75 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -59.54 -45.89 90.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.764 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.2 p90 -145.45 157.61 43.98 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.772 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.9 tt0 -136.06 141.06 44.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.606 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 53.6 mt -116.53 129.69 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.022 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -117.13 140.83 49.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.105 0.479 . . . . 0.0 111.602 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.258 179.459 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.401 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.1 mp -133.03 145.09 50.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.591 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 145' ' ' ILE . 10.5 mp -112.74 122.05 46.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.01 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.4 t30 -116.77 115.63 25.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 111.56 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.696 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 22.1 p30 -78.31 135.91 37.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.0 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.6 pt -143.84 39.08 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.98 160.4 14.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.043 0.449 . . . . 0.0 111.5 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.1 m -68.96 -36.46 77.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.615 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.49 -20.06 17.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.34 162.07 11.55 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.201 -0.999 . . . . 0.0 113.481 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.69 137.84 52.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.72 148.39 36.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.46 18.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.198 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.39 42.85 5.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.358 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.37 -5.08 85.33 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.464 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -104.86 118.51 36.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 0.0 110.738 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.0 tptp -75.67 126.04 30.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.156 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.69 163.13 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.289 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.91 127.1 31.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.7 tttp -52.44 163.44 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.197 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 35.43 35.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.948 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -112.03 137.2 50.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.107 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -80.4 130.54 35.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 27.2 mm-40 -129.54 146.9 51.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 tp -72.85 136.13 45.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.72 157.45 24.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.48 0.657 . . . . 0.0 112.006 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.44 153.37 43.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.217 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.451 ' HA ' HD12 ' A' ' 147' ' ' ILE . 15.2 mm100 -71.55 115.6 10.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.38 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.26 30.02 63.8 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.702 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.1 t70 -55.23 174.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.973 0.416 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 mt-10 -145.21 135.47 24.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.015 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 10.4 mt -111.33 126.3 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.549 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 8.2 m -104.87 137.66 42.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.0 m -140.32 158.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 112.181 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.59 16.26 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.17 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.8 t -74.53 140.41 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.684 0.754 . . . . 0.0 112.172 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.23 -41.07 1.08 Allowed Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.5 123.14 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.541 -0.83 . . . . 0.0 108.929 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.29 -28.05 7.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.427 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 6.53 48.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.62 24.37 7.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.479 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.6 mt -107.47 138.23 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.426 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 9.9 mt -125.19 134.77 52.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.339 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.678 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -104.65 139.07 40.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.213 0.53 . . . . 0.0 111.897 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.2 mp -125.06 152.51 44.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.154 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 22.5 t -120.77 134.18 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.869 0.366 . . . . 0.0 111.618 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 101' ' ' LEU . 36.3 mt -106.31 121.74 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.24 119.02 37.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 126' ' ' GLN . 5.9 mt -84.71 134.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 t30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -60.54 -42.21 96.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 -38.05 80.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.9 -32.27 72.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.675 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.11 -35.5 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.734 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -39.98 77.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.446 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -67.1 -23.8 65.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.794 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.68 -47.34 80.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.224 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.832 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -75.11 134.49 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.262 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -92.75 -61.58 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.421 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.2 p -155.19 138.03 15.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -113.99 138.45 50.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -96.13 132.14 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 mt -124.71 116.89 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 108.99 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.245 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.4 p -93.61 -20.12 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.035 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.732 HG22 ' HB2' ' A' ' 142' ' ' SER . 48.9 p -79.82 -2.99 45.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 111.499 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 74.27 75.37 0.78 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.562 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 8.8 mt-30 -147.95 -41.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.676 0.274 . . . . 0.0 111.223 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.6 mt -134.01 141.49 39.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.2 Cg_endo -73.99 146.07 36.6 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.179 1.919 . . . . 0.0 111.92 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mt -56.13 151.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.187 0.517 . . . . 0.0 111.956 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 2.0 ttt-85 -149.69 159.18 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.26 121.59 40.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 112.333 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.1 mt -94.56 137.76 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.005 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -142.61 158.17 43.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.117 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.0 ttpt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.652 0.263 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 90' ' ' GLN . 13.8 t -127.45 139.47 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.312 0.577 . . . . 0.0 112.186 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.631 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -107.78 138.56 43.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 126.23 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.5 m-85 -107.37 145.78 32.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.818 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.9 -178.58 40.54 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.782 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -78.16 -3.38 42.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 136.83 38.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.27 -6.12 17.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.796 2.331 . . . . 0.0 111.736 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.27 14.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.956 0.884 . . . . 0.0 108.684 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.07 139.23 2.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.457 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -18.62 10.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.174 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.1 t80 -129.36 131.65 46.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.04 131.09 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.18 -178.58 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.45 135.64 39.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -69.93 89.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.2 mt -104.35 127.75 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -54.98 -25.02 26.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.325 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -46.74 29.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.227 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.74 151.68 42.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.748 0.309 . . . . 0.0 111.306 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -95.56 166.16 11.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.893 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.22 -54.39 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 109.858 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -118.82 82.84 1.92 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -60.87 -46.79 89.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.652 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 p90 -147.71 159.31 43.94 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.278 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' HG13 ' A' ' 65' ' ' VAL . 6.4 tt0 -135.95 141.46 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 41.4 mt -114.37 132.33 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.251 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -122.0 144.46 48.88 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 111.341 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 HD13 ' HG ' ' A' ' 99' ' ' LEU . 2.4 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 110.821 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 8.9 mt -133.13 140.38 47.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.249 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.56 126.08 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.202 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.0 t30 -115.8 115.49 26.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -78.68 140.81 38.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.7 pt -149.22 38.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.51 159.04 15.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.007 0.432 . . . . 0.0 111.625 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.1 m -69.02 -34.96 76.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.647 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 -19.97 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.71 162.81 12.04 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.533 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.9 m -117.53 137.81 52.32 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.71 148.36 38.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.14 113.48 18.4 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.361 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 44.28 42.88 5.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -10.39 71.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.474 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.96 118.54 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.09 0.445 . . . . 0.0 110.656 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.34 130.91 41.2 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.56 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 m -101.87 164.58 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.851 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 tt0 -69.98 126.67 30.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.499 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 tttt -52.69 161.6 0.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.545 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.02 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.293 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.0 40.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.114 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.86 126.67 35.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.401 ' N ' HD21 ' A' ' 100' ' ' LEU . 39.4 mm-40 -129.3 147.28 51.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.834 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.9 120.95 19.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.984 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 99' ' ' LEU . 1.3 mm? -57.83 165.51 1.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.756 0.789 . . . . 0.0 112.076 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.38 153.18 43.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.195 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.63 120.36 17.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.94 26.39 60.7 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.246 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.1 t0 -60.82 178.54 0.23 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.7 mt-10 -144.99 135.57 24.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -112.64 126.92 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.457 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.49 141.63 36.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.101 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.41 158.53 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.99 9.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.192 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -83.69 140.37 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.646 0.736 . . . . 0.0 112.228 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.46 -39.29 1.31 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.52 120.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.592 -0.804 . . . . 0.0 108.97 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.29 -26.75 5.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.41 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 6.49 48.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.32 24.32 6.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.403 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 tt -123.32 134.78 54.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.196 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.732 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -111.98 128.7 56.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.078 0.466 . . . . 0.0 111.605 -179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.7 mt -123.01 149.1 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.777 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.9 t -113.84 138.03 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.056 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 mm -106.39 120.91 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.33 131.09 55.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.402 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -102.98 132.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.4 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.888 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -36.04 82.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -60.57 -40.05 90.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -43.54 98.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mm -71.59 -34.99 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.23 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.493 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -23.86 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.57 -47.6 79.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.296 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.832 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.676 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -73.38 135.52 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.684 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -93.1 -60.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.862 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.12 150.47 35.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.183 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.4 138.24 51.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 111.489 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.1 122.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.45 121.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.546 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.4 t -79.87 114.43 18.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -79.69 -25.99 41.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.798 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 142' ' ' SER . 72.6 p -79.83 -2.19 42.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.706 0.289 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 77.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.946 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -146.29 -44.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.389 . . . . 0.0 110.736 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -113.73 141.66 26.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.862 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.3 Cg_endo -72.06 140.87 35.33 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mt -56.43 140.2 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.641 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.38 164.13 20.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.33 119.71 33.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.1 mt -97.44 134.64 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.56 158.0 43.83 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.572 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.743 0.306 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.5 t -125.56 139.14 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 112.086 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.585 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.6 m-90 -100.89 139.4 36.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.199 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.37 128.76 56.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -119.45 145.38 46.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.346 -178.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.1 -168.5 36.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.067 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 25.1 mtm180 -80.28 2.23 25.46 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 t-20 -84.87 133.05 44.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -66.63 -14.05 42.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 0.0 111.901 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.05 17.31 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.902 0.858 . . . . 0.0 108.796 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.18 139.6 1.34 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.779 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.0 m-20 -56.34 -19.0 12.55 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.003 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.6 t80 -129.83 126.98 39.33 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.931 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.45 111.17 23.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.52 172.53 6.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.784 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.09 134.05 48.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.675 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -67.32 84.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.46 131.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -37.06 69.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -27.85 67.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 88' ' ' HIS . 37.0 mt -96.94 152.2 18.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -99.04 165.27 11.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.773 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -42.84 -53.5 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.387 0.613 . . . . 0.0 109.851 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 10.7 ptmt -118.38 81.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -59.34 -45.69 90.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.883 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 34.0 p90 -144.53 160.44 41.12 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.138 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -135.91 143.04 44.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.282 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 64.3 mt -119.31 127.59 75.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.006 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.32 148.05 32.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 111.635 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.534 179.637 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.9 mp -133.06 147.34 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.65 125.33 54.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -116.47 115.81 26.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.773 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.632 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.0 p30 -77.89 135.03 37.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 8.5 pt -143.91 34.6 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.579 ' H ' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -93.83 151.77 19.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.941 0.4 . . . . 0.0 111.457 -179.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -68.58 -31.82 71.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.921 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.62 -19.83 17.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.539 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.72 154.52 9.21 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.678 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.7 m -117.5 137.92 52.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.51 148.36 42.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.43 113.59 18.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.956 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 47.74 36.08 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.35 79.91 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.544 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.83 118.67 37.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 110.756 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.802 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -73.8 113.44 10.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 m -87.41 166.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.92 126.09 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -52.69 157.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.825 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.595 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 4.0 p30 34.77 35.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -112.32 145.11 40.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.077 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -80.84 131.87 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.24 146.66 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 tp -72.68 118.5 15.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.41 153.85 9.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.504 0.668 . . . . 0.0 111.686 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.91 153.02 43.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.465 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -71.82 125.03 26.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.258 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.57 54.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.283 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.416 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -52.0 166.03 0.18 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.6 mt-10 -139.83 135.63 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.1 mt -111.11 127.0 68.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.742 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.439 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.4 141.27 36.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.552 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.78 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.78 43.88 9.7 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -84.68 140.44 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.651 0.739 . . . . 0.0 112.441 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.59 -39.96 1.12 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.41 120.02 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.563 -0.818 . . . . 0.0 109.0 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.45 -25.87 4.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.823 0.344 . . . . 0.0 111.442 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -93.5 6.53 47.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.9 26.01 5.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.7 mt -107.13 138.83 31.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.96 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 tt -124.49 134.28 53.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG22 ' A' ' 40' ' ' THR . 44.4 t -108.41 150.3 27.57 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.619 0.723 . . . . 0.0 112.153 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 74.5 mt -135.75 156.97 47.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.8 t -125.94 138.61 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.457 HG21 HD11 ' A' ' 145' ' ' ILE . 32.4 mt -106.34 121.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.966 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.39 114.07 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.92 134.0 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.818 0.342 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -59.0 -37.68 77.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.34 -41.37 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -31.83 70.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.38 -35.49 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.803 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -42.0 81.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -67.11 -23.89 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.59 -47.56 79.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.859 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.715 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.8 mm -76.71 134.05 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.529 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.6 t -93.66 -62.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.073 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 p -146.61 155.96 42.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.189 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -122.7 133.28 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.35 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.56 122.81 49.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -122.84 121.99 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.38 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.18 114.08 22.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.442 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -85.85 -22.87 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.581 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.5 p -79.94 -2.07 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.615 0.245 . . . . 0.0 111.581 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.17 76.64 0.28 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.844 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.89 -43.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.9 mp -118.88 141.87 30.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.999 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.6 138.02 28.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.119 1.879 . . . . 0.0 112.121 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.55 136.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.745 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.09 164.1 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.256 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -118.08 119.81 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 111.787 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.5 mt -89.84 137.35 32.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.715 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.62 157.58 43.74 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.635 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 49' ' ' SER . 22.8 ttpt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.925 0.393 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.8 p -109.85 140.0 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.512 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -100.6 139.5 36.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.349 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.05 127.27 55.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -118.99 145.52 45.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.503 -178.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.52 -168.07 39.86 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -90.83 28.95 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.4 t-20 -111.43 136.62 20.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.87 -13.12 38.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.668 2.245 . . . . 0.0 111.736 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -47.45 11.8 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.824 0.821 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 140.61 1.0 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.311 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -56.61 -18.91 13.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.883 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 19.6 t80 -129.46 123.65 32.08 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.765 0.317 . . . . 0.0 110.68 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -97.93 121.94 40.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' HG12 ' A' ' 43' ' ' ILE . 12.4 mt -102.34 -64.04 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.77 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.27 -103.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -179.27 49.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 84' ' ' LEU . 19.2 mt -89.69 141.92 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -64.34 -34.77 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -60.91 -30.49 70.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 88' ' ' HIS . 1.2 mm? -105.81 152.47 23.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 p -98.39 163.32 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.591 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.16 -53.28 4.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.413 0.625 . . . . 0.0 109.67 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -118.99 82.65 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.534 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.6 t60 -61.25 -46.94 88.33 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.553 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.5 p90 -143.7 159.14 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.999 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.0 tt0 -135.5 140.52 44.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 77.1 mt -120.12 127.25 75.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.161 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.365 179.519 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mt -127.76 140.68 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.513 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.71 121.55 45.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.488 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.4 t30 -117.51 116.93 28.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.055 0.455 . . . . 0.0 112.072 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.669 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.8 p30 -77.36 134.82 38.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.817 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.72 39.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.75 149.82 23.42 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.084 0.469 . . . . 0.0 111.943 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.88 -31.34 70.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.862 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.63 -19.96 18.65 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.545 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.35 153.82 9.6 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.875 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.6 m -117.66 137.99 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.085 0.554 . . . . 0.0 109.577 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.85 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.98 148.57 39.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.23 113.53 18.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.482 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 44.32 43.51 6.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.494 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.41 -13.59 61.69 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.447 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -103.96 118.47 36.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.983 0.391 . . . . 0.0 110.586 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.85 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -72.3 125.63 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.246 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -95.29 165.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.238 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 mt-10 -69.87 125.11 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.676 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.669 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 82.7 tttt -53.49 162.33 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.779 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 36.2 32.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.18 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.49 143.28 43.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.721 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -92.17 133.6 35.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -129.08 150.01 50.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.49 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.58 122.91 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.14 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.8 tp -53.03 156.14 2.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.493 0.663 . . . . 0.0 111.85 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.58 153.53 42.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.285 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 121.36 18.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.934 0.397 . . . . 0.0 110.405 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.57 24.23 56.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.154 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -54.79 170.49 0.17 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.007 0.432 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 20.5 tt0 -145.18 135.46 24.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.41 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.6 mt -113.6 128.16 70.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.454 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.3 140.84 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.023 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.521 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.9 m -140.13 158.43 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.86 44.21 9.35 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.807 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -85.18 140.44 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.752 0.787 . . . . 0.0 112.47 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.39 -39.96 0.79 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 48.3 t -126.54 120.51 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.042 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -50.26 -26.44 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 111.54 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 p -93.61 6.62 47.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.407 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -132.49 29.83 4.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.3 mt -106.32 139.25 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.629 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 tt -124.16 134.35 53.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.701 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.0 t -112.17 150.31 31.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.722 . . . . 0.0 112.499 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.4 mm? -136.02 139.55 43.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.498 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.86 140.15 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.475 HD12 HG23 ' A' ' 145' ' ' ILE . 16.8 mt -106.18 122.29 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.76 113.74 26.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.367 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.9 127.29 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.57 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -59.0 -36.32 74.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.18 -42.46 96.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.433 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . 48.8 mm -68.91 -48.18 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.99 -33.56 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.294 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -59.79 -47.1 87.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.935 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.1 p90 -71.9 -47.44 52.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.062 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 52.3 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.014 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.676 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -74.74 134.25 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.454 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.16 -61.08 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.021 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 p -146.05 147.01 31.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.378 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.9 121.99 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 t -88.77 122.75 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.423 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.71 114.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.89 118.52 31.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -111.66 -12.46 13.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 142' ' ' SER . 18.0 p -81.05 -2.51 48.4 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.08 85.49 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.809 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 4.4 pt20 -164.3 -49.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.1 mt -132.97 142.5 44.9 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 65.6 Cg_endo -75.69 146.16 29.97 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.201 1.934 . . . . 0.0 111.511 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.9 mt -50.6 150.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 112.067 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -150.93 158.18 43.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.034 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -117.23 126.22 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 7.6 mt -101.05 137.62 39.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.75 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.89 158.78 43.68 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.532 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt . . . . . 0 CA--C 1.523 -0.096 0 CA-C-O 120.732 0.301 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.2 t -127.97 139.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.329 0.585 . . . . 0.0 112.333 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.545 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 14.5 m-90 -100.84 139.25 36.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.804 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.72 130.13 55.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -119.34 145.4 46.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.367 -178.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.45 -170.43 37.21 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.777 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -79.95 2.86 21.86 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t30 -84.94 133.01 44.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.61 0.243 . . . . 0.0 111.144 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.91 -14.51 44.89 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.571 2.181 . . . . 0.0 111.721 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -42.63 18.02 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.831 0.824 . . . . 0.0 108.972 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.39 139.75 1.89 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.914 -1.493 . . . . 0.0 110.826 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.36 -18.26 10.38 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.91 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.8 t80 -129.08 123.94 33.54 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.787 0.327 . . . . 0.0 110.922 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -105.53 116.67 32.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -99.0 -69.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.12 -92.26 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.317 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 177.95 55.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.103 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 29.2 mm -81.67 124.73 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.754 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.55 70.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -28.74 69.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 6.2 mp -97.66 153.31 18.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -96.42 167.31 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.736 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.633 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -44.15 -54.93 5.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.266 0.555 . . . . 0.0 109.623 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HD11 ' A' ' 104' ' ' ILE . 17.3 mttp -116.37 82.87 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -59.55 -46.47 88.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.763 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.0 p90 -143.92 157.77 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.008 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 102' ' ' ASN . 5.2 tt0 -135.69 141.35 44.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.956 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 59.5 mt -116.34 126.73 73.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.853 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -105.51 149.25 26.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.163 0.506 . . . . 0.0 111.858 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.233 179.32 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mt -126.69 142.66 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.425 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -112.79 121.63 45.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.808 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 90' ' ' GLN . 48.9 t30 -112.24 115.78 29.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.737 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.67 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 16.7 p30 -76.43 129.23 36.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.645 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 87' ' ' LYS . 9.5 pt -137.94 38.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.17 152.97 19.29 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.13 0.49 . . . . 0.0 111.663 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.8 m -68.85 -31.6 70.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.24 -19.88 17.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.531 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.47 156.07 10.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.675 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.42 137.72 52.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.803 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.74 148.19 42.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.422 HD22 ' CB ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -124.76 113.55 18.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 48.77 42.07 19.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.33 -6.14 80.82 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.973 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.422 ' CB ' HD22 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -106.3 118.83 37.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.275 0.537 . . . . 0.0 110.84 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.803 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptp -73.75 127.26 32.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.258 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 m -101.12 166.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.203 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 120' ' ' SER . 17.5 tt0 -69.77 123.87 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.518 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 2.1 tttt -51.32 165.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 p30 32.82 34.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.322 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.52 145.23 40.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.245 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -90.9 129.47 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.401 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 61.0 mm-40 -129.15 150.92 50.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.433 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.6 134.24 45.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . 54.7 tp -65.85 156.42 33.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.48 0.657 . . . . 0.0 111.697 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.39 153.6 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.614 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.411 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 4.5 tp60 -71.3 118.6 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.33 23.64 62.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.116 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -50.99 172.02 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.3 mt-10 -144.63 135.59 24.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.5 mt -114.32 125.01 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.474 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.57 140.4 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.7 m -140.31 158.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.94 27.22 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.179 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.0 t -71.02 140.32 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 112.212 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.8 -38.54 1.27 Allowed Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.45 124.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.662 -0.769 . . . . 0.0 109.202 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -50.47 -31.07 14.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.587 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.0 t -93.45 6.43 48.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -125.54 25.49 7.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.05 138.94 30.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.016 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' HG ' ' NE2' ' A' ' 42' ' ' GLN . 6.0 mp -124.46 134.58 53.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.508 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.596 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.54 132.74 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.5 mp -123.23 143.49 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.546 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.3 t -114.45 132.72 62.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.42 120.98 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.063 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.37 142.2 34.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -110.47 134.07 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.523 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.955 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.04 96.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.38 -35.09 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.1 -44.64 88.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.1 mm -66.86 -35.22 74.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.28 -42.92 82.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 0.0 110.353 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -67.26 -23.62 65.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.51 -47.48 79.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.297 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.9 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.7 135.29 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.416 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -91.42 -59.96 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.012 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.4 p -148.8 153.37 38.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.82 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -117.97 119.43 34.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.938 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.04 122.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 111.184 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -122.78 126.14 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.156 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.2 t -81.08 118.58 22.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 t -83.52 -27.89 29.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 142' ' ' SER . 50.6 p -79.88 -2.28 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.461 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.57 77.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.943 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -147.35 -43.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.4 mt -112.15 141.26 24.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.51 143.87 43.72 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.177 1.918 . . . . 0.0 112.172 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.4 ' CG2' ' CD ' ' A' ' 35' ' ' ARG . 35.3 mt -60.13 133.91 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.67 164.44 22.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.68 119.93 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -90.67 126.72 36.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.649 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -131.8 157.07 44.85 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.168 0.985 . . . . 0.0 113.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.216 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.937 0.399 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' ' 92' ' ' LEU . 20.6 t -136.17 139.66 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.019 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.607 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.9 m-90 -100.63 138.98 36.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.998 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.25 132.05 55.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.561 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -114.33 145.25 42.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.79 -175.08 39.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.99 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -78.99 -0.43 31.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.85 135.8 39.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.634 0.254 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.83 -9.28 25.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.686 2.257 . . . . 0.0 111.789 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.69 16.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.975 0.893 . . . . 0.0 108.669 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.05 136.5 4.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.651 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -56.49 -18.51 11.71 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.091 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.42 114.75 16.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.723 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -89.16 119.59 29.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HA ' HG12 ' A' ' 43' ' ' ILE . 10.0 mp -92.85 -77.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.34 -86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 173.65 48.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 110.929 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.47 126.48 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -58.57 -30.69 67.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -69.58 -49.23 56.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.8 mp -75.45 153.3 37.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 0.0 111.17 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 p -93.45 168.66 10.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.2 m-20 -43.95 -55.39 4.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.344 0.593 . . . . 0.0 109.765 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 6.1 ptmt -119.66 82.9 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -59.41 -45.85 90.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.981 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.2 p90 -146.36 159.53 43.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.495 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.84 143.45 45.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.381 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 25.2 mt -116.67 127.4 74.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.532 ' HB3' HG11 ' A' ' 65' ' ' VAL . 2.2 pt? -116.5 136.73 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.503 . . . . 0.0 112.065 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 179.266 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.419 ' CD2' ' CG2' ' A' ' 91' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 6.1 mt -133.16 147.15 52.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.381 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -112.68 124.8 53.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.329 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.9 t30 -115.88 115.62 26.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.031 0.443 . . . . 0.0 111.522 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.665 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.1 p30 -79.13 136.17 37.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.462 HD12 HG23 ' A' ' 67' ' ' THR . 16.6 pt -145.15 39.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.56 159.74 14.74 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.05 0.452 . . . . 0.0 111.804 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.3 m -69.06 -37.7 78.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.501 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 9.9 p30 -98.46 -19.91 17.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.55 160.78 10.95 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.695 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.0 m -117.58 137.91 52.28 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.829 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.76 148.38 38.44 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.35 18.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.366 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 44.27 42.86 5.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.91 -8.51 77.73 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.485 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 118.62 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.829 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.9 tptp -74.14 123.05 23.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.29 164.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.1 tp10 -69.86 126.71 30.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 36.9 tttm -52.63 161.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.377 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.51 34.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.32 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.3 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.153 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -84.2 130.05 34.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.5 mm-40 -129.34 146.66 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.81 135.66 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.6 tp -66.71 155.85 36.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.401 0.619 . . . . 0.0 111.545 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -124.69 153.11 42.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.41 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.61 114.0 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.202 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.63 71.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t0 -56.21 172.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 111.174 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.9 tt0 -145.19 135.56 24.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.8 mt -113.68 128.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.614 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.457 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.5 140.71 37.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.8 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.3 m -140.36 158.64 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.31 43.42 9.53 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.084 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -84.03 140.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.654 0.74 . . . . 0.0 112.275 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.19 -39.5 1.18 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.34 120.03 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -26.49 5.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.364 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -93.62 6.55 47.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.37 26.11 5.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.11 138.33 33.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.014 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tp -124.94 134.81 52.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.46 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' HG21 ' A' ' 40' ' ' THR . 39.3 t -109.89 149.54 29.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.658 0.742 . . . . 0.0 112.364 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.4 mm? -136.36 142.03 43.76 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 t -113.35 140.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 111.007 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 mt -106.08 121.13 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.13 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.799 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.9 130.59 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -36.98 84.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 -37.42 86.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.72 96.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.3 mm -67.02 -35.15 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.24 -40.98 78.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -23.87 65.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.43 79.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.235 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -79.76 133.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.563 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.4 t -92.65 -62.57 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.9 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.64 165.14 28.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -124.48 138.21 54.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 111.438 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 76' ' ' TYR . 2.4 m -108.8 122.63 63.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.627 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.94 119.86 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.792 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.4 t -83.76 102.34 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.292 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -77.27 -25.48 51.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.924 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 9.9 p -79.9 -2.59 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.515 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.52 79.95 0.19 Allowed Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.068 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -146.97 -39.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.588 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -129.11 144.09 51.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.917 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 38.5 Cg_endo -68.89 141.58 49.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.183 1.922 . . . . 0.0 111.934 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.49 140.26 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.907 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -135.38 164.11 28.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.87 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.91 119.79 29.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.8 mp -78.91 135.61 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.682 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.7 156.14 43.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.672 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.671 0.272 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG13 ' HG2' ' A' ' 90' ' ' GLN . 16.4 t -136.34 139.24 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.317 0.58 . . . . 0.0 112.247 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.2 m-90 -109.94 139.13 45.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.982 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.24 55.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -114.25 145.78 41.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.658 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -169.35 35.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.683 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -82.12 5.0 20.99 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.82 128.61 60.01 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.514 0.197 . . . . 0.0 110.668 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.4 Cg_exo -65.53 -11.8 32.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.223 1.948 . . . . 0.0 111.431 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.23 -42.96 16.62 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.781 0.801 . . . . 0.0 108.974 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.11 136.82 1.45 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.755 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.54 -18.37 11.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.927 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 28.8 t80 -129.43 117.24 20.23 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -94.03 121.9 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.4 mt -100.1 -69.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.982 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.26 -95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -178.74 54.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.9 mt -81.01 126.12 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 -36.79 69.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -68.7 -29.47 67.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 mt -95.92 152.06 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 p -96.29 165.46 12.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.656 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.622 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.3 -53.35 4.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 109.973 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.77 83.04 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -60.12 -47.07 87.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.816 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.22 157.28 43.81 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.854 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.445 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.05 135.74 39.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.346 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.9 mt -109.36 132.06 58.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.825 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -121.72 151.64 40.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 111.576 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.377 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 4.1 mp -127.13 141.57 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.6 tp -112.88 126.39 55.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.7 t30 -117.06 115.57 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.181 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.669 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.6 p30 -79.66 132.01 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 22.2 pt -141.35 40.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.64 152.72 20.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.068 0.461 . . . . 0.0 111.882 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -68.77 -31.55 70.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.986 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.12 -19.81 17.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.32 157.43 10.75 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.703 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.41 148.39 40.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.304 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 44.93 43.53 7.21 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -9.78 70.0 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.489 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.4 118.53 36.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.056 0.428 . . . . 0.0 110.808 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.8 tptm -73.7 128.62 35.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.198 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.8 m -99.47 166.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.212 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 120' ' ' SER . 23.7 mt-10 -70.0 126.02 28.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.481 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.669 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 34.3 tttt -52.36 162.18 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 110.324 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.968 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.89 145.06 40.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.12 126.64 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.625 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -129.07 147.08 50.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.91 116.39 13.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.919 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -53.38 167.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.665 0.745 . . . . 0.0 112.019 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.23 153.29 43.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.228 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -71.55 114.65 9.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.74 26.4 72.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.911 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.8 t0 -60.24 176.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 111.035 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.1 mt-10 -145.31 135.71 24.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.263 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 9.1 mt -112.69 126.21 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.495 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.473 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.48 141.45 36.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.179 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.4 m -140.26 158.5 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.01 43.79 9.54 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.013 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.4 t -84.08 140.42 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.733 0.777 . . . . 0.0 112.47 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.15 -42.44 0.86 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 57.5 t -126.53 122.13 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 114.592 -0.804 . . . . 0.0 109.033 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -24.86 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.727 0.299 . . . . 0.0 111.704 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.26 6.34 48.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 11.6 m-20 -130.75 26.65 4.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.473 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -107.06 139.39 28.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.003 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.4 134.43 54.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.52 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.505 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.66 137.05 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.07 0.462 . . . . 0.0 111.856 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.7 mm? -131.26 145.05 51.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.172 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 13.5 t -111.41 135.65 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.45 122.69 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.581 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -113.13 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.073 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.9 mt -84.79 126.48 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.205 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.832 0.348 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -58.92 -36.72 75.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.95 -42.4 93.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -32.74 71.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.1 -35.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.51 -38.02 73.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -67.17 -23.84 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.83 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.81 -47.53 80.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.11 136.13 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.479 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.67 -60.16 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.769 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -147.26 150.2 34.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.165 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.89 129.32 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.472 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.6 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -131.4 128.23 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.656 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.31 110.04 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.972 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.2 p -87.15 -24.25 24.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.792 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 142' ' ' SER . 72.5 p -79.91 -2.56 44.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 71.62 78.32 0.47 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.444 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.3 mt-30 -148.56 -40.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.246 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.9 mt -130.2 141.54 42.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.78 146.03 42.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.23 1.953 . . . . 0.0 112.195 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.02 156.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.844 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.12 164.1 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.435 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 p30 -119.58 119.94 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.069 0.461 . . . . 0.0 111.975 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.0 mt -100.77 134.64 43.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.67 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.82 158.87 43.63 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.122 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.738 0.304 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.6 t -126.38 138.09 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 112.013 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.544 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -101.85 139.66 37.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.003 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.61 130.13 55.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -120.06 145.27 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.16 -167.2 36.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.755 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.0 mtm105 -83.88 3.56 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.9 t-20 -84.93 133.41 43.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 111.019 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -66.06 -14.2 43.33 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.552 2.168 . . . . 0.0 111.676 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.61 16.71 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.946 0.879 . . . . 0.0 108.852 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.29 139.8 2.49 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.802 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.5 m-20 -56.4 -18.88 12.49 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.859 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.524 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -129.81 127.78 41.0 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.86 108.0 19.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.772 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' CD2' ' CD1' ' A' ' 43' ' ' ILE . 26.3 mt -76.7 -166.52 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.17 17.94 53.58 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.25 79.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.397 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 mt -112.03 132.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -54.99 -34.68 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.37 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.6 mt -96.64 152.19 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.82 164.77 12.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.661 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.99 -52.82 5.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 109.615 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.72 82.9 1.96 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.77 -45.97 91.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.923 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.4 p90 -143.55 162.52 35.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.436 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.57 133.99 38.92 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.202 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 67.8 mt -111.56 127.79 68.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.724 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -114.77 146.89 40.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.544 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.508 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.901 0.381 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.1 mt -133.18 146.67 51.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.72 124.41 52.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.06 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.7 t30 -117.52 115.67 25.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.664 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 p30 -78.35 139.66 38.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.165 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 20.6 pt -147.88 40.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.95 152.11 20.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.086 0.47 . . . . 0.0 111.778 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.1 m -68.93 -31.54 70.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.038 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.94 17.57 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.05 155.4 9.81 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.65 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -117.57 137.75 52.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.864 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.41 148.29 41.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.65 18.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.439 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.65 43.76 6.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.388 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -9.99 69.39 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.437 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -104.64 118.66 37.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.624 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.864 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.1 tptm -74.03 122.57 22.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.224 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -93.64 164.55 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 tp10 -69.82 127.75 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.535 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -53.71 161.03 1.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.922 0.391 . . . . 0.0 110.635 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.53 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.348 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.17 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.122 179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.97 130.2 34.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.6 mm-40 -129.46 147.68 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.86 132.9 44.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 125' ' ' SER . 38.0 tp -65.05 154.43 37.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.659 . . . . 0.0 111.61 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -124.81 153.05 43.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.36 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 122.76 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 23.89 49.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.145 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.6 t70 -54.78 170.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.46 . . . . 0.0 111.21 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.17 135.57 24.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.006 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.3 mt -109.4 128.04 65.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.438 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.37 140.3 38.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.045 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.37 158.33 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 80.07 42.97 10.16 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -82.83 140.45 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.687 0.756 . . . . 0.0 112.274 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.33 -39.92 1.14 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.48 123.98 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.619 -0.791 . . . . 0.0 109.082 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.27 10.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.412 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -93.42 6.48 48.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 133' ' ' GLY . 54.3 m-20 -124.34 23.06 8.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.5 mt -107.0 139.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.414 ' CD2' ' HG ' ' A' ' 143' ' ' LEU . 8.9 tt -122.32 134.72 54.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.76 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.99 128.18 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.087 0.47 . . . . 0.0 111.854 -179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 141' ' ' LEU . 18.6 mt -121.44 137.42 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.03 137.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.816 0.341 . . . . 0.0 111.278 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.434 HD13 HG22 ' A' ' 145' ' ' ILE . 31.6 mt -106.16 131.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.09 120.36 39.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.419 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.7 mt -84.85 131.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.21 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -59.02 -46.12 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -35.05 73.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -41.46 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.8 mm -71.92 -35.09 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.16 -38.19 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -67.34 -24.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.671 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.76 79.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.148 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.852 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.78 133.99 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.458 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -91.43 -61.7 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.149 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -148.96 150.08 32.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.408 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -113.96 138.1 50.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 76' ' ' TYR . 15.0 p -99.99 122.9 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.7 mt -130.29 119.41 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.649 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -79.95 142.07 35.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -111.42 -21.29 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.8 p -85.09 -2.78 58.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.732 0.301 . . . . 0.0 111.559 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.83 86.91 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.093 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.9 pt20 -159.72 -40.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.084 0.468 . . . . 0.0 111.374 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 4.3 mt -122.92 139.96 32.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.4 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 70.3 Cg_endo -76.76 146.16 26.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.508 2.139 . . . . 0.0 112.376 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mt -55.9 148.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.841 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.06 162.06 37.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.027 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.37 119.91 36.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.092 0.472 . . . . 0.0 111.931 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.0 mt -96.25 137.28 35.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.48 158.7 43.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.785 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.914 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.3 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.734 0.302 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.4 t -123.08 139.48 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.249 0.547 . . . . 0.0 111.752 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.572 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.6 m-90 -100.78 139.91 35.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.86 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.19 125.3 51.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.9 m-85 -113.17 145.57 40.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.926 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.9 -173.47 39.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.274 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp-105 -77.43 -1.56 30.83 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.82 134.2 42.16 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.318 . . . . 0.0 111.19 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -68.01 -10.56 29.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.728 2.286 . . . . 0.0 111.967 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -42.87 17.43 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 121.868 0.842 . . . . 0.0 108.914 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 140.3 1.0 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.848 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -56.06 -18.33 9.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.147 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 42.7 t80 -128.88 125.92 38.66 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.42 113.09 26.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.752 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' CB ' HG12 ' A' ' 43' ' ' ILE . 1.5 pp -116.63 175.71 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.5 166.2 3.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -93.83 92.14 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 mp -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 p -54.75 -24.91 24.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -74.19 -29.57 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.2 mt -92.2 152.21 19.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.98 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -96.16 163.44 13.1 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.506 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.65 -53.2 3.64 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 109.763 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 28.9 mttp -118.41 84.28 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -63.93 -45.13 90.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 104' ' ' ILE . 30.7 p90 -152.67 163.24 40.03 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.189 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.519 ' HG2' HG21 ' A' ' 67' ' ' THR . 13.1 mt-30 -135.29 154.94 51.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.494 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 3.8 mt -123.63 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.167 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.92 148.02 37.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 111.589 -179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.473 179.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.819 0.343 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.455 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 3.7 mp -133.02 145.79 51.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.312 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.96 131.79 55.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -119.76 115.57 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.9 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.669 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 p30 -78.68 143.21 36.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.062 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.47 HG12 ' HG3' ' A' ' 90' ' ' GLN . 10.2 pt -150.39 36.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.04 152.53 18.65 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.151 0.5 . . . . 0.0 112.19 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.83 -31.44 70.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.852 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.08 -19.84 18.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.508 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.531 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.79 158.65 11.69 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.59 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.9 m -117.31 137.67 52.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.58 148.38 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.55 18.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.602 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 43.63 43.68 4.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.18 -14.22 61.37 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.451 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.39 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 110.517 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.73 128.24 35.38 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.527 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.4 m -96.25 162.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.834 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.9 mp0 -69.89 127.63 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.669 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 49.6 tttm -53.41 161.72 0.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 103' ' ' ASP . 9.0 m-80 33.84 35.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.261 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.974 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -89.78 130.21 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.224 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 47.1 mm-40 -129.33 148.66 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.417 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.59 121.5 19.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.351 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.27 156.51 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.462 0.649 . . . . 0.0 111.563 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.63 153.41 42.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.587 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.51 120.39 17.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.76 22.68 62.32 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.679 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.46 170.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.006 0.431 . . . . 0.0 111.237 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.5 tt0 -145.14 135.45 24.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.906 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 19.0 mt -118.36 128.14 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.45 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.41 140.77 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.233 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.0 m -140.37 158.34 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 112.145 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.13 37.24 11.47 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.815 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -80.53 140.48 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.671 0.748 . . . . 0.0 112.503 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.3 -39.35 0.71 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.35 121.76 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.09 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.54 7.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t -93.51 6.52 47.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.05 29.68 4.9 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.7 mt -107.26 138.91 30.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.932 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.401 ' CD2' ' OG1' ' A' ' 40' ' ' THR . 3.0 mt -124.45 134.38 53.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.728 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.7 t -106.02 150.43 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.67 0.748 . . . . 0.0 112.318 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 68.4 mt -135.68 147.16 48.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.01 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 36.9 t -120.14 139.98 45.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.343 . . . . 0.0 111.061 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mt -106.24 139.09 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.86 116.85 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.94 132.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.189 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.865 0.364 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -61.95 -36.05 80.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.41 -37.69 81.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.682 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.09 -33.09 74.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.727 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -73.19 -35.51 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.53 -46.11 84.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.58 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.08 -23.67 65.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.605 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -47.55 79.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.5 mm -73.08 135.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.67 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.95 -60.58 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 p -149.42 151.14 33.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.084 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.84 134.66 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.383 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.6 t -101.48 122.68 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.98 123.12 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.561 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.9 t -83.15 119.09 24.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -25.49 32.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 142' ' ' SER . 58.6 p -79.94 -2.3 43.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.446 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.67 77.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.024 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -146.03 -44.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.4 mt -109.12 141.17 22.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -72.97 133.56 20.05 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.79 138.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.563 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 162.99 28.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.553 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.57 119.66 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.999 0.428 . . . . 0.0 111.659 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.0 mt -95.12 133.63 38.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 158.49 43.85 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.817 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.763 0.316 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.5 t -130.77 139.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.323 0.582 . . . . 0.0 112.148 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.517 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.2 m-90 -102.67 139.42 38.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.062 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -111.72 129.31 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 1.1 m-85 -120.12 145.22 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.49 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -166.86 35.16 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 12.2 mtm105 -80.94 4.52 19.18 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.68 130.54 52.73 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.533 0.206 . . . . 0.0 110.917 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.3 Cg_exo -65.33 -14.71 46.46 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.415 2.077 . . . . 0.0 111.594 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -44.12 15.62 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.929 0.871 . . . . 0.0 108.873 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -38.88 139.7 0.43 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.815 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.3 m-20 -56.35 -19.13 13.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.2 t80 -130.21 119.73 23.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.695 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -89.67 109.14 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.485 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 8.8 mt -106.03 162.39 13.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.833 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.55 129.4 49.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.093 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -62.93 79.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.831 0.348 . . . . 0.0 111.09 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 32.7 mm -105.0 139.64 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 81' ' ' ILE . 25.7 m -60.08 -31.6 70.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -68.77 -29.82 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.217 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.3 mp -102.39 152.65 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 162.24 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.878 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.59 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.14 -52.1 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.757 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -119.18 80.89 1.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 16.1 t60 -61.14 -45.87 92.89 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.786 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 39.1 p90 -147.75 159.97 43.23 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.992 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.451 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.5 tt0 -136.18 141.88 44.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 58.7 mt -116.49 127.59 74.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.943 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -111.29 151.46 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 179.508 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.814 0.34 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 3.1 mt -133.07 146.91 52.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.315 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -112.67 123.66 50.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.481 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.9 t30 -117.15 115.66 25.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.4 p30 -79.21 140.51 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 pt -143.46 30.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.554 0.216 . . . . 0.0 111.577 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.542 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -89.96 158.31 17.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.447 0.641 . . . . 0.0 112.243 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 m -69.68 -49.17 56.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.499 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.28 3.04 56.31 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.43 157.4 23.75 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.053 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.82 137.92 52.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.811 -0.694 . . . . 0.0 109.215 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.31 148.8 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.83 113.47 18.58 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.197 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 44.14 42.91 5.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.86 -14.09 61.21 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.501 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -103.42 118.5 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.54 124.56 24.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.373 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.57 163.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.039 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 tm-20 -69.85 127.03 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.3 tttm -53.68 160.98 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.964 0.411 . . . . 0.0 110.611 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.89 34.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.288 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.19 40.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.114 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -88.49 131.7 34.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.2 mm-40 -129.29 151.92 49.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.69 136.04 45.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.708 0.289 . . . . 0.0 110.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 125' ' ' SER . 28.1 tp -62.94 152.66 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.575 0.702 . . . . 0.0 111.521 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.439 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.4 152.51 44.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.653 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.46 121.36 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.36 25.29 60.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.983 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t70 -49.88 165.19 0.08 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.258 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 tt0 -144.33 135.47 25.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.1 mt -114.39 128.27 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 5.9 m -104.03 141.57 35.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.607 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.6 m -140.52 158.72 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.95 9.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -84.25 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.585 0.707 . . . . 0.0 112.13 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.27 -37.05 1.43 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 24.9 t -126.16 119.13 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.446 -0.877 . . . . 0.0 108.814 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -29.39 9.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.2 p -93.46 6.46 48.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.458 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.85 27.53 5.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.479 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -106.49 138.67 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.65 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 134.43 53.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.558 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 40' ' ' THR . 36.1 t -106.54 149.43 27.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.791 0.805 . . . . 0.0 112.221 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.1 mt -136.12 143.74 44.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.597 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.37 138.03 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.2 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.482 HD13 HG21 ' A' ' 145' ' ' ILE . 23.9 mt -106.13 131.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 120.2 39.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.678 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -84.84 131.18 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.264 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.876 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.838 0.351 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -58.98 -39.33 81.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -59.47 -39.23 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -31.92 73.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -73.01 -35.44 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.6 -42.75 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.37 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -67.18 -23.68 65.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.633 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.79 -47.4 80.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.776 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.14 136.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.295 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -90.85 -59.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.866 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.4 p -146.24 165.2 29.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.523 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 138.27 51.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.395 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.24 122.73 64.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.878 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -127.15 121.03 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.6 t -79.98 105.58 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.438 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -71.35 -25.1 62.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.874 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.83 -2.26 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.529 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.0 0.26 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.995 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -146.05 -44.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.695 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.568 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -112.01 141.78 25.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.1 Cg_endo -70.73 138.69 35.26 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.107 1.872 . . . . 0.0 112.293 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -53.83 146.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.647 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 164.23 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.58 119.65 26.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.457 . . . . 0.0 111.636 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.3 mp -91.35 132.56 36.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.475 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -140.95 155.8 46.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.314 1.054 . . . . 0.0 113.638 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.676 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.816 0.341 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 5.6 t -126.32 134.66 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.233 0.54 . . . . 0.0 111.601 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.517 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.0 140.07 36.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.246 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 130.5 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -120.31 145.51 47.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -167.82 36.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.954 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.3 mtp180 -83.83 3.35 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.85 133.12 44.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.15 -12.91 37.54 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.547 2.165 . . . . 0.0 111.678 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.79 -44.09 15.95 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.914 0.864 . . . . 0.0 108.822 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.64 138.89 2.39 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.943 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.35 -18.86 12.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.094 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 43' ' ' ILE . 9.3 t80 -129.8 123.99 32.29 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 111.392 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.38 107.93 18.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.32 78.91 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.31 -117.04 2.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.851 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -176.71 92.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.063 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 23.1 mm -109.63 129.86 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -38.28 67.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.093 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -28.05 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.48 152.11 19.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.97 162.9 13.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.723 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.11 -52.27 4.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 0.0 109.655 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HB3' HD12 ' A' ' 104' ' ' ILE . 1.8 mtpm? -117.87 83.9 2.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -64.89 -45.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.198 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 37.4 p90 -150.3 162.03 41.3 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.206 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HG2' HG22 ' A' ' 67' ' ' THR . 13.6 mt-30 -135.65 155.71 50.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.401 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 54.1 mt -126.28 132.35 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.029 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -128.66 144.67 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.998 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.142 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.705 0.288 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -131.33 142.48 50.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.777 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.79 126.22 53.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.738 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 46.7 t30 -116.8 115.69 26.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.661 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -77.4 143.2 38.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.815 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' A' ' 90' ' ' GLN . 9.6 pt -149.6 36.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.564 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.74 151.97 19.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.11 0.481 . . . . 0.0 111.934 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.78 -31.45 70.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.854 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.61 -19.79 18.08 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.38 156.43 10.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.89 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.9 m -117.42 137.74 52.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.809 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.52 148.39 38.0 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 113.5 18.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.461 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 44.33 43.27 5.91 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.53 64.02 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.518 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -104.72 118.49 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.62 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.809 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.58 127.24 31.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.411 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 m -97.46 164.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.837 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.3 tt0 -69.89 126.71 30.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.661 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 13.5 tttm -53.28 161.42 0.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 0.0 110.593 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.33 33.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.438 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.44 145.14 40.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.936 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -90.48 130.07 36.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.048 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -129.1 148.82 51.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 tp -72.51 116.31 12.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD2' HG12 ' A' ' 147' ' ' ILE . 67.2 tp -53.46 157.54 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.406 0.622 . . . . 0.0 111.729 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 1.5 t -124.26 153.3 41.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.339 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.404 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.5 tp60 -71.47 123.51 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.3 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.28 21.81 54.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.131 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 125' ' ' SER . 22.8 t70 -55.87 175.25 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 mt-10 -145.05 135.62 24.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.7 mt -114.48 126.14 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.462 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.475 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.5 140.07 38.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.3 158.35 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.122 0.487 . . . . 0.0 112.278 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.04 27.42 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.141 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.4 t -71.37 140.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.681 0.753 . . . . 0.0 112.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.76 -37.48 0.77 Allowed Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 41.6 t -126.25 131.99 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.805 -0.697 . . . . 0.0 109.3 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -40.1 51.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 6.47 48.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 8.2 t0 -119.64 28.44 8.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.3 mt -107.26 139.65 28.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.987 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.0 tt -123.48 134.35 53.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.496 ' HB3' HG22 ' A' ' 40' ' ' THR . 39.0 t -110.06 150.64 28.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 112.36 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.0 mt -135.55 156.8 48.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.02 137.12 58.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 145' ' ' ILE . 35.3 mt -106.34 123.45 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 115.1 28.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.8 mt -84.82 134.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 26.5 t30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.684 179.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.852 0.358 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -59.27 -39.81 84.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -40.68 91.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.84 96.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mm -67.78 -34.88 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.265 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -57.06 -36.11 70.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -67.33 -23.92 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.768 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.8 -47.59 79.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.298 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -73.12 136.86 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.466 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -92.35 -59.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.843 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.1 p -146.67 165.46 29.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.506 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.25 138.07 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.366 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.42 122.67 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.565 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HD13 ' CG ' ' A' ' 146' ' ' PHE . 19.3 mt -129.51 119.44 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.551 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.91 108.04 13.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.379 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -25.89 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.72 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.86 -2.22 42.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.532 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.01 76.17 0.27 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -145.73 -44.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.799 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.6 mt -111.72 141.35 24.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.759 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.7 Cg_endo -72.18 137.58 29.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.217 1.945 . . . . 0.0 112.355 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.3 mt -56.07 136.98 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.55 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.51 164.3 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.48 119.71 34.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 111.843 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.0 mp -94.24 126.59 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.38 156.67 47.94 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.038 0.923 . . . . 0.0 113.309 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.089 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.856 0.36 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG11 ' CA ' ' A' ' 92' ' ' LEU . 15.3 t -130.08 139.11 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.196 0.522 . . . . 0.0 111.843 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.3 m-90 -105.27 139.54 39.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.259 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.79 132.19 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.3 145.61 45.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.353 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.63 -167.88 35.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.029 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtp-105 -81.1 3.31 23.83 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -84.8 132.22 46.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.534 0.207 . . . . 0.0 111.102 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.7 Cg_exo -66.24 -14.19 43.17 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.686 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.05 -42.98 16.83 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.872 0.844 . . . . 0.0 109.026 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.41 138.92 1.16 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.109 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.8 m-20 -56.47 -18.94 13.0 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.147 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE2' HG22 ' A' ' 43' ' ' ILE . 14.2 t80 -129.63 114.16 15.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.741 0.305 . . . . 0.0 111.04 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.22 107.88 19.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.555 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD13 ' CD2' ' A' ' 76' ' ' TYR . 10.7 mp -79.78 -80.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.6 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.345 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.57 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 111.195 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.8 mp -84.34 119.18 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -54.81 -29.85 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.241 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -68.51 -26.94 65.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 mt -102.71 151.18 22.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -94.1 164.12 13.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.568 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -41.59 -52.44 3.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.48 0.657 . . . . 0.0 109.832 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.96 82.51 1.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.4 t60 -60.91 -47.15 87.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.767 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.1 p90 -143.99 159.21 42.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.7 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.434 ' NE2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -136.19 138.52 42.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 68' ' ' PHE . 81.0 mt -112.56 128.67 69.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.064 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.438 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -113.31 143.26 44.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.9 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.375 179.536 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.49 145.43 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.549 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 mt -112.51 124.09 51.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.872 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.7 t30 -118.01 115.58 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.6 p30 -76.43 139.98 41.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 17.8 pt -148.12 39.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.55 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 152.32 20.11 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.034 0.445 . . . . 0.0 111.548 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.86 -31.55 70.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.942 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.24 -19.82 17.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.69 156.48 10.17 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.945 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.43 137.95 52.17 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.89 148.62 38.38 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.51 18.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.455 177.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 44.09 43.26 5.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.66 -13.58 62.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.392 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.58 118.51 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.083 0.442 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.65 127.09 31.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.532 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.95 164.46 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.5 mt-10 -69.85 124.91 25.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.2 tttt -53.0 162.79 0.58 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.6 m-80 33.97 35.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.151 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.11 145.06 40.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.075 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.98 129.15 35.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -129.29 146.83 51.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.804 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.73 125.3 27.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.2 tp -58.15 155.37 11.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 1.1 t -124.83 153.04 43.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.412 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 122.48 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.3 22.02 57.86 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.93 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 125' ' ' SER . 42.1 t0 -51.69 170.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.13 135.49 24.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.072 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 20.7 mt -118.37 128.04 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.445 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.453 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.43 141.52 36.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.5 m -140.21 158.33 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.029 0.442 . . . . 0.0 112.104 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.25 43.69 8.5 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.9 t -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.707 0.765 . . . . 0.0 112.498 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.79 -37.74 0.82 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 48.2 t -126.38 120.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.037 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.26 -29.52 9.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.763 0.316 . . . . 0.0 111.459 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.8 p -93.45 6.56 47.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -130.67 30.59 4.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 141' ' ' LEU . 4.7 mt -107.11 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.614 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 140' ' ' ILE . 1.6 tt -122.17 134.49 54.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.635 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.497 ' HB3' HG21 ' A' ' 40' ' ' THR . 39.4 t -108.52 150.58 27.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.304 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 74.9 mt -135.8 147.85 48.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.783 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 29.3 t -119.92 139.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mt -106.09 128.62 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 37' ' ' ILE . 3.5 m-85 -114.56 114.86 26.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.1 mt -84.75 134.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.894 0.378 . . . . 0.0 111.439 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.799 0.333 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -58.99 -35.98 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -37.29 80.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.36 -33.44 75.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.16 -35.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.742 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.43 -41.5 80.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -67.13 -23.79 65.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.75 -47.46 80.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.281 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.925 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.19 135.38 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 113.668 -1.605 . . . . 0.0 112.554 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.72 -60.13 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.917 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -145.34 161.84 38.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.402 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.53 138.04 53.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 68' ' ' PHE . 29.8 m -110.85 122.68 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.655 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 mt -124.45 122.56 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.66 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.85 99.94 7.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.206 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -68.24 -24.33 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.928 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.47 HG21 ' HB3' ' A' ' 142' ' ' SER . 59.7 p -79.92 -2.21 42.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.603 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.81 78.01 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.878 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -147.33 -43.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.579 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -115.82 142.49 29.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.8 Cg_endo -70.12 139.03 38.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.104 1.869 . . . . 0.0 112.191 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mt -56.61 145.93 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.825 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.44 164.18 28.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.006 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.99 120.04 30.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 0.0 112.06 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.3 mp -90.26 126.78 35.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.92 157.0 47.91 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.036 0.922 . . . . 0.0 113.45 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.874 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.042 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG13 ' HG2' ' A' ' 90' ' ' GLN . 11.9 t -131.29 139.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.127 0.489 . . . . 0.0 111.859 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -102.82 139.32 38.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.013 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.58 127.2 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.592 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.1 m-85 -110.81 145.56 37.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.773 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.59 178.52 34.65 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.697 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -68.25 -6.72 25.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.1 t-20 -84.51 133.69 43.92 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.7 0.286 . . . . 0.0 111.19 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.8 Cg_exo -70.03 -5.9 17.47 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.588 2.192 . . . . 0.0 111.654 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -42.81 17.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -43.88 137.14 3.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.14 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.34 -19.21 13.49 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 57.2 t80 -130.54 130.55 44.26 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.386 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.91 136.44 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.44 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -109.59 -53.0 2.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.08 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.62 -115.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.761 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -154.17 65.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.297 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.45 120.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.765 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.92 -24.97 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -17.37 61.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.362 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.5 mt -107.24 150.26 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.99 164.26 12.43 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.0 m-20 -43.0 -52.12 5.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.423 0.63 . . . . 0.0 109.777 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -121.44 82.76 1.98 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 11.6 t60 -62.38 -46.19 89.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.892 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 17.5 p90 -150.36 157.72 43.37 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.58 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.463 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.9 tt0 -135.84 140.07 43.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.485 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.492 HD13 ' CE1' ' A' ' 68' ' ' PHE . 3.8 mp -117.93 131.55 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.349 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.13 145.47 43.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.508 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.8 tm? . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.534 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.744 0.307 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 5.5 mp -132.76 144.65 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.99 128.51 56.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.416 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.86 119.17 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.853 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.663 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.4 p30 -79.81 137.8 37.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.986 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 89' ' ' PHE . 13.6 pt -145.56 30.99 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -88.73 158.18 18.27 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.053 0.454 . . . . 0.0 111.553 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -68.94 -36.28 77.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.659 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.93 17.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.8 157.34 9.68 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.07 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.61 137.97 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.208 0.603 . . . . 0.0 109.42 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.836 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -114.3 148.57 37.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.51 18.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.492 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 44.34 43.22 5.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.33 -10.85 67.5 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.43 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -104.83 118.59 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.016 0.436 . . . . 0.0 110.69 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.5 tptt -72.97 119.12 16.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.7 166.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.177 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.5 mm-40 -69.93 128.01 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.521 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -55.13 158.0 3.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.571 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER 38.34 32.77 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.791 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.2 145.07 40.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.868 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -95.38 133.79 38.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.981 0.419 . . . . 0.0 110.959 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.7 mm-40 -129.07 152.07 49.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.547 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.47 123.92 24.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.829 0.347 . . . . 0.0 110.306 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.1 tp -54.49 155.88 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.535 0.683 . . . . 0.0 111.682 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.77 153.1 42.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 120.95 18.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.928 0.394 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 23.66 59.51 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.231 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.5 t0 -54.83 172.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.9 mt-10 -145.3 135.61 24.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.4 mt -114.09 126.14 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.462 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -104.63 142.75 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.341 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.54 158.58 24.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.082 0.467 . . . . 0.0 112.254 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.04 43.54 8.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.053 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.6 t -85.1 140.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.76 0.791 . . . . 0.0 112.428 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.32 -40.96 0.86 Allowed Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.55 120.82 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.075 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -24.96 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.731 0.301 . . . . 0.0 111.48 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 t -93.5 6.44 48.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -132.13 27.86 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.9 mt -107.11 138.82 31.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.56 134.32 53.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.556 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.7 t -108.96 150.31 27.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.6 0.714 . . . . 0.0 112.192 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 71.9 mt -135.67 148.36 48.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.549 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.92 138.12 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.04 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.37 121.11 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 117.63 34.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.431 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.5 mt -84.98 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.553 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.919 179.809 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.333 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -58.96 -38.26 78.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -40.71 90.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.47 -31.92 71.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.7 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.79 -35.38 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.31 82.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.423 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -67.08 -23.83 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.647 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.239 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.796 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.747 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -88.41 95.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.4 -177.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.4 t -51.84 -64.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 p -147.9 164.9 32.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 125.72 36.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.4 t -88.84 122.85 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.398 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mt -126.19 117.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.0 t -79.94 119.96 23.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.494 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.59 -25.59 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.736 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.501 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 9.1 p -79.85 -2.6 44.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.44 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.33 76.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.973 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -144.06 -43.65 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.7 mp -122.69 142.71 38.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.02 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.67 140.66 36.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.057 1.838 . . . . 0.0 111.799 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.61 127.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.882 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -118.0 160.62 21.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.854 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.93 120.35 38.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.031 0.443 . . . . 0.0 112.124 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.7 mt -101.1 136.38 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.175 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.747 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.09 158.26 44.04 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.714 0 CA-C-N 113.585 -1.643 . . . . 0.0 110.585 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -132.08 139.3 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.341 0.591 . . . . 0.0 112.026 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.539 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -101.34 139.12 37.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.208 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -110.24 130.46 55.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -120.15 145.44 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.377 -178.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.82 -166.8 35.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.839 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -83.83 5.05 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -84.82 132.13 47.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.028 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.16 -14.97 48.05 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.471 2.114 . . . . 0.0 111.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -42.94 17.38 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 138.04 3.48 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.722 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -56.59 -18.23 11.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.831 178.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.526 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.7 t80 -126.41 120.59 30.18 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.93 116.28 31.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.3 -170.08 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.15 14.98 59.3 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.841 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.88 78.55 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 111.487 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.9 mt -102.99 132.43 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.807 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -55.11 -28.63 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -47.37 17.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.16 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.73 150.73 42.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -95.9 164.24 12.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.806 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.61 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.94 -52.51 5.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.485 0.66 . . . . 0.0 109.771 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 104' ' ' ILE . 4.7 mttt -119.93 81.92 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.1 t60 -62.48 -46.14 89.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.711 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -144.22 159.62 42.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.789 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.459 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.8 tt0 -135.94 142.65 44.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 HG13 ' CE1' ' A' ' 68' ' ' PHE . 57.0 mt -116.94 128.06 74.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -111.67 147.99 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 111.714 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 179.527 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB3' HD23 ' A' ' 92' ' ' LEU . 3.0 mp -133.01 147.27 52.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.64 125.32 54.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.43 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.1 t30 -115.13 115.66 27.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 111.522 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.5 p30 -79.33 135.17 36.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.056 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 87' ' ' LYS . 16.3 pt -142.72 40.04 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.556 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.21 157.18 16.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.998 0.427 . . . . 0.0 111.629 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.9 m -68.98 -35.03 76.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.601 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.62 -20.03 17.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.02 161.33 11.26 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.597 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.4 m -117.64 137.94 52.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.08 148.5 38.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.38 18.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.191 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.47 42.81 5.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.76 77.22 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.484 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.69 118.58 36.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.14 131.43 41.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.213 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -103.66 166.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.87 126.18 28.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.557 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 83.6 tttt -53.36 162.14 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 110.727 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.9 m-80 34.63 34.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.243 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 145.09 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.149 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -85.87 131.0 34.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.803 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -129.35 145.69 51.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.619 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.82 114.32 10.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.339 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 125' ' ' SER . 63.5 tp -53.7 157.74 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.613 . . . . 0.0 111.53 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.8 OUTLIER -124.3 153.17 42.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.077 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.28 125.26 26.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.589 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.6 19.22 47.75 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.327 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.4 t70 -58.41 172.88 0.42 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.9 tt0 -145.19 135.58 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.439 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.6 mt -107.65 128.15 63.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.503 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.25 138.09 41.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 28.3 m -140.33 158.53 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.37 28.71 29.5 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.136 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.44 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.5 t -69.91 140.45 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.607 0.718 . . . . 0.0 112.357 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.53 0.97 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.8 t -126.39 128.72 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.629 -0.785 . . . . 0.0 109.07 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.53 -36.12 32.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.313 . . . . 0.0 111.75 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.4 m -93.4 6.31 48.58 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.5 t0 -120.31 26.51 9.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.503 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.3 mt -106.9 139.58 27.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.042 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.401 ' CD2' HD21 ' A' ' 143' ' ' LEU . 1.4 tt -120.41 134.59 55.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.707 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.501 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -112.2 134.63 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.474 . . . . 0.0 111.843 -179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.3 mm? -129.73 135.02 47.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.607 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.72 136.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mm -106.11 137.26 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.176 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.2 124.31 51.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 125' ' ' SER . 3.1 mp -99.4 130.76 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 111.663 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.768 0.318 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -68.94 -35.89 77.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.28 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.54 -44.78 95.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -45.24 86.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.471 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 39.8 mm -63.54 -47.26 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.9 -33.58 74.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.2 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -56.07 -47.12 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.949 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 5.8 p90 -71.85 -47.12 55.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.44 133.55 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-N 113.846 -1.525 . . . . 0.0 112.393 -177.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.26 -61.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.203 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.02 146.22 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.287 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -113.95 138.03 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 111.398 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.47 122.95 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.855 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 146' ' ' PHE . 20.8 mt -123.9 126.13 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.553 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.33 107.85 19.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.5 p -88.16 -20.02 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.756 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 142' ' ' SER . 6.6 p -79.9 -2.52 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 111.401 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.57 76.04 0.52 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.795 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -146.7 -42.15 0.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 12.4 mt -131.1 142.51 45.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.11 146.02 40.39 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.239 1.959 . . . . 0.0 112.102 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.7 mt -56.34 148.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.897 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.01 159.51 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.051 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.18 119.76 35.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.025 0.441 . . . . 0.0 112.061 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -95.54 137.49 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.708 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.58 158.76 43.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 113.655 -1.612 . . . . 0.0 110.695 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 35.0 ttpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.041 0.448 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 91' ' ' ILE . 10.6 p -107.53 139.88 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.707 0.765 . . . . 0.0 112.519 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.557 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.5 m-90 -100.59 139.05 36.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.99 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 127.01 55.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -113.57 145.36 41.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.47 -178.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.63 -175.71 39.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.779 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 28.4 mtm180 -74.97 -1.59 23.3 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t-20 -84.65 132.09 47.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.594 0.235 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.0 Cg_exo -68.52 -8.28 22.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 111.669 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.84 -42.91 17.24 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.916 0.865 . . . . 0.0 108.693 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 138.2 1.46 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.66 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -56.46 -19.24 14.3 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.984 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 52.8 t80 -130.21 126.39 37.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -101.49 137.62 39.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -124.59 -68.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.185 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.3 -127.9 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.632 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 2.1 p30 -159.76 65.7 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.46 HD12 HG21 ' A' ' 81' ' ' ILE . 35.2 mt -89.7 127.75 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.82 -24.92 25.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.238 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 2.0 mmm180 -78.27 -48.23 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD23 ' CE1' ' A' ' 88' ' ' HIS . 37.9 mt -72.84 152.25 41.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.904 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.0 p -95.71 164.53 12.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.29 -53.3 5.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.382 0.611 . . . . 0.0 109.757 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.76 81.1 1.64 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -60.0 -45.61 92.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.916 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.6 p90 -145.53 159.48 43.05 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.791 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 102' ' ' ASN . 5.3 tt0 -135.99 141.39 44.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.472 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 51.4 mt -118.15 129.91 73.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.809 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.5 140.94 45.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.003 0.43 . . . . 0.0 111.729 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.41 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.7 tm? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 5.9 mp -132.6 145.3 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.8 127.01 56.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.219 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 90' ' ' GLN . 45.5 t30 -117.12 115.42 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.283 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.7 p30 -79.89 137.59 36.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.742 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.7 pt -146.44 40.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.54 157.84 16.17 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 120.957 0.408 . . . . 0.0 111.409 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -68.82 -34.77 76.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.61 -19.8 17.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.01 160.32 11.18 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.39 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.66 137.86 52.37 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.826 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.73 148.78 39.4 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.4 ' O ' ' CG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -124.29 113.38 18.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.423 176.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 45.75 42.52 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.318 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.97 -3.37 87.03 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.626 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.51 118.54 36.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.052 0.426 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.5 tptt -76.33 121.06 22.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.121 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -97.32 164.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.231 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 mt-10 -69.9 126.98 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 46.0 tttm -52.96 161.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.942 0.401 . . . . 0.0 110.634 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.05 34.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.312 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.36 145.08 40.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -86.11 130.01 34.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.48 146.77 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.589 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.8 119.32 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.198 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 tp -52.93 156.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.396 0.617 . . . . 0.0 111.654 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.61 153.32 42.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.802 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 122.76 21.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.52 48.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.315 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t70 -53.03 174.01 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 mt-10 -145.01 135.53 24.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.2 mt -110.72 123.21 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.755 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 2.9 m -104.64 140.12 38.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.15 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.32 158.71 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.982 0.42 . . . . 0.0 112.129 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 36.36 13.72 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.0 t -80.13 140.36 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 111.917 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.79 -30.11 2.69 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 82.9 t -126.46 118.55 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.425 -0.887 . . . . 0.0 108.708 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -50.73 -35.68 32.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.33 6.73 47.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -125.52 29.3 6.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.0 mt -107.13 139.36 29.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 tt -121.59 134.43 55.01 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -111.25 132.49 54.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 0.0 111.686 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.4 mt -125.01 150.22 46.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.377 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.5 140.24 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 111.349 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 145' ' ' ILE . 13.1 mt -106.22 121.74 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -107.99 110.96 22.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.491 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.99 133.93 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.1 t30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.711 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.745 0.307 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.05 -39.65 82.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.912 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 10.9 t80 -60.25 -39.25 86.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.694 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -31.9 72.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.82 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.63 -46.18 84.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.358 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -67.31 -23.95 65.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.61 -47.76 78.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.289 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.5 mm -85.38 95.75 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.936 -1.483 . . . . 0.0 112.677 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -45.58 -62.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.0 p -152.08 165.2 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.723 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -124.3 138.44 54.39 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.824 0.345 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.444 HG23 ' CE1' ' A' ' 76' ' ' TYR . 1.1 m -104.08 122.91 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 HD11 ' CD1' ' A' ' 146' ' ' PHE . 21.1 mt -126.83 118.88 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.659 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.92 102.31 9.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.169 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 t -67.84 -20.65 65.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.269 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 142' ' ' SER . 73.2 p -79.74 -2.41 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.47 75.88 0.26 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.831 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -145.77 -42.99 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.572 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.5 mt -112.41 142.82 27.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.881 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.35 135.18 26.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.223 1.948 . . . . 0.0 111.972 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.51 141.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.06 164.1 28.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -119.84 119.55 33.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.036 0.446 . . . . 0.0 111.986 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.3 mp -86.3 129.02 34.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.86 154.32 49.5 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.045 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.695 0.283 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' NE2' ' A' ' 90' ' ' GLN . 8.4 t -124.64 138.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 112.071 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.588 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.9 m-90 -103.65 139.07 39.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.774 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.87 126.22 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 0.0 109.931 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CD2' ' CE2' ' A' ' 89' ' ' PHE . 2.0 m-85 -107.58 145.77 32.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.53 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 167.12 -175.1 42.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.848 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -81.45 -4.82 56.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.86 137.18 38.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.325 . . . . 0.0 111.199 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.9 -5.97 16.96 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.779 2.319 . . . . 0.0 111.818 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.2 17.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.014 0.912 . . . . 0.0 108.621 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.36 137.61 4.67 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.514 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -56.34 -18.55 11.19 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.014 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 32.5 t80 -129.43 120.16 25.01 Favored 'General case' 0 C--N 1.338 0.078 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.811 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.26 112.14 23.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.743 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.52 -79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.238 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.59 -108.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.39 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -166.54 46.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 111.258 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 7.0 mt -84.3 122.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.72 -29.64 53.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.117 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.794 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -72.92 149.93 42.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.267 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 76.2 p -95.0 165.93 12.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.893 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.34 -53.65 4.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.828 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -120.79 82.7 1.95 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.2 t60 -60.42 -46.2 90.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.817 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 10.2 p90 -148.51 158.65 44.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.278 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.451 ' NE2' HG13 ' A' ' 65' ' ' VAL . 5.1 tt0 -136.03 141.29 44.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.42 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 3.8 mp -114.23 127.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -113.25 145.15 41.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.13 0.491 . . . . 0.0 112.012 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.281 179.217 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.06 143.56 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 122.99 49.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.88 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.2 t30 -114.94 115.72 27.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.542 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.0 p30 -77.72 138.94 39.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.7 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.0 pt -148.47 38.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.41 157.71 15.85 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.076 0.465 . . . . 0.0 111.533 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -69.07 -33.78 74.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.557 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -19.92 17.43 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.48 160.15 11.2 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.456 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.082 0.553 . . . . 0.0 109.535 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.54 148.36 38.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 113.56 18.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.372 177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.29 43.34 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.43 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.41 -9.75 72.05 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.433 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.4 tptt -73.6 122.85 22.93 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.206 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.58 164.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.215 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.6 pm0 -69.89 124.06 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.583 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.7 tttm -51.87 161.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.04 0.448 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.6 32.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.497 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.64 145.13 40.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.12 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -87.34 131.04 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.864 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 40.3 mm-40 -129.2 150.01 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.71 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.63 133.18 44.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.405 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.4 tp -64.74 155.5 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.51 0.672 . . . . 0.0 111.689 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.85 152.9 43.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.511 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 124.05 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.328 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.02 22.68 43.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.088 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t70 -53.01 172.05 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.6 mt-10 -145.05 135.8 24.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.6 mt -114.66 124.81 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.999 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.78 141.65 36.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.51 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 23.0 m -140.44 158.74 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.32 43.5 9.46 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.251 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.7 t -84.28 140.35 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.595 0.712 . . . . 0.0 112.336 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.2 -39.17 1.27 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.4 119.64 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.455 -0.872 . . . . 0.0 108.917 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.39 -26.45 4.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.8 0.334 . . . . 0.0 111.455 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -93.45 6.49 47.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.7 25.48 5.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.8 mt -107.19 138.75 31.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.17 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.61 134.57 52.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.157 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.96 150.36 28.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.676 0.751 . . . . 0.0 112.381 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -135.25 154.06 51.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.782 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.417 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -126.1 137.89 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mm -106.32 120.91 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.837 0.351 . . . . 0.0 110.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.4 m-85 -109.33 112.68 24.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.0 mt -86.01 133.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.361 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.713 179.836 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.95 -39.46 94.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.21 -35.45 75.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.475 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 mt -65.99 -33.3 75.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.672 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.07 -35.61 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.667 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -42.15 82.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.451 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -67.1 -23.77 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.687 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.66 -47.41 79.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.732 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-80 . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.695 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.22 135.46 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.5 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -91.92 -60.41 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.925 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 p -150.15 147.42 27.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.24 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.95 132.8 55.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.25 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -95.08 122.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -127.36 125.66 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.263 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.4 t -89.4 109.84 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.491 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -82.6 -24.76 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.776 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.508 HG22 ' CB ' ' A' ' 142' ' ' SER . 7.2 p -79.92 -2.71 44.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.712 0.291 . . . . 0.0 111.496 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 77.5 0.3 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.965 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -147.46 -39.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -126.44 141.69 40.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.7 Cg_endo -72.09 145.66 44.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.171 1.914 . . . . 0.0 112.139 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mt -60.82 149.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.711 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -142.71 164.08 31.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.092 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.92 119.89 35.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 111.881 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.5 mt -97.65 137.21 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.695 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.13 158.78 43.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.845 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 16.5 t -131.96 139.16 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.245 0.545 . . . . 0.0 111.852 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.572 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -101.11 139.26 37.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.006 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.51 129.04 56.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -118.46 145.29 45.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.523 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.63 -169.05 37.0 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.762 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -80.76 3.57 21.91 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.76 132.56 45.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 0.0 111.134 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.19 -14.16 43.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.45 2.1 . . . . 0.0 111.637 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.78 -42.73 17.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.861 0.838 . . . . 0.0 108.909 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.42 139.02 1.14 Allowed 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.021 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 m-20 -56.3 -18.99 12.3 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.977 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.0 t80 -129.8 123.09 30.09 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 120.731 0.3 . . . . 0.0 111.083 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.07 107.9 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.417 ' CB ' HG12 ' A' ' 43' ' ' ILE . 1.5 pp -111.14 177.35 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.29 131.77 50.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.618 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -70.97 88.26 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.33 135.08 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.06 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.27 -31.87 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.091 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.26 57.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.189 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 88' ' ' HIS . 25.6 mt -74.54 151.21 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.996 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 p -95.38 164.15 12.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.55 -52.63 4.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.424 0.631 . . . . 0.0 109.648 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.97 82.35 1.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -60.88 -46.13 91.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.761 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.7 p90 -143.46 160.0 41.37 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.907 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.452 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.97 142.33 44.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.462 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 67.6 mt -117.67 131.52 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.805 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -118.93 140.21 50.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.049 0.452 . . . . 0.0 111.96 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.237 179.155 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.6 mt -125.84 141.01 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.69 122.24 47.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.386 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.5 t30 -113.95 115.69 28.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.978 0.418 . . . . 0.0 111.404 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.6 p30 -78.59 137.52 37.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.002 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -145.93 40.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.578 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.13 161.07 13.9 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.01 0.433 . . . . 0.0 111.712 -179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.6 m -69.05 -38.63 79.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.799 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -20.1 17.22 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.55 161.02 10.96 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.609 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.2 m -117.59 137.97 52.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.565 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.97 148.56 36.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.5 18.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.219 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 44.52 43.24 6.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.87 -10.86 68.65 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.514 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -104.61 118.5 36.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.5 tptm -73.5 131.11 41.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.228 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -102.79 165.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.193 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.5 tt0 -69.9 126.4 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.573 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.0 tttp -53.75 162.5 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 110.619 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.32 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.111 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.53 145.07 40.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.109 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -88.75 130.71 35.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.968 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -129.12 147.56 50.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -72.6 119.23 16.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.422 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' HG ' ' N ' ' A' ' 125' ' ' SER . 65.6 tp -54.68 157.79 2.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 111.537 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.31 153.25 42.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.26 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 122.41 20.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.458 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.62 23.01 54.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.138 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.7 t70 -57.41 173.86 0.24 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 59.9 tt0 -145.13 135.61 24.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.041 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.8 mp -109.24 127.37 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.62 139.01 40.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.528 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.29 37.41 15.02 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.15 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.3 t -77.58 140.39 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.671 0.748 . . . . 0.0 112.202 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.82 -39.59 1.26 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.9 t -126.45 123.89 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.078 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.32 -29.59 10.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.808 0.337 . . . . 0.0 111.454 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -93.41 6.51 47.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.15 23.02 8.55 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -106.8 139.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.24 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.7 tt -124.4 134.65 53.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.508 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.92 129.12 55.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.177 0.513 . . . . 0.0 111.606 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 20.9 mt -122.53 136.78 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.677 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.85 140.17 31.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.331 . . . . 0.0 111.12 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.479 HG23 HD11 ' A' ' 145' ' ' ILE . 25.3 mt -105.97 136.39 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.82 111.78 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.86 128.65 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.482 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -36.04 74.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -36.95 85.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -45.02 77.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.789 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.8 mm -66.83 -35.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.075 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.05 -43.03 81.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.2 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -67.14 -23.87 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.403 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.57 -47.43 79.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -76.03 135.2 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 113.617 -1.629 . . . . 0.0 112.696 -177.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.79 -61.09 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.86 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.1 p -144.52 145.98 32.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.076 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 138.13 50.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.493 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -105.33 122.69 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.39 118.44 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.98 115.22 19.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.369 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -82.57 -26.0 32.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.885 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 142' ' ' SER . 67.1 p -79.9 -2.24 42.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.722 0.296 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.16 76.29 0.3 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.98 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -146.02 -43.76 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mt -114.13 141.3 26.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.1 Cg_endo -72.98 135.48 23.28 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.21 1.94 . . . . 0.0 112.198 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.0 mt -55.47 134.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.538 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.04 164.29 20.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.49 119.83 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.214 0.531 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.6 mt -97.38 131.53 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.85 159.0 44.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -178.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.475 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG12 ' CA ' ' A' ' 92' ' ' LEU . 18.1 t -133.34 139.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.226 0.536 . . . . 0.0 112.007 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -103.42 139.08 39.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.99 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.93 130.24 56.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -120.05 145.27 47.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.49 -167.1 35.04 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.49 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.75 1.96 21.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.56 127.01 67.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.464 0.174 . . . . 0.0 110.948 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -63.85 -14.33 42.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.317 2.012 . . . . 0.0 111.47 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -42.17 17.95 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.738 0.78 . . . . 0.0 108.925 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.09 138.61 1.07 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.592 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 t70 -56.35 -18.63 11.48 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.164 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.47 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 16.0 t80 -129.75 116.06 18.21 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -89.15 107.94 19.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.586 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.417 ' HA ' HG12 ' A' ' 43' ' ' ILE . 57.0 mt -71.87 -76.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.87 -98.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.465 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -162.89 53.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.334 . . . . 0.0 111.167 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 4.1 mp -93.02 117.67 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -28.98 56.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -47.88 40.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 16.1 mt -72.78 146.5 46.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.2 p -94.29 163.52 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.723 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.552 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -41.43 -52.11 3.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.589 0.709 . . . . 0.0 110.007 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -121.34 81.37 1.78 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -61.21 -46.49 90.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.609 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.8 p90 -144.86 157.15 44.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.722 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 102' ' ' ASN . 4.8 tt0 -136.15 138.92 42.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 HG22 HD12 ' A' ' 91' ' ' ILE . 58.5 mt -113.0 127.86 70.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.678 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.414 ' CA ' HG12 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -110.01 149.23 30.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.493 . . . . 0.0 111.836 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.117 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.732 0.301 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -133.17 145.29 50.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.9 mt -112.73 122.91 49.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.8 t30 -115.62 115.72 26.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 112.013 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.1 p30 -77.0 134.66 38.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 87' ' ' LYS . 13.0 pt -142.0 39.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.62 159.7 14.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.956 0.408 . . . . 0.0 111.778 -178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.0 m -68.88 -37.97 79.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -19.77 17.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.71 162.97 11.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.432 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.35 137.85 52.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.863 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.11 148.36 35.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.43 18.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.302 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 42.75 44.1 3.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.527 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.65 -13.55 63.84 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -103.26 118.56 37.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.863 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.6 tptm -73.49 124.2 25.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.487 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -91.53 161.88 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.3 pt-20 -69.82 123.07 20.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.499 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 72.0 tttt -50.08 161.65 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.15 35.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.332 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.21 145.05 40.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.387 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.78 125.43 32.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.718 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.54 147.16 51.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.28 115.18 16.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.122 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.43 162.5 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 111.912 -179.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.93 153.41 42.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.421 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.37 119.92 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.543 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.39 56.89 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.434 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.7 t70 -60.55 -179.01 0.1 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 mt-10 -145.28 135.64 24.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.296 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.7 mt -113.72 127.72 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.458 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.46 141.09 36.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.574 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.28 158.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 43.52 8.71 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.026 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.3 t -84.35 140.42 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.663 0.744 . . . . 0.0 112.396 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.06 -38.81 0.83 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.5 t -126.42 123.15 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.166 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.4 -29.83 11.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -93.57 6.41 48.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -127.56 27.43 5.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -107.04 139.25 29.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.032 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.21 134.43 53.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.618 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.508 ' HB3' HG22 ' A' ' 40' ' ' THR . 39.7 t -108.71 150.51 27.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.597 0.713 . . . . 0.0 112.145 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.4 mt -135.66 158.13 45.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.415 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 22.0 t -126.52 130.53 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.888 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.64 120.8 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.29 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.29 112.17 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.586 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.2 mt -84.79 131.06 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.846 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.814 0.34 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -35.96 74.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -44.23 94.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -44.68 94.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -65.87 -35.0 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -57.14 -36.94 71.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -67.24 -23.9 65.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.53 79.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.714 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -74.02 133.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.465 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -90.74 -60.81 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -146.55 147.59 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.178 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.08 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.49 122.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -126.87 121.17 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.449 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t -79.87 115.73 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -87.01 -25.05 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.742 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 142' ' ' SER . 30.4 p -79.89 -2.13 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.599 0.238 . . . . 0.0 111.441 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.36 76.99 0.26 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.897 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -147.26 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.565 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -122.17 142.08 35.93 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.0 Cg_endo -72.43 145.05 41.99 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.148 1.899 . . . . 0.0 112.228 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -56.61 147.35 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.49 161.38 35.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.198 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -118.63 119.74 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 111.707 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.4 mt -99.11 132.56 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.714 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.35 158.58 43.9 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.501 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.5 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.712 0.291 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.0 t -125.79 139.14 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.239 0.542 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.505 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.2 m-90 -102.81 139.44 38.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.15 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.38 128.88 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -118.35 145.34 45.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.477 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.02 -166.59 35.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.644 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -84.34 5.42 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -84.95 132.47 45.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.72 -14.79 46.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.449 2.099 . . . . 0.0 111.462 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -43.31 16.96 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.854 0.835 . . . . 0.0 108.76 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.05 138.96 1.92 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.739 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.35 -18.86 12.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.922 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.505 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.5 t80 -129.78 125.23 35.3 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.778 0.323 . . . . 0.0 111.257 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -103.28 112.84 25.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.614 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.29 72.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.26 -131.87 19.83 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.919 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.69 84.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.046 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.59 128.6 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -28.77 63.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -27.76 61.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.059 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -99.5 152.12 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.956 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.8 p -94.96 166.65 11.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.533 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.561 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.58 -53.85 5.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.353 0.597 . . . . 0.0 109.596 179.26 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.14 83.75 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -60.33 -46.27 90.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.8 p90 -144.59 160.27 41.43 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.171 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.5 tt0 -135.78 141.32 44.77 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.196 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 49.5 mt -117.3 132.18 67.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.027 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -110.93 151.59 27.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.087 0.47 . . . . 0.0 111.612 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.76 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.6 mt -129.67 143.92 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' CD2' HD12 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.66 127.47 56.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.538 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.5 t30 -118.9 115.5 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 0.0 111.493 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.3 p30 -78.84 138.37 38.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.9 pt -145.74 40.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 150.94 21.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.037 0.446 . . . . 0.0 111.798 -178.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -68.62 -31.56 70.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.769 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.14 -19.71 17.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.34 10.61 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.53 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.19 137.71 52.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.805 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.76 148.58 39.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 113.59 18.61 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.349 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 43.97 43.44 5.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.45 -12.55 64.65 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.485 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.42 118.53 36.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 110.56 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.805 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.83 130.63 41.52 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.501 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 m -100.05 163.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.045 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 pm0 -69.98 124.69 24.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.9 tttt -50.99 161.01 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 111.012 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 34.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.401 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.37 145.16 40.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -85.49 128.55 34.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.34 147.53 51.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.705 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.89 120.1 18.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.31 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.7 tp -56.81 157.54 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.291 0.567 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.38 153.24 42.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.61 121.8 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.95 24.57 54.55 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.19 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.8 t70 -57.72 175.6 0.18 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.902 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 7.6 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.035 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.418 HD12 ' CD2' ' A' ' 101' ' ' LEU . 6.7 mt -113.14 128.19 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.383 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.19 138.88 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.805 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.26 158.41 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.35 21.46 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.936 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.0 t -75.07 140.43 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.661 0.743 . . . . 0.0 112.428 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.26 -37.8 0.85 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.38 123.26 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.96 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -32.54 16.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.783 0.325 . . . . 0.0 111.585 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 6.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -125.86 29.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.29 139.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 tt -124.4 134.41 53.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.577 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.431 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 45.7 t -112.71 150.27 31.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.481 0.658 . . . . 0.0 112.424 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -134.1 148.5 51.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.14 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.411 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 16.6 t -114.04 135.5 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 145' ' ' ILE . 27.9 mt -106.3 122.79 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 120.57 42.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.55 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.416 HG12 ' CD2' ' A' ' 124' ' ' LEU . 6.1 mt -84.59 134.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.826 0.346 . . . . 0.0 111.322 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.77 0.319 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -128.73 -61.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.88 -42.56 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -59.01 -39.08 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -39.11 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.81 -31.98 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.99 -35.53 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.38 -45.34 84.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -67.07 -23.78 65.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.581 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -47.62 79.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m -80.85 -38.34 28.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.07 76.2 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.82 135.69 37.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.46 101.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.9 mm -86.99 138.47 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.711 0.767 . . . . 0.0 111.826 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.52 36.61 0.73 Allowed Glycine 0 C--N 1.314 -0.668 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.626 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -44.05 97.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 178.6 38.53 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -76.4 136.09 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.533 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -92.32 -60.0 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.803 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 p -145.97 165.27 29.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.281 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.44 122.79 34.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.386 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -90.35 122.86 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.922 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 146' ' ' PHE . 20.4 mt -126.34 120.46 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.444 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.3 t -80.83 121.31 25.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.399 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -26.17 19.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.379 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.445 HG21 ' HB3' ' A' ' 142' ' ' SER . 40.2 p -79.87 -2.18 42.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.579 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.32 76.49 0.29 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.807 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -146.32 -42.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -117.72 141.26 28.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.8 141.06 36.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.152 1.902 . . . . 0.0 112.167 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.7 mt -55.9 133.56 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.82 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -127.1 164.05 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.137 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.85 119.78 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -87.18 130.45 34.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.463 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.627 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.91 155.99 48.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.287 1.041 . . . . 0.0 113.497 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.69 165.84 31.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.226 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 3.6 m-20 -81.31 126.73 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.123 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.1 mt -64.42 -43.31 96.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.896 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -62.51 -40.11 95.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.333 0.587 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 28.9 mm-40 -68.48 -36.92 79.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.683 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.3 t -73.08 -42.48 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.009 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.89 -39.35 72.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -75.19 -40.84 59.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.93 126.02 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 33.12 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -147.94 153.6 39.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.1 t 61.19 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 92' ' ' LEU . 6.0 tp -179.02 161.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 111.141 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.45 -68.53 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.718 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 16.4 ttpt -145.91 117.91 8.27 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 92' ' ' LEU . 11.9 p -111.35 140.08 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.575 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.6 m-90 -100.67 139.34 36.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.107 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 131.41 55.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -120.2 145.58 46.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.659 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.45 -169.18 36.18 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.768 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -81.95 3.75 25.26 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.82 132.65 45.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.572 0.225 . . . . 0.0 111.007 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.88 -13.3 39.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.514 2.143 . . . . 0.0 111.63 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -42.92 17.41 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.914 0.864 . . . . 0.0 108.847 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.54 137.52 3.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.805 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -18.09 11.01 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.226 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.457 ' CE2' HG22 ' A' ' 43' ' ' ILE . 9.8 t80 -129.06 119.43 24.19 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.031 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.97 111.41 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HA ' HG12 ' A' ' 43' ' ' ILE . 1.7 mt -88.07 -65.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.06 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.169 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.4 p30 178.78 54.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 111.007 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.1 mm -75.06 126.66 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 p -54.94 -40.83 70.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.277 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -68.81 -44.9 72.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -72.99 150.07 42.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -95.69 166.83 11.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.78 -53.15 6.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 109.805 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 9.7 ptmt -120.9 81.83 1.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.7 t60 -60.4 -46.15 91.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.829 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.8 p90 -142.45 160.2 40.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.077 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HG3' ' HA ' ' A' ' 67' ' ' THR . 3.8 tt0 -135.99 143.87 45.05 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 69.9 mt -120.03 125.68 74.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.632 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.9 pt? -114.17 137.3 51.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 18.9 tp -110.94 128.76 55.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.307 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.99 -130.68 1.31 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.294 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.05 -165.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.313 . . . . 0.0 110.978 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.74 53.6 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.68 40.62 4.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.0 165.05 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' CB ' HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -107.51 156.96 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.82 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.8 mp -133.14 147.13 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.224 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mp -112.62 125.66 54.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.365 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 90' ' ' GLN . 41.1 t30 -116.69 115.63 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.8 p30 -80.44 132.6 35.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.808 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -139.57 41.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.95 157.76 16.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.018 0.437 . . . . 0.0 111.473 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -68.84 -36.35 78.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.445 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -19.84 17.34 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.46 161.45 11.25 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.489 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.0 m -117.6 137.99 52.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.821 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.6 148.38 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -124.33 113.54 18.37 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 45.78 42.75 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.37 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.84 -5.5 84.87 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.493 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.39 118.72 37.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.108 0.454 . . . . 0.0 110.868 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.821 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.4 tptm -75.11 126.91 32.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.327 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 m -101.52 165.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.256 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tt0 -69.86 125.92 28.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 47.9 tttm -52.12 161.82 0.56 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.91 0.386 . . . . 0.0 110.558 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.63 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.281 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.23 145.07 40.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.251 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.67 130.13 34.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.008 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.8 mm-40 -129.39 147.89 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.477 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tt -72.8 135.99 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.331 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.421 ' CD2' HG12 ' A' ' 147' ' ' ILE . 63.4 tp -65.62 155.23 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.463 0.649 . . . . 0.0 111.733 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.95 153.12 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.515 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 123.13 21.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.139 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.38 46.15 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.063 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.5 t70 -52.14 170.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 mt-10 -145.02 135.56 24.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 11.3 mt -113.52 126.68 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.48 138.57 40.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.745 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.8 m -140.27 158.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.84 31.49 23.62 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.6 t -73.41 140.36 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.604 0.716 . . . . 0.0 112.217 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.01 -39.33 0.88 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 21.6 t -126.23 128.31 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.017 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.4 -35.42 28.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.38 6.55 47.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.423 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.92 27.32 8.16 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -107.12 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.172 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -124.35 134.48 53.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.434 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.445 ' HB3' HG21 ' A' ' 40' ' ' THR . 41.6 t -112.61 150.41 31.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.671 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.2 mm? -135.91 152.4 50.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.379 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.403 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 18.9 t -119.82 140.08 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.34 . . . . 0.0 111.334 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 145' ' ' ILE . 47.7 mt -106.32 121.0 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -109.11 114.38 28.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.512 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.3 mt -84.86 132.76 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.551 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.21 111.41 15.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.8 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.58 -28.72 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -45.87 90.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -43.18 88.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.054 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.2 -37.17 76.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.1 t -63.75 -46.03 87.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -40.83 98.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -59.47 -34.12 72.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.96 -33.49 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.45 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.547 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 147.2 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.1 m -96.34 134.34 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.188 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -97.37 105.53 17.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.09 136.45 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' B' ' 4' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.593 0.235 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' B' ' 3' ' ' ASN . 6.3 tt 52.47 161.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.822 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.65 128.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.66 125.84 10.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.384 2.056 . . . . 0.0 112.439 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 175.22 10.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.07 173.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.822 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -161.78 130.79 4.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.55 109.45 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.27 -55.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -69.45 -47.08 65.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -38.88 86.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -35.45 77.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.843 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -42.17 88.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.22 -35.14 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.22 -43.35 82.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.853 0.359 . . . . 0.0 110.377 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.428 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.47 79.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 -38.78 92.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.827 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -92.93 75.1 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.7 131.43 37.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -67.24 111.78 4.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.03 138.41 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.692 0.758 . . . . 0.0 111.703 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.62 69.0 1.23 Allowed Glycine 0 C--N 1.314 -0.664 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.456 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -39.08 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 179.62 37.81 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -75.35 135.04 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.561 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -92.26 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.838 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.7 p -146.49 147.21 30.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.326 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 128.17 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.265 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.472 ' CG2' ' CE1' ' A' ' 76' ' ' TYR . 34.5 m -94.58 122.9 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.798 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.15 111.38 29.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.655 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.04 106.42 18.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -97.76 -10.76 24.29 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.678 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.1 p -79.94 -2.59 44.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.408 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.45 84.26 0.69 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.432 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.426 ' NE2' ' CD1' ' A' ' 141' ' ' LEU . 15.1 pt20 -161.72 -47.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.422 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.6 mt -134.16 142.79 44.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.711 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 63.4 Cg_endo -75.92 146.01 29.03 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.255 1.97 . . . . 0.0 111.794 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mt -52.24 136.77 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.969 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -132.08 161.89 32.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -117.77 120.02 36.68 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.1 mt -96.04 136.96 35.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.56 159.07 43.91 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -178.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -152.14 141.96 21.98 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.709 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -85.65 135.03 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.159 0.504 . . . . 0.0 111.126 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 52' ' ' ILE . 1.5 mp -64.19 -39.99 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -41.6 78.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.668 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.1 mt-30 -68.68 -37.02 79.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.96 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 pp -70.93 -28.03 64.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.134 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -26.93 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.052 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.82 99.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.29 93.57 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.82 95.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.32 -168.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.841 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 64' ' ' LYS . 8.7 tp -104.24 8.27 9.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt 61.2 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.322 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 62' ' ' ILE . 8.7 ttpt -155.07 136.47 14.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.848 0.356 . . . . 0.0 111.454 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG13 ' HG2' ' A' ' 90' ' ' GLN . 19.5 t -132.55 139.48 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.22 0.533 . . . . 0.0 111.761 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.523 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.4 m-90 -100.88 137.67 38.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.69 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.01 127.48 56.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -115.25 145.53 42.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.66 -173.06 35.63 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.663 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 14.3 mtm105 -77.79 4.87 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -84.97 131.91 47.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 0.0 111.043 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 Cg_exo -66.07 -14.21 43.35 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.362 2.041 . . . . 0.0 111.573 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.01 -42.61 17.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.946 0.879 . . . . 0.0 109.014 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.65 138.19 1.44 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.096 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.39 -18.21 10.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CZ ' HG23 ' A' ' 43' ' ' ILE . 6.6 t80 -128.48 112.22 14.12 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.79 0.328 . . . . 0.0 111.222 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -90.46 118.28 29.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.415 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -126.95 172.4 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.33 137.09 45.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.577 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -71.51 81.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.9 127.31 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.955 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -55.04 -24.93 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -46.07 15.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.157 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.3 mt -72.7 152.18 41.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.036 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.4 p -95.88 166.03 11.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.693 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.608 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.14 -53.77 6.17 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 109.614 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.36 81.85 1.75 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -59.54 -45.89 90.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.764 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.2 p90 -145.45 157.61 43.98 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.772 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.443 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.9 tt0 -136.06 141.06 44.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.606 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 53.6 mt -116.53 129.69 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.022 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -117.13 140.83 49.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.105 0.479 . . . . 0.0 111.602 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.427 HD21 ' CZ ' ' A' ' 151' ' ' PHE . 9.8 tp -125.24 123.0 38.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.258 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.1 -140.28 6.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.559 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 69.11 -67.19 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.964 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.87 -47.19 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.79 -35.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -59.74 179.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.401 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.52 156.33 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.1 mp -133.03 145.09 50.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.591 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 145' ' ' ILE . 10.5 mp -112.74 122.05 46.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.01 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.4 t30 -116.77 115.63 25.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 111.56 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.696 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 22.1 p30 -78.31 135.91 37.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.0 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.6 pt -143.84 39.08 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.98 160.4 14.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.043 0.449 . . . . 0.0 111.5 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.1 m -68.96 -36.46 77.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.615 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.49 -20.06 17.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.34 162.07 11.55 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.201 -0.999 . . . . 0.0 113.481 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.69 137.84 52.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.72 148.39 36.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.46 18.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.198 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.39 42.85 5.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.358 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.37 -5.08 85.33 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.464 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -104.86 118.51 36.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 0.0 110.738 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.0 tptp -75.67 126.04 30.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.156 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.69 163.13 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.289 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.91 127.1 31.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.7 tttp -52.44 163.44 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.197 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 35.43 35.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.948 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -112.03 137.2 50.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.107 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -80.4 130.54 35.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 27.2 mm-40 -129.54 146.9 51.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 tp -72.85 136.13 45.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.72 157.45 24.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.48 0.657 . . . . 0.0 112.006 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.44 153.37 43.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.217 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.451 ' HA ' HD12 ' A' ' 147' ' ' ILE . 15.2 mm100 -71.55 115.6 10.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.38 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.26 30.02 63.8 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.702 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.1 t70 -55.23 174.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.973 0.416 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 mt-10 -145.21 135.47 24.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.015 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 10.4 mt -111.33 126.3 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.549 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 8.2 m -104.87 137.66 42.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.0 m -140.32 158.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 112.181 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.59 16.26 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.17 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.8 t -74.53 140.41 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.684 0.754 . . . . 0.0 112.172 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.23 -41.07 1.08 Allowed Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.5 123.14 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.541 -0.83 . . . . 0.0 108.929 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.29 -28.05 7.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.427 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 6.53 48.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.62 24.37 7.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.479 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.6 mt -107.47 138.23 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.426 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 9.9 mt -125.19 134.77 52.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.339 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.678 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -104.65 139.07 40.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.213 0.53 . . . . 0.0 111.897 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.2 mp -125.06 152.51 44.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.154 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 22.5 t -120.77 134.18 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.869 0.366 . . . . 0.0 111.618 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 101' ' ' LEU . 36.3 mt -106.31 121.74 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.24 119.02 37.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 126' ' ' GLN . 5.9 mt -84.71 134.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -81.66 126.35 31.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.79 -24.45 61.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -57.9 -43.84 86.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.534 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 1.1 t80 -57.9 -40.99 81.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -33.96 77.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -46.27 80.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -65.85 -43.19 89.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -36.03 82.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.81 -39.44 85.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -91.42 -34.54 14.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.002 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 p30 44.85 -172.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.619 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 151.13 46.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.97 117.63 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -134.12 -48.2 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.61 177.36 7.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.6 114.98 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.898 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' B' ' 4' ' ' ILE . 5.9 m-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.519 0.199 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' B' ' 3' ' ' ASN . 9.3 tp 52.04 157.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.999 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -79.84 143.01 57.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 -176.76 2.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.532 2.155 . . . . 0.0 112.256 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 25.5 m -163.49 111.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 58.88 97.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -139.8 148.5 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 t -163.43 164.53 24.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -124.03 -44.31 2.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -63.64 -47.1 82.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -60.54 -42.21 96.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 -38.05 80.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.9 -32.27 72.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.675 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.11 -35.5 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.734 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -39.98 77.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.446 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -67.1 -23.8 65.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.794 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.68 -47.34 80.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.224 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -36.51 49.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.832 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.67 81.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 150.82 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.57 129.14 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.27 138.34 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 121.715 0.769 . . . . 0.0 111.809 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.68 66.79 3.85 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.02 -39.18 93.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.167 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 177.11 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -75.11 134.49 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.262 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -92.75 -61.58 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.421 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.2 p -155.19 138.03 15.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.443 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -113.99 138.45 50.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -96.13 132.14 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 mt -124.71 116.89 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 108.99 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.245 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.4 p -93.61 -20.12 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.035 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.732 HG22 ' HB2' ' A' ' 142' ' ' SER . 48.9 p -79.82 -2.99 45.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 111.499 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 74.27 75.37 0.78 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.562 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 8.8 mt-30 -147.95 -41.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.676 0.274 . . . . 0.0 111.223 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.6 mt -134.01 141.49 39.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.2 Cg_endo -73.99 146.07 36.6 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.179 1.919 . . . . 0.0 111.92 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mt -56.13 151.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.187 0.517 . . . . 0.0 111.956 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 2.0 ttt-85 -149.69 159.18 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.26 121.59 40.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 112.333 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.1 mt -94.56 137.76 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.005 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -142.61 158.17 43.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.55 143.44 35.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.117 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 31.5 m-20 -86.2 114.02 22.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.479 . . . . 0.0 111.263 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -64.38 -41.44 92.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.376 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 t -56.74 -38.26 72.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.307 0.575 . . . . 0.0 110.802 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.0 mm-40 -68.49 -36.83 79.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.73 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.63 -50.08 69.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.49 -28.1 63.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.02 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.8 -32.82 40.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.73 123.2 40.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 88.55 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.65 172.35 18.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.54 29.86 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.6 tp -151.38 145.45 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HD3' ' CD2' ' A' ' 93' ' ' LEU . 10.0 mttp -119.66 -67.07 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.0 ttpt -153.76 142.78 21.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 90' ' ' GLN . 13.8 t -127.45 139.47 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.312 0.577 . . . . 0.0 112.186 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.631 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -107.78 138.56 43.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 126.23 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.5 m-85 -107.37 145.78 32.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.818 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.9 -178.58 40.54 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.782 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -78.16 -3.38 42.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 136.83 38.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.27 -6.12 17.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.796 2.331 . . . . 0.0 111.736 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.27 14.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.956 0.884 . . . . 0.0 108.684 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.07 139.23 2.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.457 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -18.62 10.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.174 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.1 t80 -129.36 131.65 46.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.04 131.09 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.18 -178.58 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.45 135.64 39.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -69.93 89.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.2 mt -104.35 127.75 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -54.98 -25.02 26.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.325 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -46.74 29.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.227 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.74 151.68 42.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.748 0.309 . . . . 0.0 111.306 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -95.56 166.16 11.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.893 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.22 -54.39 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 109.858 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -118.82 82.84 1.92 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -60.87 -46.79 89.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.652 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 p90 -147.71 159.31 43.94 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.278 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.533 ' HG2' HG13 ' A' ' 65' ' ' VAL . 6.4 tt0 -135.95 141.46 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 41.4 mt -114.37 132.33 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.251 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -122.0 144.46 48.88 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 111.341 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 HD13 ' HG ' ' A' ' 99' ' ' LEU . 2.4 tp -125.12 123.0 38.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.64 -132.63 1.49 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.553 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 62.38 -80.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.021 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.39 42.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.27 -30.29 8.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.68 162.16 21.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.302 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.97 150.68 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.821 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 8.9 mt -133.13 140.38 47.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.249 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.56 126.08 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.202 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.0 t30 -115.8 115.49 26.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -78.68 140.81 38.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 14.7 pt -149.22 38.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.51 159.04 15.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.007 0.432 . . . . 0.0 111.625 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.1 m -69.02 -34.96 76.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.647 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 -19.97 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.71 162.81 12.04 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.533 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.9 m -117.53 137.81 52.32 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.71 148.36 38.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.14 113.48 18.4 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.361 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 44.28 42.88 5.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -10.39 71.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.474 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.96 118.54 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.09 0.445 . . . . 0.0 110.656 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.34 130.91 41.2 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.56 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 m -101.87 164.58 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.851 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 tt0 -69.98 126.67 30.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.499 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 tttt -52.69 161.6 0.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.545 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.02 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.293 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.0 40.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.114 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.86 126.67 35.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.401 ' N ' HD21 ' A' ' 100' ' ' LEU . 39.4 mm-40 -129.3 147.28 51.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.834 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.9 120.95 19.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.984 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 99' ' ' LEU . 1.3 mm? -57.83 165.51 1.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.756 0.789 . . . . 0.0 112.076 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.38 153.18 43.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.195 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.63 120.36 17.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.94 26.39 60.7 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.246 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.1 t0 -60.82 178.54 0.23 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.7 mt-10 -144.99 135.57 24.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -112.64 126.92 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.457 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.49 141.63 36.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.101 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.41 158.53 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.99 9.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.192 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -83.69 140.37 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.646 0.736 . . . . 0.0 112.228 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.46 -39.29 1.31 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.52 120.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.592 -0.804 . . . . 0.0 108.97 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.29 -26.75 5.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.41 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 6.49 48.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.32 24.32 6.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.403 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 tt -123.32 134.78 54.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.196 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.732 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -111.98 128.7 56.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.078 0.466 . . . . 0.0 111.605 -179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.7 mt -123.01 149.1 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.777 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.9 t -113.84 138.03 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.056 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 mm -106.39 120.91 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.33 131.09 55.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.402 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -102.98 132.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -84.03 116.63 22.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.45 -24.51 67.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -45.83 90.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.72 -42.17 83.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.975 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -64.9 -35.45 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.2 -44.61 79.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -47.6 81.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.51 -38.57 77.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -69.81 -27.04 64.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -115.61 65.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 130.46 39.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 123.92 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.063 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -127.89 142.08 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.935 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -124.79 137.63 54.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pp -100.56 132.62 45.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.932 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.751 0.31 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.99 120.12 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -61.09 110.17 2.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.04 -168.7 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.361 2.04 . . . . 0.0 112.323 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.94 174.98 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -82.16 76.64 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -121.23 149.3 43.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.954 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.85 79.98 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.944 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m 60.76 30.04 19.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -72.08 -47.04 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -36.04 82.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -60.57 -40.05 90.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -43.54 98.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mm -71.59 -34.99 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.23 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.493 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -23.86 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.57 -47.6 79.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.296 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -75.43 -35.97 60.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.832 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 50.9 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -74.85 124.2 26.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -77.91 103.36 7.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.04 138.42 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.689 0.757 . . . . 0.0 111.668 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 102.78 2.79 Favored Glycine 0 C--N 1.314 -0.648 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.359 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -66.28 -33.04 74.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.69 0.281 . . . . 0.0 111.005 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 178.8 37.97 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.676 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -73.38 135.52 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.684 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -93.1 -60.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.862 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.12 150.47 35.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.183 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.4 138.24 51.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 111.489 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 m -103.1 122.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -127.45 121.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.546 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.4 t -79.87 114.43 18.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -79.69 -25.99 41.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.798 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 142' ' ' SER . 72.6 p -79.83 -2.19 42.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.706 0.289 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 77.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.946 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -146.29 -44.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.389 . . . . 0.0 110.736 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -113.73 141.66 26.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.862 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.3 Cg_endo -72.06 140.87 35.33 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mt -56.43 140.2 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.641 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.38 164.13 20.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.33 119.71 33.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.1 mt -97.44 134.64 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.56 158.0 43.83 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.19 141.94 32.63 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.572 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.418 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 26.0 m-20 -80.41 136.39 36.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 111.404 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -64.31 -45.43 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.071 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -39.42 74.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.3 mm-40 -68.55 -38.53 80.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.1 -37.88 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -30.66 71.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -89.29 -29.8 18.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.124 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.42 119.02 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -103.08 -21.46 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.09 176.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.033 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -77.47 -30.19 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.5 151.15 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -127.92 -68.45 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -142.02 130.19 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.5 t -125.56 139.14 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 112.086 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.585 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.6 m-90 -100.89 139.4 36.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.199 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.37 128.76 56.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -119.45 145.38 46.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.346 -178.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.1 -168.5 36.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.067 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 25.1 mtm180 -80.28 2.23 25.46 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 t-20 -84.87 133.05 44.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -66.63 -14.05 42.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 0.0 111.901 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.05 17.31 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.902 0.858 . . . . 0.0 108.796 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.18 139.6 1.34 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.779 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.0 m-20 -56.34 -19.0 12.55 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.003 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.6 t80 -129.83 126.98 39.33 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.931 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.45 111.17 23.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 pp -114.52 172.53 6.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.784 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.09 134.05 48.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.675 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -67.32 84.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.46 131.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -37.06 69.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -27.85 67.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 88' ' ' HIS . 37.0 mt -96.94 152.2 18.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -99.04 165.27 11.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.773 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -42.84 -53.5 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.387 0.613 . . . . 0.0 109.851 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 10.7 ptmt -118.38 81.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -59.34 -45.69 90.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.883 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 34.0 p90 -144.53 160.44 41.12 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.138 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -135.91 143.04 44.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.282 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 64.3 mt -119.31 127.59 75.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.006 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.32 148.05 32.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 111.635 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.4 tp -125.04 123.01 38.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.534 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.56 -165.42 36.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 63.18 90.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 63.6 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -171.35 32.73 0.14 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -106.37 178.88 4.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 150.59 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.9 mp -133.06 147.34 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.65 125.33 54.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.192 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -116.47 115.81 26.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.773 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.632 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.0 p30 -77.89 135.03 37.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 8.5 pt -143.91 34.6 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.579 ' H ' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -93.83 151.77 19.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.941 0.4 . . . . 0.0 111.457 -179.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -68.58 -31.82 71.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.921 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.62 -19.83 17.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.539 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.72 154.52 9.21 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.678 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.7 m -117.5 137.92 52.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.802 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.51 148.36 42.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.43 113.59 18.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.956 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 47.74 36.08 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.35 79.91 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.544 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.83 118.67 37.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 110.756 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.802 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -73.8 113.44 10.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.7 m -87.41 166.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.262 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.92 126.09 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -52.69 157.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.825 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.595 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 4.0 p30 34.77 35.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -112.32 145.11 40.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.077 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -80.84 131.87 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.24 146.66 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 tp -72.68 118.5 15.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.41 153.85 9.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.504 0.668 . . . . 0.0 111.686 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.91 153.02 43.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.465 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -71.82 125.03 26.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.258 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.57 54.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.283 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.416 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -52.0 166.03 0.18 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.6 mt-10 -139.83 135.63 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.1 mt -111.11 127.0 68.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.742 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.439 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.4 141.27 36.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.552 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.78 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.78 43.88 9.7 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -84.68 140.44 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.651 0.739 . . . . 0.0 112.441 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.59 -39.96 1.12 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.41 120.02 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.563 -0.818 . . . . 0.0 109.0 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.45 -25.87 4.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.823 0.344 . . . . 0.0 111.442 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -93.5 6.53 47.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.9 26.01 5.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.7 mt -107.13 138.83 31.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.96 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 tt -124.49 134.28 53.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG22 ' A' ' 40' ' ' THR . 44.4 t -108.41 150.3 27.57 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.619 0.723 . . . . 0.0 112.153 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 74.5 mt -135.75 156.97 47.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.8 t -125.94 138.61 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.457 HG21 HD11 ' A' ' 145' ' ' ILE . 32.4 mt -106.34 121.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.966 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.39 114.07 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.92 134.0 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.395 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -82.87 125.38 31.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.76 -25.41 62.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -59.15 -45.68 90.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.935 0.397 . . . . 0.0 110.662 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.18 -43.47 87.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -42.77 99.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -59.1 -46.63 87.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.49 -46.11 84.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.987 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -36.16 82.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.045 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.71 -35.47 79.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -32.89 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.59 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.02 140.24 41.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.8 134.94 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -129.48 174.34 9.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -178.43 -37.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.993 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.42 139.22 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 tp -148.7 143.71 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.96 127.96 67.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -167.66 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.422 2.081 . . . . 0.0 112.244 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.25 173.15 11.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.867 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -102.68 146.3 28.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -136.38 51.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 95.43 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.831 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m 74.55 -59.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -59.79 -44.79 93.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.004 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -59.0 -37.68 77.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.34 -41.37 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -31.83 70.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.38 -35.49 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.803 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -42.0 81.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -67.11 -23.89 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.59 -47.56 79.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 m -77.03 -30.92 55.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 86.07 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.94 151.17 40.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.0 101.86 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -89.38 138.38 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.581 0.705 . . . . 0.0 111.964 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.44 38.31 0.49 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.664 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.42 -45.8 24.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -169.6 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.715 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.8 mm -76.71 134.05 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.529 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.6 t -93.66 -62.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.073 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 p -146.61 155.96 42.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.189 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -122.7 133.28 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.35 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.56 122.81 49.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -122.84 121.99 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.38 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.8 t -85.18 114.08 22.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.442 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -85.85 -22.87 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.581 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 42.5 p -79.94 -2.07 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.615 0.245 . . . . 0.0 111.581 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.17 76.64 0.28 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.844 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.89 -43.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.9 mp -118.88 141.87 30.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.999 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.6 138.02 28.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.119 1.879 . . . . 0.0 112.121 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.55 136.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.745 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.09 164.1 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.256 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -118.08 119.81 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 111.787 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.5 mt -89.84 137.35 32.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.715 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.62 157.58 43.74 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -137.66 143.65 41.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.635 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.8 m-20 -74.7 136.09 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.239 0.542 . . . . 0.0 111.119 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.01 -42.1 94.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.102 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.36 -40.1 73.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.967 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -68.43 -40.87 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.302 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -64.36 -41.19 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 tp -71.09 -30.29 66.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.31 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 27.68 9.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.281 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.7 98.99 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.818 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 39.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -139.6 178.25 7.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.0 p -70.86 -20.76 62.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.2 tp -145.94 158.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.326 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -93.48 -65.07 1.02 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.215 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 49' ' ' SER . 22.8 ttpt -154.94 119.86 4.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.925 0.393 . . . . 0.0 111.812 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.8 p -109.85 140.0 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.512 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -100.6 139.5 36.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.349 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.05 127.27 55.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -118.99 145.52 45.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.503 -178.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.52 -168.07 39.86 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -90.83 28.95 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.4 t-20 -111.43 136.62 20.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.87 -13.12 38.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.668 2.245 . . . . 0.0 111.736 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -47.45 11.8 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.824 0.821 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 140.61 1.0 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.311 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -56.61 -18.91 13.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.883 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 19.6 t80 -129.46 123.65 32.08 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.765 0.317 . . . . 0.0 110.68 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -97.93 121.94 40.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' HG12 ' A' ' 43' ' ' ILE . 12.4 mt -102.34 -64.04 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.77 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.27 -103.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -179.27 49.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 84' ' ' LEU . 19.2 mt -89.69 141.92 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -64.34 -34.77 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -60.91 -30.49 70.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 88' ' ' HIS . 1.2 mm? -105.81 152.47 23.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 p -98.39 163.32 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.591 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.16 -53.28 4.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.413 0.625 . . . . 0.0 109.67 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -118.99 82.65 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.534 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.6 t60 -61.25 -46.94 88.33 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.553 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.5 p90 -143.7 159.14 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.999 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.0 tt0 -135.5 140.52 44.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 77.1 mt -120.12 127.25 75.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.161 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp -118.23 123.53 45.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.365 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.89 39.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.592 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 59.16 105.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.09 -177.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 54.35 4.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.416 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.25 -176.07 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.32 158.62 41.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mt -127.76 140.68 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.513 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.71 121.55 45.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.488 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.4 t30 -117.51 116.93 28.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.055 0.455 . . . . 0.0 112.072 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.669 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.8 p30 -77.36 134.82 38.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.817 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.72 39.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.75 149.82 23.42 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.084 0.469 . . . . 0.0 111.943 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.88 -31.34 70.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.862 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.63 -19.96 18.65 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.545 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.35 153.82 9.6 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.875 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.6 m -117.66 137.99 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.085 0.554 . . . . 0.0 109.577 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.85 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.98 148.57 39.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.23 113.53 18.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.482 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 44.32 43.51 6.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.494 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.41 -13.59 61.69 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.447 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -103.96 118.47 36.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.983 0.391 . . . . 0.0 110.586 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.85 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -72.3 125.63 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.246 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 m -95.29 165.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.238 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 mt-10 -69.87 125.11 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.676 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.669 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 82.7 tttt -53.49 162.33 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.779 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 36.2 32.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.18 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.49 143.28 43.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.721 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -92.17 133.6 35.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -129.08 150.01 50.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.49 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.58 122.91 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.14 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.8 tp -53.03 156.14 2.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.493 0.663 . . . . 0.0 111.85 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.58 153.53 42.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.285 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 121.36 18.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.934 0.397 . . . . 0.0 110.405 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.57 24.23 56.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.154 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -54.79 170.49 0.17 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.007 0.432 . . . . 0.0 111.249 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 20.5 tt0 -145.18 135.46 24.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.6 mt -113.6 128.16 70.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.454 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.3 140.84 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.023 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.521 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.9 m -140.13 158.43 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.86 44.21 9.35 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.807 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -85.18 140.44 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.752 0.787 . . . . 0.0 112.47 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.39 -39.96 0.79 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 48.3 t -126.54 120.51 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.042 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -50.26 -26.44 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 111.54 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.5 p -93.61 6.62 47.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.407 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -132.49 29.83 4.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.3 mt -106.32 139.25 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.629 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 tt -124.16 134.35 53.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.701 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.0 t -112.17 150.31 31.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.722 . . . . 0.0 112.499 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.4 mm? -136.02 139.55 43.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.498 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.86 140.15 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.475 HD12 HG23 ' A' ' 145' ' ' ILE . 16.8 mt -106.18 122.29 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.76 113.74 26.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.367 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.9 127.29 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.57 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.36 124.59 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.68 -27.33 64.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -60.06 -46.05 90.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.762 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 32' ' ' ILE . 1.2 t80 -58.27 -44.03 88.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.073 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -33.86 72.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.981 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -44.65 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -68.12 -44.06 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.12 -35.94 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -45.77 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -79.98 -36.53 35.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.68 31.9 0.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.454 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -124.99 153.74 42.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.22 133.22 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.096 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -158.42 -61.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -46.82 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.68 139.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.122 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.917 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.55 129.07 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -69.33 112.26 11.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.55 -170.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.514 2.143 . . . . 0.0 112.223 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -97.34 166.93 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -102.98 163.47 12.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -92.59 129.77 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m 61.6 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.7 m -142.42 -54.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -38.94 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -59.0 -36.32 74.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.18 -42.46 96.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . 48.8 mm -68.91 -48.18 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.99 -33.56 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.294 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -59.79 -47.1 87.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.935 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.1 p90 -71.9 -47.44 52.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.062 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 52.3 p -65.28 -28.14 69.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.014 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 64.1 -78.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.17 146.21 39.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 104.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.814 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.95 138.3 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 121.708 0.766 . . . . 0.0 111.725 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.5 107.42 0.01 OUTLIER Glycine 0 C--N 1.315 -0.63 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.422 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -27.98 35.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.138 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 177.27 39.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.676 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -74.74 134.25 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.454 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.16 -61.08 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.021 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 p -146.05 147.01 31.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.378 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.9 121.99 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 t -88.77 122.75 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.423 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.71 114.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.89 118.52 31.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -111.66 -12.46 13.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 142' ' ' SER . 18.0 p -81.05 -2.51 48.4 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.08 85.49 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.809 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 4.4 pt20 -164.3 -49.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.1 mt -132.97 142.5 44.9 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 65.6 Cg_endo -75.69 146.16 29.97 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.201 1.934 . . . . 0.0 111.511 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.9 mt -50.6 150.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 112.067 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -150.93 158.18 43.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.034 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -117.23 126.22 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 7.6 mt -101.05 137.62 39.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.75 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.676 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.89 158.78 43.68 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.74 141.87 23.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.532 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.492 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -82.35 133.95 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 111.203 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mp -64.36 -44.61 97.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.465 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -42.14 79.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.319 0.581 . . . . 0.0 110.881 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 5.4 mt-30 -68.55 -36.91 79.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.95 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.14 -46.69 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.93 -29.5 67.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -76.41 -40.16 51.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -62.92 129.66 41.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 31.04 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -123.59 46.49 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 62' ' ' ILE . 6.0 p 63.66 137.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.985 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER 56.49 166.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.289 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.6 -59.22 0.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -148.36 129.37 14.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.2 t -127.97 139.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.329 0.585 . . . . 0.0 112.333 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.545 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 14.5 m-90 -100.84 139.25 36.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.804 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.72 130.13 55.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -119.34 145.4 46.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.367 -178.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.45 -170.43 37.21 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.777 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -79.95 2.86 21.86 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t30 -84.94 133.01 44.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.61 0.243 . . . . 0.0 111.144 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.91 -14.51 44.89 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.571 2.181 . . . . 0.0 111.721 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -42.63 18.02 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.831 0.824 . . . . 0.0 108.972 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.39 139.75 1.89 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.914 -1.493 . . . . 0.0 110.826 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.36 -18.26 10.38 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.91 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.8 t80 -129.08 123.94 33.54 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.787 0.327 . . . . 0.0 110.922 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -105.53 116.67 32.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -99.0 -69.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.12 -92.26 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.317 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 177.95 55.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.103 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 29.2 mm -81.67 124.73 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.754 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.55 70.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -28.74 69.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 6.2 mp -97.66 153.31 18.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -96.42 167.31 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.736 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.633 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -44.15 -54.93 5.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.266 0.555 . . . . 0.0 109.623 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HD11 ' A' ' 104' ' ' ILE . 17.3 mttp -116.37 82.87 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -59.55 -46.47 88.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.763 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.0 p90 -143.92 157.77 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.008 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 102' ' ' ASN . 5.2 tt0 -135.69 141.35 44.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.956 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 59.5 mt -116.34 126.73 73.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.853 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -105.51 149.25 26.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.163 0.506 . . . . 0.0 111.858 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tt -119.44 122.88 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.233 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.84 -166.06 14.6 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.692 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -59.42 172.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 111.038 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.69 -171.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.4 26.44 19.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.479 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -105.31 135.37 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.77 160.13 15.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mt -126.69 142.66 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.425 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -112.79 121.63 45.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.808 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 90' ' ' GLN . 48.9 t30 -112.24 115.78 29.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.737 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.67 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 16.7 p30 -76.43 129.23 36.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.645 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 87' ' ' LYS . 9.5 pt -137.94 38.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.17 152.97 19.29 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.13 0.49 . . . . 0.0 111.663 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.8 m -68.85 -31.6 70.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.24 -19.88 17.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.531 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.47 156.07 10.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.675 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.42 137.72 52.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.803 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.74 148.19 42.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.422 HD22 ' CB ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -124.76 113.55 18.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 48.77 42.07 19.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.33 -6.14 80.82 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.973 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.422 ' CB ' HD22 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -106.3 118.83 37.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.275 0.537 . . . . 0.0 110.84 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.803 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptp -73.75 127.26 32.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.258 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 m -101.12 166.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.203 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 120' ' ' SER . 17.5 tt0 -69.77 123.87 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.518 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 2.1 tttt -51.32 165.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 p30 32.82 34.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.322 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.52 145.23 40.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.245 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -90.9 129.47 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.401 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 61.0 mm-40 -129.15 150.92 50.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.433 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.6 134.24 45.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 101' ' ' LEU . 54.7 tp -65.85 156.42 33.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.48 0.657 . . . . 0.0 111.697 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.39 153.6 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.614 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.411 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 4.5 tp60 -71.3 118.6 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.33 23.64 62.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.116 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -50.99 172.02 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.3 mt-10 -144.63 135.59 24.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.5 mt -114.32 125.01 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.474 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.57 140.4 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.7 m -140.31 158.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.94 27.22 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.179 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.0 t -71.02 140.32 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 112.212 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.8 -38.54 1.27 Allowed Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.45 124.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.662 -0.769 . . . . 0.0 109.202 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -50.47 -31.07 14.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.587 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.0 t -93.45 6.43 48.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -125.54 25.49 7.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.3 mt -107.05 138.94 30.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.016 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' HG ' ' NE2' ' A' ' 42' ' ' GLN . 6.0 mp -124.46 134.58 53.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.508 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.596 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.54 132.74 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.5 mp -123.23 143.49 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.546 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.3 t -114.45 132.72 62.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.42 120.98 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.063 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.37 142.2 34.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -110.47 134.07 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.523 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -82.55 131.46 35.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.43 -20.95 60.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.29 87.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.4 -40.48 82.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -65.0 -47.84 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.964 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.08 -46.47 88.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -62.02 -44.36 96.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.949 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.99 -39.17 79.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.02 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -58.46 -38.42 77.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -91.74 -36.61 13.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.924 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.0 p30 44.75 -171.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.565 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.22 152.26 29.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.911 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.09 134.94 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.41 155.98 22.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -65.93 120.23 12.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.57 129.7 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.884 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.77 0.319 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -152.48 121.71 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.95 121.61 84.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.96 174.66 10.9 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.343 2.029 . . . . 0.0 112.386 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 m -157.22 164.14 38.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 125.49 38.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -90.2 151.31 21.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -105.96 91.94 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.925 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.328 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -127.14 -49.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -47.02 54.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.04 96.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.38 -35.09 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.1 -44.64 88.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.1 mm -66.86 -35.22 74.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.28 -42.92 82.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 0.0 110.353 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -67.26 -23.62 65.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.51 -47.48 79.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.297 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.9 p -76.15 -41.8 48.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -60.79 -46.09 91.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -93.84 143.74 26.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -85.57 126.01 33.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 29' ' ' GLY . 18.3 mm -83.63 138.19 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.599 0.714 . . . . 0.0 111.718 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 28' ' ' ILE . . . -153.01 35.63 0.78 Allowed Glycine 0 C--N 1.313 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.426 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.34 -40.28 96.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 176.23 39.34 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.7 135.29 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.416 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -91.42 -59.96 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.012 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.4 p -148.8 153.37 38.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.82 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -117.97 119.43 34.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.938 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.7 t -90.04 122.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 111.184 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -122.78 126.14 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.156 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.2 t -81.08 118.58 22.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.579 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 t -83.52 -27.89 29.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 142' ' ' SER . 50.6 p -79.88 -2.28 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.461 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.57 77.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.943 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -147.35 -43.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.4 mt -112.15 141.26 24.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.51 143.87 43.72 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.177 1.918 . . . . 0.0 112.172 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.4 ' CG2' ' CD ' ' A' ' 35' ' ' ARG . 35.3 mt -60.13 133.91 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.67 164.44 22.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.68 119.93 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -90.67 126.72 36.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.649 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -131.8 157.07 44.85 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.168 0.985 . . . . 0.0 113.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.99 159.68 40.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.216 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 68.2 m-20 -84.99 119.86 25.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 151' ' ' PHE . 55.1 mt -64.49 -43.21 96.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.916 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -61.7 -40.82 96.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 0.0 110.668 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.7 mm-40 -68.48 -36.91 79.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.02 -44.33 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.084 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.95 -35.28 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -68.1 -51.8 42.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.942 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.03 136.95 36.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 21.46 13.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -167.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -80.04 -25.24 40.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 63' ' ' LYS . 8.3 tp -175.69 158.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 111.148 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -131.31 -49.16 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.538 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -128.3 129.43 46.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.937 0.399 . . . . 0.0 111.844 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' ' 92' ' ' LEU . 20.6 t -136.17 139.66 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.019 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.607 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.9 m-90 -100.63 138.98 36.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.998 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.25 132.05 55.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.561 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -114.33 145.25 42.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.79 -175.08 39.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.99 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -78.99 -0.43 31.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.85 135.8 39.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.634 0.254 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.83 -9.28 25.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.686 2.257 . . . . 0.0 111.789 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.69 16.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.975 0.893 . . . . 0.0 108.669 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.05 136.5 4.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.651 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -56.49 -18.51 11.71 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.091 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.42 114.75 16.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.723 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -89.16 119.59 29.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HA ' HG12 ' A' ' 43' ' ' ILE . 10.0 mp -92.85 -77.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.34 -86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 173.65 48.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 110.929 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.47 126.48 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -58.57 -30.69 67.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -69.58 -49.23 56.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.8 mp -75.45 153.3 37.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 0.0 111.17 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 p -93.45 168.66 10.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.2 m-20 -43.95 -55.39 4.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.344 0.593 . . . . 0.0 109.765 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 6.1 ptmt -119.66 82.9 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -59.41 -45.85 90.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.981 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.2 p90 -146.36 159.53 43.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.495 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.84 143.45 45.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.381 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 25.2 mt -116.67 127.4 74.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.532 ' HB3' HG11 ' A' ' 65' ' ' VAL . 2.2 pt? -116.5 136.73 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.503 . . . . 0.0 112.065 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tp -125.0 129.47 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.36 63.02 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.477 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.0 -57.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -150.34 37.49 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.83 16.57 63.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 -133.72 -173.53 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.419 ' CD2' ' CG2' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -109.34 153.63 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 6.1 mt -133.16 147.15 52.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.381 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -112.68 124.8 53.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.329 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.9 t30 -115.88 115.62 26.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.031 0.443 . . . . 0.0 111.522 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.665 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.1 p30 -79.13 136.17 37.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.462 HD12 HG23 ' A' ' 67' ' ' THR . 16.6 pt -145.15 39.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.56 159.74 14.74 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.05 0.452 . . . . 0.0 111.804 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.3 m -69.06 -37.7 78.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.501 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 9.9 p30 -98.46 -19.91 17.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.55 160.78 10.95 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.695 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.0 m -117.58 137.91 52.28 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.829 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.76 148.38 38.44 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.35 18.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.366 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 44.27 42.86 5.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.91 -8.51 77.73 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.485 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 118.62 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.829 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.9 tptp -74.14 123.05 23.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.29 164.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.1 tp10 -69.86 126.71 30.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 36.9 tttm -52.63 161.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.377 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.51 34.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.32 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.3 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.153 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -84.2 130.05 34.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.5 mm-40 -129.34 146.66 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.81 135.66 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.6 tp -66.71 155.85 36.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.401 0.619 . . . . 0.0 111.545 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -124.69 153.11 42.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.41 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.61 114.0 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.202 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.63 71.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t0 -56.21 172.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 111.174 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.9 tt0 -145.19 135.56 24.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.8 mt -113.68 128.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.614 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.457 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.5 140.71 37.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.8 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.3 m -140.36 158.64 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.31 43.42 9.53 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.084 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -84.03 140.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.654 0.74 . . . . 0.0 112.275 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.19 -39.5 1.18 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.34 120.03 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -26.49 5.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.364 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -93.62 6.55 47.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.37 26.11 5.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.11 138.33 33.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.014 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tp -124.94 134.81 52.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.46 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' HG21 ' A' ' 40' ' ' THR . 39.3 t -109.89 149.54 29.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.658 0.742 . . . . 0.0 112.364 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.4 mm? -136.36 142.03 43.76 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 t -113.35 140.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 111.007 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.6 mt -106.08 121.13 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.82 113.13 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.799 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.9 130.59 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -75.85 133.69 40.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -73.88 -28.81 61.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -44.48 87.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 4.2 t80 -57.82 -43.99 86.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -41.2 94.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.023 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -58.96 -46.63 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.034 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.93 -45.91 89.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.59 -47.18 80.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -36.77 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.21 -23.73 64.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -125.86 92.78 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -106.43 130.9 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -76.2 138.36 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 60.97 112.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.09 89.9 3.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.64 137.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.837 0.351 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 15.8 tt -178.56 158.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.14 123.33 68.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.41 138.83 27.84 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.434 2.089 . . . . 0.0 112.349 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -78.14 154.39 31.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -76.6 148.79 36.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -169.95 87.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t 60.19 86.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.925 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.781 0.324 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -83.69 67.3 9.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.37 -46.97 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -36.98 84.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 -37.42 86.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.72 96.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.3 mm -67.02 -35.15 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.24 -40.98 78.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -23.87 65.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.43 79.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.235 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -59.59 -42.31 92.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -85.52 67.14 10.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.89 120.98 16.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 105.96 16.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.92 138.32 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.602 0.715 . . . . 0.0 111.759 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.81 79.18 0.07 OUTLIER Glycine 0 C--N 1.313 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.558 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.74 -35.67 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.61 38.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -79.76 133.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.563 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.4 t -92.65 -62.57 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.9 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.64 165.14 28.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -124.48 138.21 54.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 111.438 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 76' ' ' TYR . 2.4 m -108.8 122.63 63.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.627 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.94 119.86 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.792 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.4 t -83.76 102.34 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.292 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -77.27 -25.48 51.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.924 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 9.9 p -79.9 -2.59 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.515 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.52 79.95 0.19 Allowed Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.068 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -146.97 -39.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.588 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -129.11 144.09 51.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.917 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 38.5 Cg_endo -68.89 141.58 49.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.183 1.922 . . . . 0.0 111.934 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.49 140.26 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.907 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -135.38 164.11 28.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.87 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.91 119.79 29.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.8 mp -78.91 135.61 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.682 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.7 156.14 43.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -145.74 141.74 28.29 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.672 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -75.01 141.73 43.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.162 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mm -64.02 -40.65 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.487 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -56.77 -39.65 74.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.645 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.0 OUTLIER -68.4 -36.93 79.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.47 -42.81 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -39.4 72.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -40.88 97.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 109.59 12.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.45 30.7 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -115.67 -167.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -95.13 44.07 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -166.07 134.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -124.4 -58.71 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -148.82 141.37 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG13 ' HG2' ' A' ' 90' ' ' GLN . 16.4 t -136.34 139.24 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.317 0.58 . . . . 0.0 112.247 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.2 m-90 -109.94 139.13 45.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.982 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.85 127.24 55.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -114.25 145.78 41.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.658 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -169.35 35.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.683 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -82.12 5.0 20.99 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.82 128.61 60.01 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.514 0.197 . . . . 0.0 110.668 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.4 Cg_exo -65.53 -11.8 32.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.223 1.948 . . . . 0.0 111.431 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.23 -42.96 16.62 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.781 0.801 . . . . 0.0 108.974 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.11 136.82 1.45 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.755 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.54 -18.37 11.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.927 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 28.8 t80 -129.43 117.24 20.23 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -94.03 121.9 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.4 mt -100.1 -69.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.982 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.26 -95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -178.74 54.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.9 mt -81.01 126.12 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 -36.79 69.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -68.7 -29.47 67.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 mt -95.92 152.06 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 p -96.29 165.46 12.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.656 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.622 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.3 -53.35 4.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 109.973 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.77 83.04 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -60.12 -47.07 87.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.816 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.22 157.28 43.81 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.854 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.445 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.05 135.74 39.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.346 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.9 mt -109.36 132.06 58.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.825 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -121.72 151.64 40.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 111.576 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.6 tp -125.02 122.68 37.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.377 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.7 -153.79 8.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 58.39 -171.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.57 63.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.42 -173.06 38.48 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 63.0 162.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.363 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 160.13 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.757 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 4.1 mp -127.13 141.57 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.6 tp -112.88 126.39 55.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.7 t30 -117.06 115.57 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.181 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.669 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.6 p30 -79.66 132.01 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 22.2 pt -141.35 40.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.64 152.72 20.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.068 0.461 . . . . 0.0 111.882 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -68.77 -31.55 70.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.986 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.12 -19.81 17.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.32 157.43 10.75 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.703 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.41 148.39 40.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.304 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 44.93 43.53 7.21 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -9.78 70.0 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.489 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.4 118.53 36.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.056 0.428 . . . . 0.0 110.808 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.8 tptm -73.7 128.62 35.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.198 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.8 m -99.47 166.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.212 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 120' ' ' SER . 23.7 mt-10 -70.0 126.02 28.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.481 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.669 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 34.3 tttt -52.36 162.18 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 110.324 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.968 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.89 145.06 40.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.12 126.64 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.625 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -129.07 147.08 50.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.91 116.39 13.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.919 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -53.38 167.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.665 0.745 . . . . 0.0 112.019 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.23 153.29 43.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.228 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -71.55 114.65 9.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.74 26.4 72.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.911 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.8 t0 -60.24 176.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 111.035 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.1 mt-10 -145.31 135.71 24.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.263 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 9.1 mt -112.69 126.21 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.495 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.473 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.48 141.45 36.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.179 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.492 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.4 m -140.26 158.5 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.01 43.79 9.54 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.013 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.4 t -84.08 140.42 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.733 0.777 . . . . 0.0 112.47 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.15 -42.44 0.86 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 57.5 t -126.53 122.13 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 114.592 -0.804 . . . . 0.0 109.033 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -24.86 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.727 0.299 . . . . 0.0 111.704 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.26 6.34 48.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 11.6 m-20 -130.75 26.65 4.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.473 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -107.06 139.39 28.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.003 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.4 134.43 54.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.52 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.505 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.66 137.05 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.07 0.462 . . . . 0.0 111.856 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.7 mm? -131.26 145.05 51.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.172 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 13.5 t -111.41 135.65 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.45 122.69 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.581 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -113.13 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.073 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.9 mt -84.79 126.48 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.205 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -81.76 115.47 21.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.72 -22.33 65.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.34 -43.56 83.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -38.18 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.694 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -65.08 -33.91 77.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -47.04 87.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.88 -46.02 89.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.062 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -43.96 88.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -35.17 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -24.85 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -123.95 77.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 150.56 46.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.11 117.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.086 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -109.05 118.86 37.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -99.78 146.22 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.7 128.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.17 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.79 0.329 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -158.24 131.51 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -95.68 132.92 26.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 168.96 22.79 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.482 2.121 . . . . 0.0 112.359 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 97.7 m -137.38 147.07 45.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.713 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.21 175.99 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.59 -171.72 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 4.2 t -99.46 124.09 44.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.897 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -121.55 -48.28 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -65.33 -47.07 77.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -58.92 -36.72 75.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.95 -42.4 93.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -32.74 71.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.1 -35.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.51 -38.02 73.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -67.17 -23.84 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.83 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.81 -47.53 80.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -37.55 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -61.6 -68.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -79.78 139.33 37.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -98.27 130.35 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.56 136.61 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 C-N-CA 123.068 0.547 . . . . 0.0 110.683 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.33 63.4 2.05 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -77.95 -39.31 43.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 177.68 38.42 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.11 136.13 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.479 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.67 -60.16 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.769 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -147.26 150.2 34.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.165 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.89 129.32 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.472 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.6 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -131.4 128.23 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.656 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.31 110.04 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.972 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.2 p -87.15 -24.25 24.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.792 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 142' ' ' SER . 72.5 p -79.91 -2.56 44.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 71.62 78.32 0.47 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.444 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.3 mt-30 -148.56 -40.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.246 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.9 mt -130.2 141.54 42.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.78 146.03 42.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.23 1.953 . . . . 0.0 112.195 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.02 156.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.844 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.12 164.1 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 p30 -119.58 119.94 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.069 0.461 . . . . 0.0 111.975 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.0 mt -100.77 134.64 43.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.67 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.82 158.87 43.63 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.37 149.83 35.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.122 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 72.1 m-20 -75.02 120.6 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.9 mt -64.53 -42.24 94.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.141 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -40.07 75.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.293 0.568 . . . . 0.0 110.67 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 4.7 mm100 -68.53 -39.45 81.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.63 -43.07 98.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.0 -22.08 62.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.243 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.97 13.0 23.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.616 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.08 137.07 47.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.81 124.31 18.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -48.32 99.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.04 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -173.37 150.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -63.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -145.89 136.59 24.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.6 t -126.38 138.09 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 112.013 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.544 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -101.85 139.66 37.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.003 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.61 130.13 55.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -120.06 145.27 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.16 -167.2 36.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.755 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.0 mtm105 -83.88 3.56 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.9 t-20 -84.93 133.41 43.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 111.019 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -66.06 -14.2 43.33 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.552 2.168 . . . . 0.0 111.676 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.61 16.71 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.946 0.879 . . . . 0.0 108.852 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.29 139.8 2.49 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.802 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.5 m-20 -56.4 -18.88 12.49 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.859 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.524 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -129.81 127.78 41.0 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.86 108.0 19.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.772 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' CD2' ' CD1' ' A' ' 43' ' ' ILE . 26.3 mt -76.7 -166.52 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.17 17.94 53.58 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.25 79.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.397 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 mt -112.03 132.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -54.99 -34.68 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -27.37 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.6 mt -96.64 152.19 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.82 164.77 12.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.661 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.99 -52.82 5.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 109.615 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.72 82.9 1.96 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.77 -45.97 91.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.923 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.4 p90 -143.55 162.52 35.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.436 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.57 133.99 38.92 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.202 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 67.8 mt -111.56 127.79 68.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.724 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -114.77 146.89 40.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.544 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.0 122.94 38.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.508 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 95' ' ' GLU . . . 147.8 -155.15 26.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 94' ' ' GLY . 1.6 tp10 84.77 -21.79 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.481 0.312 . . . . 0.0 111.699 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -177.46 -46.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.884 0.374 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.51 -32.33 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.355 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -75.13 -172.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.13 157.6 19.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.1 mt -133.18 146.67 51.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.72 124.41 52.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.06 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.7 t30 -117.52 115.67 25.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.664 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 p30 -78.35 139.66 38.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.165 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 20.6 pt -147.88 40.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.95 152.11 20.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.086 0.47 . . . . 0.0 111.778 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.1 m -68.93 -31.54 70.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.038 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.94 17.57 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.05 155.4 9.81 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.65 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -117.57 137.75 52.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.864 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.41 148.29 41.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.65 18.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.439 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.65 43.76 6.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.388 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -9.99 69.39 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.437 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -104.64 118.66 37.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.624 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.864 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.1 tptm -74.03 122.57 22.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.224 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -93.64 164.55 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 tp10 -69.82 127.75 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.535 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -53.71 161.03 1.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.922 0.391 . . . . 0.0 110.635 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.53 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.348 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.17 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.122 179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.97 130.2 34.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.6 mm-40 -129.46 147.68 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.86 132.9 44.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 125' ' ' SER . 38.0 tp -65.05 154.43 37.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.659 . . . . 0.0 111.61 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -124.81 153.05 43.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.36 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 122.76 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 23.89 49.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.145 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.6 t70 -54.78 170.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.46 . . . . 0.0 111.21 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -145.17 135.57 24.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.006 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.3 mt -109.4 128.04 65.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.438 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.37 140.3 38.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.045 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.37 158.33 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 80.07 42.97 10.16 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.433 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -82.83 140.45 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.687 0.756 . . . . 0.0 112.274 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.33 -39.92 1.14 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.48 123.98 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.619 -0.791 . . . . 0.0 109.082 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.27 10.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.412 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -93.42 6.48 48.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 133' ' ' GLY . 54.3 m-20 -124.34 23.06 8.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.5 mt -107.0 139.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.414 ' CD2' ' HG ' ' A' ' 143' ' ' LEU . 8.9 tt -122.32 134.72 54.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.76 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.99 128.18 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.087 0.47 . . . . 0.0 111.854 -179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 141' ' ' LEU . 18.6 mt -121.44 137.42 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.03 137.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.816 0.341 . . . . 0.0 111.278 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.434 HD13 HG22 ' A' ' 145' ' ' ILE . 31.6 mt -106.16 131.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.09 120.36 39.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.419 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.7 mt -84.85 131.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.21 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -75.99 118.43 18.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.54 -30.82 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.88 -45.94 90.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.29 -43.12 87.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.96 -45.66 89.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.7 t -60.94 -46.06 92.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.2 -35.76 78.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.03 -41.87 93.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 159' ' ' LYS . 10.5 tt0 -84.7 -31.39 24.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.69 -91.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.692 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' GLN . 18.0 mtmt -73.07 133.82 44.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.848 0.356 . . . . 0.0 110.955 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.05 132.38 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.05 30.4 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.47 114.94 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.0 mt -84.22 113.63 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.038 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.779 0.323 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.87 60.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.16 98.36 5.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.05 -167.5 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.453 2.102 . . . . 0.0 112.308 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -93.75 145.68 24.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.33 121.0 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.93 173.95 6.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 40.4 p -83.83 91.44 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.834 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -139.55 -47.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -70.88 -45.41 64.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -59.02 -46.12 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -35.05 73.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -41.46 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.8 mm -71.92 -35.09 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.16 -38.19 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -67.34 -24.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.671 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.76 79.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.148 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -81.12 -31.56 34.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.852 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 64.34 72.8 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.01 121.0 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -69.88 125.01 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.99 138.34 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.66 0.743 . . . . 0.0 111.776 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.98 90.06 0.26 Allowed Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -36.21 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 178.56 38.32 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.78 133.99 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.458 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -91.43 -61.7 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.149 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -148.96 150.08 32.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.408 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -113.96 138.1 50.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 76' ' ' TYR . 15.0 p -99.99 122.9 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.7 mt -130.29 119.41 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.649 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -79.95 142.07 35.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -111.42 -21.29 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.8 p -85.09 -2.78 58.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.732 0.301 . . . . 0.0 111.559 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.83 86.91 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.093 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 2.9 pt20 -159.72 -40.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.084 0.468 . . . . 0.0 111.374 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 4.3 mt -122.92 139.96 32.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.4 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 70.3 Cg_endo -76.76 146.16 26.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.508 2.139 . . . . 0.0 112.376 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mt -55.9 148.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.841 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.06 162.06 37.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.027 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.37 119.91 36.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.092 0.472 . . . . 0.0 111.931 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.0 mt -96.25 137.28 35.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.48 158.7 43.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.52 142.42 33.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.914 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -74.99 115.8 15.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.072 0.463 . . . . 0.0 111.161 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.38 -44.08 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.077 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.49 -40.73 92.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.0 mm-40 -68.45 -36.93 79.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.26 -37.85 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mt -70.58 -31.78 68.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -74.75 -50.53 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.915 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.45 116.89 10.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.2 88.25 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.61 176.59 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.67 -57.64 3.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.82 149.79 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.027 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -126.6 -66.75 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.3 ttpt -140.65 125.55 18.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.169 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.4 t -123.08 139.48 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.249 0.547 . . . . 0.0 111.752 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.572 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.6 m-90 -100.78 139.91 35.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.86 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.19 125.3 51.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.9 m-85 -113.17 145.57 40.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.926 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.9 -173.47 39.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.274 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp-105 -77.43 -1.56 30.83 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.82 134.2 42.16 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.318 . . . . 0.0 111.19 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -68.01 -10.56 29.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.728 2.286 . . . . 0.0 111.967 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -42.87 17.43 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 121.868 0.842 . . . . 0.0 108.914 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 140.3 1.0 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.848 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -56.06 -18.33 9.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.147 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 42.7 t80 -128.88 125.92 38.66 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.42 113.09 26.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.752 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' CB ' HG12 ' A' ' 43' ' ' ILE . 1.5 pp -116.63 175.71 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.5 166.2 3.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -93.83 92.14 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 mp -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 p -54.75 -24.91 24.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -74.19 -29.57 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.2 mt -92.2 152.21 19.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.98 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -96.16 163.44 13.1 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.506 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.65 -53.2 3.64 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 109.763 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 28.9 mttp -118.41 84.28 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -63.93 -45.13 90.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 104' ' ' ILE . 30.7 p90 -152.67 163.24 40.03 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.189 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' HG2' HG21 ' A' ' 67' ' ' THR . 13.1 mt-30 -135.29 154.94 51.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.494 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 3.8 mt -123.63 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.167 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.92 148.02 37.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 111.589 -179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -125.14 125.45 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.473 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.54 -163.58 21.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.652 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.61 -168.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.996 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.56 99.28 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.9 51.18 58.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.62 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -147.54 162.71 38.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 110.885 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.02 152.1 51.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.455 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 3.7 mp -133.02 145.79 51.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.312 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.96 131.79 55.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.534 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -119.76 115.57 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.9 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.669 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 p30 -78.68 143.21 36.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.062 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.47 HG12 ' HG3' ' A' ' 90' ' ' GLN . 10.2 pt -150.39 36.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.04 152.53 18.65 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.151 0.5 . . . . 0.0 112.19 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.83 -31.44 70.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.852 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.08 -19.84 18.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.508 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.531 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.79 158.65 11.69 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.59 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.9 m -117.31 137.67 52.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.58 148.38 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.55 18.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.602 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 43.63 43.68 4.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.18 -14.22 61.37 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.451 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.39 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 110.517 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.73 128.24 35.38 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.527 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.4 m -96.25 162.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.834 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.9 mp0 -69.89 127.63 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.669 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 49.6 tttm -53.41 161.72 0.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 103' ' ' ASP . 9.0 m-80 33.84 35.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.261 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.974 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -89.78 130.21 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.224 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 47.1 mm-40 -129.33 148.66 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.417 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.59 121.5 19.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.351 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.27 156.51 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.462 0.649 . . . . 0.0 111.563 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.63 153.41 42.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.587 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.51 120.39 17.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.76 22.68 62.32 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.679 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.46 170.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.006 0.431 . . . . 0.0 111.237 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.5 tt0 -145.14 135.45 24.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.906 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 19.0 mt -118.36 128.14 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.45 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.41 140.77 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.233 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.0 m -140.37 158.34 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 112.145 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.13 37.24 11.47 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.815 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -80.53 140.48 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.671 0.748 . . . . 0.0 112.503 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.3 -39.35 0.71 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.35 121.76 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.09 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.54 7.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.6 t -93.51 6.52 47.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.05 29.68 4.9 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.7 mt -107.26 138.91 30.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.932 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.401 ' CD2' ' OG1' ' A' ' 40' ' ' THR . 3.0 mt -124.45 134.38 53.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.728 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.7 t -106.02 150.43 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.67 0.748 . . . . 0.0 112.318 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 68.4 mt -135.68 147.16 48.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.01 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 36.9 t -120.14 139.98 45.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.343 . . . . 0.0 111.061 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.5 mt -106.24 139.09 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.86 116.85 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.94 132.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.189 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.47 113.05 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.78 -27.47 68.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -45.04 89.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.04 -41.4 95.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -44.59 95.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -61.79 -45.85 92.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -36.96 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.9 77.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.85 -36.99 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.4 p30 44.41 -171.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.585 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -104.43 161.78 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.936 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.34 130.44 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -72.02 149.41 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -34.68 78.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 pt -101.78 139.93 21.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.903 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 9.0 tp -120.33 146.68 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.43 108.8 1.38 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.68 136.85 78.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 77.3 m -90.51 162.34 15.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -57.06 130.91 48.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -133.18 -178.47 4.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 11.5 m -82.32 99.73 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.938 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -108.54 -34.83 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.87 -47.14 55.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.82 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -61.95 -36.05 80.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.41 -37.69 81.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.682 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.09 -33.09 74.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.727 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -73.19 -35.51 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.53 -46.11 84.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.58 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.08 -23.67 65.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.605 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -47.55 79.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -75.55 -31.51 60.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.93 91.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -90.59 144.92 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.36 112.06 23.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.07 138.32 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.584 0.707 . . . . 0.0 111.823 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.27 29.19 9.11 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.445 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -67.11 -36.69 82.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.18 38.89 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.5 mm -73.08 135.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.67 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.95 -60.58 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 p -149.42 151.14 33.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.084 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.84 134.66 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.383 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.6 t -101.48 122.68 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.98 123.12 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.561 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.9 t -83.15 119.09 24.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.369 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -25.49 32.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 142' ' ' SER . 58.6 p -79.94 -2.3 43.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.446 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.67 77.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.024 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -146.03 -44.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.4 mt -109.12 141.17 22.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -72.97 133.56 20.05 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.79 138.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.563 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 162.99 28.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.553 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.57 119.66 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.999 0.428 . . . . 0.0 111.659 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.0 mt -95.12 133.63 38.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 158.49 43.85 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.4 145.96 35.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.817 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.8 m-20 -74.97 120.56 20.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.563 . . . . 0.0 111.366 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 HG13 ' CE1' ' A' ' 151' ' ' PHE . 18.0 mt -65.35 -38.81 83.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.153 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 p -60.33 -43.28 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.11 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.65 -36.79 79.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -69.87 -46.78 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.998 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -32.25 71.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -82.4 -46.79 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.56 129.07 41.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 80.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.8 -174.57 2.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.23 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 tp -130.15 145.52 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -114.82 -59.16 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.998 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -154.97 138.36 15.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.5 t -130.77 139.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.323 0.582 . . . . 0.0 112.148 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.517 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.2 m-90 -102.67 139.42 38.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.062 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -111.72 129.31 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 1.1 m-85 -120.12 145.22 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.49 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -166.86 35.16 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 12.2 mtm105 -80.94 4.52 19.18 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.68 130.54 52.73 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.533 0.206 . . . . 0.0 110.917 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.3 Cg_exo -65.33 -14.71 46.46 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.415 2.077 . . . . 0.0 111.594 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -44.12 15.62 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.929 0.871 . . . . 0.0 108.873 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -38.88 139.7 0.43 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.815 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.3 m-20 -56.35 -19.13 13.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.2 t80 -130.21 119.73 23.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.695 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -89.67 109.14 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.485 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 8.8 mt -106.03 162.39 13.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.833 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.55 129.4 49.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.093 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -62.93 79.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.831 0.348 . . . . 0.0 111.09 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 32.7 mm -105.0 139.64 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 81' ' ' ILE . 25.7 m -60.08 -31.6 70.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -68.77 -29.82 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.217 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.3 mp -102.39 152.65 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 162.24 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.878 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.59 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.14 -52.1 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.757 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -119.18 80.89 1.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 16.1 t60 -61.14 -45.87 92.89 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.786 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 39.1 p90 -147.75 159.97 43.23 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.992 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.451 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.5 tt0 -136.18 141.88 44.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 58.7 mt -116.49 127.59 74.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.943 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -111.29 151.46 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -125.07 122.76 38.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.68 -138.81 2.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.595 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 68.74 -67.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.704 0.288 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -178.03 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.11 28.28 2.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.418 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -131.34 174.62 9.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 159.66 22.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 3.1 mt -133.07 146.91 52.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.315 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -112.67 123.66 50.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.481 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.9 t30 -117.15 115.66 25.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.4 p30 -79.21 140.51 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 pt -143.46 30.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.554 0.216 . . . . 0.0 111.577 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.542 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -89.96 158.31 17.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.447 0.641 . . . . 0.0 112.243 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 m -69.68 -49.17 56.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.499 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.28 3.04 56.31 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.43 157.4 23.75 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.053 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.4 m -117.82 137.92 52.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.811 -0.694 . . . . 0.0 109.215 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.31 148.8 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.83 113.47 18.58 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.197 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 44.14 42.91 5.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.86 -14.09 61.21 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.501 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -103.42 118.5 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.54 124.56 24.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.373 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.57 163.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.039 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 tm-20 -69.85 127.03 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.3 tttm -53.68 160.98 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.964 0.411 . . . . 0.0 110.611 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.89 34.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.288 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.19 40.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.114 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -88.49 131.7 34.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.2 mm-40 -129.29 151.92 49.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.69 136.04 45.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.708 0.289 . . . . 0.0 110.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 125' ' ' SER . 28.1 tp -62.94 152.66 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.575 0.702 . . . . 0.0 111.521 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.439 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.4 152.51 44.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.653 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.46 121.36 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.36 25.29 60.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.983 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.0 t70 -49.88 165.19 0.08 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.258 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 tt0 -144.33 135.47 25.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.1 mt -114.39 128.27 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.479 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 5.9 m -104.03 141.57 35.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.607 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.6 m -140.52 158.72 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.95 9.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -84.25 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.585 0.707 . . . . 0.0 112.13 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.27 -37.05 1.43 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 24.9 t -126.16 119.13 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.446 -0.877 . . . . 0.0 108.814 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -29.39 9.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.2 p -93.46 6.46 48.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.458 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.85 27.53 5.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.479 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -106.49 138.67 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.65 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 134.43 53.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.558 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 40' ' ' THR . 36.1 t -106.54 149.43 27.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.791 0.805 . . . . 0.0 112.221 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.1 mt -136.12 143.74 44.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.597 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.37 138.03 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.2 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.482 HD13 HG21 ' A' ' 145' ' ' ILE . 23.9 mt -106.13 131.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 120.2 39.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.678 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -84.84 131.18 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.264 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -83.55 107.19 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -59.61 -26.91 65.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -59.12 -45.7 90.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.016 0.436 . . . . 0.0 110.611 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.416 ' CE1' HG13 ' A' ' 52' ' ' ILE . 2.2 t80 -58.11 -44.1 87.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.909 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -65.13 -39.4 92.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -59.06 -43.31 91.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.07 -42.64 80.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -43.15 84.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.94 -40.93 86.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -83.74 -36.67 23.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.53 86.05 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.444 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -76.18 122.55 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.33 132.28 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -110.68 -33.03 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.959 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.25 127.28 40.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.96 120.28 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.91 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.823 0.344 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tt -137.45 133.38 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -64.72 111.57 6.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.15 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.478 2.119 . . . . 0.0 112.17 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.8 m -99.53 167.87 10.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.26 147.07 29.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.09 50.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.85 104.32 16.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.937 -179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -112.33 67.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -46.99 79.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -58.98 -39.33 81.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -59.47 -39.23 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -31.92 73.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -73.01 -35.44 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.6 -42.75 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.37 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -67.18 -23.68 65.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.633 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.79 -47.4 80.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -32.18 69.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 64.63 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.96 149.04 24.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -84.62 142.11 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 136.7 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.131 0 CA-C-O 121.144 0.497 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.54 44.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.345 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.04 -39.6 83.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 111.08 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.04 38.04 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.14 136.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.295 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -90.85 -59.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.866 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.4 p -146.24 165.2 29.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.523 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 138.27 51.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.395 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.24 122.73 64.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.878 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -127.15 121.03 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.6 t -79.98 105.58 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.438 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -71.35 -25.1 62.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.874 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.83 -2.26 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.529 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.0 0.26 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.995 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -146.05 -44.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.695 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.568 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -112.01 141.78 25.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.1 Cg_endo -70.73 138.69 35.26 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.107 1.872 . . . . 0.0 112.293 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -53.83 146.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.647 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 164.23 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.58 119.65 26.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.457 . . . . 0.0 111.636 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.3 mp -91.35 132.56 36.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.475 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -140.95 155.8 46.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.314 1.054 . . . . 0.0 113.638 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.24 141.92 29.06 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.676 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -79.5 143.69 34.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 0.0 111.271 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.05 -43.97 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.717 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m -55.95 -37.2 68.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.781 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.35 -36.82 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.971 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' HA ' ' CG ' ' A' ' 63' ' ' LYS . 49.8 t -70.75 -44.67 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.234 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.95 -27.4 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.998 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -53.01 17.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.95 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.93 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.35 73.85 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 59.29 100.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -178.71 -63.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 tp -178.77 130.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -102.74 -62.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.035 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -155.2 140.04 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.624 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 5.6 t -126.32 134.66 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.233 0.54 . . . . 0.0 111.601 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.517 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.0 140.07 36.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.246 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 130.5 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -120.31 145.51 47.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.06 -167.82 36.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.954 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.3 mtp180 -83.83 3.35 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -84.85 133.12 44.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.15 -12.91 37.54 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.547 2.165 . . . . 0.0 111.678 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.79 -44.09 15.95 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.914 0.864 . . . . 0.0 108.822 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.64 138.89 2.39 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.943 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.35 -18.86 12.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.094 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 43' ' ' ILE . 9.3 t80 -129.8 123.99 32.29 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 111.392 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.38 107.93 18.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.32 78.91 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.31 -117.04 2.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.851 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -176.71 92.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.063 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 23.1 mm -109.63 129.86 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -38.28 67.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.093 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -28.05 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.877 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.48 152.11 19.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.97 162.9 13.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.723 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.11 -52.27 4.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 0.0 109.655 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HB3' HD12 ' A' ' 104' ' ' ILE . 1.8 mtpm? -117.87 83.9 2.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -64.89 -45.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.198 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.41 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 37.4 p90 -150.3 162.03 41.3 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.206 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HG2' HG22 ' A' ' 67' ' ' THR . 13.6 mt-30 -135.65 155.71 50.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.401 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 54.1 mt -126.28 132.35 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.029 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -128.66 144.67 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.998 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -125.1 131.11 53.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.142 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.77 -155.24 8.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.498 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 58.22 -165.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.53 56.37 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.74 -169.02 14.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.461 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.27 171.38 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.03 160.09 32.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -131.33 142.48 50.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.777 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.79 126.22 53.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.738 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 46.7 t30 -116.8 115.69 26.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.661 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -77.4 143.2 38.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.815 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' A' ' 90' ' ' GLN . 9.6 pt -149.6 36.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.564 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.74 151.97 19.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.11 0.481 . . . . 0.0 111.934 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.78 -31.45 70.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.854 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.61 -19.79 18.08 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.38 156.43 10.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.89 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.9 m -117.42 137.74 52.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.809 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.52 148.39 38.0 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 113.5 18.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.461 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 44.33 43.27 5.91 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.53 64.02 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.518 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -104.72 118.49 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.62 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.809 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.58 127.24 31.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.411 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 m -97.46 164.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.837 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.3 tt0 -69.89 126.71 30.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.661 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 13.5 tttm -53.28 161.42 0.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 0.0 110.593 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.33 33.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.438 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.44 145.14 40.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.936 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -90.48 130.07 36.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.048 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -129.1 148.82 51.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 tp -72.51 116.31 12.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD2' HG12 ' A' ' 147' ' ' ILE . 67.2 tp -53.46 157.54 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.406 0.622 . . . . 0.0 111.729 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 1.5 t -124.26 153.3 41.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.339 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.404 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.5 tp60 -71.47 123.51 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.3 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.28 21.81 54.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.131 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 125' ' ' SER . 22.8 t70 -55.87 175.25 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 mt-10 -145.05 135.62 24.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.7 mt -114.48 126.14 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.462 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.475 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.5 140.07 38.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.3 158.35 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.122 0.487 . . . . 0.0 112.278 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.04 27.42 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.141 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.4 t -71.37 140.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.681 0.753 . . . . 0.0 112.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.76 -37.48 0.77 Allowed Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.422 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 41.6 t -126.25 131.99 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.805 -0.697 . . . . 0.0 109.3 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -40.1 51.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 6.47 48.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 8.2 t0 -119.64 28.44 8.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.3 mt -107.26 139.65 28.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.987 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.0 tt -123.48 134.35 53.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.496 ' HB3' HG22 ' A' ' 40' ' ' THR . 39.0 t -110.06 150.64 28.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 112.36 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.0 mt -135.55 156.8 48.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.02 137.12 58.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 145' ' ' ILE . 35.3 mt -106.34 123.45 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 115.1 28.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.8 mt -84.82 134.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -82.73 113.95 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.684 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -29.53 70.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.015 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -46.09 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.793 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.47 -44.01 93.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.01 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -33.93 76.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -46.92 87.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -66.61 -46.15 76.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -39.9 92.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.953 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.21 -42.03 94.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -83.4 -37.04 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.16 35.96 0.65 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 132.44 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.49 141.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -163.86 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.99 97.36 7.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.95 140.04 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.768 0.318 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.72 137.92 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -58.58 110.07 2.33 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 -168.36 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.509 2.139 . . . . 0.0 112.363 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.15 146.63 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 91.73 3.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -167.28 160.25 13.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -117.02 94.12 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.905 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.3 p -124.47 -64.84 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -42.83 66.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -59.27 -39.81 84.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -40.68 91.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.84 96.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mm -67.78 -34.88 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.265 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -57.06 -36.11 70.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -67.33 -23.92 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.768 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.8 -47.59 79.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.298 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -70.72 -44.15 67.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -156.08 137.24 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.62 132.63 42.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.2 107.7 18.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.29 138.39 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.63 0.728 . . . . 0.0 111.736 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.25 3.21 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.449 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.02 -44.49 26.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.14 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -73.12 136.86 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.466 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -92.35 -59.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.843 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.1 p -146.67 165.46 29.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.506 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.25 138.07 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.366 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.42 122.67 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.565 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HD13 ' CG ' ' A' ' 146' ' ' PHE . 19.3 mt -129.51 119.44 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.551 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.91 108.04 13.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.379 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 -25.89 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.72 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.86 -2.22 42.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.532 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.01 76.17 0.27 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -145.73 -44.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.799 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.6 mt -111.72 141.35 24.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.759 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.7 Cg_endo -72.18 137.58 29.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.217 1.945 . . . . 0.0 112.355 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.3 mt -56.07 136.98 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.55 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.51 164.3 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.48 119.71 34.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 111.843 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.0 mp -94.24 126.59 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.38 156.67 47.94 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.038 0.923 . . . . 0.0 113.309 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.33 145.74 26.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.089 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 8.3 m-20 -75.09 128.67 36.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.0 mt -64.51 -45.03 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.223 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -56.98 -40.18 76.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.718 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.3 mm-40 -68.52 -36.96 79.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.673 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.42 -38.85 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 tp -69.4 -30.21 68.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -54.21 6.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.48 117.51 14.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -123.27 -3.81 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.409 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -40.6 2.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.9 157.73 15.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.962 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 150.35 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -68.24 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -155.08 136.9 14.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG11 ' CA ' ' A' ' 92' ' ' LEU . 15.3 t -130.08 139.11 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.196 0.522 . . . . 0.0 111.843 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.3 m-90 -105.27 139.54 39.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.259 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.79 132.19 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.3 145.61 45.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.353 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.63 -167.88 35.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.029 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtp-105 -81.1 3.31 23.83 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -84.8 132.22 46.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.534 0.207 . . . . 0.0 111.102 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.7 Cg_exo -66.24 -14.19 43.17 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.686 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.05 -42.98 16.83 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.872 0.844 . . . . 0.0 109.026 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.41 138.92 1.16 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.109 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.8 m-20 -56.47 -18.94 13.0 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.147 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE2' HG22 ' A' ' 43' ' ' ILE . 14.2 t80 -129.63 114.16 15.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.741 0.305 . . . . 0.0 111.04 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.22 107.88 19.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.555 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD13 ' CD2' ' A' ' 76' ' ' TYR . 10.7 mp -79.78 -80.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.6 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.345 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.57 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 111.195 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.8 mp -84.34 119.18 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -54.81 -29.85 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.241 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -68.51 -26.94 65.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 mt -102.71 151.18 22.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.047 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -94.1 164.12 13.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.568 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -41.59 -52.44 3.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.48 0.657 . . . . 0.0 109.832 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.96 82.51 1.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.4 t60 -60.91 -47.15 87.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.767 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.1 p90 -143.99 159.21 42.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.7 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.434 ' NE2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -136.19 138.52 42.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 68' ' ' PHE . 81.0 mt -112.56 128.67 69.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.064 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.438 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -113.31 143.26 44.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.9 tp -122.05 129.86 52.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.375 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.18 -119.2 0.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 63.92 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.992 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.11 37.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.45 24.95 8.0 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.529 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -128.9 -177.6 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.27 143.81 47.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.49 145.43 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.549 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 mt -112.51 124.09 51.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.872 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.7 t30 -118.01 115.58 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.6 p30 -76.43 139.98 41.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 17.8 pt -148.12 39.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.55 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 152.32 20.11 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.034 0.445 . . . . 0.0 111.548 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.86 -31.55 70.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.942 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.24 -19.82 17.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.69 156.48 10.17 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.945 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.43 137.95 52.17 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.89 148.62 38.38 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.51 18.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.455 177.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 44.09 43.26 5.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.66 -13.58 62.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.392 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.58 118.51 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.083 0.442 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.65 127.09 31.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.532 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.95 164.46 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.5 mt-10 -69.85 124.91 25.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.2 tttt -53.0 162.79 0.58 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.6 m-80 33.97 35.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.151 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.11 145.06 40.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.075 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -87.98 129.15 35.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -129.29 146.83 51.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.804 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.73 125.3 27.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.2 tp -58.15 155.37 11.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 1.1 t -124.83 153.04 43.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.412 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 122.48 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.3 22.02 57.86 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.93 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 125' ' ' SER . 42.1 t0 -51.69 170.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.13 135.49 24.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.072 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 20.7 mt -118.37 128.04 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.445 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.453 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.43 141.52 36.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.5 m -140.21 158.33 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.029 0.442 . . . . 0.0 112.104 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.25 43.69 8.5 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.9 t -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.707 0.765 . . . . 0.0 112.498 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.79 -37.74 0.82 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 48.2 t -126.38 120.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.037 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.26 -29.52 9.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.763 0.316 . . . . 0.0 111.459 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.8 p -93.45 6.56 47.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -130.67 30.59 4.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 141' ' ' LEU . 4.7 mt -107.11 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.614 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 140' ' ' ILE . 1.6 tt -122.17 134.49 54.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.635 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.497 ' HB3' HG21 ' A' ' 40' ' ' THR . 39.4 t -108.52 150.58 27.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.304 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 89' ' ' PHE . 74.9 mt -135.8 147.85 48.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.783 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 29.3 t -119.92 139.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mt -106.09 128.62 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 37' ' ' ILE . 3.5 m-85 -114.56 114.86 26.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.1 mt -84.75 134.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.894 0.378 . . . . 0.0 111.439 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -84.32 110.09 18.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -62.07 -26.0 68.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.99 90.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.896 0.379 . . . . 0.0 110.75 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -59.42 -44.2 92.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.983 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -65.25 -38.5 90.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.065 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -59.51 -43.91 93.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.94 -41.66 82.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.972 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.97 -38.72 91.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -88.4 -36.73 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.039 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 44.96 -172.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.49 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.26 153.31 37.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.025 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.88 138.38 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.51 149.2 44.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -66.07 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.4 pt -95.71 127.84 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.905 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.18 137.79 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -94.02 105.79 19.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 173.66 14.12 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.444 2.096 . . . . 0.0 112.43 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.8 m -150.96 147.74 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.75 176.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -129.88 151.88 49.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.75 156.67 24.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.868 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.748 0.309 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 t -68.16 -51.65 43.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -72.2 -40.04 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.811 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -58.99 -35.98 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -37.29 80.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.36 -33.44 75.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.16 -35.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.742 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.43 -41.5 80.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -67.13 -23.79 65.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.75 -47.46 80.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.281 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m -69.31 -47.0 65.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -147.38 137.97 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -95.8 132.56 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -80.06 106.65 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.54 136.75 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 123.105 0.562 . . . . 0.0 110.763 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.23 70.75 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.606 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.09 -36.28 15.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.887 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 174.6 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.19 135.38 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 113.668 -1.605 . . . . 0.0 112.554 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.72 -60.13 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.917 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -145.34 161.84 38.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.402 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.53 138.04 53.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 68' ' ' PHE . 29.8 m -110.85 122.68 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.655 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 mt -124.45 122.56 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.66 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.85 99.94 7.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.206 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -68.24 -24.33 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.928 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.47 HG21 ' HB3' ' A' ' 142' ' ' SER . 59.7 p -79.92 -2.21 42.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.603 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.81 78.01 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.878 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -147.33 -43.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.579 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -115.82 142.49 29.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.8 Cg_endo -70.12 139.03 38.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.104 1.869 . . . . 0.0 112.191 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mt -56.61 145.93 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.825 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.44 164.18 28.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.006 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.99 120.04 30.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 0.0 112.06 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.3 mp -90.26 126.78 35.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.92 157.0 47.91 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.036 0.922 . . . . 0.0 113.45 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.15 154.0 40.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.042 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -85.09 138.72 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.103 0.477 . . . . 0.0 111.308 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.35 -44.53 97.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.984 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -36.52 69.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.286 0.565 . . . . 0.0 110.538 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.416 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 5.8 mm-40 -68.53 -36.9 79.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.456 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.0 -46.72 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -27.37 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.924 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -73.55 -46.18 49.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.63 136.83 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -104.32 90.05 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 44.29 46.12 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.45 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.508 ' O ' ' CG2' ' A' ' 62' ' ' ILE . 2.0 m -138.01 53.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 61' ' ' SER . 8.9 tp 52.41 158.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.832 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 -64.92 0.47 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.195 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -141.81 134.2 28.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.546 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG13 ' HG2' ' A' ' 90' ' ' GLN . 11.9 t -131.29 139.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.127 0.489 . . . . 0.0 111.859 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -102.82 139.32 38.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.013 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.58 127.2 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.592 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.1 m-85 -110.81 145.56 37.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.773 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.59 178.52 34.65 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.697 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -68.25 -6.72 25.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.1 t-20 -84.51 133.69 43.92 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.7 0.286 . . . . 0.0 111.19 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.8 Cg_exo -70.03 -5.9 17.47 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.588 2.192 . . . . 0.0 111.654 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -42.81 17.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -43.88 137.14 3.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.14 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.34 -19.21 13.49 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 57.2 t80 -130.54 130.55 44.26 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.386 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.91 136.44 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.44 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -109.59 -53.0 2.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.08 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.62 -115.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.761 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -154.17 65.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.297 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.45 120.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.765 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.92 -24.97 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -17.37 61.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.362 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.5 mt -107.24 150.26 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.99 164.26 12.43 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.0 m-20 -43.0 -52.12 5.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.423 0.63 . . . . 0.0 109.777 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -121.44 82.76 1.98 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 11.6 t60 -62.38 -46.19 89.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.892 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 17.5 p90 -150.36 157.72 43.37 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.58 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.463 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.9 tt0 -135.84 140.07 43.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.485 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.492 HD13 ' CE1' ' A' ' 68' ' ' PHE . 3.8 mp -117.93 131.55 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.349 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.13 145.47 43.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.508 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.8 tm? -125.25 127.73 47.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.534 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.45 -134.92 3.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.694 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 68.97 -67.11 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.922 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -171.46 45.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.19 -27.49 16.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.64 158.06 34.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.13 151.29 25.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 5.5 mp -132.76 144.65 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.99 128.51 56.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.416 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.86 119.17 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.853 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.663 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.4 p30 -79.81 137.8 37.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.986 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 89' ' ' PHE . 13.6 pt -145.56 30.99 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -88.73 158.18 18.27 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.053 0.454 . . . . 0.0 111.553 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -68.94 -36.28 77.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.659 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.93 17.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.8 157.34 9.68 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.07 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.61 137.97 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.208 0.603 . . . . 0.0 109.42 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.836 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -114.3 148.57 37.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.51 18.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.492 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 44.34 43.22 5.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.33 -10.85 67.5 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.43 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -104.83 118.59 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.016 0.436 . . . . 0.0 110.69 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.5 tptt -72.97 119.12 16.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.7 166.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.177 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.5 mm-40 -69.93 128.01 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.521 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -55.13 158.0 3.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.571 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER 38.34 32.77 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.791 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.2 145.07 40.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.868 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -95.38 133.79 38.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.981 0.419 . . . . 0.0 110.959 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.7 mm-40 -129.07 152.07 49.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.547 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.47 123.92 24.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.829 0.347 . . . . 0.0 110.306 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.1 tp -54.49 155.88 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.535 0.683 . . . . 0.0 111.682 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.77 153.1 42.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 120.95 18.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.928 0.394 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 23.66 59.51 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.231 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.5 t0 -54.83 172.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.9 mt-10 -145.3 135.61 24.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.4 mt -114.09 126.14 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.462 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -104.63 142.75 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.341 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.54 158.58 24.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.082 0.467 . . . . 0.0 112.254 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.04 43.54 8.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.053 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.6 t -85.1 140.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.76 0.791 . . . . 0.0 112.428 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.32 -40.96 0.86 Allowed Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.55 120.82 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.075 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -24.96 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.731 0.301 . . . . 0.0 111.48 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 t -93.5 6.44 48.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -132.13 27.86 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.9 mt -107.11 138.82 31.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.56 134.32 53.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.556 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.7 t -108.96 150.31 27.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.6 0.714 . . . . 0.0 112.192 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 71.9 mt -135.67 148.36 48.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.549 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.92 138.12 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.04 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.37 121.11 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.086 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 117.63 34.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.431 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.5 mt -84.98 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.553 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -79.13 119.17 21.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.919 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.26 -18.7 63.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -58.76 -45.13 90.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 110.699 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -42.28 85.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.989 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -37.17 77.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.57 -47.3 79.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.99 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -68.21 -45.82 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -35.94 71.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.41 -38.76 92.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.42 -29.28 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.0 101.94 7.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.15 156.21 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.62 136.89 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.91 167.78 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -73.97 106.28 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.2 tp -82.78 120.94 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 17.8 tt -140.32 147.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -57.01 109.65 1.87 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.18 163.6 3.26 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.45 2.1 . . . . 0.0 112.188 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 3.7 m -86.68 154.24 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.39 83.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -136.15 75.47 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 17.9 t -98.8 89.2 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.804 0.335 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -90.46 -53.81 4.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -66.24 -44.34 84.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -58.96 -38.26 78.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -40.71 90.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.47 -31.92 71.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.7 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.79 -35.38 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.31 82.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.423 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -67.08 -23.83 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.647 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.239 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.3 m -78.05 -37.67 46.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -66.52 79.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -94.87 134.23 37.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.31 102.05 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.75 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.41 138.39 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.657 0.741 . . . . 0.0 111.901 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.78 29.3 1.15 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.41 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -83.35 -23.55 32.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.747 0.308 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -175.08 33.38 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.747 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -88.41 95.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.4 -177.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.4 t -51.84 -64.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 p -147.9 164.9 32.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 125.72 36.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.4 t -88.84 122.85 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.398 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mt -126.19 117.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.0 t -79.94 119.96 23.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.494 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.59 -25.59 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.736 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.501 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 9.1 p -79.85 -2.6 44.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.44 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.33 76.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.973 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -144.06 -43.65 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.7 mp -122.69 142.71 38.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.02 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.67 140.66 36.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.057 1.838 . . . . 0.0 111.799 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.61 127.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.882 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -118.0 160.62 21.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.854 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.93 120.35 38.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.031 0.443 . . . . 0.0 112.124 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.7 mt -101.1 136.38 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.175 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.747 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.09 158.26 44.04 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.68 141.87 33.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.585 -1.643 . . . . 0.0 110.585 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.406 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 8.7 m-20 -84.43 135.35 34.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mt -64.36 -45.49 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.153 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -57.45 -40.0 77.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.607 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.406 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 4.2 mm-40 -68.54 -37.22 79.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.685 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.93 -41.36 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.877 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 tp -71.04 -29.83 65.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -80.33 -51.01 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -63.0 112.28 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.74 62.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.91 -178.62 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.838 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.3 m -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.032 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.8 tp -138.08 154.85 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.228 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -112.39 -64.23 1.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.025 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -143.16 133.57 24.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.249 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -132.08 139.3 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.341 0.591 . . . . 0.0 112.026 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.539 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -101.34 139.12 37.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.208 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -110.24 130.46 55.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -120.15 145.44 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.377 -178.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.82 -166.8 35.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.839 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -83.83 5.05 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -84.82 132.13 47.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.028 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.16 -14.97 48.05 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.471 2.114 . . . . 0.0 111.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -42.94 17.38 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 138.04 3.48 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.722 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -56.59 -18.23 11.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.831 178.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.526 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.7 t80 -126.41 120.59 30.18 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.93 116.28 31.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.3 -170.08 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.15 14.98 59.3 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.841 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.88 78.55 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 111.487 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.9 mt -102.99 132.43 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.807 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -55.11 -28.63 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -47.37 17.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.16 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.73 150.73 42.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -95.9 164.24 12.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.806 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.61 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.94 -52.51 5.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.485 0.66 . . . . 0.0 109.771 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 104' ' ' ILE . 4.7 mttt -119.93 81.92 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.1 t60 -62.48 -46.14 89.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.711 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -144.22 159.62 42.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.789 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.459 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.8 tt0 -135.94 142.65 44.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 HG13 ' CE1' ' A' ' 68' ' ' PHE . 57.0 mt -116.94 128.06 74.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -111.67 147.99 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 111.714 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 tp -125.14 122.89 38.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.7 -159.25 30.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.55 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.13 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.76 -70.71 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.37 42.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -131.86 -177.58 4.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.92 148.49 28.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB3' HD23 ' A' ' 92' ' ' LEU . 3.0 mp -133.01 147.27 52.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.64 125.32 54.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.43 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.1 t30 -115.13 115.66 27.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 111.522 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.5 p30 -79.33 135.17 36.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.056 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 87' ' ' LYS . 16.3 pt -142.72 40.04 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.556 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.21 157.18 16.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.998 0.427 . . . . 0.0 111.629 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.9 m -68.98 -35.03 76.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.601 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.62 -20.03 17.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.02 161.33 11.26 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.597 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.4 m -117.64 137.94 52.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.08 148.5 38.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.38 18.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.191 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.47 42.81 5.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.76 77.22 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.484 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.69 118.58 36.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.14 131.43 41.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.213 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -103.66 166.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.87 126.18 28.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.557 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 83.6 tttt -53.36 162.14 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 110.727 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.9 m-80 34.63 34.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.243 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 145.09 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.149 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -85.87 131.0 34.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.803 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -129.35 145.69 51.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.619 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.82 114.32 10.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.339 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 125' ' ' SER . 63.5 tp -53.7 157.74 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.613 . . . . 0.0 111.53 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.8 OUTLIER -124.3 153.17 42.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.077 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.28 125.26 26.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.589 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.6 19.22 47.75 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.327 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.4 t70 -58.41 172.88 0.42 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.9 tt0 -145.19 135.58 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.439 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.6 mt -107.65 128.15 63.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.503 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.25 138.09 41.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 28.3 m -140.33 158.53 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.37 28.71 29.5 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.136 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.44 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.5 t -69.91 140.45 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.607 0.718 . . . . 0.0 112.357 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.53 0.97 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.8 t -126.39 128.72 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.629 -0.785 . . . . 0.0 109.07 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.53 -36.12 32.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.313 . . . . 0.0 111.75 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.4 m -93.4 6.31 48.58 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.5 t0 -120.31 26.51 9.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.503 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.3 mt -106.9 139.58 27.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.042 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.401 ' CD2' HD21 ' A' ' 143' ' ' LEU . 1.4 tt -120.41 134.59 55.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.707 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.501 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -112.2 134.63 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.474 . . . . 0.0 111.843 -179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.3 mm? -129.73 135.02 47.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.607 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.72 136.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mm -106.11 137.26 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.176 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.2 124.31 51.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 125' ' ' SER . 3.1 mp -99.4 130.76 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 111.663 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -82.5 116.65 22.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -62.84 -22.81 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -58.89 -45.24 90.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.752 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.0 -40.47 80.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -65.01 -34.02 77.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.943 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -38.31 86.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.021 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.54 -46.06 90.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.74 83.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.99 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.59 -47.39 85.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.987 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -81.26 -35.15 31.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p30 42.43 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.549 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.55 144.88 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.71 138.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.6 115.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -32.08 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.74 138.51 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.864 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.769 0.319 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.72 133.86 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -80.18 140.22 53.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.76 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.05 -169.79 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.322 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.04 158.69 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.02 156.18 16.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 92.41 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -101.0 98.99 9.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.9 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.785 0.326 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.462 ' HB ' ' CB ' ' A' ' 18' ' ' PHE . 3.2 p 56.01 52.24 10.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.032 0.444 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.31 86.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.91 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -68.94 -35.89 77.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.28 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' CB ' ' HB ' ' A' ' 15' ' ' THR . 3.1 t80 -60.54 -44.78 95.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -45.24 86.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.471 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 39.8 mm -63.54 -47.26 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.9 -33.58 74.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.2 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -56.07 -47.12 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.949 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 5.8 p90 -71.85 -47.12 55.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -57.92 -47.13 83.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.944 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -177.53 5.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.44 157.99 16.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.63 138.09 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.09 138.32 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.644 0.735 . . . . 0.0 111.819 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.56 44.36 0.06 OUTLIER Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.19 -38.86 60.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER 177.54 38.49 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.44 133.55 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-N 113.846 -1.525 . . . . 0.0 112.393 -177.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.26 -61.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.203 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.02 146.22 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.287 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -113.95 138.03 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 111.398 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.47 122.95 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.855 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 146' ' ' PHE . 20.8 mt -123.9 126.13 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.553 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.33 107.85 19.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.5 p -88.16 -20.02 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.756 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 142' ' ' SER . 6.6 p -79.9 -2.52 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 111.401 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.57 76.04 0.52 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.795 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -146.7 -42.15 0.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 12.4 mt -131.1 142.51 45.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.11 146.02 40.39 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.239 1.959 . . . . 0.0 112.102 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.7 mt -56.34 148.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.897 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.01 159.51 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.051 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.18 119.76 35.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.025 0.441 . . . . 0.0 112.061 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -95.54 137.49 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.708 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.58 158.76 43.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.04 141.81 36.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.655 -1.612 . . . . 0.0 110.695 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.83 134.24 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -64.27 -42.65 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.759 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -57.02 -38.66 73.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.498 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HA ' ' CG ' ' A' ' 63' ' ' LYS . 43.2 t -70.62 -41.66 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.006 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.06 -31.46 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -50.24 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.27 112.87 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -29.67 15.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.7 174.31 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 m 61.34 -168.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.995 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.4 tp -101.34 144.04 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 55' ' ' VAL . 12.6 mptt -65.89 -71.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.957 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 35.0 ttpt -149.22 121.19 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.625 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 91' ' ' ILE . 10.6 p -107.53 139.88 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.707 0.765 . . . . 0.0 112.519 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.557 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.5 m-90 -100.59 139.05 36.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.99 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 127.01 55.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -113.57 145.36 41.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.47 -178.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.63 -175.71 39.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.779 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 28.4 mtm180 -74.97 -1.59 23.3 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t-20 -84.65 132.09 47.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.594 0.235 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.0 Cg_exo -68.52 -8.28 22.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 111.669 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.84 -42.91 17.24 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.916 0.865 . . . . 0.0 108.693 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 138.2 1.46 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.66 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -56.46 -19.24 14.3 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.984 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 52.8 t80 -130.21 126.39 37.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -101.49 137.62 39.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -124.59 -68.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.185 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.3 -127.9 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.632 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 2.1 p30 -159.76 65.7 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.46 HD12 HG21 ' A' ' 81' ' ' ILE . 35.2 mt -89.7 127.75 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.82 -24.92 25.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.238 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 2.0 mmm180 -78.27 -48.23 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD23 ' CE1' ' A' ' 88' ' ' HIS . 37.9 mt -72.84 152.25 41.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.904 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.0 p -95.71 164.53 12.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.29 -53.3 5.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.382 0.611 . . . . 0.0 109.757 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.76 81.1 1.64 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -60.0 -45.61 92.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.916 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.6 p90 -145.53 159.48 43.05 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.791 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 102' ' ' ASN . 5.3 tt0 -135.99 141.39 44.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.472 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 51.4 mt -118.15 129.91 73.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.809 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.5 140.94 45.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.003 0.43 . . . . 0.0 111.729 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.41 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.7 tm? -121.27 131.94 54.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.05 -162.99 28.66 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.627 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 62.7 105.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.931 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.51 -80.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.05 37.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -125.06 -173.85 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.11 150.36 40.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 5.9 mp -132.6 145.3 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tp -112.8 127.01 56.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.219 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 90' ' ' GLN . 45.5 t30 -117.12 115.42 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.283 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.7 p30 -79.89 137.59 36.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.742 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.7 pt -146.44 40.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.557 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.54 157.84 16.17 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 120.957 0.408 . . . . 0.0 111.409 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -68.82 -34.77 76.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.61 -19.8 17.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.01 160.32 11.18 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.39 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.66 137.86 52.37 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.826 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.73 148.78 39.4 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.4 ' O ' ' CG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -124.29 113.38 18.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.423 176.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 45.75 42.52 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.318 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.97 -3.37 87.03 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.626 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.51 118.54 36.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.052 0.426 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.5 tptt -76.33 121.06 22.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.121 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -97.32 164.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.231 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 mt-10 -69.9 126.98 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 46.0 tttm -52.96 161.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.942 0.401 . . . . 0.0 110.634 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.05 34.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.312 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.36 145.08 40.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -86.11 130.01 34.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -129.48 146.77 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.589 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.8 119.32 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.198 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 tp -52.93 156.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.396 0.617 . . . . 0.0 111.654 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.61 153.32 42.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.802 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 122.76 21.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.52 48.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.315 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t70 -53.03 174.01 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 mt-10 -145.01 135.53 24.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.2 mt -110.72 123.21 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.755 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 2.9 m -104.64 140.12 38.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.15 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.32 158.71 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.982 0.42 . . . . 0.0 112.129 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 36.36 13.72 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.0 t -80.13 140.36 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 111.917 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.79 -30.11 2.69 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 82.9 t -126.46 118.55 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.425 -0.887 . . . . 0.0 108.708 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -50.73 -35.68 32.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.33 6.73 47.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -125.52 29.3 6.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.0 mt -107.13 139.36 29.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 tt -121.59 134.43 55.01 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -111.25 132.49 54.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 0.0 111.686 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.4 mt -125.01 150.22 46.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.377 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.5 140.24 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 111.349 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 145' ' ' ILE . 13.1 mt -106.22 121.74 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -107.99 110.96 22.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.491 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.99 133.93 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.47 105.78 16.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.711 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -58.38 -30.73 67.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -59.26 -45.23 91.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.85 -41.79 83.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.034 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -62.57 -35.92 81.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -63.64 -40.35 96.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.54 -44.36 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.964 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -39.63 78.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -48.07 77.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -37.03 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.5 37.32 0.95 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -125.02 150.14 47.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.01 125.73 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.11 100.74 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.03 173.91 10.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 15.7 pt -79.23 130.62 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.448 HG22 ' O ' ' B' ' 4' ' ' ILE . 0.5 OUTLIER 42.67 93.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.617 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.53 122.99 83.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.15 176.46 7.79 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.432 2.088 . . . . 0.0 112.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.04 169.62 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 146.2 24.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.66 156.58 47.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t 60.63 85.34 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -140.98 -59.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -71.94 -38.54 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.05 -39.65 82.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.912 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 10.9 t80 -60.25 -39.25 86.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.694 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -31.9 72.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.82 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.63 -46.18 84.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.358 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -67.31 -23.95 65.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.61 -47.76 78.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.289 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.23 -22.64 61.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.012 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 62.43 169.26 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.949 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 132.83 53.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -91.8 107.27 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.07 138.35 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.635 0.731 . . . . 0.0 111.759 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.92 41.6 0.12 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.474 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.47 -47.35 56.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 177.92 40.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.5 mm -85.38 95.75 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.936 -1.483 . . . . 0.0 112.677 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -45.58 -62.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.0 p -152.08 165.2 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.723 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -124.3 138.44 54.39 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.824 0.345 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.444 HG23 ' CE1' ' A' ' 76' ' ' TYR . 1.1 m -104.08 122.91 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 HD11 ' CD1' ' A' ' 146' ' ' PHE . 21.1 mt -126.83 118.88 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.659 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.92 102.31 9.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.169 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 t -67.84 -20.65 65.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.269 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 142' ' ' SER . 73.2 p -79.74 -2.41 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.47 75.88 0.26 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.831 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -145.77 -42.99 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.572 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.5 mt -112.41 142.82 27.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.881 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.35 135.18 26.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.223 1.948 . . . . 0.0 111.972 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -55.51 141.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.06 164.1 28.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -119.84 119.55 33.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.036 0.446 . . . . 0.0 111.986 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.3 mp -86.3 129.02 34.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.86 154.32 49.5 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.48 148.22 30.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.045 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 19.3 m-20 -79.62 125.33 29.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.162 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -40.98 87.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.143 0.497 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 47.9 mm-40 -68.42 -36.97 79.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.02 -40.88 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.6 tp -71.07 -29.97 65.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -49.96 10.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.66 133.29 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -110.47 -21.43 12.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -52.09 167.61 0.12 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.403 ' O ' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -59.23 126.29 27.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 61' ' ' SER . 1.3 tp 54.09 172.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -132.09 -63.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.7 OUTLIER -134.44 124.35 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' NE2' ' A' ' 90' ' ' GLN . 8.4 t -124.64 138.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 112.071 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.588 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.9 m-90 -103.65 139.07 39.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.774 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.87 126.22 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 0.0 109.931 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CD2' ' CE2' ' A' ' 89' ' ' PHE . 2.0 m-85 -107.58 145.77 32.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.53 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.657 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 167.12 -175.1 42.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.848 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -81.45 -4.82 56.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.86 137.18 38.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.325 . . . . 0.0 111.199 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.9 -5.97 16.96 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.779 2.319 . . . . 0.0 111.818 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.2 17.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.014 0.912 . . . . 0.0 108.621 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.36 137.61 4.67 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.514 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -56.34 -18.55 11.19 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.014 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 32.5 t80 -129.43 120.16 25.01 Favored 'General case' 0 C--N 1.338 0.078 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.811 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.26 112.14 23.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.743 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.52 -79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.238 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.59 -108.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.39 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -166.54 46.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 111.258 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 7.0 mt -84.3 122.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.72 -29.64 53.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.117 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.794 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -72.92 149.93 42.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.267 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 76.2 p -95.0 165.93 12.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.893 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.34 -53.65 4.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.828 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -120.79 82.7 1.95 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.2 t60 -60.42 -46.2 90.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.817 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 10.2 p90 -148.51 158.65 44.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.278 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.451 ' NE2' HG13 ' A' ' 65' ' ' VAL . 5.1 tt0 -136.03 141.29 44.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.42 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 3.8 mp -114.23 127.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -113.25 145.15 41.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.13 0.491 . . . . 0.0 112.012 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.8 tp -125.21 123.0 38.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.281 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.73 119.94 2.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.617 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -177.3 -39.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.812 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.83 -42.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.807 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.04 39.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.509 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.64 -175.21 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.95 158.42 17.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.06 143.56 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.59 122.99 49.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.88 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.2 t30 -114.94 115.72 27.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.542 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.0 p30 -77.72 138.94 39.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.7 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.0 pt -148.47 38.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.41 157.71 15.85 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.076 0.465 . . . . 0.0 111.533 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -69.07 -33.78 74.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.557 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -19.92 17.43 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.48 160.15 11.2 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.456 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.082 0.553 . . . . 0.0 109.535 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.54 148.36 38.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 113.56 18.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.372 177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.29 43.34 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.43 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.41 -9.75 72.05 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.433 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.4 tptt -73.6 122.85 22.93 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.206 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.58 164.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.215 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.6 pm0 -69.89 124.06 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.583 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.7 tttm -51.87 161.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.04 0.448 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.6 32.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.497 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.64 145.13 40.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.12 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -87.34 131.04 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.864 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 40.3 mm-40 -129.2 150.01 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.71 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.63 133.18 44.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.405 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.4 tp -64.74 155.5 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.51 0.672 . . . . 0.0 111.689 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.85 152.9 43.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.511 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 124.05 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.328 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.02 22.68 43.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.088 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t70 -53.01 172.05 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.6 mt-10 -145.05 135.8 24.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.6 mt -114.66 124.81 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.999 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.78 141.65 36.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.51 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 23.0 m -140.44 158.74 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.32 43.5 9.46 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.251 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.7 t -84.28 140.35 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.595 0.712 . . . . 0.0 112.336 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.2 -39.17 1.27 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.4 119.64 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.455 -0.872 . . . . 0.0 108.917 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.39 -26.45 4.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.8 0.334 . . . . 0.0 111.455 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -93.45 6.49 47.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.7 25.48 5.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.8 mt -107.19 138.75 31.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.17 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.61 134.57 52.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.157 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.96 150.36 28.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.676 0.751 . . . . 0.0 112.381 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -135.25 154.06 51.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.782 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.417 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -126.1 137.89 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mm -106.32 120.91 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.837 0.351 . . . . 0.0 110.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.4 m-85 -109.33 112.68 24.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.0 mt -86.01 133.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.361 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -77.49 135.2 38.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.713 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -32.56 71.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -60.29 -46.0 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.757 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -59.61 -43.97 93.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.033 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -45.86 87.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -47.17 86.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.74 -45.99 73.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.84 -35.89 77.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -42.84 92.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.73 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 159' ' ' LYS . 5.8 mm100 -84.78 -30.17 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.16 -91.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.658 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 157' ' ' GLN . 14.1 mttt -84.18 151.88 24.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.9 131.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -114.86 158.05 22.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -98.94 104.8 16.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.0 pt -84.59 133.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.876 0.369 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 19.0 tt -173.81 157.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -74.41 111.65 13.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.8 161.08 42.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 25.4 m -81.85 144.65 30.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -86.68 174.6 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -93.27 144.87 24.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 131.96 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.859 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -71.81 0.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -63.82 -33.32 75.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.95 -39.46 94.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.21 -35.45 75.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.475 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 mt -65.99 -33.3 75.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.672 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.07 -35.61 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.667 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -42.15 82.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.451 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -67.1 -23.77 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.687 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.66 -47.41 79.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -31.08 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.79 159.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.01 120.95 12.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.51 102.8 15.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.95 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -82.01 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.709 0.766 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.5 68.53 0.07 OUTLIER Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -38.52 21.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-80 179.39 38.03 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.695 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.22 135.46 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.5 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -91.92 -60.41 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.925 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 p -150.15 147.42 27.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.24 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.95 132.8 55.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.25 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -95.08 122.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -127.36 125.66 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.263 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.4 t -89.4 109.84 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.491 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -82.6 -24.76 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.776 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.508 HG22 ' CB ' ' A' ' 142' ' ' SER . 7.2 p -79.92 -2.71 44.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.712 0.291 . . . . 0.0 111.496 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 77.5 0.3 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.965 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -147.46 -39.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -126.44 141.69 40.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.7 Cg_endo -72.09 145.66 44.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.171 1.914 . . . . 0.0 112.139 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mt -60.82 149.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.711 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -142.71 164.08 31.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.092 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.92 119.89 35.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 111.881 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.5 mt -97.65 137.21 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.695 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.13 158.78 43.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.94 141.98 25.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.845 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 1.1 m-20 -76.55 126.09 30.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.325 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.0 mt -64.65 -45.24 95.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.188 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -60.79 -39.44 88.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 0.0 110.634 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 33.5 mm-40 -68.48 -36.87 79.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.728 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.43 -37.85 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.18 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -27.82 64.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.393 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -93.44 -23.29 18.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.327 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.82 119.36 9.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.018 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.96 64.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -145.94 173.97 11.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -55.21 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.7 tp -123.91 156.96 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 -75.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt -121.68 133.89 54.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.42 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 16.5 t -131.96 139.16 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.245 0.545 . . . . 0.0 111.852 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.572 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -101.11 139.26 37.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.006 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.51 129.04 56.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -118.46 145.29 45.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.523 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.63 -169.05 37.0 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.762 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -80.76 3.57 21.91 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.76 132.56 45.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 0.0 111.134 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.19 -14.16 43.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.45 2.1 . . . . 0.0 111.637 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.78 -42.73 17.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.861 0.838 . . . . 0.0 108.909 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.42 139.02 1.14 Allowed 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.021 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 m-20 -56.3 -18.99 12.3 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.977 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.0 t80 -129.8 123.09 30.09 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 120.731 0.3 . . . . 0.0 111.083 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.07 107.9 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.417 ' CB ' HG12 ' A' ' 43' ' ' ILE . 1.5 pp -111.14 177.35 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.29 131.77 50.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.618 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -70.97 88.26 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.33 135.08 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.06 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.27 -31.87 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.091 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -49.26 57.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.189 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 88' ' ' HIS . 25.6 mt -74.54 151.21 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.996 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 p -95.38 164.15 12.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.55 -52.63 4.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.424 0.631 . . . . 0.0 109.648 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.97 82.35 1.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -60.88 -46.13 91.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.761 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.7 p90 -143.46 160.0 41.37 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.907 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.452 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.97 142.33 44.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.462 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 67.6 mt -117.67 131.52 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.805 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -118.93 140.21 50.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.049 0.452 . . . . 0.0 111.96 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.419 HD21 ' CE2' ' A' ' 151' ' ' PHE . 10.4 tp -125.19 122.9 38.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.237 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.07 -130.71 2.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.941 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.35 172.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.398 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 59.49 167.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.981 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.66 21.22 42.36 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.637 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -108.98 -177.15 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.828 0.346 . . . . 0.0 110.801 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.48 160.06 29.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.6 mt -125.84 141.01 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.099 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.69 122.24 47.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.386 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.5 t30 -113.95 115.69 28.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.978 0.418 . . . . 0.0 111.404 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.6 p30 -78.59 137.52 37.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.002 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -145.93 40.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.578 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.13 161.07 13.9 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.01 0.433 . . . . 0.0 111.712 -179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.6 m -69.05 -38.63 79.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.799 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -20.1 17.22 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.55 161.02 10.96 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.609 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.2 m -117.59 137.97 52.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.565 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.97 148.56 36.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.5 18.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.219 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 44.52 43.24 6.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.87 -10.86 68.65 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.514 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -104.61 118.5 36.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.5 tptm -73.5 131.11 41.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.228 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -102.79 165.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.193 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.5 tt0 -69.9 126.4 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.573 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.0 tttp -53.75 162.5 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 110.619 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.32 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.111 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.53 145.07 40.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.109 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -88.75 130.71 35.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.968 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -129.12 147.56 50.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -72.6 119.23 16.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.422 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' HG ' ' N ' ' A' ' 125' ' ' SER . 65.6 tp -54.68 157.79 2.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 111.537 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.31 153.25 42.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.26 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 122.41 20.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.458 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.62 23.01 54.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.138 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.7 t70 -57.41 173.86 0.24 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 59.9 tt0 -145.13 135.61 24.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.041 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.8 mp -109.24 127.37 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.62 139.01 40.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.528 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.29 37.41 15.02 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.15 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.3 t -77.58 140.39 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.671 0.748 . . . . 0.0 112.202 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.82 -39.59 1.26 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.9 t -126.45 123.89 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.078 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.32 -29.59 10.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.808 0.337 . . . . 0.0 111.454 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -93.41 6.51 47.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.15 23.02 8.55 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -106.8 139.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.24 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.7 tt -124.4 134.65 53.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.508 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.92 129.12 55.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.177 0.513 . . . . 0.0 111.606 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 20.9 mt -122.53 136.78 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.677 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.85 140.17 31.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.331 . . . . 0.0 111.12 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.479 HG23 HD11 ' A' ' 145' ' ' ILE . 25.3 mt -105.97 136.39 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.82 111.78 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.86 128.65 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.482 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -75.87 134.82 40.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -74.03 -29.43 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.204 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -59.57 -45.64 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.419 ' CE2' HD21 ' A' ' 93' ' ' LEU . 5.1 t80 -63.06 -42.69 99.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.21 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -50.03 67.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.277 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -59.37 -36.94 76.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.108 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -68.0 -45.98 72.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.71 -35.94 77.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.797 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.54 -39.63 91.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.93 -36.99 15.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.834 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 44.44 -171.5 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.583 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.73 115.36 13.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.877 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.32 138.45 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -40.15 43.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -146.6 123.85 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.67 130.46 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.825 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 tt -130.4 114.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.67 119.3 57.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.3 55.73 5.51 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 112.552 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m 61.66 149.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.947 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -56.47 175.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -88.29 132.03 34.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -116.86 130.13 56.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.86 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -106.84 -58.41 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.83 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -36.04 74.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -36.95 85.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -45.02 77.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.789 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.8 mm -66.83 -35.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.075 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.05 -43.03 81.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.2 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -67.14 -23.87 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.403 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.57 -47.43 79.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -41.44 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -59.08 -66.62 0.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -83.8 130.99 34.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.13 124.8 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.07 138.36 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.713 0.768 . . . . 0.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 57.26 2.34 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.542 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.82 -43.42 94.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -177.19 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -76.03 135.2 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 113.617 -1.629 . . . . 0.0 112.696 -177.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.79 -61.09 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.86 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.1 p -144.52 145.98 32.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.076 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 138.13 50.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.493 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -105.33 122.69 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.39 118.44 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -79.98 115.22 19.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.369 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -82.57 -26.0 32.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.885 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 142' ' ' SER . 67.1 p -79.9 -2.24 42.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.722 0.296 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.16 76.29 0.3 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.98 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -146.02 -43.76 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mt -114.13 141.3 26.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.1 Cg_endo -72.98 135.48 23.28 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.21 1.94 . . . . 0.0 112.198 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.0 mt -55.47 134.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.538 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.04 164.29 20.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.49 119.83 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.214 0.531 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.6 mt -97.38 131.53 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.85 159.0 44.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -178.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.83 141.76 30.52 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.475 178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.487 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -82.75 147.16 28.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 111.436 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 mt -64.18 -45.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.069 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.8 t -56.53 -40.32 74.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.873 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.5 -36.8 79.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.444 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' HA ' ' CG ' ' A' ' 63' ' ' LYS . 40.7 t -69.79 -41.8 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.2 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.03 -28.34 64.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -49.03 38.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.23 116.81 22.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.54 -20.03 8.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.297 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -106.12 -70.66 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.062 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 177.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 tt -75.02 147.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -81.81 -78.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.338 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 ttpt -143.56 139.41 29.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 111.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG12 ' CA ' ' A' ' 92' ' ' LEU . 18.1 t -133.34 139.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.226 0.536 . . . . 0.0 112.007 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -103.42 139.08 39.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.99 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.93 130.24 56.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -120.05 145.27 47.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.49 -167.1 35.04 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.49 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.75 1.96 21.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.56 127.01 67.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.464 0.174 . . . . 0.0 110.948 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -63.85 -14.33 42.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.317 2.012 . . . . 0.0 111.47 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -42.17 17.95 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.738 0.78 . . . . 0.0 108.925 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.09 138.61 1.07 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.592 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 t70 -56.35 -18.63 11.48 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.164 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.47 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 16.0 t80 -129.75 116.06 18.21 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -89.15 107.94 19.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.586 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.417 ' HA ' HG12 ' A' ' 43' ' ' ILE . 57.0 mt -71.87 -76.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.87 -98.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.465 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -162.89 53.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.334 . . . . 0.0 111.167 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 4.1 mp -93.02 117.67 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -28.98 56.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -47.88 40.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 16.1 mt -72.78 146.5 46.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.2 p -94.29 163.52 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.723 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.552 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -41.43 -52.11 3.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.589 0.709 . . . . 0.0 110.007 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -121.34 81.37 1.78 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.9 t60 -61.21 -46.49 90.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.609 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.8 p90 -144.86 157.15 44.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.722 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' A' ' 102' ' ' ASN . 4.8 tt0 -136.15 138.92 42.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 HG22 HD12 ' A' ' 91' ' ' ILE . 58.5 mt -113.0 127.86 70.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.678 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' CA ' HG12 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -110.01 149.23 30.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.493 . . . . 0.0 111.836 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -123.31 123.85 41.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.117 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.44 -174.21 29.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.716 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 61.74 18.51 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.636 0.255 . . . . 0.0 111.22 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 50.73 89.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.281 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.01 -65.42 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.661 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -56.38 134.13 53.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 111.109 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.95 153.38 24.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.764 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -133.17 145.29 50.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.9 mt -112.73 122.91 49.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.8 t30 -115.62 115.72 26.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 112.013 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.1 p30 -77.0 134.66 38.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 87' ' ' LYS . 13.0 pt -142.0 39.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -96.62 159.7 14.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.956 0.408 . . . . 0.0 111.778 -178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.0 m -68.88 -37.97 79.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -19.77 17.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.71 162.97 11.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.432 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.35 137.85 52.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.863 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.11 148.36 35.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.43 18.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.302 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 42.75 44.1 3.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.527 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.65 -13.55 63.84 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -103.26 118.56 37.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.863 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.6 tptm -73.49 124.2 25.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.487 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -91.53 161.88 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.3 pt-20 -69.82 123.07 20.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.499 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 72.0 tttt -50.08 161.65 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.15 35.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.332 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.21 145.05 40.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.387 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.78 125.43 32.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.718 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.54 147.16 51.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.28 115.18 16.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.122 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.43 162.5 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 111.912 -179.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.93 153.41 42.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.421 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.37 119.92 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.543 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.39 56.89 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.434 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.7 t70 -60.55 -179.01 0.1 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 mt-10 -145.28 135.64 24.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.296 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.7 mt -113.72 127.72 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.458 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.46 141.09 36.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.574 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.28 158.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 43.52 8.71 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.026 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.3 t -84.35 140.42 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.663 0.744 . . . . 0.0 112.396 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.06 -38.81 0.83 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.5 t -126.42 123.15 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.166 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.4 -29.83 11.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -93.57 6.41 48.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -127.56 27.43 5.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -107.04 139.25 29.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.032 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.21 134.43 53.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.618 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.508 ' HB3' HG22 ' A' ' 40' ' ' THR . 39.7 t -108.71 150.51 27.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.597 0.713 . . . . 0.0 112.145 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.4 mt -135.66 158.13 45.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.415 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 22.0 t -126.52 130.53 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.888 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.64 120.8 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.29 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.29 112.17 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.586 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.2 mt -84.79 131.06 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.94 117.44 17.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.846 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -33.69 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.036 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -59.95 -45.81 91.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.91 -42.73 85.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.084 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -34.86 74.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -61.13 -43.49 98.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -62.47 -45.91 90.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.27 -36.01 80.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -62.52 -36.61 83.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -91.97 -36.51 13.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.983 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 p30 44.94 -172.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.593 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -77.74 156.85 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.63 121.05 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.88 -170.02 2.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 30.61 3.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.57 112.15 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.878 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p30 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.809 0.338 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.456 HD12 HG21 ' B' ' 4' ' ' ILE . 13.4 tt -165.59 139.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.76 124.76 77.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.28 139.22 34.65 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.503 2.135 . . . . 0.0 112.345 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.89 168.64 10.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -71.29 129.85 39.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -151.8 133.17 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.2 98.25 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.919 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.5 m -155.7 -50.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -64.58 -44.83 89.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -35.96 74.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -44.23 94.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -44.68 94.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -65.87 -35.0 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -57.14 -36.94 71.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -67.24 -23.9 65.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.53 79.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -36.15 82.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 60.1 84.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -99.12 139.75 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -84.4 103.61 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.94 138.34 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.631 0.729 . . . . 0.0 111.76 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 94.04 2.33 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.504 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -80.22 -34.06 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.953 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 178.61 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.714 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -74.02 133.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.465 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -90.74 -60.81 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -146.55 147.59 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.178 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.08 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 t -105.49 122.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -126.87 121.17 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.449 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.8 t -79.87 115.73 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -87.01 -25.05 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.742 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 142' ' ' SER . 30.4 p -79.89 -2.13 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.599 0.238 . . . . 0.0 111.441 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.36 76.99 0.26 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.897 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -147.26 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.565 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -122.17 142.08 35.93 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.0 Cg_endo -72.43 145.05 41.99 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.148 1.899 . . . . 0.0 112.228 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -56.61 147.35 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.49 161.38 35.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.198 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -118.63 119.74 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 111.707 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.4 mt -99.11 132.56 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.714 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.35 158.58 43.9 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.58 141.74 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.501 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -83.5 134.39 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.245 0.545 . . . . 0.0 111.331 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.5 -45.09 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.906 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.4 -39.18 86.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.0 110.585 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm100 -68.49 -36.81 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.579 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -65.88 -48.21 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.801 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.05 -32.85 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -77.72 -42.55 33.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.95 120.16 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.975 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.34 70.21 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -145.58 171.4 14.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.2 p -71.13 -30.65 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tp -114.66 147.54 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -103.91 -66.66 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.5 ttpt -150.72 131.46 14.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.0 t -125.79 139.14 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.239 0.542 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.505 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.2 m-90 -102.81 139.44 38.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.15 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.38 128.88 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -118.35 145.34 45.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.477 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.02 -166.59 35.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.644 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -84.34 5.42 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -84.95 132.47 45.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.72 -14.79 46.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.449 2.099 . . . . 0.0 111.462 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -43.31 16.96 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.854 0.835 . . . . 0.0 108.76 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.05 138.96 1.92 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.739 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.35 -18.86 12.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.922 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.505 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.5 t80 -129.78 125.23 35.3 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.778 0.323 . . . . 0.0 111.257 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -103.28 112.84 25.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.614 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.29 72.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.26 -131.87 19.83 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.919 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.69 84.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.046 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.59 128.6 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -28.77 63.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -27.76 61.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.059 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -99.5 152.12 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.956 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.8 p -94.96 166.65 11.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.533 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.561 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.58 -53.85 5.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.353 0.597 . . . . 0.0 109.596 179.26 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.14 83.75 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -60.33 -46.27 90.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.8 p90 -144.59 160.27 41.43 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.171 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.5 tt0 -135.78 141.32 44.77 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.196 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 49.5 mt -117.3 132.18 67.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.027 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -110.93 151.59 27.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.087 0.47 . . . . 0.0 111.612 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -125.05 122.9 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.91 165.44 19.87 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.711 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -58.66 -30.37 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.757 0.313 . . . . 0.0 111.05 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.07 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.95 29.7 8.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -133.73 -178.31 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.826 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.23 160.11 37.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.6 mt -129.67 143.92 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' CD2' HD12 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.66 127.47 56.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.538 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.5 t30 -118.9 115.5 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 0.0 111.493 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.674 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.3 p30 -78.84 138.37 38.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.9 pt -145.74 40.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 150.94 21.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.037 0.446 . . . . 0.0 111.798 -178.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -68.62 -31.56 70.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.769 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.14 -19.71 17.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.34 10.61 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.53 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.19 137.71 52.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.805 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.76 148.58 39.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 113.59 18.61 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.349 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 43.97 43.44 5.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.45 -12.55 64.65 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.485 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.42 118.53 36.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 110.56 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.805 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.83 130.63 41.52 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.501 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.1 m -100.05 163.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.045 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 pm0 -69.98 124.69 24.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.9 tttt -50.99 161.01 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 111.012 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 34.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.401 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.37 145.16 40.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -85.49 128.55 34.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.34 147.53 51.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.705 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.89 120.1 18.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.31 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.7 tp -56.81 157.54 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.291 0.567 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.38 153.24 42.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.61 121.8 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.95 24.57 54.55 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.19 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.8 t70 -57.72 175.6 0.18 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.902 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 7.6 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.035 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.418 HD12 ' CD2' ' A' ' 101' ' ' LEU . 6.7 mt -113.14 128.19 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.383 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.19 138.88 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.805 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.26 158.41 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.35 21.46 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.936 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.0 t -75.07 140.43 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.661 0.743 . . . . 0.0 112.428 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.26 -37.8 0.85 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.38 123.26 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.96 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -32.54 16.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.783 0.325 . . . . 0.0 111.585 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 6.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -125.86 29.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.29 139.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 tt -124.4 134.41 53.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.577 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.431 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 45.7 t -112.71 150.27 31.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.481 0.658 . . . . 0.0 112.424 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 142' ' ' SER . 0.3 OUTLIER -134.1 148.5 51.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.14 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.411 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 16.6 t -114.04 135.5 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 145' ' ' ILE . 27.9 mt -106.3 122.79 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 120.57 42.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.55 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.416 HG12 ' CD2' ' A' ' 124' ' ' LEU . 6.1 mt -84.59 134.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.826 0.346 . . . . 0.0 111.322 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -84.29 123.37 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.8 -17.97 62.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -57.44 -44.4 84.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.51 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -44.11 90.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.711 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -65.21 -33.93 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.85 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -46.31 71.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -59.89 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.94 -39.1 84.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.803 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -78.5 -37.07 44.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 p30 42.43 44.03 3.31 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.488 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.27 114.01 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.73 131.9 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.18 -176.7 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.36 167.84 15.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.7 126.4 40.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.863 0.363 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.14 142.38 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -90.05 107.59 20.38 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.11 -169.08 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.444 2.096 . . . . 0.0 112.389 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -157.2 157.76 34.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -93.17 142.3 27.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -122.25 151.24 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 16.2 m 60.43 179.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.894 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -59.01 -39.08 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -39.11 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.81 -31.98 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.99 -35.53 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.38 -45.34 84.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -67.07 -23.78 65.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.581 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.63 -47.62 79.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -76.4 136.09 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.533 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.944 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.32 -60.0 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.803 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.4 p -145.97 165.27 29.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.281 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.44 122.79 34.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.386 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.659 HG11 ' HE2' ' A' ' 68' ' ' PHE . 5.4 m -90.35 122.86 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.922 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.833 HG23 HG12 ' A' ' 45' ' ' ILE . 20.4 mt -126.34 120.46 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.444 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.746 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.3 t -80.83 121.31 25.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -26.17 19.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.379 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' H ' ' A' ' 142' ' ' SER . 40.2 p -79.87 -2.18 42.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.579 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.32 76.49 0.29 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.807 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HB2' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -146.32 -42.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -117.72 141.26 28.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.8 141.06 36.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.152 1.902 . . . . 0.0 112.167 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.833 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -55.9 133.56 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.82 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -127.1 164.05 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.137 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.85 119.78 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.814 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -87.18 130.45 34.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.463 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.944 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.91 155.99 48.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.287 1.041 . . . . 0.0 113.497 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.226 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 16.4 ttpt . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.9 p -111.35 140.08 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.814 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.6 m-90 -100.67 139.34 36.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.107 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 131.41 55.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -120.2 145.58 46.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.659 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.45 -169.18 36.18 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.768 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.0 mtm180 -81.95 3.75 25.26 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.744 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.6 t-20 -84.82 132.65 45.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.572 0.225 . . . . 0.0 111.007 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.88 -13.3 39.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.514 2.143 . . . . 0.0 111.63 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.92 17.41 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.914 0.864 . . . . 0.0 108.847 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.54 137.52 3.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.805 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -18.09 11.01 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.226 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 9.8 t80 -129.06 119.43 24.19 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.031 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.97 111.41 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.547 ' HA ' HG12 ' A' ' 43' ' ' ILE . 1.7 mt -88.07 -65.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.06 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.169 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.78 54.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 34.1 mm -75.06 126.66 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 p -54.94 -40.83 70.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.277 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -68.81 -44.9 72.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -72.99 150.07 42.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -95.69 166.83 11.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.78 -53.15 6.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 109.805 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HB2' HG22 ' A' ' 67' ' ' THR . 9.7 ptmt -120.9 81.83 1.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.7 t60 -60.4 -46.15 91.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.829 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.8 p90 -142.45 160.2 40.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.077 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.712 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.99 143.87 45.05 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.713 ' C ' HG23 ' A' ' 65' ' ' VAL . 69.9 mt -120.03 125.68 74.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.632 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.9 pt? -114.17 137.3 51.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.787 HD22 HG11 ' A' ' 33' ' ' VAL . 18.9 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.307 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.8 mp -133.14 147.13 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.224 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 145' ' ' ILE . 8.2 mp -112.62 125.66 54.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD22 ' A' ' 92' ' ' LEU . 41.1 t30 -116.69 115.63 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.8 p30 -80.44 132.6 35.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.808 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -139.57 41.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.95 157.76 16.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.018 0.437 . . . . 0.0 111.473 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -68.84 -36.35 78.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.445 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -19.84 17.34 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.46 161.45 11.25 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.489 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.0 m -117.6 137.99 52.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.6 148.38 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -124.33 113.54 18.37 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 45.78 42.75 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.37 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.84 -5.5 84.87 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.493 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.39 118.72 37.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.108 0.454 . . . . 0.0 110.868 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.4 tptm -75.11 126.91 32.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.327 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -101.52 165.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tt0 -69.86 125.92 28.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 47.9 tttm -52.12 161.82 0.56 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.91 0.386 . . . . 0.0 110.558 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.63 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.281 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.23 145.07 40.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.251 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.481 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.4 m120 -86.67 130.13 34.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.8 mm-40 -129.39 147.89 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.477 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.5 tt -72.8 135.99 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.331 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.848 HD21 HG12 ' A' ' 147' ' ' ILE . 63.4 tp -65.62 155.23 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.463 0.649 . . . . 0.0 111.733 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.95 153.12 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.515 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.67 123.13 21.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.139 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.38 46.15 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.063 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.5 t70 -52.14 170.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.02 135.56 24.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 145' ' ' ILE . 11.3 mt -113.52 126.68 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.48 138.57 40.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.745 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.8 m -140.27 158.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.84 31.49 23.62 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.6 t -73.41 140.36 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.604 0.716 . . . . 0.0 112.217 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.01 -39.33 0.88 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 21.6 t -126.23 128.31 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.017 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.4 -35.42 28.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.38 6.55 47.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.92 27.32 8.16 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.12 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.172 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -124.35 134.48 53.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.434 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.588 ' C ' HD22 ' A' ' 143' ' ' LEU . 41.6 t -112.61 150.41 31.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.671 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.746 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.91 152.4 50.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.379 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.9 t -119.82 140.08 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.34 . . . . 0.0 111.334 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 130' ' ' ILE . 47.7 mt -106.32 121.0 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -109.11 114.38 28.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.512 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.848 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.86 132.76 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.551 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.8 179.768 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -38.88 86.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -35.45 77.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.843 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -42.17 88.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.22 -35.14 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.22 -43.35 82.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.853 0.359 . . . . 0.0 110.377 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.428 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.47 79.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.827 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -75.35 135.04 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.561 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.26 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.838 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -146.49 147.21 30.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.326 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 128.17 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.265 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.5 m -94.58 122.9 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.798 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -123.15 111.38 29.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.655 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.04 106.42 18.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -97.76 -10.76 24.29 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.682 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.1 p -79.94 -2.59 44.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.408 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.45 84.26 0.69 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.432 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.928 ' NE2' HD13 ' A' ' 141' ' ' LEU . 15.1 pt20 -161.72 -47.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.422 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.58 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.6 mt -134.16 142.79 44.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.711 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' HG23 ' A' ' 43' ' ' ILE . 63.4 Cg_endo -75.92 146.01 29.03 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.255 1.97 . . . . 0.0 111.794 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 36.9 mt -52.24 136.77 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.969 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -132.08 161.89 32.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 120.02 36.68 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.712 HD11 HG13 ' A' ' 36' ' ' VAL . 4.1 mt -96.04 136.96 35.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 159.07 43.91 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -178.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.709 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.7 ttpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.848 0.356 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.5 t -132.55 139.48 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.22 0.533 . . . . 0.0 111.761 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -100.88 137.67 38.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.69 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.01 127.48 56.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.213 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.25 145.53 42.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.66 -173.06 35.63 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.663 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 14.3 mtm105 -77.79 4.87 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 11.4 t-20 -84.97 131.91 47.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 0.0 111.043 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 Cg_exo -66.07 -14.21 43.35 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.362 2.041 . . . . 0.0 111.573 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.01 -42.61 17.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.946 0.879 . . . . 0.0 109.014 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.65 138.19 1.44 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.096 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.39 -18.21 10.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' A' ' 36' ' ' VAL . 6.6 t80 -128.48 112.22 14.12 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.79 0.328 . . . . 0.0 111.222 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -90.46 118.28 29.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.415 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -126.95 172.4 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.33 137.09 45.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.577 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -71.51 81.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 83' ' ' ARG . 27.8 mm -88.9 127.31 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.955 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -55.04 -24.93 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.665 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.03 -46.07 15.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.157 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 132' ' ' VAL . 42.3 mt -72.7 152.18 41.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.036 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.4 p -95.88 166.03 11.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.693 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.607 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -44.14 -53.77 6.17 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 109.614 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.36 81.85 1.75 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -59.54 -45.89 90.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.764 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.2 p90 -145.45 157.61 43.98 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.772 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -136.06 141.06 44.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.606 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 65' ' ' VAL . 53.6 mt -116.53 129.69 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.022 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -117.13 140.83 49.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.105 0.479 . . . . 0.0 111.602 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.803 HD22 HG11 ' A' ' 33' ' ' VAL . 9.8 tp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.258 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.748 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.1 mp -133.03 145.09 50.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.591 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 145' ' ' ILE . 10.5 mp -112.74 122.05 46.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.01 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.582 ' HB2' HD21 ' A' ' 92' ' ' LEU . 57.4 t30 -116.77 115.63 25.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 111.56 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.1 p30 -78.31 135.91 37.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.0 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -143.84 39.08 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.98 160.4 14.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.043 0.449 . . . . 0.0 111.5 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.1 m -68.96 -36.46 77.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.615 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.49 -20.06 17.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.34 162.07 11.55 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.201 -0.999 . . . . 0.0 113.481 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.69 137.84 52.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.852 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.72 148.39 36.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.46 18.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.198 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m120 44.39 42.85 5.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.358 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.37 -5.08 85.33 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.464 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -104.86 118.51 36.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 0.0 110.738 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.852 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.0 tptp -75.67 126.04 30.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.156 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.789 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.2 m -102.69 163.13 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.289 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.91 127.1 31.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.7 tttp -52.44 163.44 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.197 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 35.43 35.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.948 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -112.03 137.2 50.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.107 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.466 ' HB3' HD23 ' A' ' 100' ' ' LEU . 55.3 m-20 -80.4 130.54 35.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 27.2 mm-40 -129.54 146.9 51.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 tp -72.85 136.13 45.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -63.72 157.45 24.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.48 0.657 . . . . 0.0 112.006 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.475 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.44 153.37 43.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.217 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.456 ' OE1' HD12 ' A' ' 147' ' ' ILE . 15.2 mm100 -71.55 115.6 10.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.38 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.26 30.02 63.8 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.702 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.457 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.1 t70 -55.23 174.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.973 0.416 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.907 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.21 135.47 24.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.015 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 10.4 mt -111.33 126.3 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.549 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.564 HG22 ' CG2' ' A' ' 140' ' ' ILE . 8.2 m -104.87 137.66 42.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.0 m -140.32 158.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 112.181 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.59 16.26 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.17 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.8 t -74.53 140.41 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.684 0.754 . . . . 0.0 112.172 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.23 -41.07 1.08 Allowed Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 43.1 t -126.5 123.14 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.541 -0.83 . . . . 0.0 108.929 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.29 -28.05 7.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.427 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -93.64 6.53 48.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.62 24.37 7.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.564 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.47 138.23 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.928 HD13 ' NE2' ' A' ' 42' ' ' GLN . 9.9 mt -125.19 134.77 52.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.339 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.682 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -104.65 139.07 40.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.213 0.53 . . . . 0.0 111.897 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.2 mp -125.06 152.51 44.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.154 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.907 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.5 t -120.77 134.18 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.869 0.366 . . . . 0.0 111.618 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 36.3 mt -106.31 121.74 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -110.24 119.02 37.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.599 HD13 HD22 ' A' ' 124' ' ' LEU . 5.9 mt -84.71 134.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 t30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -60.54 -42.21 96.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 -38.05 80.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.9 -32.27 72.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.675 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.11 -35.5 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.734 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -39.98 77.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.446 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -67.1 -23.8 65.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.794 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.68 -47.34 80.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.224 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.832 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.711 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -75.11 134.49 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.262 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.75 -61.58 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.421 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.453 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.2 p -155.19 138.03 15.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.443 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -113.99 138.45 50.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.3 t -96.13 132.14 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.388 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.788 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.71 116.89 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 108.99 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.245 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.4 p -93.61 -20.12 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.035 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.852 HG21 ' OG ' ' A' ' 142' ' ' SER . 48.9 p -79.82 -2.99 45.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 111.499 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 74.27 75.37 0.78 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.562 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 8.8 mt-30 -147.95 -41.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.676 0.274 . . . . 0.0 111.223 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.6 mt -134.01 141.49 39.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.2 Cg_endo -73.99 146.07 36.6 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.179 1.919 . . . . 0.0 111.92 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.788 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -56.13 151.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.187 0.517 . . . . 0.0 111.956 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 2.0 ttt-85 -149.69 159.18 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.26 121.59 40.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 112.333 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD11 ' HZ ' ' A' ' 68' ' ' PHE . 8.1 mt -94.56 137.76 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.005 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 158.17 43.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.117 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.0 ttpt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.652 0.263 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.8 t -127.45 139.47 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.312 0.577 . . . . 0.0 112.186 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.636 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -107.78 138.56 43.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -110.69 126.23 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.746 ' CE2' HG21 ' A' ' 36' ' ' VAL . 2.5 m-85 -107.37 145.78 32.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.818 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.9 -178.58 40.54 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.782 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -78.16 -3.38 42.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 136.83 38.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.27 -6.12 17.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.796 2.331 . . . . 0.0 111.736 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.27 14.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.956 0.884 . . . . 0.0 108.684 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.07 139.23 2.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.457 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -18.62 10.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.174 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.1 t80 -129.36 131.65 46.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.04 131.09 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -133.18 -178.58 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.45 135.64 39.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -69.93 89.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' H ' ' A' ' 83' ' ' ARG . 25.2 mt -104.35 127.75 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -54.98 -25.02 26.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.325 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -75.62 -46.74 29.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.227 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 132' ' ' VAL . 39.8 mt -72.74 151.68 42.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.748 0.309 . . . . 0.0 111.306 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -95.56 166.16 11.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.893 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.22 -54.39 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 109.858 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.9 mttp -118.82 82.84 1.92 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -60.87 -46.79 89.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.652 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 p90 -147.71 159.31 43.94 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.278 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 65' ' ' VAL . 35.7 tt0 -135.95 141.46 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 65' ' ' VAL . 41.4 mt -114.37 132.33 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.251 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -122.0 144.46 48.88 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 111.341 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.762 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.544 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 110.821 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.9 mt -133.13 140.38 47.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.249 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -112.56 126.08 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.202 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -115.8 115.49 26.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.784 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.68 140.81 38.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.7 pt -149.22 38.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.51 159.04 15.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.007 0.432 . . . . 0.0 111.625 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.1 m -69.02 -34.96 76.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.647 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 -19.97 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.71 162.81 12.04 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.533 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.9 m -117.53 137.81 52.32 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.71 148.36 38.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.526 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.14 113.48 18.4 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.361 177.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 44.28 42.88 5.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -10.39 71.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.474 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.96 118.54 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.09 0.445 . . . . 0.0 110.656 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.34 130.91 41.2 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.56 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.784 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -101.87 164.58 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.851 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 tt0 -69.98 126.67 30.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.499 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 tttt -52.69 161.6 0.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.545 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 35.02 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.293 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.0 40.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.114 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.631 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.0 m-80 -89.86 126.67 35.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.76 ' O ' HD23 ' A' ' 100' ' ' LEU . 39.4 mm-40 -129.3 147.28 51.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.834 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.9 120.95 19.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.984 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 101' ' ' LEU . 1.3 mm? -57.83 165.51 1.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.756 0.789 . . . . 0.0 112.076 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.38 153.18 43.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.195 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.489 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.63 120.36 17.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.94 26.39 60.7 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.246 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.1 t0 -60.82 178.54 0.23 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.914 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.7 mt-10 -144.99 135.57 24.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -112.64 126.92 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.457 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.49 141.63 36.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.101 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.41 158.53 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.99 9.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.192 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -83.69 140.37 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.646 0.736 . . . . 0.0 112.228 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.46 -39.29 1.31 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.52 120.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.592 -0.804 . . . . 0.0 108.97 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 mt-10 -50.29 -26.75 5.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.41 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.42 6.49 48.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.32 24.32 6.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.403 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 142' ' ' SER . 7.9 tt -123.32 134.78 54.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.196 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.852 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -111.98 128.7 56.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.078 0.466 . . . . 0.0 111.605 -179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.7 mt -123.01 149.1 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.777 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.914 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.9 t -113.84 138.03 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.056 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 124' ' ' LEU . 1.4 mm -106.39 120.91 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.411 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -108.33 131.09 55.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -102.98 132.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.4 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.888 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -36.04 82.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -60.57 -40.05 90.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -61.13 -43.54 98.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mm -71.59 -34.99 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.23 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.493 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -23.86 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.57 -47.6 79.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.296 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.832 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -73.38 135.52 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.684 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -93.1 -60.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.862 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.7 p -146.12 150.47 35.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.183 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.4 138.24 51.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 111.489 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.689 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -103.1 122.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.792 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.45 121.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.546 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD23 ' A' ' 143' ' ' LEU . 48.4 t -79.87 114.43 18.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -79.69 -25.99 41.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.798 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.6 p -79.83 -2.19 42.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.706 0.289 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 77.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.946 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -146.29 -44.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.389 . . . . 0.0 110.736 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.1 mt -113.73 141.66 26.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.862 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.3 Cg_endo -72.06 140.87 35.33 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HG23 ' A' ' 37' ' ' ILE . 38.4 mt -56.43 140.2 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.641 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.38 164.13 20.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.33 119.71 33.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.1 mt -97.44 134.64 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 158.0 43.83 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.572 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.743 0.306 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.673 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.5 t -125.56 139.14 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 112.086 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.597 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.6 m-90 -100.89 139.4 36.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.199 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 128.76 56.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.45 145.38 46.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.346 -178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.1 -168.5 36.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.067 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.446 ' N ' HD11 ' A' ' 78' ' ' LEU . 25.1 mtm180 -80.28 2.23 25.46 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 t-20 -84.87 133.05 44.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -66.63 -14.05 42.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 0.0 111.901 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.05 17.31 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.902 0.858 . . . . 0.0 108.796 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.18 139.6 1.34 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.779 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.0 m-20 -56.34 -19.0 12.55 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.003 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.6 t80 -129.83 126.98 39.33 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.931 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.45 111.17 23.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -114.52 172.53 6.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.784 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.09 134.05 48.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.675 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -67.32 84.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 83' ' ' ARG . 53.3 mt -100.46 131.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -37.06 69.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.21 -27.85 67.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.005 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.0 mt -96.94 152.2 18.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -99.04 165.27 11.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.773 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -42.84 -53.5 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.387 0.613 . . . . 0.0 109.851 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB2' HG22 ' A' ' 67' ' ' THR . 10.7 ptmt -118.38 81.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.7 t60 -59.34 -45.69 90.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.883 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 34.0 p90 -144.53 160.44 41.12 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.138 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -135.91 143.04 44.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.282 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.3 mt -119.31 127.59 75.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.006 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.32 148.05 32.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 111.635 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.624 HD13 ' CG1' ' A' ' 33' ' ' VAL . 9.4 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.534 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -133.06 147.34 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.58 HD22 HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -112.65 125.33 54.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.192 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 48.2 t30 -116.47 115.81 26.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.773 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.735 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -77.89 135.03 37.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 8.5 pt -143.91 34.6 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.83 151.77 19.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.941 0.4 . . . . 0.0 111.457 -179.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -68.58 -31.82 71.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.921 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.62 -19.83 17.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.72 154.52 9.21 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.678 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.7 m -117.5 137.92 52.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.51 148.36 42.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.809 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.43 113.59 18.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.956 177.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 47.74 36.08 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.35 79.91 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.544 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.83 118.67 37.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 110.756 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -73.8 113.44 10.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.809 HG11 HD12 ' A' ' 111' ' ' LEU . 11.7 m -87.41 166.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.262 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.92 126.09 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -52.69 157.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.825 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.6 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 5.0 p-10 34.77 35.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -112.32 145.11 40.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.077 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.649 ' HB3' HD23 ' A' ' 100' ' ' LEU . 15.3 m-80 -80.84 131.87 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm100 -129.24 146.66 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 tp -72.68 118.5 15.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 99' ' ' LEU . 7.6 tt -56.41 153.85 9.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.504 0.668 . . . . 0.0 111.686 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.91 153.02 43.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.465 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.82 125.03 26.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.258 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.57 54.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.283 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.454 ' OD1' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -52.0 166.03 0.18 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.911 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -139.83 135.63 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -111.11 127.0 68.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.742 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.4 141.27 36.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.563 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.78 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.78 43.88 9.7 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -84.68 140.44 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.651 0.739 . . . . 0.0 112.441 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.59 -39.96 1.12 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 50.0 t -126.41 120.02 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.563 -0.818 . . . . 0.0 109.0 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.45 -25.87 4.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.823 0.344 . . . . 0.0 111.442 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.6 t -93.5 6.53 47.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.9 26.01 5.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.627 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.13 138.83 31.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.96 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.49 134.28 53.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.55 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.4 t -108.41 150.3 27.57 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.619 0.723 . . . . 0.0 112.153 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.5 mt -135.75 156.97 47.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.911 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.8 t -125.94 138.61 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 130' ' ' ILE . 32.4 mt -106.34 121.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.966 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.39 114.07 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 124' ' ' LEU . 4.7 mm -84.92 134.0 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.395 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.818 0.342 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -59.0 -37.68 77.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.34 -41.37 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -31.83 70.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.38 -35.49 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.803 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -42.0 81.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -67.11 -23.89 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.59 -47.56 79.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.859 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.8 mm -76.71 134.05 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.529 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -93.66 -62.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.073 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.722 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.6 p -146.61 155.96 42.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.189 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -122.7 133.28 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.35 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 68' ' ' PHE . 38.4 t -97.56 122.81 49.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 23.1 mt -122.84 121.99 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.38 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.595 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.8 t -85.18 114.08 22.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.442 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -85.85 -22.87 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.581 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.485 HG21 ' H ' ' A' ' 142' ' ' SER . 42.5 p -79.94 -2.07 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.615 0.245 . . . . 0.0 111.581 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.17 76.64 0.28 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.844 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.702 ' HB2' HD12 ' A' ' 43' ' ' ILE . 12.5 mt-30 -146.89 -43.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.9 mp -118.88 141.87 30.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.999 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.6 138.02 28.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.119 1.879 . . . . 0.0 112.121 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -55.55 136.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.745 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.09 164.1 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.256 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -118.08 119.81 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 111.787 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.722 HD12 ' SG ' ' A' ' 34' ' ' CYS . 5.5 mt -89.84 137.35 32.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.62 157.58 43.74 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.635 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 49' ' ' SER . 22.8 ttpt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.925 0.393 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.733 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.8 p -109.85 140.0 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -100.6 139.5 36.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.349 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.05 127.27 55.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -118.99 145.52 45.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.503 -178.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.52 -168.07 39.86 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -90.83 28.95 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.4 t-20 -111.43 136.62 20.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.87 -13.12 38.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.668 2.245 . . . . 0.0 111.736 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -47.45 11.8 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.824 0.821 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.88 140.61 1.0 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.311 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -56.61 -18.91 13.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.883 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 19.6 t80 -129.46 123.65 32.08 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.765 0.317 . . . . 0.0 110.68 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -97.93 121.94 40.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' ILE . 12.4 mt -102.34 -64.04 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.77 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.27 -103.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -179.27 49.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 84' ' ' LEU . 19.2 mt -89.69 141.92 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -64.34 -34.77 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.9 mmt-85 -60.91 -30.49 70.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 81' ' ' ILE . 1.2 mm? -105.81 152.47 23.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 p -98.39 163.32 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.593 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.16 -53.28 4.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.413 0.625 . . . . 0.0 109.67 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -118.99 82.65 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' HD12 ' A' ' 84' ' ' LEU . 13.6 t60 -61.25 -46.94 88.33 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.553 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.5 p90 -143.7 159.14 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.999 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.706 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.0 tt0 -135.5 140.52 44.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.733 ' C ' HG23 ' A' ' 65' ' ' VAL . 77.1 mt -120.12 127.25 75.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.161 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.747 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.812 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.365 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.1 mt -127.76 140.68 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.513 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.2 OUTLIER -112.71 121.55 45.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.4 t30 -117.51 116.93 28.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.055 0.455 . . . . 0.0 112.072 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -77.36 134.82 38.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.817 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.4 pt -141.72 39.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.75 149.82 23.42 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.084 0.469 . . . . 0.0 111.943 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.88 -31.34 70.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.862 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.63 -19.96 18.65 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.35 153.82 9.6 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.875 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.6 m -117.66 137.99 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.085 0.554 . . . . 0.0 109.577 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.98 148.57 39.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.53 18.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.482 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 30.5 m-20 44.32 43.51 6.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.494 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.41 -13.59 61.69 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.447 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -103.96 118.47 36.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.983 0.391 . . . . 0.0 110.586 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -72.3 125.63 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.246 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.3 m -95.29 165.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.238 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 mt-10 -69.87 125.11 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.676 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 82.7 tttt -53.49 162.33 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.779 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 36.2 32.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.18 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.49 143.28 43.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.721 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.747 ' OD1' HD21 ' A' ' 92' ' ' LEU . 17.4 m-80 -92.17 133.6 35.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.793 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.6 mm-40 -129.08 150.01 50.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.58 122.91 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.14 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 145' ' ' ILE . 65.8 tp -53.03 156.14 2.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.493 0.663 . . . . 0.0 111.85 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.539 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -124.58 153.53 42.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.285 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.646 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.1 mm-40 -71.22 121.36 18.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.934 0.397 . . . . 0.0 110.405 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.57 24.23 56.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.154 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 38.1 t0 -54.79 170.49 0.17 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.007 0.432 . . . . 0.0 111.249 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 144' ' ' VAL . 20.5 tt0 -145.18 135.46 24.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 145' ' ' ILE . 2.6 mt -113.6 128.16 70.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.3 140.84 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.023 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.9 m -140.13 158.43 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.86 44.21 9.35 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.807 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -85.18 140.44 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.752 0.787 . . . . 0.0 112.47 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.39 -39.96 0.79 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.54 120.51 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.042 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 140' ' ' ILE . 9.2 tp10 -50.26 -26.44 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 111.54 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.581 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.5 p -93.61 6.62 47.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -132.49 29.83 4.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -106.32 139.25 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.629 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 142' ' ' SER . 1.5 tt -124.16 134.35 53.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.701 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.528 ' O ' HD22 ' A' ' 143' ' ' LEU . 41.0 t -112.17 150.31 31.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.722 . . . . 0.0 112.499 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -136.02 139.55 43.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.498 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.86 140.15 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 130' ' ' ILE . 16.8 mt -106.18 122.29 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.76 113.74 26.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.367 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.9 127.29 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.57 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -59.0 -36.32 74.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.18 -42.46 96.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 48.8 mm -68.91 -48.18 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.99 -33.56 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.294 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -59.79 -47.1 87.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.935 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.1 p90 -71.9 -47.44 52.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.062 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 52.3 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.014 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.692 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -74.74 134.25 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.454 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.014 HG12 HD21 ' A' ' 99' ' ' LEU . 2.9 t -91.16 -61.08 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.021 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -146.05 147.01 31.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.378 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.9 121.99 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.8 t -88.77 122.75 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.423 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.71 114.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.89 118.52 31.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -111.66 -12.46 13.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.853 HG21 ' CB ' ' A' ' 142' ' ' SER . 18.0 p -81.05 -2.51 48.4 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.08 85.49 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.809 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 4.4 pt20 -164.3 -49.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.704 HD13 HD22 ' A' ' 78' ' ' LEU . 5.1 mt -132.97 142.5 44.9 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 65.6 Cg_endo -75.69 146.16 29.97 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.201 1.934 . . . . 0.0 111.511 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -50.6 150.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 112.067 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -150.93 158.18 43.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.034 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -117.23 126.22 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.6 mt -101.05 137.62 39.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.75 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.89 158.78 43.68 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.532 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt . . . . . 0 CA--C 1.523 -0.096 0 CA-C-O 120.732 0.301 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.2 t -127.97 139.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.329 0.585 . . . . 0.0 112.333 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.605 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -100.84 139.25 36.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.804 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.72 130.13 55.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -119.34 145.4 46.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.367 -178.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.45 -170.43 37.21 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.777 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 13.8 mtm180 -79.95 2.86 21.86 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -84.94 133.01 44.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.61 0.243 . . . . 0.0 111.144 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.91 -14.51 44.89 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.571 2.181 . . . . 0.0 111.721 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -42.63 18.02 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.831 0.824 . . . . 0.0 108.972 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.39 139.75 1.89 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.914 -1.493 . . . . 0.0 110.826 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.36 -18.26 10.38 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.91 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.8 t80 -129.08 123.94 33.54 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.787 0.327 . . . . 0.0 110.922 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.53 116.67 32.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -99.0 -69.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.12 -92.26 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.317 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.95 55.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.103 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.2 mm -81.67 124.73 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.754 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.55 70.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -28.74 69.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.774 HD13 ' HB ' ' A' ' 81' ' ' ILE . 6.2 mp -97.66 153.31 18.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -96.42 167.31 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.736 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -44.15 -54.93 5.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.266 0.555 . . . . 0.0 109.623 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.612 ' HB2' HD12 ' A' ' 104' ' ' ILE . 17.3 mttp -116.37 82.87 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -59.55 -46.47 88.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.763 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.0 p90 -143.92 157.77 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.008 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.2 tt0 -135.69 141.35 44.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.956 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -116.34 126.73 73.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.853 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -105.51 149.25 26.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.163 0.506 . . . . 0.0 111.858 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 50' ' ' ALA . 2.0 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.233 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.014 HD21 HG12 ' A' ' 33' ' ' VAL . 5.7 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 121' ' ' ASN . 7.8 mt -126.69 142.66 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.425 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.1 OUTLIER -112.79 121.63 45.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.808 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.817 ' HB2' HD11 ' A' ' 92' ' ' LEU . 48.9 t30 -112.24 115.78 29.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.737 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.802 ' OD2' HG23 ' A' ' 116' ' ' VAL . 16.7 p30 -76.43 129.23 36.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.645 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -137.94 38.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.17 152.97 19.29 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.13 0.49 . . . . 0.0 111.663 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.8 m -68.85 -31.6 70.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.24 -19.88 17.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.47 156.07 10.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.675 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.42 137.72 52.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.74 148.19 42.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -124.76 113.55 18.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 48.77 42.07 19.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.33 -6.14 80.82 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.973 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.722 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -106.3 118.83 37.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.275 0.537 . . . . 0.0 110.84 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptp -73.75 127.26 32.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.258 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.802 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -101.12 166.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.203 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 17.5 tt0 -69.77 123.87 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.518 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 2.1 tttt -51.32 165.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p-10 32.82 34.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.322 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.52 145.23 40.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.245 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.77 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.0 m-80 -90.9 129.47 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.15 150.92 50.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.433 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.6 134.24 45.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 145' ' ' ILE . 54.7 tp -65.85 156.42 33.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.48 0.657 . . . . 0.0 111.697 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.39 153.6 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.614 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.666 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.5 tp60 -71.3 118.6 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.33 23.64 62.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.116 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -50.99 172.02 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.871 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.63 135.59 24.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.5 mt -114.32 125.01 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.57 140.4 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.712 ' CG2' HD21 ' A' ' 84' ' ' LEU . 32.7 m -140.31 158.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.94 27.22 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.179 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.0 t -71.02 140.32 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 112.212 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.8 -38.54 1.27 Allowed Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 44.9 t -126.45 124.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.662 -0.769 . . . . 0.0 109.202 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -50.47 -31.07 14.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.587 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 38.0 t -93.45 6.43 48.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -125.54 25.49 7.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.58 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.05 138.94 30.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.016 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 140' ' ' ILE . 6.0 mp -124.46 134.58 53.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.508 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.853 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.54 132.74 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.5 mp -123.23 143.49 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.546 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.871 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.3 t -114.45 132.72 62.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.635 HG21 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -106.42 120.98 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.063 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -104.37 142.2 34.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -110.47 134.07 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.523 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.955 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.04 96.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.38 -35.09 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.1 -44.64 88.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.1 mm -66.86 -35.22 74.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.28 -42.92 82.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 0.0 110.353 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -67.26 -23.62 65.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.51 -47.48 79.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.297 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.9 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.7 135.29 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.416 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.968 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.42 -59.96 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.012 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.4 p -148.8 153.37 38.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.82 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.416 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -117.97 119.43 34.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.938 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -90.04 122.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 111.184 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.836 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -122.78 126.14 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.156 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.72 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.2 t -81.08 118.58 22.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.579 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.65 HG21 ' OE2' ' A' ' 129' ' ' GLU . 4.1 t -83.52 -27.89 29.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' H ' ' A' ' 142' ' ' SER . 50.6 p -79.88 -2.28 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.461 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.57 77.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.943 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.4 mt-30 -147.35 -43.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.931 HD11 HD21 ' A' ' 141' ' ' LEU . 1.4 mt -112.15 141.26 24.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.51 143.87 43.72 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.177 1.918 . . . . 0.0 112.172 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.836 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -60.13 133.91 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.67 164.44 22.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.68 119.93 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -90.67 126.72 36.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.968 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -131.8 157.07 44.85 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.168 0.985 . . . . 0.0 113.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.216 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.937 0.399 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.728 HG12 ' HG2' ' A' ' 90' ' ' GLN . 20.6 t -136.17 139.66 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.019 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.707 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.9 m-90 -100.63 138.98 36.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.998 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.25 132.05 55.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.33 145.25 42.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.79 -175.08 39.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.99 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -78.99 -0.43 31.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.85 135.8 39.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.634 0.254 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.83 -9.28 25.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.686 2.257 . . . . 0.0 111.789 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.69 16.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.975 0.893 . . . . 0.0 108.669 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.05 136.5 4.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.651 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -56.49 -18.51 11.71 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.091 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.42 114.75 16.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.723 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -89.16 119.59 29.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.428 ' HA ' HG12 ' A' ' 43' ' ' ILE . 10.0 mp -92.85 -77.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.34 -86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 173.65 48.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 110.929 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 83' ' ' ARG . 4.6 mt -77.47 126.48 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -58.57 -30.69 67.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.58 -49.23 56.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.8 mp -75.45 153.3 37.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 0.0 111.17 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 p -93.45 168.66 10.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.2 m-20 -43.95 -55.39 4.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.344 0.593 . . . . 0.0 109.765 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' THR . 6.1 ptmt -119.66 82.9 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -59.41 -45.85 90.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.981 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.2 p90 -146.36 159.53 43.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.728 ' HG2' HG12 ' A' ' 65' ' ' VAL . 17.1 tt0 -135.84 143.45 45.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.381 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 25.2 mt -116.67 127.4 74.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.2 pt? -116.5 136.73 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.503 . . . . 0.0 112.065 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 6.1 tp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.52 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.848 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.16 147.15 52.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.381 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.661 HD21 HD11 ' A' ' 145' ' ' ILE . 1.3 mt -112.68 124.8 53.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.9 t30 -115.88 115.62 26.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.031 0.443 . . . . 0.0 111.522 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -79.13 136.17 37.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 89' ' ' PHE . 16.6 pt -145.15 39.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.56 159.74 14.74 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.05 0.452 . . . . 0.0 111.804 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.3 m -69.06 -37.7 78.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.501 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 9.9 p30 -98.46 -19.91 17.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.55 160.78 10.95 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.695 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.0 m -117.58 137.91 52.28 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.76 148.38 38.44 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.35 18.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.366 177.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 44.27 42.86 5.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.91 -8.51 77.73 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.485 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 118.62 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.9 tptp -74.14 123.05 23.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.29 164.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.261 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.1 tp10 -69.86 126.71 30.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 36.9 tttm -52.63 161.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.377 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.51 34.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.32 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.3 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.153 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.848 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.0 m-80 -84.2 130.05 34.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.754 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.5 mm-40 -129.34 146.66 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.81 135.66 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 145' ' ' ILE . 67.6 tp -66.71 155.85 36.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.401 0.619 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.69 153.11 42.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.41 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.632 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -71.61 114.0 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.63 71.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t0 -56.21 172.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 111.174 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 144' ' ' VAL . 6.9 tt0 -145.19 135.56 24.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -113.68 128.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.614 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.652 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.5 140.71 37.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.8 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.546 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.3 m -140.36 158.64 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.31 43.42 9.53 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.084 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -84.03 140.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.654 0.74 . . . . 0.0 112.275 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.19 -39.5 1.18 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.34 120.03 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -50.42 -26.49 5.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.364 -178.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 136' ' ' VAL . 32.9 m -93.62 6.55 47.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.37 26.11 5.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.652 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.11 138.33 33.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.014 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 HD11 ' A' ' 43' ' ' ILE . 5.6 tp -124.94 134.81 52.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.649 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.3 t -109.89 149.54 29.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.658 0.742 . . . . 0.0 112.364 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -136.36 142.03 43.76 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.713 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.3 t -113.35 140.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 111.007 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 130' ' ' ILE . 23.6 mt -106.08 121.13 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.533 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -107.82 113.13 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.799 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -84.9 130.59 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -36.98 84.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 -37.42 86.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.72 96.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.3 mm -67.02 -35.15 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.24 -40.98 78.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -23.87 65.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.43 79.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.235 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -79.76 133.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.563 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.029 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -92.65 -62.57 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.9 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.8 p -141.64 165.14 28.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -124.48 138.21 54.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 111.438 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.701 HG11 ' HE2' ' A' ' 68' ' ' PHE . 2.4 m -108.8 122.63 63.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.627 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -126.94 119.86 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.792 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.773 ' HA ' HD13 ' A' ' 143' ' ' LEU . 16.4 t -83.76 102.34 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.292 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.528 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.2 t -77.27 -25.48 51.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.924 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.619 HG21 ' H ' ' A' ' 142' ' ' SER . 9.9 p -79.9 -2.59 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.515 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.52 79.95 0.19 Allowed Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.068 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' A' ' 141' ' ' LEU . 5.5 mt-30 -146.97 -39.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -129.11 144.09 51.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.917 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' A' ' 43' ' ' ILE . 38.5 Cg_endo -68.89 141.58 49.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.183 1.922 . . . . 0.0 111.934 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.0 mt -56.49 140.26 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.907 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -135.38 164.11 28.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.87 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.91 119.79 29.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -78.91 135.61 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.029 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.7 156.14 43.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.672 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.671 0.272 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.4 t -136.34 139.24 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.317 0.58 . . . . 0.0 112.247 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.859 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.2 m-90 -109.94 139.13 45.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.982 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.85 127.24 55.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.701 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.25 145.78 41.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.658 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -169.35 35.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.683 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -82.12 5.0 20.99 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.82 128.61 60.01 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.514 0.197 . . . . 0.0 110.668 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.53 -11.8 32.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.223 1.948 . . . . 0.0 111.431 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.23 -42.96 16.62 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.781 0.801 . . . . 0.0 108.974 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.11 136.82 1.45 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.755 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.54 -18.37 11.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.927 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 28.8 t80 -129.43 117.24 20.23 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.03 121.9 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.908 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD12 ' HA2' ' A' ' 69' ' ' GLY . 10.4 mt -100.1 -69.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.26 -95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -178.74 54.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.815 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.9 mt -81.01 126.12 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 -36.79 69.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.2 mmt-85 -68.7 -29.47 67.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.815 ' CD1' HD12 ' A' ' 81' ' ' ILE . 38.9 mt -95.92 152.06 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 p -96.29 165.46 12.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.656 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.3 -53.35 4.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 109.973 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.77 83.04 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -60.12 -47.07 87.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.816 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.22 157.28 43.81 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.854 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HG3' HG23 ' A' ' 67' ' ' THR . 30.2 tt0 -136.05 135.74 39.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.346 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 46.9 mt -109.36 132.06 58.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.825 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HB2' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -121.72 151.64 40.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 111.576 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 ' CG1' ' A' ' 33' ' ' VAL . 14.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.377 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.862 HD21 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -127.13 141.57 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 91' ' ' ILE . 21.6 tp -112.88 126.39 55.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.7 t30 -117.06 115.57 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.181 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.78 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -79.66 132.01 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 67' ' ' THR . 22.2 pt -141.35 40.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.64 152.72 20.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.068 0.461 . . . . 0.0 111.882 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -68.77 -31.55 70.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.986 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.12 -19.81 17.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.32 157.43 10.75 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.703 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.873 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.41 148.39 40.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.304 177.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 99.4 m-20 44.93 43.53 7.21 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -9.78 70.0 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.489 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.4 118.53 36.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.056 0.428 . . . . 0.0 110.808 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.873 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.8 tptm -73.7 128.62 35.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.198 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.78 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.8 m -99.47 166.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.212 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.0 126.02 28.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 34.3 tttt -52.36 162.18 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 110.324 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.52 36.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.968 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.89 145.06 40.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.404 ' HB3' HD23 ' A' ' 100' ' ' LEU . 7.5 m-80 -92.12 126.64 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.625 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.07 147.08 50.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.4 tt -72.91 116.39 13.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.919 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 123' ' ' LEU . 1.2 mm? -53.38 167.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.665 0.745 . . . . 0.0 112.019 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.23 153.29 43.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.228 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.9 tp60 -71.55 114.65 9.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.74 26.4 72.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.911 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.8 t0 -60.24 176.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 111.035 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.882 ' CG ' HG22 ' A' ' 144' ' ' VAL . 8.1 mt-10 -145.31 135.71 24.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.263 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 9.1 mt -112.69 126.21 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.495 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.48 141.45 36.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.179 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.4 m -140.26 158.5 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.01 43.79 9.54 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.013 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.4 t -84.08 140.42 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.733 0.777 . . . . 0.0 112.47 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.15 -42.44 0.86 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 138' ' ' SER . 57.5 t -126.53 122.13 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 114.592 -0.804 . . . . 0.0 109.033 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.532 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.36 -24.86 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.727 0.299 . . . . 0.0 111.704 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.26 6.34 48.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 11.6 m-20 -130.75 26.65 4.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.06 139.39 28.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.003 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 43' ' ' ILE . 31.7 tp -122.4 134.43 54.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.619 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.66 137.05 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.07 0.462 . . . . 0.0 111.856 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -131.26 145.05 51.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.172 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.882 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.5 t -111.41 135.65 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.585 HG21 ' CD1' ' A' ' 124' ' ' LEU . 1.3 mm -106.45 122.69 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.581 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -113.13 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.073 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.59 HG23 ' CD1' ' A' ' 99' ' ' LEU . 5.9 mt -84.79 126.48 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.205 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.832 0.348 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -58.92 -36.72 75.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.95 -42.4 93.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -32.74 71.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.1 -35.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.51 -38.02 73.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -67.17 -23.84 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.83 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.81 -47.53 80.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.11 136.13 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.479 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.67 -60.16 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.769 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -147.26 150.2 34.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.165 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.89 129.32 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.472 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 48' ' ' LEU . 3.3 m -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.6 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.825 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -131.4 128.23 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.656 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.31 110.04 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.972 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.2 p -87.15 -24.25 24.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.792 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.845 HG21 ' OG ' ' A' ' 142' ' ' SER . 72.5 p -79.91 -2.56 44.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 71.62 78.32 0.47 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.444 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.3 mt-30 -148.56 -40.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.246 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -130.2 141.54 42.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.78 146.03 42.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.23 1.953 . . . . 0.0 112.195 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.825 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -56.02 156.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.844 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.12 164.1 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 p30 -119.58 119.94 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.069 0.461 . . . . 0.0 111.975 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.0 mt -100.77 134.64 43.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.82 158.87 43.63 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.122 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.738 0.304 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.524 HG13 ' C ' ' A' ' 91' ' ' ILE . 10.6 t -126.38 138.09 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 112.013 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.551 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -101.85 139.66 37.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.003 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.97 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.61 130.13 55.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.06 145.27 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.16 -167.2 36.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.755 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.0 mtm105 -83.88 3.56 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.9 t-20 -84.93 133.41 43.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 111.019 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -66.06 -14.2 43.33 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.552 2.168 . . . . 0.0 111.676 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.61 16.71 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.946 0.879 . . . . 0.0 108.852 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -44.29 139.8 2.49 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.802 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.5 m-20 -56.4 -18.88 12.49 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.859 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.535 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -129.81 127.78 41.0 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.86 108.0 19.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.772 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 43' ' ' ILE . 26.3 mt -76.7 -166.52 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.17 17.94 53.58 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.25 79.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.397 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.8 mt -112.03 132.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -54.99 -34.68 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.12 -27.37 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 132' ' ' VAL . 40.6 mt -96.64 152.19 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.82 164.77 12.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.661 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.99 -52.82 5.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 109.615 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.72 82.9 1.96 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.77 -45.97 91.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.923 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.4 p90 -143.55 162.52 35.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.436 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.97 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 133.99 38.92 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.202 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.58 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.8 mt -111.56 127.79 68.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.724 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -114.77 146.89 40.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.544 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.508 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.901 0.381 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.18 146.67 51.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 124' ' ' LEU . 10.7 mt -112.72 124.41 52.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.06 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.673 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.7 t30 -117.52 115.67 25.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.6 p30 -78.35 139.66 38.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.165 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 89' ' ' PHE . 20.6 pt -147.88 40.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.95 152.11 20.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.086 0.47 . . . . 0.0 111.778 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.1 m -68.93 -31.54 70.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.038 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.94 17.57 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.05 155.4 9.81 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.65 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -117.57 137.75 52.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.892 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.41 148.29 41.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.65 18.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.439 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m120 44.65 43.76 6.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.388 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -9.99 69.39 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.437 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -104.64 118.66 37.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.624 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.892 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.1 tptm -74.03 122.57 22.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.224 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -93.64 164.55 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 tp10 -69.82 127.75 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.535 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -53.71 161.03 1.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.922 0.391 . . . . 0.0 110.635 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.53 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.348 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.17 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.122 179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.837 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.9 m-80 -83.97 130.2 34.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.864 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.762 ' O ' HD23 ' A' ' 100' ' ' LEU . 6.5 mm100 -129.46 147.68 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.86 132.9 44.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.853 HD21 HG12 ' A' ' 147' ' ' ILE . 38.0 tp -65.05 154.43 37.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.659 . . . . 0.0 111.61 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.454 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -124.81 153.05 43.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.36 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.73 122.76 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 23.89 49.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.145 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.6 t70 -54.78 170.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.46 . . . . 0.0 111.21 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.1 tt0 -145.17 135.57 24.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.006 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 145' ' ' ILE . 2.3 mt -109.4 128.04 65.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.438 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.37 140.3 38.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.045 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.651 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.37 158.33 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 80.07 42.97 10.16 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -82.83 140.45 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.687 0.756 . . . . 0.0 112.274 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.33 -39.92 1.14 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.48 123.98 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.619 -0.791 . . . . 0.0 109.082 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.27 10.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.412 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.42 6.48 48.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 133' ' ' GLY . 54.3 m-20 -124.34 23.06 8.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.0 139.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 142' ' ' SER . 8.9 tt -122.32 134.72 54.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.845 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.99 128.18 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.087 0.47 . . . . 0.0 111.854 -179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 43' ' ' ILE . 18.6 mt -121.44 137.42 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.03 137.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.816 0.341 . . . . 0.0 111.278 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 130' ' ' ILE . 31.6 mt -106.16 131.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.09 120.36 39.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.853 HG12 HD21 ' A' ' 124' ' ' LEU . 5.7 mt -84.85 131.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.21 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -59.02 -46.12 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -35.05 73.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -41.46 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.8 mm -71.92 -35.09 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.16 -38.19 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -67.34 -24.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.671 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.76 79.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.148 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.852 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.78 133.99 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.458 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.43 -61.7 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.149 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -148.96 150.08 32.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.408 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.51 HH11 HD11 ' A' ' 37' ' ' ILE . 6.0 ttm180 -113.96 138.1 50.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.694 HG11 ' CE1' ' A' ' 76' ' ' TYR . 15.0 p -99.99 122.9 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 45' ' ' ILE . 18.7 mt -130.29 119.41 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.649 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HA ' HD23 ' A' ' 143' ' ' LEU . 40.9 t -79.95 142.07 35.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 144' ' ' VAL . 2.9 p -111.42 -21.29 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.727 ' OG1' HD23 ' A' ' 141' ' ' LEU . 74.8 p -85.09 -2.78 58.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.732 0.301 . . . . 0.0 111.559 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.83 86.91 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.093 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.9 pt20 -159.72 -40.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.084 0.468 . . . . 0.0 111.374 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.572 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 4.3 mt -122.92 139.96 32.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.4 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 70.3 Cg_endo -76.76 146.16 26.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.508 2.139 . . . . 0.0 112.376 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.8 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -55.9 148.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.841 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.06 162.06 37.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.027 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.37 119.91 36.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.092 0.472 . . . . 0.0 111.931 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.0 mt -96.25 137.28 35.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.48 158.7 43.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.785 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.914 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.3 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.734 0.302 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.4 t -123.08 139.48 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.249 0.547 . . . . 0.0 111.752 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.6 m-90 -100.78 139.91 35.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.86 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.19 125.3 51.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.9 m-85 -113.17 145.57 40.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.926 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.9 -173.47 39.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.274 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp-105 -77.43 -1.56 30.83 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.82 134.2 42.16 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.318 . . . . 0.0 111.19 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -68.01 -10.56 29.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.728 2.286 . . . . 0.0 111.967 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.76 -42.87 17.43 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 121.868 0.842 . . . . 0.0 108.914 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 140.3 1.0 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.848 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -56.06 -18.33 9.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.147 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.694 ' CE1' HG11 ' A' ' 36' ' ' VAL . 42.7 t80 -128.88 125.92 38.66 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.42 113.09 26.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.752 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -116.63 175.71 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 81' ' ' ILE . . . -55.5 166.2 3.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.596 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -93.83 92.14 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.013 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 p -54.75 -24.91 24.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.5 mmp_? -74.19 -29.57 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.013 HD12 HD13 ' A' ' 81' ' ' ILE . 30.2 mt -92.2 152.21 19.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.98 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -96.16 163.44 13.1 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.506 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.65 -53.2 3.64 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 109.763 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.9 mttp -118.41 84.28 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -63.93 -45.13 90.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 30.7 p90 -152.67 163.24 40.03 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.189 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.1 mt-30 -135.29 154.94 51.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.494 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mt -123.63 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.167 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.92 148.02 37.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 111.589 -179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.6 tm? . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.473 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.94 HD21 HG12 ' A' ' 33' ' ' VAL . 4.4 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.819 0.343 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -133.02 145.79 51.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.312 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.933 HD11 HD12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -112.96 131.79 55.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.534 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -119.76 115.57 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.9 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.826 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -78.68 143.21 36.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.062 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.528 HG21 ' OE1' ' A' ' 90' ' ' GLN . 10.2 pt -150.39 36.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.04 152.53 18.65 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.151 0.5 . . . . 0.0 112.19 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.83 -31.44 70.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.852 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.08 -19.84 18.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.508 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.79 158.65 11.69 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.59 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.9 m -117.31 137.67 52.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.58 148.38 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.55 18.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.602 177.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 62.5 m-20 43.63 43.68 4.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.18 -14.22 61.37 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.451 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.39 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 110.517 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.73 128.24 35.38 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.527 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.826 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.4 m -96.25 162.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.834 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.9 mp0 -69.89 127.63 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 49.6 tttm -53.41 161.72 0.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.41 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 9.0 m-80 33.84 35.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.261 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.974 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 45.8 m-80 -89.78 130.21 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.224 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 47.1 mm-40 -129.33 148.66 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.417 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.59 121.5 19.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.351 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 147' ' ' ILE . 66.0 tp -55.27 156.51 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.462 0.649 . . . . 0.0 111.563 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.411 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.63 153.41 42.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.587 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.51 120.39 17.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.76 22.68 62.32 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.679 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.46 170.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.006 0.431 . . . . 0.0 111.237 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.5 tt0 -145.14 135.45 24.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.906 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.491 ' CD1' HD22 ' A' ' 101' ' ' LEU . 19.0 mt -118.36 128.14 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.41 140.77 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.233 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 32.0 m -140.37 158.34 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 112.145 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.13 37.24 11.47 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.815 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -80.53 140.48 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.671 0.748 . . . . 0.0 112.503 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.3 -39.35 0.71 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 138' ' ' SER . 35.4 t -126.35 121.76 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.09 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.54 7.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.502 ' H ' HG12 ' A' ' 136' ' ' VAL . 19.6 t -93.51 6.52 47.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -130.05 29.68 4.9 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.26 138.91 30.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.932 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.727 HD23 ' OG1' ' A' ' 40' ' ' THR . 3.0 mt -124.45 134.38 53.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.728 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -106.02 150.43 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.67 0.748 . . . . 0.0 112.318 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 38' ' ' CYS . 68.4 mt -135.68 147.16 48.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.01 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.413 HG21 ' CG2' ' A' ' 39' ' ' THR . 36.9 t -120.14 139.98 45.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.343 . . . . 0.0 111.061 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.933 HD12 HD11 ' A' ' 101' ' ' LEU . 2.5 mt -106.24 139.09 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.86 116.85 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.94 132.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.189 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.55 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.865 0.364 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -61.95 -36.05 80.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.41 -37.69 81.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.682 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 22' ' ' LYS . 6.3 mt -66.09 -33.09 74.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.727 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.19 -35.51 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.53 -46.11 84.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.58 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.813 ' HE2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -67.08 -23.67 65.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.605 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.55 79.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.5 mm -73.08 135.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.67 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.95 -60.58 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.6 p -149.42 151.14 33.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.084 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.84 134.66 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.383 -179.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 48' ' ' LEU . 26.6 t -101.48 122.68 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.98 123.12 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.561 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.9 t -83.15 119.09 24.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.369 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -25.49 32.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 142' ' ' SER . 58.6 p -79.94 -2.3 43.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.446 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.67 77.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.024 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.827 ' OE1' HD11 ' A' ' 141' ' ' LEU . 10.0 mt-30 -146.03 -44.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 110.773 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.063 HD13 HD22 ' A' ' 78' ' ' LEU . 5.4 mt -109.12 141.17 22.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -72.97 133.56 20.05 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.79 138.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.563 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 162.99 28.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.553 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -115.57 119.66 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.999 0.428 . . . . 0.0 111.659 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 36' ' ' VAL . 3.0 mt -95.12 133.63 38.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.71 158.49 43.85 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.817 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.763 0.316 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -130.77 139.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.323 0.582 . . . . 0.0 112.148 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.2 m-90 -102.67 139.42 38.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.062 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -111.72 129.31 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.744 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 1.1 m-85 -120.12 145.22 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.49 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -166.86 35.16 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 12.2 mtm105 -80.94 4.52 19.18 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.68 130.54 52.73 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.533 0.206 . . . . 0.0 110.917 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.3 Cg_exo -65.33 -14.71 46.46 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.415 2.077 . . . . 0.0 111.594 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -44.12 15.62 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.929 0.871 . . . . 0.0 108.873 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -38.88 139.7 0.43 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.815 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.3 m-20 -56.35 -19.13 13.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CD2' HD21 ' A' ' 78' ' ' LEU . 1.2 t80 -130.21 119.73 23.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.695 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -89.67 109.14 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.063 HD22 HD13 ' A' ' 43' ' ' ILE . 8.8 mt -106.03 162.39 13.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.833 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.55 129.4 49.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.093 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -62.93 79.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.831 0.348 . . . . 0.0 111.09 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 83' ' ' ARG . 32.7 mm -105.0 139.64 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.7 m -60.08 -31.6 70.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.77 -29.82 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.217 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.596 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.3 mp -102.39 152.65 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 162.24 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.878 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.14 -52.1 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.757 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CB ' HD12 ' A' ' 104' ' ' ILE . 40.0 mttt -119.18 80.89 1.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.7 t-80 -61.14 -45.87 92.89 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.786 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 39.1 p90 -147.75 159.97 43.23 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.992 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG2' HG12 ' A' ' 65' ' ' VAL . 28.6 tt0 -136.18 141.88 44.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.744 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 58.7 mt -116.49 127.59 74.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.943 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -111.29 151.46 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.9 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.814 0.34 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.1 mt -133.07 146.91 52.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.315 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 145' ' ' ILE . 1.3 mt -112.67 123.66 50.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.481 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.9 t30 -117.15 115.66 25.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.4 p30 -79.21 140.51 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' CB ' ' A' ' 87' ' ' LYS . 10.3 pt -143.46 30.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.554 0.216 . . . . 0.0 111.577 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.512 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.3 t -89.96 158.31 17.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.447 0.641 . . . . 0.0 112.243 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 m -69.68 -49.17 56.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.499 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.28 3.04 56.31 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.43 157.4 23.75 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.053 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 HG22 ' CG2' ' A' ' 130' ' ' ILE . 7.4 m -117.82 137.92 52.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.811 -0.694 . . . . 0.0 109.215 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.31 148.8 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.433 HD13 ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -123.83 113.47 18.58 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.197 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 44.14 42.91 5.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.86 -14.09 61.21 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.501 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -103.42 118.5 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.54 124.56 24.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.373 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.7 m -96.57 163.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.039 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 tm-20 -69.85 127.03 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.3 tttm -53.68 160.98 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.964 0.411 . . . . 0.0 110.611 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.89 34.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.288 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.19 40.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.114 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.8 m-80 -88.49 131.7 34.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.874 ' O ' HD23 ' A' ' 100' ' ' LEU . 41.2 mm-40 -129.29 151.92 49.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.69 136.04 45.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.708 0.289 . . . . 0.0 110.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.735 HD22 ' HB2' ' A' ' 99' ' ' LEU . 28.1 tp -62.94 152.66 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.575 0.702 . . . . 0.0 111.521 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.4 152.51 44.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.653 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.46 121.36 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.36 25.29 60.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.983 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' HD13 ' A' ' 111' ' ' LEU . 25.0 t70 -49.88 165.19 0.08 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.258 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 tt0 -144.33 135.47 25.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 145' ' ' ILE . 3.1 mt -114.39 128.27 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.608 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.9 m -104.03 141.57 35.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.607 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.6 m -140.52 158.72 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.95 9.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -84.25 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.585 0.707 . . . . 0.0 112.13 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.27 -37.05 1.43 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 24.9 t -126.16 119.13 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.446 -0.877 . . . . 0.0 108.814 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -29.39 9.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.2 p -93.46 6.46 48.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.85 27.53 5.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.608 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.49 138.67 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.65 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.827 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -124.51 134.43 53.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.558 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.507 ' H ' HG21 ' A' ' 40' ' ' THR . 36.1 t -106.54 149.43 27.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.791 0.805 . . . . 0.0 112.221 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.56 HD21 HD12 ' A' ' 43' ' ' ILE . 77.1 mt -136.12 143.74 44.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.597 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.37 138.03 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.2 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 101' ' ' LEU . 23.9 mt -106.13 131.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 120.2 39.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.678 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.732 HG12 HD21 ' A' ' 124' ' ' LEU . 5.4 mt -84.84 131.18 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.876 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.838 0.351 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -58.98 -39.33 81.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -59.47 -39.23 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -31.92 73.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -73.01 -35.44 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.6 -42.75 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.37 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -67.18 -23.68 65.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.633 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.79 -47.4 80.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.776 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.14 136.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.295 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.976 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -90.85 -59.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.866 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.712 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.4 p -146.24 165.2 29.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.523 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.34 138.27 51.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.395 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 68' ' ' PHE . 41.1 t -109.24 122.73 64.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.878 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.861 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -127.15 121.03 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.465 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.6 t -79.98 105.58 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.438 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -71.35 -25.1 62.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.874 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.83 -2.26 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.529 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.0 0.26 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.995 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -146.05 -44.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.695 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.0 mt -112.01 141.78 25.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.1 Cg_endo -70.73 138.69 35.26 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.107 1.872 . . . . 0.0 112.293 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.861 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.83 146.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.647 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 164.23 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -127.58 119.65 26.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.457 . . . . 0.0 111.636 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 8.3 mp -91.35 132.56 36.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.475 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.976 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.95 155.8 46.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.314 1.054 . . . . 0.0 113.638 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.676 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.816 0.341 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 92' ' ' LEU . 5.6 t -126.32 134.66 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.233 0.54 . . . . 0.0 111.601 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.0 140.07 36.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.246 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.634 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 130.5 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.8 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -120.31 145.51 47.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.713 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 162.06 -167.82 36.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.954 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.3 mtp180 -83.83 3.35 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 5.6 t-20 -84.85 133.12 44.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -12.91 37.54 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.547 2.165 . . . . 0.0 111.678 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.79 -44.09 15.95 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.914 0.864 . . . . 0.0 108.822 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.64 138.89 2.39 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.943 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.35 -18.86 12.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.094 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.3 t80 -129.8 123.99 32.29 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 111.392 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.38 107.93 18.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.713 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -110.32 78.91 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.31 -117.04 2.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.851 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -176.71 92.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.063 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 23.1 mm -109.63 129.86 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -38.28 67.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.093 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -63.43 -28.05 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.877 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 78' ' ' LEU . 27.8 mt -97.48 152.11 19.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.97 162.9 13.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.723 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.11 -52.27 4.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 0.0 109.655 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.8 mtpm? -117.87 83.9 2.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -64.89 -45.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.198 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.4 p90 -150.3 162.03 41.3 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.206 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.634 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.6 mt-30 -135.65 155.71 50.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.401 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.1 mt -126.28 132.35 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.029 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -128.66 144.67 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.998 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.142 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.698 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.705 0.288 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 122' ' ' GLN . 12.2 mt -131.33 142.48 50.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.777 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.79 126.22 53.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.738 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.548 ' HB2' HD21 ' A' ' 92' ' ' LEU . 46.7 t30 -116.8 115.69 26.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -77.4 143.2 38.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.815 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' CG ' ' A' ' 90' ' ' GLN . 9.6 pt -149.6 36.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.612 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.74 151.97 19.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.11 0.481 . . . . 0.0 111.934 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.78 -31.45 70.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.854 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.61 -19.79 18.08 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.38 156.43 10.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.89 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.9 m -117.42 137.74 52.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.52 148.39 38.0 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.5 18.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.461 177.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 44.33 43.27 5.91 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.53 64.02 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.518 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -104.72 118.49 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.62 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.58 127.24 31.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.411 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -97.46 164.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.3 tt0 -69.89 126.71 30.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 13.5 tttm -53.28 161.42 0.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 0.0 110.593 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 35.33 33.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.438 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.44 145.14 40.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.936 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.654 ' HB3' HD22 ' A' ' 100' ' ' LEU . 63.6 m-80 -90.48 130.07 36.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.838 ' O ' HD23 ' A' ' 100' ' ' LEU . 46.8 mm-40 -129.1 148.82 51.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 tp -72.51 116.31 12.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 145' ' ' ILE . 67.2 tp -53.46 157.54 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.406 0.622 . . . . 0.0 111.729 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.5 t -124.26 153.3 41.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.339 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.5 tp60 -71.47 123.51 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.3 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.28 21.81 54.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.131 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.87 175.25 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.05 135.62 24.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 145' ' ' ILE . 14.7 mt -114.48 126.14 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.462 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.563 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.5 140.07 38.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.494 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.3 158.35 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.122 0.487 . . . . 0.0 112.278 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.04 27.42 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.141 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.4 t -71.37 140.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.681 0.753 . . . . 0.0 112.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.76 -37.48 0.77 Allowed Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 41.6 t -126.25 131.99 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.805 -0.697 . . . . 0.0 109.3 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -40.1 51.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 6.47 48.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 8.2 t0 -119.64 28.44 8.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.563 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.26 139.65 28.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.987 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.0 tt -123.48 134.35 53.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.0 t -110.06 150.64 28.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 112.36 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.0 mt -135.55 156.8 48.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -125.02 137.12 58.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 130' ' ' ILE . 35.3 mt -106.34 123.45 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 115.1 28.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.512 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 26.5 t30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.684 179.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.852 0.358 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -59.27 -39.81 84.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -40.68 91.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.84 96.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mm -67.78 -34.88 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.265 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -57.06 -36.11 70.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -67.33 -23.92 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.768 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.8 -47.59 79.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.298 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -73.12 136.86 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.466 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -92.35 -59.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.843 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' A' ' 99' ' ' LEU . 4.1 p -146.67 165.46 29.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.506 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.25 138.07 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.366 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 36' ' ' VAL . 11.8 p -105.42 122.67 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.565 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.72 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -129.51 119.44 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.551 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.558 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -79.91 108.04 13.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.379 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.594 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -72.17 -25.89 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.72 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.86 -2.22 42.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.532 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.01 76.17 0.27 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HB2' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -145.73 -44.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.799 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.6 mt -111.72 141.35 24.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.759 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.7 Cg_endo -72.18 137.58 29.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.217 1.945 . . . . 0.0 112.355 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.72 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.07 136.98 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.51 164.3 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.48 119.71 34.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 111.843 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.0 mp -94.24 126.59 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.949 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.38 156.67 47.94 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.038 0.923 . . . . 0.0 113.309 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.089 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.856 0.36 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -130.08 139.11 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.196 0.522 . . . . 0.0 111.843 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.825 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.3 m-90 -105.27 139.54 39.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.259 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.79 132.19 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -119.3 145.61 45.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.353 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.63 -167.88 35.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.029 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtp-105 -81.1 3.31 23.83 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.8 t-20 -84.8 132.22 46.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.534 0.207 . . . . 0.0 111.102 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.24 -14.19 43.17 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.686 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.05 -42.98 16.83 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.872 0.844 . . . . 0.0 109.026 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.41 138.92 1.16 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.109 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.8 m-20 -56.47 -18.94 13.0 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.147 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 43' ' ' ILE . 14.2 t80 -129.63 114.16 15.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.741 0.305 . . . . 0.0 111.04 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.22 107.88 19.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.555 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD13 ' CA ' ' A' ' 69' ' ' GLY . 10.7 mp -79.78 -80.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.6 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.345 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.57 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 111.195 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp -84.34 119.18 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -54.81 -29.85 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.241 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.5 mmp_? -68.51 -26.94 65.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 81' ' ' ILE . 10.6 mt -102.71 151.18 22.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.047 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -94.1 164.12 13.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.568 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -41.59 -52.44 3.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.48 0.657 . . . . 0.0 109.832 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.96 82.51 1.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.4 t60 -60.91 -47.15 87.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.767 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.1 p90 -143.99 159.21 42.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.7 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 67' ' ' THR . 25.9 tt0 -136.19 138.52 42.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.0 mt -112.56 128.67 69.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.064 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -113.31 143.26 44.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.852 HD22 HG11 ' A' ' 33' ' ' VAL . 22.9 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.375 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.4 mm? -126.49 145.43 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.549 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.558 HD21 HD13 ' A' ' 124' ' ' LEU . 14.8 mt -112.51 124.09 51.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.872 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD23 ' A' ' 92' ' ' LEU . 51.7 t30 -118.01 115.58 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.856 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.6 p30 -76.43 139.98 41.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 67' ' ' THR . 17.8 pt -148.12 39.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 152.32 20.11 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.034 0.445 . . . . 0.0 111.548 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.86 -31.55 70.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.942 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.24 -19.82 17.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.69 156.48 10.17 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.945 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.43 137.95 52.17 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.839 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.89 148.62 38.38 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.17 113.51 18.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.455 177.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 27.8 m-20 44.09 43.26 5.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.66 -13.58 62.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.392 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.58 118.51 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.083 0.442 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.65 127.09 31.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.532 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.856 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.4 m -95.95 164.46 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.5 mt-10 -69.85 124.91 25.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.2 tttt -53.0 162.79 0.58 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.6 m-80 33.97 35.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.151 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.11 145.06 40.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.075 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.98 129.15 35.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.763 ' O ' HD13 ' A' ' 100' ' ' LEU . 40.5 mm-40 -129.29 146.83 51.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.804 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.73 125.3 27.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.841 HD11 HG21 ' A' ' 145' ' ' ILE . 66.2 tp -58.15 155.37 11.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.418 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.1 t -124.83 153.04 43.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 122.48 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.3 22.02 57.86 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.93 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.69 170.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.13 135.49 24.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.072 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.623 HD11 HD11 ' A' ' 145' ' ' ILE . 20.7 mt -118.37 128.04 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.445 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.599 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.43 141.52 36.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.5 m -140.21 158.33 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.029 0.442 . . . . 0.0 112.104 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.25 43.69 8.5 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.9 t -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.707 0.765 . . . . 0.0 112.498 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.79 -37.74 0.82 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.38 120.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.037 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.26 -29.52 9.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.763 0.316 . . . . 0.0 111.459 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 52.8 p -93.45 6.56 47.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -130.67 30.59 4.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.599 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.11 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.614 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt -122.17 134.49 54.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.635 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.4 t -108.52 150.58 27.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.304 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.9 mt -135.8 147.85 48.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.783 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 39' ' ' THR . 29.3 t -119.92 139.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.841 HG21 HD11 ' A' ' 124' ' ' LEU . 31.8 mt -106.09 128.62 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.56 114.86 26.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 124' ' ' LEU . 5.1 mt -84.75 134.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.894 0.378 . . . . 0.0 111.439 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.895 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.799 0.333 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -58.99 -35.98 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -37.29 80.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.36 -33.44 75.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.16 -35.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.742 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.43 -41.5 80.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -67.13 -23.79 65.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.75 -47.46 80.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.281 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.925 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.19 135.38 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 113.668 -1.605 . . . . 0.0 112.554 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.72 -60.13 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.917 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -145.34 161.84 38.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.402 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.53 138.04 53.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG21 ' HE2' ' A' ' 68' ' ' PHE . 29.8 m -110.85 122.68 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.655 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.84 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.45 122.56 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.66 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.85 99.94 7.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.206 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -68.24 -24.33 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.928 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.498 HG21 ' H ' ' A' ' 142' ' ' SER . 59.7 p -79.92 -2.21 42.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.603 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.81 78.01 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.878 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -147.33 -43.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -115.82 142.49 29.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.8 Cg_endo -70.12 139.03 38.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.104 1.869 . . . . 0.0 112.191 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -56.61 145.93 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.825 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.44 164.18 28.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.006 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.99 120.04 30.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 0.0 112.06 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.767 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -90.26 126.78 35.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.982 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.92 157.0 47.91 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.036 0.922 . . . . 0.0 113.45 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.874 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.042 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.9 t -131.29 139.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.127 0.489 . . . . 0.0 111.859 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.767 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.4 m-90 -102.82 139.32 38.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.013 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.58 127.2 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 177.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -110.81 145.56 37.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.773 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.68 ' C ' HD21 ' A' ' 78' ' ' LEU . . . 160.59 178.52 34.65 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.697 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.599 ' N ' HD21 ' A' ' 78' ' ' LEU . 14.9 mtp180 -68.25 -6.72 25.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 4.1 t-20 -84.51 133.69 43.92 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.7 0.286 . . . . 0.0 111.19 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.8 Cg_exo -70.03 -5.9 17.47 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.588 2.192 . . . . 0.0 111.654 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.68 -42.81 17.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -43.88 137.14 3.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.14 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.34 -19.21 13.49 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 57.2 t80 -130.54 130.55 44.26 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.386 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.53 ' C ' HD13 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -109.91 136.44 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.44 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.888 HD13 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -109.59 -53.0 2.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.08 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.62 -115.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.761 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -154.17 65.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.297 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.8 mp -103.45 120.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.765 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.92 -24.97 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.42 -17.37 61.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.362 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 81' ' ' ILE . 34.5 mt -107.24 150.26 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.99 164.26 12.43 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.0 m-20 -43.0 -52.12 5.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.423 0.63 . . . . 0.0 109.777 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' CB ' HD12 ' A' ' 104' ' ' ILE . 11.9 mttm -121.44 82.76 1.98 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 11.6 t60 -62.38 -46.19 89.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.892 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 17.5 p90 -150.36 157.72 43.37 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.58 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.7 tt0 -135.84 140.07 43.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.485 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.573 ' C ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -117.93 131.55 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.349 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.736 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -116.13 145.47 43.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.508 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.598 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.8 tm? . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.534 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.744 0.307 . . . . 0.0 110.691 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.5 mp -132.76 144.65 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.99 128.51 56.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.416 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.6 t30 -118.86 119.17 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.853 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.675 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.4 p30 -79.81 137.8 37.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.986 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' CB ' ' A' ' 87' ' ' LYS . 13.6 pt -145.56 30.99 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -88.73 158.18 18.27 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.053 0.454 . . . . 0.0 111.553 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -68.94 -36.28 77.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.659 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.93 17.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.546 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.8 157.34 9.68 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.07 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.61 137.97 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.208 0.603 . . . . 0.0 109.42 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -114.3 148.57 37.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.51 18.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.492 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 78.0 m-20 44.34 43.22 5.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.33 -10.85 67.5 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.43 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -104.83 118.59 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.016 0.436 . . . . 0.0 110.69 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.5 tptt -72.97 119.12 16.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.675 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -88.7 166.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.177 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.5 mm-40 -69.93 128.01 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.521 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -55.13 158.0 3.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.577 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 0.9 OUTLIER 38.34 32.77 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.791 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.2 145.07 40.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.868 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.736 ' OD1' HD11 ' A' ' 92' ' ' LEU . 13.2 m-20 -95.38 133.79 38.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.981 0.419 . . . . 0.0 110.959 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.7 mm-40 -129.07 152.07 49.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.547 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.47 123.92 24.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.829 0.347 . . . . 0.0 110.306 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 145' ' ' ILE . 65.1 tp -54.49 155.88 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.535 0.683 . . . . 0.0 111.682 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.77 153.1 42.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 120.95 18.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.928 0.394 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 23.66 59.51 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.231 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.5 t0 -54.83 172.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.9 mt-10 -145.3 135.61 24.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.4 mt -114.09 126.14 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -104.63 142.75 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.341 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.568 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.54 158.58 24.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.082 0.467 . . . . 0.0 112.254 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.04 43.54 8.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.053 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.537 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.6 t -85.1 140.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.76 0.791 . . . . 0.0 112.428 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.32 -40.96 0.86 Allowed Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.55 120.82 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.075 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -50.52 -24.96 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.731 0.301 . . . . 0.0 111.48 -178.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 t -93.5 6.44 48.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -132.13 27.86 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 138.82 31.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.56 134.32 53.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.556 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.498 ' H ' HG21 ' A' ' 40' ' ' THR . 46.7 t -108.96 150.31 27.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.6 0.714 . . . . 0.0 112.192 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.9 mt -135.67 148.36 48.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.549 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.0 t -116.92 138.12 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 124' ' ' LEU . 1.3 mm -106.37 121.11 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.086 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 117.63 34.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.795 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -84.98 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.553 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.919 179.809 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.333 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -58.96 -38.26 78.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -40.71 90.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' LEU . 11.9 tp -61.47 -31.92 71.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.7 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.79 -35.38 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.31 82.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.423 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -67.08 -23.83 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.647 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.239 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.796 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -88.41 95.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.4 -177.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -51.84 -64.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.1 p -147.9 164.9 32.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 125.72 36.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 19.4 t -88.84 122.85 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.398 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -126.19 117.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.0 t -79.94 119.96 23.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.494 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.59 -25.59 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.736 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 9.1 p -79.85 -2.6 44.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.44 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.33 76.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.973 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.551 ' HB2' HD12 ' A' ' 43' ' ' ILE . 4.7 mt-30 -144.06 -43.65 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.632 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.7 mp -122.69 142.71 38.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.02 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.67 140.66 36.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.057 1.838 . . . . 0.0 111.799 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -53.61 127.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.882 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -118.0 160.62 21.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.854 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.93 120.35 38.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.031 0.443 . . . . 0.0 112.124 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.7 mt -101.1 136.38 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.175 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.73 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.09 158.26 44.04 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.714 0 CA-C-N 113.585 -1.643 . . . . 0.0 110.585 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -132.08 139.3 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.341 0.591 . . . . 0.0 112.026 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.553 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -101.34 139.12 37.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.208 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.24 130.46 55.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -120.15 145.44 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.377 -178.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.82 -166.8 35.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.839 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 20.5 mtm180 -83.83 5.05 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 11.0 t-20 -84.82 132.13 47.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.028 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 20.3 Cg_exo -65.16 -14.97 48.05 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.471 2.114 . . . . 0.0 111.541 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.94 17.38 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 138.04 3.48 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.722 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -56.59 -18.23 11.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.831 178.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.7 t80 -126.41 120.59 30.18 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.93 116.28 31.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.54 HD13 HD13 ' A' ' 84' ' ' LEU . 29.6 mt -89.3 -170.08 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.15 14.98 59.3 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.841 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 63.88 78.55 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 111.487 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.831 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.9 mt -102.99 132.43 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.807 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -55.11 -28.63 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -78.6 -47.37 17.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.16 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.831 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.7 mt -72.73 150.73 42.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -95.9 164.24 12.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.806 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.94 -52.51 5.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.485 0.66 . . . . 0.0 109.771 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.7 mttt -119.93 81.92 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.1 t60 -62.48 -46.14 89.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.711 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -144.22 159.62 42.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.789 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 30.3 tt0 -135.94 142.65 44.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.61 ' O ' HG13 ' A' ' 65' ' ' VAL . 57.0 mt -116.94 128.06 74.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -111.67 147.99 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 111.714 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.406 HD22 HG11 ' A' ' 33' ' ' VAL . 24.5 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.852 HD13 HD22 ' A' ' 124' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.0 mp -133.01 147.27 52.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.64 125.32 54.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.43 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.1 t30 -115.13 115.66 27.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 111.522 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.5 p30 -79.33 135.17 36.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.056 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 16.3 pt -142.72 40.04 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 157.18 16.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.998 0.427 . . . . 0.0 111.629 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.9 m -68.98 -35.03 76.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.601 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.62 -20.03 17.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.561 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.02 161.33 11.26 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.597 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.4 m -117.64 137.94 52.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.08 148.5 38.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.38 18.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.191 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.47 42.81 5.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.76 77.22 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.484 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.69 118.58 36.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.14 131.43 41.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.213 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -103.66 166.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.87 126.18 28.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.557 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 83.6 tttt -53.36 162.14 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 110.727 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.9 m-80 34.63 34.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.243 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 145.09 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.149 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.61 ' HB3' HD23 ' A' ' 100' ' ' LEU . 76.1 m-20 -85.87 131.0 34.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.3 mm-40 -129.35 145.69 51.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.619 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.82 114.32 10.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.339 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.852 HD22 HD13 ' A' ' 99' ' ' LEU . 63.5 tp -53.7 157.74 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.613 . . . . 0.0 111.53 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.3 153.17 42.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.077 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.764 ' HA ' HD13 ' A' ' 147' ' ' ILE . 5.2 mm100 -71.28 125.26 26.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.589 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.6 19.22 47.75 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.327 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.4 t70 -58.41 172.88 0.42 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.9 tt0 -145.19 135.58 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -107.65 128.15 63.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.67 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.25 138.09 41.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 28.3 m -140.33 158.53 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.37 28.71 29.5 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.136 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.5 t -69.91 140.45 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.607 0.718 . . . . 0.0 112.357 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.53 0.97 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 138' ' ' SER . 51.8 t -126.39 128.72 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.629 -0.785 . . . . 0.0 109.07 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.53 -36.12 32.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.313 . . . . 0.0 111.75 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.474 ' H ' HG12 ' A' ' 136' ' ' VAL . 24.4 m -93.4 6.31 48.58 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.5 t0 -120.31 26.51 9.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.67 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -106.9 139.58 27.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.042 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.4 tt -120.41 134.59 55.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.707 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.639 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -112.2 134.63 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.474 . . . . 0.0 111.843 -179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.732 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.3 mm? -129.73 135.02 47.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.607 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.72 136.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.701 ' CD1' HG22 ' A' ' 36' ' ' VAL . 4.1 mm -106.11 137.26 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.176 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.2 124.31 51.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.764 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -99.4 130.76 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 111.663 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.768 0.318 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -68.94 -35.89 77.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.28 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.54 -44.78 95.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -45.24 86.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 HG23 ' CE2' ' A' ' 23' ' ' PHE . 39.8 mm -63.54 -47.26 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.9 -33.58 74.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.2 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -56.07 -47.12 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.949 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CE2' HG23 ' A' ' 20' ' ' ILE . 5.8 p90 -71.85 -47.12 55.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.44 133.55 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-N 113.846 -1.525 . . . . 0.0 112.393 -177.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.26 -61.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.203 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.429 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.8 p -149.02 146.22 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.287 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -113.95 138.03 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 111.398 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 25.0 t -101.47 122.95 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.855 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.848 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -123.9 126.13 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.553 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.9 t -95.33 107.85 19.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.5 p -88.16 -20.02 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.756 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.71 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.9 -2.52 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 111.401 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.57 76.04 0.52 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.795 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -146.7 -42.15 0.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' A' ' 44' ' ' PRO . 12.4 mt -131.1 142.51 45.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.11 146.02 40.39 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.239 1.959 . . . . 0.0 112.102 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 37' ' ' ILE . 34.7 mt -56.34 148.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.897 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.01 159.51 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.051 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.18 119.76 35.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.025 0.441 . . . . 0.0 112.061 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -95.54 137.49 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.58 158.76 43.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 113.655 -1.612 . . . . 0.0 110.695 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 35.0 ttpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.041 0.448 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 91' ' ' ILE . 10.6 p -107.53 139.88 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.707 0.765 . . . . 0.0 112.519 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.561 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.5 m-90 -100.59 139.05 36.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.99 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.4 127.01 55.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.679 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -113.57 145.36 41.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.47 -178.134 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.63 -175.71 39.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.779 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 28.4 mtm180 -74.97 -1.59 23.3 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t-20 -84.65 132.09 47.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.594 0.235 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.0 Cg_exo -68.52 -8.28 22.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 111.669 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.84 -42.91 17.24 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.916 0.865 . . . . 0.0 108.693 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.68 138.2 1.46 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.66 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -56.46 -19.24 14.3 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.984 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 52.8 t80 -130.21 126.39 37.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -101.49 137.62 39.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.665 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -124.59 -68.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.185 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 78' ' ' LEU . . . -168.3 -127.9 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 2.1 p30 -159.76 65.7 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 83' ' ' ARG . 35.2 mt -89.7 127.75 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.82 -24.92 25.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.238 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.0 mmm180 -78.27 -48.23 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.9 mt -72.84 152.25 41.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.904 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.0 p -95.71 164.53 12.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.29 -53.3 5.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.382 0.611 . . . . 0.0 109.757 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.76 81.1 1.64 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.397 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.3 t60 -60.0 -45.61 92.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.916 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.6 p90 -145.53 159.48 43.05 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.791 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.3 tt0 -135.99 141.39 44.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.472 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 65' ' ' VAL . 51.4 mt -118.15 129.91 73.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.809 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.5 140.94 45.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.003 0.43 . . . . 0.0 111.729 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.605 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.7 tm? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 110.837 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -132.6 145.3 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 130' ' ' ILE . 2.2 tp -112.8 127.01 56.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.219 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 90' ' ' GLN . 45.5 t30 -117.12 115.42 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.283 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.7 p30 -79.89 137.59 36.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.742 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 67' ' ' THR . 19.7 pt -146.44 40.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 157.84 16.17 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 120.957 0.408 . . . . 0.0 111.409 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -68.82 -34.77 76.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.61 -19.8 17.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.01 160.32 11.18 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.39 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.66 137.86 52.37 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.73 148.78 39.4 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.29 113.38 18.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.423 176.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 45.75 42.52 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.318 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.97 -3.37 87.03 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.626 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.51 118.54 36.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.052 0.426 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.5 tptt -76.33 121.06 22.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.121 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -97.32 164.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.231 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 mt-10 -69.9 126.98 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 46.0 tttm -52.96 161.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.942 0.401 . . . . 0.0 110.634 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 35.05 34.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.312 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.36 145.08 40.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.729 ' HB3' HD23 ' A' ' 100' ' ' LEU . 17.4 m-80 -86.11 130.01 34.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 28.6 mm-40 -129.48 146.77 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 119.32 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.797 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -52.93 156.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.396 0.617 . . . . 0.0 111.654 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.597 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.61 153.32 42.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.802 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.699 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.6 mm-40 -71.57 122.76 21.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.52 48.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.315 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t70 -53.03 174.01 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.01 135.53 24.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 145' ' ' ILE . 7.2 mt -110.72 123.21 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.755 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.64 140.12 38.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.15 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.32 158.71 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.982 0.42 . . . . 0.0 112.129 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 36.36 13.72 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.0 t -80.13 140.36 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 111.917 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.79 -30.11 2.69 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 82.9 t -126.46 118.55 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.425 -0.887 . . . . 0.0 108.708 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -50.73 -35.68 32.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.33 6.73 47.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -125.52 29.3 6.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.13 139.36 29.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.59 134.43 55.01 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.71 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -111.25 132.49 54.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 0.0 111.686 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.4 mt -125.01 150.22 46.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.377 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.4 t -117.5 140.24 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 111.349 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 130' ' ' ILE . 13.1 mt -106.22 121.74 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.99 110.96 22.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.491 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.99 133.93 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.1 t30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.711 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.745 0.307 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.05 -39.65 82.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.912 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 10.9 t80 -60.25 -39.25 86.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.694 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -31.9 72.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.82 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.63 -46.18 84.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.358 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -67.31 -23.95 65.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.61 -47.76 78.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.289 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.5 mm -85.38 95.75 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.936 -1.483 . . . . 0.0 112.677 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 99' ' ' LEU . 3.1 t -45.58 -62.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.0 p -152.08 165.2 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.723 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -124.3 138.44 54.39 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.824 0.345 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -104.08 122.91 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.86 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -126.83 118.88 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.659 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.743 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -79.92 102.31 9.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.169 179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 t -67.84 -20.65 65.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.269 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 142' ' ' SER . 73.2 p -79.74 -2.41 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.47 75.88 0.26 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.831 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.77 -42.99 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.743 HD12 ' SG ' ' A' ' 38' ' ' CYS . 4.5 mt -112.41 142.82 27.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.881 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.655 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.35 135.18 26.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.223 1.948 . . . . 0.0 111.972 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.86 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -55.51 141.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.755 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.06 164.1 28.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HB3' HG21 ' A' ' 32' ' ' ILE . 4.5 m-20 -119.84 119.55 33.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.036 0.446 . . . . 0.0 111.986 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.3 mp -86.3 129.02 34.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.691 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.86 154.32 49.5 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.045 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.695 0.283 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -124.64 138.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 112.071 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -103.65 139.07 39.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.774 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.87 126.22 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 0.0 109.931 177.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.0 m-85 -107.58 145.77 32.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.53 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 167.12 -175.1 42.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.848 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -81.45 -4.82 56.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.86 137.18 38.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.325 . . . . 0.0 111.199 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.9 -5.97 16.96 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.779 2.319 . . . . 0.0 111.818 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.2 17.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.014 0.912 . . . . 0.0 108.621 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.36 137.61 4.67 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.514 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -56.34 -18.55 11.19 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.014 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 32.5 t80 -129.43 120.16 25.01 Favored 'General case' 0 C--N 1.338 0.078 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.811 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.26 112.14 23.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.743 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.727 ' CD2' HD13 ' A' ' 43' ' ' ILE . 60.9 mt -85.52 -79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.238 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.59 -108.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.39 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -166.54 46.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 111.258 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 84' ' ' LEU . 7.0 mt -84.3 122.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.72 -29.64 53.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.117 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.561 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.794 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD12 HD12 ' A' ' 81' ' ' ILE . 24.5 mt -72.92 149.93 42.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.267 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 76.2 p -95.0 165.93 12.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.893 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.666 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.34 -53.65 4.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.828 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.608 ' HB2' HD12 ' A' ' 104' ' ' ILE . 9.7 mttt -120.79 82.7 1.95 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.2 t60 -60.42 -46.2 90.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.817 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 10.2 p90 -148.51 158.65 44.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.278 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.695 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.3 tt0 -136.03 141.29 44.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.42 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -114.23 127.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -113.25 145.15 41.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.13 0.491 . . . . 0.0 112.012 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 99' ' ' LEU . 17.8 tp . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.281 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.672 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.06 143.56 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -112.59 122.99 49.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.88 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.765 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.2 t30 -114.94 115.72 27.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.542 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -77.72 138.94 39.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.7 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.47 38.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.41 157.71 15.85 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.076 0.465 . . . . 0.0 111.533 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -69.07 -33.78 74.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.557 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -19.92 17.43 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.48 160.15 11.2 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.456 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.082 0.553 . . . . 0.0 109.535 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.54 148.36 38.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.56 18.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.372 177.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 4.0 m120 44.29 43.34 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.43 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.41 -9.75 72.05 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.433 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.4 tptt -73.6 122.85 22.93 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.206 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.9 m -93.58 164.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.215 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.6 pm0 -69.89 124.06 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.583 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.7 tttm -51.87 161.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.04 0.448 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.6 32.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.497 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.64 145.13 40.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.12 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.856 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.3 m-80 -87.34 131.04 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.864 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.3 mm-40 -129.2 150.01 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.71 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.63 133.18 44.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.023 HD11 HG21 ' A' ' 145' ' ' ILE . 65.4 tp -64.74 155.5 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.51 0.672 . . . . 0.0 111.689 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.85 152.9 43.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.511 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' HD12 ' A' ' 147' ' ' ILE . 5.3 mm-40 -71.88 124.05 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.328 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.02 22.68 43.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.088 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t70 -53.01 172.05 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.939 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -145.05 135.8 24.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 143' ' ' LEU . 15.6 mt -114.66 124.81 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.999 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.621 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.78 141.65 36.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' CD2' ' A' ' 88' ' ' HIS . 23.0 m -140.44 158.74 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.32 43.5 9.46 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.251 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.7 t -84.28 140.35 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.595 0.712 . . . . 0.0 112.336 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.2 -39.17 1.27 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.4 119.64 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.455 -0.872 . . . . 0.0 108.917 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.4 tt0 -50.39 -26.45 4.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.8 0.334 . . . . 0.0 111.455 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.45 6.49 47.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.7 25.48 5.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.19 138.75 31.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.17 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.61 134.57 52.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.157 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.2 t -109.96 150.36 28.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.676 0.751 . . . . 0.0 112.381 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.572 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -135.25 154.06 51.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.782 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.939 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -126.1 137.89 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.023 HG21 HD11 ' A' ' 124' ' ' LEU . 1.6 mm -106.32 120.91 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.837 0.351 . . . . 0.0 110.817 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.33 112.68 24.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.717 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -86.01 133.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.361 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.713 179.836 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pm0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.95 -39.46 94.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.21 -35.45 75.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.475 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 16' ' ' GLN . 34.6 mt -65.99 -33.3 75.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.672 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.07 -35.61 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.667 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -42.15 82.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.451 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -67.1 -23.77 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.687 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.66 -47.41 79.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.732 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-80 . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.22 135.46 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.5 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.92 -60.41 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.925 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.597 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.9 p -150.15 147.42 27.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.24 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.443 HH11 HD11 ' A' ' 37' ' ' ILE . 3.1 ttm180 -113.95 132.8 55.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.25 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.1 m -95.08 122.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.7 mt -127.36 125.66 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.263 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HA ' HD23 ' A' ' 143' ' ' LEU . 5.4 t -89.4 109.84 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.491 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -82.6 -24.76 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.776 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.67 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.2 p -79.92 -2.71 44.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.712 0.291 . . . . 0.0 111.496 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 77.5 0.3 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.965 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -147.46 -39.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -126.44 141.69 40.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.7 Cg_endo -72.09 145.66 44.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.171 1.914 . . . . 0.0 112.139 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.8 mt -60.82 149.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.711 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -142.71 164.08 31.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.092 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.92 119.89 35.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 111.881 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.5 mt -97.65 137.21 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.13 158.78 43.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.845 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.643 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -131.96 139.16 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.245 0.545 . . . . 0.0 111.852 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.11 139.26 37.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.006 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.51 129.04 56.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -118.46 145.29 45.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.523 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.63 -169.05 37.0 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.762 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.434 ' HG3' HD11 ' A' ' 78' ' ' LEU . 20.3 mtm180 -80.76 3.57 21.91 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.915 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 56.7 t30 -84.76 132.56 45.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 0.0 111.134 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.19 -14.16 43.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.45 2.1 . . . . 0.0 111.637 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.78 -42.73 17.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.861 0.838 . . . . 0.0 108.909 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.42 139.02 1.14 Allowed 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.021 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 m-20 -56.3 -18.99 12.3 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.977 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.0 t80 -129.8 123.09 30.09 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 120.731 0.3 . . . . 0.0 111.083 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.07 107.9 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -111.14 177.35 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.29 131.77 50.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.618 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -70.97 88.26 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.4 mt -106.33 135.08 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.06 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.27 -31.87 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.091 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.25 -49.26 57.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.189 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 81' ' ' ILE . 25.6 mt -74.54 151.21 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.996 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 p -95.38 164.15 12.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.61 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.55 -52.63 4.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.424 0.631 . . . . 0.0 109.648 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.97 82.35 1.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -60.88 -46.13 91.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.761 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.7 p90 -143.46 160.0 41.37 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.907 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.97 142.33 44.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.462 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.645 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.6 mt -117.67 131.52 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.805 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.457 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -118.93 140.21 50.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.049 0.452 . . . . 0.0 111.96 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.719 HD22 HG11 ' A' ' 33' ' ' VAL . 10.4 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.237 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.6 mt -125.84 141.01 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.099 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.69 122.24 47.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.386 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -113.95 115.69 28.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.978 0.418 . . . . 0.0 111.404 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.6 p30 -78.59 137.52 37.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.002 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -145.93 40.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.13 161.07 13.9 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.01 0.433 . . . . 0.0 111.712 -179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.6 m -69.05 -38.63 79.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.799 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -20.1 17.22 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.55 161.02 10.96 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.609 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.2 m -117.59 137.97 52.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.565 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.888 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.97 148.56 36.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.5 18.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.219 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 44.52 43.24 6.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.87 -10.86 68.65 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.514 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -104.61 118.5 36.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.888 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.5 tptm -73.5 131.11 41.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.228 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -102.79 165.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.193 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.5 tt0 -69.9 126.4 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.573 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.0 tttp -53.75 162.5 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 110.619 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.32 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.111 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.53 145.07 40.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.109 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.685 ' HB3' HD22 ' A' ' 100' ' ' LEU . 78.3 m-20 -88.75 130.71 35.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.968 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.846 ' O ' HD23 ' A' ' 100' ' ' LEU . 37.3 mm-40 -129.12 147.56 50.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.4 tm? -72.6 119.23 16.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.48 HD21 ' CG1' ' A' ' 147' ' ' ILE . 65.6 tp -54.68 157.79 2.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 111.537 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.438 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.31 153.25 42.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.26 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.31 122.41 20.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.458 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.62 23.01 54.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.138 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.7 t70 -57.41 173.86 0.24 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' VAL . 59.9 tt0 -145.13 135.61 24.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.041 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 145' ' ' ILE . 2.8 mp -109.24 127.37 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.62 139.01 40.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.29 37.41 15.02 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.15 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.3 t -77.58 140.39 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.671 0.748 . . . . 0.0 112.202 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.82 -39.59 1.26 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 138' ' ' SER . 42.9 t -126.45 123.89 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.078 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.32 -29.59 10.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.808 0.337 . . . . 0.0 111.454 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.543 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.7 m -93.41 6.51 47.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.15 23.02 8.55 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -106.8 139.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.24 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 142' ' ' SER . 6.7 tt -124.4 134.65 53.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.702 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -110.92 129.12 55.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.177 0.513 . . . . 0.0 111.606 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 20.9 mt -122.53 136.78 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.677 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -110.85 140.17 31.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.331 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.622 ' CD1' HD11 ' A' ' 130' ' ' ILE . 25.3 mt -105.97 136.39 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.82 111.78 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.86 128.65 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.482 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -36.04 74.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -36.95 85.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -45.02 77.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.789 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.8 mm -66.83 -35.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.075 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.05 -43.03 81.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.2 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -67.14 -23.87 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.403 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.57 -47.43 79.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.737 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -76.03 135.2 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 113.617 -1.629 . . . . 0.0 112.696 -177.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.79 -61.09 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.86 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.1 p -144.52 145.98 32.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.076 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 138.13 50.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.493 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 36' ' ' VAL . 11.9 p -105.33 122.69 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -129.39 118.44 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.514 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -79.98 115.22 19.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.369 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -82.57 -26.0 32.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.885 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 67.1 p -79.9 -2.24 42.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.722 0.296 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.16 76.29 0.3 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.98 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -146.02 -43.76 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mt -114.13 141.3 26.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.1 Cg_endo -72.98 135.48 23.28 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.21 1.94 . . . . 0.0 112.198 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.75 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -55.47 134.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.04 164.29 20.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.49 119.83 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.214 0.531 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -97.38 131.53 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.988 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.85 159.0 44.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -178.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.475 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.1 t -133.34 139.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.226 0.536 . . . . 0.0 112.007 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -103.42 139.08 39.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.99 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.93 130.24 56.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -120.05 145.27 47.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.49 -167.1 35.04 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.49 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.75 1.96 21.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.56 127.01 67.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.464 0.174 . . . . 0.0 110.948 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.9 Cg_exo -63.85 -14.33 42.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.317 2.012 . . . . 0.0 111.47 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -42.17 17.95 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.738 0.78 . . . . 0.0 108.925 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.09 138.61 1.07 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.592 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 t70 -56.35 -18.63 11.48 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.164 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' CE2' HG21 ' A' ' 43' ' ' ILE . 16.0 t80 -129.75 116.06 18.21 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -89.15 107.94 19.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.586 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD13 ' A' ' 84' ' ' LEU . 57.0 mt -71.87 -76.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.87 -98.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.465 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -162.89 53.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.334 . . . . 0.0 111.167 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -93.02 117.67 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -28.98 56.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.12 -47.88 40.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.01 HD12 HD13 ' A' ' 81' ' ' ILE . 16.1 mt -72.78 146.5 46.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.2 p -94.29 163.52 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.723 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.55 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -41.43 -52.11 3.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.589 0.709 . . . . 0.0 110.007 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -121.34 81.37 1.78 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.9 t60 -61.21 -46.49 90.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.609 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.8 p90 -144.86 157.15 44.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.722 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 67' ' ' THR . 26.5 tt0 -136.15 138.92 42.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.5 mt -113.0 127.86 70.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.678 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -110.01 149.23 30.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.493 . . . . 0.0 111.836 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.673 HD12 HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.117 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.815 HD21 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.732 0.301 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.0 mm? -133.17 145.29 50.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.943 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 124' ' ' LEU . 13.9 mt -112.73 122.91 49.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.596 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.8 t30 -115.62 115.72 26.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 112.013 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.874 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.1 p30 -77.0 134.66 38.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.0 pt -142.0 39.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.62 159.7 14.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.956 0.408 . . . . 0.0 111.778 -178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.0 m -68.88 -37.97 79.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -19.77 17.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.71 162.97 11.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.432 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.35 137.85 52.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.894 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.11 148.36 35.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.578 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.19 113.43 18.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.302 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 5.0 m120 42.75 44.1 3.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.527 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.65 -13.55 63.84 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -103.26 118.56 37.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.6 tptm -73.49 124.2 25.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.487 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.874 HG23 ' OD2' ' A' ' 103' ' ' ASP . 19.1 m -91.53 161.88 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.3 pt-20 -69.82 123.07 20.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.499 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 72.0 tttt -50.08 161.65 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.15 35.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.332 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.21 145.05 40.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.387 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -84.78 125.43 32.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.718 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.572 ' O ' HD13 ' A' ' 100' ' ' LEU . 36.0 mm-40 -129.54 147.16 51.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -77.28 115.18 16.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.122 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.43 162.5 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 111.912 -179.159 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.507 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.93 153.41 42.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.421 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.37 119.92 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.543 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.39 56.89 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.434 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.578 ' OD2' HD13 ' A' ' 111' ' ' LEU . 12.7 t70 -60.55 -179.01 0.1 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.946 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.28 135.64 24.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.296 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.866 HG13 HD11 ' A' ' 145' ' ' ILE . 3.7 mt -113.72 127.72 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.579 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.46 141.09 36.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.28 158.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 43.52 8.71 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.026 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.494 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.3 t -84.35 140.42 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.663 0.744 . . . . 0.0 112.396 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.06 -38.81 0.83 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.42 123.15 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.166 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.4 -29.83 11.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.556 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.7 m -93.57 6.41 48.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -127.56 27.43 5.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.579 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 139.25 29.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.032 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.21 134.43 53.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.512 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -108.71 150.51 27.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.597 0.713 . . . . 0.0 112.145 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.4 mt -135.66 158.13 45.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.946 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.0 t -126.52 130.53 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.888 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.866 HD11 HG13 ' A' ' 130' ' ' ILE . 1.1 mp -105.64 120.8 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.29 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.29 112.17 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.586 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.515 ' CD1' HD22 ' A' ' 124' ' ' LEU . 5.2 mt -84.79 131.06 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.846 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.814 0.34 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -35.96 74.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -44.23 94.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -44.68 94.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -65.87 -35.0 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -57.14 -36.94 71.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -67.24 -23.9 65.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.53 79.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -74.02 133.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.465 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.74 -60.81 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.646 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 p -146.55 147.59 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.178 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.08 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' CE2' ' A' ' 68' ' ' PHE . 28.5 t -105.49 122.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.859 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -126.87 121.17 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.449 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' HD21 ' A' ' 141' ' ' LEU . 17.8 t -79.87 115.73 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -87.01 -25.05 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.742 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' H ' ' A' ' 142' ' ' SER . 30.4 p -79.89 -2.13 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.599 0.238 . . . . 0.0 111.441 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.36 76.99 0.26 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.897 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -147.26 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -122.17 142.08 35.93 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.0 Cg_endo -72.43 145.05 41.99 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.148 1.899 . . . . 0.0 112.228 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.859 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -56.61 147.35 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.49 161.38 35.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.198 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -118.63 119.74 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 111.707 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.4 mt -99.11 132.56 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.35 158.58 43.9 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.501 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.5 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.712 0.291 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.79 139.14 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.239 0.542 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.2 m-90 -102.81 139.44 38.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.15 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.38 128.88 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -118.35 145.34 45.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.477 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.709 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 161.02 -166.59 35.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.644 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.4 mtm180 -84.34 5.42 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.4 t-20 -84.95 132.47 45.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.72 -14.79 46.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.449 2.099 . . . . 0.0 111.462 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -43.31 16.96 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.854 0.835 . . . . 0.0 108.76 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.05 138.96 1.92 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.739 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.35 -18.86 12.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.922 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.5 t80 -129.78 125.23 35.3 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.778 0.323 . . . . 0.0 111.257 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -103.28 112.84 25.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.614 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.709 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -119.29 72.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.26 -131.87 19.83 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.919 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.69 84.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.046 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -96.59 128.6 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -28.77 63.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.63 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -74.13 -27.76 61.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.059 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.971 HD12 HD13 ' A' ' 81' ' ' ILE . 17.5 mt -99.5 152.12 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.956 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.8 p -94.96 166.65 11.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.533 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.564 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.58 -53.85 5.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.353 0.597 . . . . 0.0 109.596 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.566 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.14 83.75 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -60.33 -46.27 90.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.8 p90 -144.59 160.27 41.43 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.171 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.78 141.32 44.77 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.196 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.5 mt -117.3 132.18 67.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.027 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.93 151.59 27.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.087 0.47 . . . . 0.0 111.612 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 93' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 33' ' ' VAL . 5.8 mp . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.6 mt -129.67 143.92 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -112.66 127.47 56.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.538 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.5 t30 -118.9 115.5 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 0.0 111.493 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -78.84 138.37 38.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -145.74 40.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 150.94 21.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.037 0.446 . . . . 0.0 111.798 -178.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -68.62 -31.56 70.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.769 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.14 -19.71 17.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.34 10.61 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.53 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.19 137.71 52.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.76 148.58 39.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.59 18.61 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.349 177.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 43.97 43.44 5.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.45 -12.55 64.65 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.485 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.42 118.53 36.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 110.56 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.83 130.63 41.52 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.501 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.866 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.1 m -100.05 163.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 pm0 -69.98 124.69 24.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.9 tttt -50.99 161.01 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 111.012 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.37 34.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.401 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.37 145.16 40.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.8 ' HB3' HD22 ' A' ' 100' ' ' LEU . 24.9 m-80 -85.49 128.55 34.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.34 147.53 51.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.705 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.4 tt -72.89 120.1 18.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.31 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -56.81 157.54 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.291 0.567 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.38 153.24 42.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.452 ' HG2' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 121.8 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.357 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.95 24.57 54.55 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.19 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.8 t70 -57.72 175.6 0.18 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.902 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.6 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.035 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 145' ' ' ILE . 6.7 mt -113.14 128.19 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.383 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.651 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.19 138.88 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.805 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.26 158.41 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.35 21.46 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.936 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.0 t -75.07 140.43 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.661 0.743 . . . . 0.0 112.428 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.26 -37.8 0.85 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.38 123.26 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.96 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -32.54 16.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.783 0.325 . . . . 0.0 111.585 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.461 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 3.6 t0 -125.86 29.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.651 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.29 139.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 142' ' ' SER . 4.4 tt -124.4 134.41 53.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.577 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD23 ' A' ' 141' ' ' LEU . 45.7 t -112.71 150.27 31.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.481 0.658 . . . . 0.0 112.424 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HZ ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -134.1 148.5 51.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.14 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.6 t -114.04 135.5 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 130' ' ' ILE . 27.9 mt -106.3 122.79 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 120.57 42.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.55 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.583 HG12 HD21 ' A' ' 124' ' ' LEU . 6.1 mt -84.59 134.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.826 0.346 . . . . 0.0 111.322 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.77 0.319 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -128.73 -61.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.88 -42.56 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -59.01 -39.08 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -39.11 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.81 -31.98 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.99 -35.53 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.38 -45.34 84.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -67.07 -23.78 65.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.581 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.63 -47.62 79.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m -80.85 -38.34 28.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.07 76.2 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.82 135.69 37.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.46 101.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.9 mm -86.99 138.47 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.711 0.767 . . . . 0.0 111.826 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.52 36.61 0.73 Allowed Glycine 0 C--N 1.314 -0.668 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.626 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -44.05 97.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 178.6 38.53 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -76.4 136.09 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.533 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.944 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.32 -60.0 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.803 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.4 p -145.97 165.27 29.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.281 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.44 122.79 34.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.386 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.659 HG11 ' HE2' ' A' ' 68' ' ' PHE . 5.4 m -90.35 122.86 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.922 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.833 HG23 HG12 ' A' ' 45' ' ' ILE . 20.4 mt -126.34 120.46 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.444 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.746 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.3 t -80.83 121.31 25.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -26.17 19.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.379 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' H ' ' A' ' 142' ' ' SER . 40.2 p -79.87 -2.18 42.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.579 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.32 76.49 0.29 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.807 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HB2' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -146.32 -42.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -117.72 141.26 28.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.8 141.06 36.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.152 1.902 . . . . 0.0 112.167 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.833 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -55.9 133.56 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.82 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -127.1 164.05 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.137 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.85 119.78 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.814 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -87.18 130.45 34.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.463 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.944 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.91 155.99 48.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.287 1.041 . . . . 0.0 113.497 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.69 165.84 31.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.226 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.6 m-20 -81.31 126.73 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.123 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.563 HD13 ' SG ' ' A' ' 154' ' ' CYS . 56.1 mt -64.42 -43.31 96.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.896 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -62.51 -40.11 95.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.333 0.587 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 28.9 mm-40 -68.48 -36.92 79.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.683 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 51' ' ' ASP . 53.3 t -73.08 -42.48 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.009 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.89 -39.35 72.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -75.19 -40.84 59.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.93 126.02 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 33.12 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -147.94 153.6 39.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.1 t 61.19 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.77 HD13 HD12 ' A' ' 92' ' ' LEU . 6.0 tp -179.02 161.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 111.141 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.45 -68.53 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.718 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 16.4 ttpt -145.91 117.91 8.27 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.9 p -111.35 140.08 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.814 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.6 m-90 -100.67 139.34 36.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.107 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 131.41 55.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -120.2 145.58 46.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.659 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.45 -169.18 36.18 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.768 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.0 mtm180 -81.95 3.75 25.26 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.744 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.6 t-20 -84.82 132.65 45.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.572 0.225 . . . . 0.0 111.007 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.88 -13.3 39.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.514 2.143 . . . . 0.0 111.63 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.92 17.41 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.914 0.864 . . . . 0.0 108.847 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.54 137.52 3.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.805 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -18.09 11.01 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.226 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 9.8 t80 -129.06 119.43 24.19 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.031 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.97 111.41 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.547 ' HA ' HG12 ' A' ' 43' ' ' ILE . 1.7 mt -88.07 -65.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.06 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.169 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.78 54.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 34.1 mm -75.06 126.66 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 p -54.94 -40.83 70.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.277 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -68.81 -44.9 72.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -72.99 150.07 42.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -95.69 166.83 11.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.78 -53.15 6.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 109.805 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HB2' HG22 ' A' ' 67' ' ' THR . 9.7 ptmt -120.9 81.83 1.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.7 t60 -60.4 -46.15 91.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.829 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.8 p90 -142.45 160.2 40.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.077 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.712 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.99 143.87 45.05 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.713 ' C ' HG23 ' A' ' 65' ' ' VAL . 69.9 mt -120.03 125.68 74.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.632 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.77 HD12 HD13 ' A' ' 62' ' ' ILE . 1.9 pt? -114.17 137.3 51.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.787 HD22 HG11 ' A' ' 33' ' ' VAL . 18.9 tp -110.94 128.76 55.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.307 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.99 -130.68 1.31 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.294 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.05 -165.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.313 . . . . 0.0 110.978 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.74 53.6 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 155' ' ' LEU . . . 93.68 40.62 4.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.0 165.05 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -107.51 156.96 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.82 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.8 mp -133.14 147.13 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.224 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 145' ' ' ILE . 8.2 mp -112.62 125.66 54.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD22 ' A' ' 92' ' ' LEU . 41.1 t30 -116.69 115.63 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.8 p30 -80.44 132.6 35.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.808 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -139.57 41.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.95 157.76 16.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.018 0.437 . . . . 0.0 111.473 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.539 ' OG1' HG21 ' B' ' 5' ' ' TPO . 85.6 m -68.84 -36.35 78.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.445 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -19.84 17.34 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.46 161.45 11.25 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.489 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.0 m -117.6 137.99 52.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.6 148.38 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -124.33 113.54 18.37 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 45.78 42.75 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.37 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.84 -5.5 84.87 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.493 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.39 118.72 37.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.108 0.454 . . . . 0.0 110.868 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.4 tptm -75.11 126.91 32.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.327 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -101.52 165.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tt0 -69.86 125.92 28.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 47.9 tttm -52.12 161.82 0.56 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.91 0.386 . . . . 0.0 110.558 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.63 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.281 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.23 145.07 40.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.251 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.481 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.4 m120 -86.67 130.13 34.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.8 mm-40 -129.39 147.89 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.477 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.5 tt -72.8 135.99 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.331 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.848 HD21 HG12 ' A' ' 147' ' ' ILE . 63.4 tp -65.62 155.23 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.463 0.649 . . . . 0.0 111.733 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.95 153.12 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.515 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.67 123.13 21.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.139 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.38 46.15 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.063 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.5 t70 -52.14 170.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.02 135.56 24.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 145' ' ' ILE . 11.3 mt -113.52 126.68 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.48 138.57 40.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.745 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.8 m -140.27 158.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.84 31.49 23.62 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.6 t -73.41 140.36 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.604 0.716 . . . . 0.0 112.217 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 150.01 -39.33 0.88 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 21.6 t -126.23 128.31 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.017 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.4 -35.42 28.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.38 6.55 47.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.92 27.32 8.16 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.12 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.172 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -124.35 134.48 53.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.434 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.588 ' C ' HD22 ' A' ' 143' ' ' LEU . 41.6 t -112.61 150.41 31.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.671 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.746 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.91 152.4 50.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.379 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.9 t -119.82 140.08 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.34 . . . . 0.0 111.334 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 130' ' ' ILE . 47.7 mt -106.32 121.0 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -109.11 114.38 28.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.512 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.848 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.86 132.76 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.551 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.21 111.41 15.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.8 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.58 -28.72 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -45.87 90.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -43.18 88.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.054 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.2 -37.17 76.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.563 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.1 t -63.75 -46.03 87.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.428 HD22 ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -62.61 -40.83 98.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -59.47 -34.12 72.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.96 -33.49 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.45 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.547 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 147.2 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.1 m -96.34 134.34 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.188 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -97.37 105.53 17.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.09 136.45 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.717 ' O ' HG22 ' B' ' 4' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.593 0.235 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.717 HG22 ' O ' ' B' ' 3' ' ' ASN . 6.3 tt 52.47 161.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.822 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.539 HG21 ' OG1' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.65 128.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.66 125.84 10.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.384 2.056 . . . . 0.0 112.439 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.623 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -78.95 175.22 10.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.5 ' H ' HG22 ' B' ' 8' ' ' THR . 49.1 mt-30 -67.07 173.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -161.78 130.79 4.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.55 109.45 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -158.27 -55.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -69.45 -47.08 65.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -38.88 86.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -35.45 77.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.843 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -42.17 88.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.22 -35.14 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.22 -43.35 82.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.853 0.359 . . . . 0.0 110.377 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.428 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.47 79.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 -38.78 92.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.827 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -92.93 75.1 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.7 131.43 37.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -67.24 111.78 4.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.03 138.41 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.692 0.758 . . . . 0.0 111.703 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.62 69.0 1.23 Allowed Glycine 0 C--N 1.314 -0.664 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.456 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -39.08 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 179.62 37.81 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -75.35 135.04 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.561 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.26 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.838 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -146.49 147.21 30.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.326 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 128.17 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.265 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.5 m -94.58 122.9 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.798 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -123.15 111.38 29.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.655 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.04 106.42 18.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -97.76 -10.76 24.29 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.682 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.1 p -79.94 -2.59 44.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.408 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.45 84.26 0.69 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.432 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.928 ' NE2' HD13 ' A' ' 141' ' ' LEU . 15.1 pt20 -161.72 -47.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.422 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.58 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.6 mt -134.16 142.79 44.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.711 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' HG23 ' A' ' 43' ' ' ILE . 63.4 Cg_endo -75.92 146.01 29.03 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.255 1.97 . . . . 0.0 111.794 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 36.9 mt -52.24 136.77 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.969 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -132.08 161.89 32.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 120.02 36.68 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.712 HD11 HG13 ' A' ' 36' ' ' VAL . 4.1 mt -96.04 136.96 35.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 159.07 43.91 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -178.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -152.14 141.96 21.98 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.709 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -85.65 135.03 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.159 0.504 . . . . 0.0 111.126 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 52' ' ' ILE . 1.5 mp -64.19 -39.99 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -41.6 78.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.668 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.1 mt-30 -68.68 -37.02 79.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.6 t -62.96 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 57' ' ' LYS . 4.4 pp -70.93 -28.03 64.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.134 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.727 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -80.05 -26.93 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.052 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 63' ' ' LYS . 1.3 tp10 -62.82 99.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.29 93.57 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.82 95.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.32 -168.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.841 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.558 HD11 HD13 ' A' ' 92' ' ' LEU . 8.7 tp -104.24 8.27 9.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG3' HG13 ' A' ' 55' ' ' VAL . 3.3 mmtt 61.2 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.322 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ILE . 8.7 ttpt -155.07 136.47 14.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.848 0.356 . . . . 0.0 111.454 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.5 t -132.55 139.48 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.22 0.533 . . . . 0.0 111.761 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -100.88 137.67 38.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.69 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.01 127.48 56.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.25 145.53 42.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.66 -173.06 35.63 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.663 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 14.3 mtm105 -77.79 4.87 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 11.4 t-20 -84.97 131.91 47.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 0.0 111.043 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 Cg_exo -66.07 -14.21 43.35 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.362 2.041 . . . . 0.0 111.573 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.01 -42.61 17.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.946 0.879 . . . . 0.0 109.014 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.65 138.19 1.44 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.096 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.39 -18.21 10.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' A' ' 36' ' ' VAL . 6.6 t80 -128.48 112.22 14.12 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.79 0.328 . . . . 0.0 111.222 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -90.46 118.28 29.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.415 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -126.95 172.4 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.33 137.09 45.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.577 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -71.51 81.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 83' ' ' ARG . 27.8 mm -88.9 127.31 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.955 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -55.04 -24.93 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.665 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.03 -46.07 15.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.157 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 132' ' ' VAL . 42.3 mt -72.7 152.18 41.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.036 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.4 p -95.88 166.03 11.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.693 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.607 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -44.14 -53.77 6.17 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 109.614 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.36 81.85 1.75 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -59.54 -45.89 90.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.764 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.2 p90 -145.45 157.61 43.98 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.772 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -136.06 141.06 44.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.606 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 65' ' ' VAL . 53.6 mt -116.53 129.69 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.022 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -117.13 140.83 49.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.105 0.479 . . . . 0.0 111.602 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.803 HD22 HG11 ' A' ' 33' ' ' VAL . 9.8 tp -125.24 123.0 38.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.258 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.1 -140.28 6.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.559 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 69.11 -67.19 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.964 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.87 -47.19 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.79 -35.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.521 ' O ' HD12 ' A' ' 93' ' ' LEU . 6.7 p-10 -59.74 179.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.748 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.52 156.33 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.1 mp -133.03 145.09 50.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.591 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 145' ' ' ILE . 10.5 mp -112.74 122.05 46.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.01 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.582 ' HB2' HD21 ' A' ' 92' ' ' LEU . 57.4 t30 -116.77 115.63 25.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 111.56 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.1 p30 -78.31 135.91 37.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.0 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -143.84 39.08 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.98 160.4 14.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.043 0.449 . . . . 0.0 111.5 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.1 m -68.96 -36.46 77.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.615 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.49 -20.06 17.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.34 162.07 11.55 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.201 -0.999 . . . . 0.0 113.481 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.69 137.84 52.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.852 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.72 148.39 36.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.46 18.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.198 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m120 44.39 42.85 5.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.358 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.37 -5.08 85.33 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.464 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -104.86 118.51 36.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 0.0 110.738 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.852 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.0 tptp -75.67 126.04 30.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.156 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.789 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.2 m -102.69 163.13 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.289 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.91 127.1 31.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.7 tttp -52.44 163.44 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.197 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 35.43 35.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.948 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -112.03 137.2 50.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.107 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.466 ' HB3' HD23 ' A' ' 100' ' ' LEU . 55.3 m-20 -80.4 130.54 35.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 27.2 mm-40 -129.54 146.9 51.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 tp -72.85 136.13 45.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -63.72 157.45 24.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.48 0.657 . . . . 0.0 112.006 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.475 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.44 153.37 43.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.217 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.456 ' OE1' HD12 ' A' ' 147' ' ' ILE . 15.2 mm100 -71.55 115.6 10.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.38 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.26 30.02 63.8 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.702 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.457 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.1 t70 -55.23 174.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.973 0.416 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.907 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.21 135.47 24.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.015 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 10.4 mt -111.33 126.3 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.549 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.564 HG22 ' CG2' ' A' ' 140' ' ' ILE . 8.2 m -104.87 137.66 42.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.0 m -140.32 158.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 112.181 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.59 16.26 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.17 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.8 t -74.53 140.41 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.684 0.754 . . . . 0.0 112.172 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' B' ' 8' ' ' THR . . . 145.23 -41.07 1.08 Allowed Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 43.1 t -126.5 123.14 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.541 -0.83 . . . . 0.0 108.929 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.29 -28.05 7.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.427 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -93.64 6.53 48.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.62 24.37 7.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.564 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.47 138.23 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.928 HD13 ' NE2' ' A' ' 42' ' ' GLN . 9.9 mt -125.19 134.77 52.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.339 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.682 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -104.65 139.07 40.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.213 0.53 . . . . 0.0 111.897 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.2 mp -125.06 152.51 44.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.154 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.907 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.5 t -120.77 134.18 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.869 0.366 . . . . 0.0 111.618 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 36.3 mt -106.31 121.74 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -110.24 119.02 37.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.599 HD13 HD22 ' A' ' 124' ' ' LEU . 5.9 mt -84.71 134.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -81.66 126.35 31.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.79 -24.45 61.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -57.9 -43.84 86.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.534 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 1.1 t80 -57.9 -40.99 81.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -33.96 77.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -46.27 80.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -65.85 -43.19 89.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -36.03 82.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.81 -39.44 85.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -91.42 -34.54 14.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.002 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 44.85 -172.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.619 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 151.13 46.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.1 p -72.97 117.63 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -134.12 -48.2 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.61 177.36 7.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.5 mp -89.6 114.98 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.898 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.691 ' O ' HG22 ' B' ' 4' ' ' ILE . 5.9 m-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.519 0.199 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.691 HG22 ' O ' ' B' ' 3' ' ' ASN . 9.3 tp 52.04 157.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.999 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -79.84 143.01 57.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 -176.76 2.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.532 2.155 . . . . 0.0 112.256 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.453 HG22 ' HA3' ' A' ' 135' ' ' GLY . 25.5 m -163.49 111.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 58.88 97.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -139.8 148.5 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 t -163.43 164.53 24.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -124.03 -44.31 2.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -63.64 -47.1 82.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -60.54 -42.21 96.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 -38.05 80.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.9 -32.27 72.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.675 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.11 -35.5 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.734 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -39.98 77.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.446 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -67.1 -23.8 65.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.794 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.68 -47.34 80.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.224 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -36.51 49.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.832 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.67 81.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 150.82 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.57 129.14 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.27 138.34 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 121.715 0.769 . . . . 0.0 111.809 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.68 66.79 3.85 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 32' ' ' ILE . 3.9 pt-20 -65.02 -39.18 93.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.167 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 177.11 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.711 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -75.11 134.49 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.262 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.75 -61.58 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.421 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.453 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.2 p -155.19 138.03 15.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.443 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -113.99 138.45 50.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.3 t -96.13 132.14 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.388 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.788 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.71 116.89 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 108.99 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.245 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.4 p -93.61 -20.12 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.035 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.852 HG21 ' OG ' ' A' ' 142' ' ' SER . 48.9 p -79.82 -2.99 45.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 111.499 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 74.27 75.37 0.78 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.562 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 8.8 mt-30 -147.95 -41.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.676 0.274 . . . . 0.0 111.223 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.6 mt -134.01 141.49 39.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.2 Cg_endo -73.99 146.07 36.6 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.179 1.919 . . . . 0.0 111.92 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.788 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -56.13 151.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.187 0.517 . . . . 0.0 111.956 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 2.0 ttt-85 -149.69 159.18 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.26 121.59 40.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 112.333 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD11 ' HZ ' ' A' ' 68' ' ' PHE . 8.1 mt -94.56 137.76 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.005 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 158.17 43.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.55 143.44 35.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.117 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 31.5 m-20 -86.2 114.02 22.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.479 . . . . 0.0 111.263 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -64.38 -41.44 92.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.376 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 t -56.74 -38.26 72.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.307 0.575 . . . . 0.0 110.802 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.0 mm-40 -68.49 -36.83 79.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.73 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.63 -50.08 69.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.49 -28.1 63.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.02 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.8 -32.82 40.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.73 123.2 40.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 88.55 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.65 172.35 18.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.54 29.86 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.409 HD11 ' CG2' ' A' ' 65' ' ' VAL . 7.6 tp -151.38 145.45 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HD3' HD23 ' A' ' 93' ' ' LEU . 10.0 mttp -119.66 -67.07 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.0 ttpt -153.76 142.78 21.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.8 t -127.45 139.47 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.312 0.577 . . . . 0.0 112.186 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.636 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -107.78 138.56 43.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -110.69 126.23 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.746 ' CE2' HG21 ' A' ' 36' ' ' VAL . 2.5 m-85 -107.37 145.78 32.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.818 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.9 -178.58 40.54 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.782 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -78.16 -3.38 42.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 136.83 38.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.27 -6.12 17.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.796 2.331 . . . . 0.0 111.736 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.27 14.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.956 0.884 . . . . 0.0 108.684 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.07 139.23 2.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.457 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -18.62 10.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.174 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.1 t80 -129.36 131.65 46.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.04 131.09 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -133.18 -178.58 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.45 135.64 39.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -69.93 89.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' H ' ' A' ' 83' ' ' ARG . 25.2 mt -104.35 127.75 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -54.98 -25.02 26.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.325 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -75.62 -46.74 29.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.227 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 132' ' ' VAL . 39.8 mt -72.74 151.68 42.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.748 0.309 . . . . 0.0 111.306 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -95.56 166.16 11.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.893 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.22 -54.39 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 109.858 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.9 mttp -118.82 82.84 1.92 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -60.87 -46.79 89.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.652 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 p90 -147.71 159.31 43.94 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.278 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 65' ' ' VAL . 35.7 tt0 -135.95 141.46 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 65' ' ' VAL . 41.4 mt -114.37 132.33 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.251 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -122.0 144.46 48.88 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 111.341 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.762 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp -125.12 123.0 38.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.64 -132.63 1.49 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.553 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 62.38 -80.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.021 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.39 42.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.27 -30.29 8.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.68 162.16 21.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.302 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.544 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -106.97 150.68 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.821 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.9 mt -133.13 140.38 47.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.249 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -112.56 126.08 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.202 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -115.8 115.49 26.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.784 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.68 140.81 38.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.7 pt -149.22 38.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.51 159.04 15.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.007 0.432 . . . . 0.0 111.625 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.1 m -69.02 -34.96 76.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.647 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 -19.97 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.71 162.81 12.04 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.533 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.9 m -117.53 137.81 52.32 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.71 148.36 38.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.526 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.14 113.48 18.4 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.361 177.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 44.28 42.88 5.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -10.39 71.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.474 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.96 118.54 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.09 0.445 . . . . 0.0 110.656 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.34 130.91 41.2 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.56 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.784 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -101.87 164.58 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.851 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 tt0 -69.98 126.67 30.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.499 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 tttt -52.69 161.6 0.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.545 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 35.02 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.293 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.0 40.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.114 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.631 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.0 m-80 -89.86 126.67 35.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.76 ' O ' HD23 ' A' ' 100' ' ' LEU . 39.4 mm-40 -129.3 147.28 51.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.834 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.9 120.95 19.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.984 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 101' ' ' LEU . 1.3 mm? -57.83 165.51 1.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.756 0.789 . . . . 0.0 112.076 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.38 153.18 43.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.195 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.489 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.63 120.36 17.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.94 26.39 60.7 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.246 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.1 t0 -60.82 178.54 0.23 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.914 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.7 mt-10 -144.99 135.57 24.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -112.64 126.92 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.457 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.49 141.63 36.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.101 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.41 158.53 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.99 9.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.192 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -83.69 140.37 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.646 0.736 . . . . 0.0 112.228 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.662 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 143.46 -39.29 1.31 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.52 120.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.592 -0.804 . . . . 0.0 108.97 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 mt-10 -50.29 -26.75 5.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.41 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.42 6.49 48.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.32 24.32 6.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.403 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 142' ' ' SER . 7.9 tt -123.32 134.78 54.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.196 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.852 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -111.98 128.7 56.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.078 0.466 . . . . 0.0 111.605 -179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.7 mt -123.01 149.1 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.777 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.914 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.9 t -113.84 138.03 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.056 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 124' ' ' LEU . 1.4 mm -106.39 120.91 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.411 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -108.33 131.09 55.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -102.98 132.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -84.03 116.63 22.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.45 -24.51 67.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -45.83 90.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.72 -42.17 83.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.975 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -64.9 -35.45 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.2 -44.61 79.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -47.6 81.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.51 -38.57 77.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -69.81 -27.04 64.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -115.61 65.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 130.46 39.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 123.92 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.063 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -127.89 142.08 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.935 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -124.79 137.63 54.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pp -100.56 132.62 45.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.932 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.751 0.31 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.502 HG23 ' O ' ' B' ' 4' ' ' ILE . 1.0 OUTLIER -140.99 120.12 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.618 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -61.09 110.17 2.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.04 -168.7 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.361 2.04 . . . . 0.0 112.323 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.662 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.4 OUTLIER -104.94 174.98 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.489 ' H ' HG22 ' B' ' 8' ' ' THR . 19.6 mt-30 -82.16 76.64 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -121.23 149.3 43.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.954 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.85 79.98 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.514 ' OXT' HG22 ' B' ' 12' ' ' THR . 29.5 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m 60.76 30.04 19.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -72.08 -47.04 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -36.04 82.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -60.57 -40.05 90.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -61.13 -43.54 98.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mm -71.59 -34.99 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.23 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.493 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -23.86 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.57 -47.6 79.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.296 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -75.43 -35.97 60.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.832 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 50.9 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -74.85 124.2 26.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -77.91 103.36 7.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.04 138.42 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.689 0.757 . . . . 0.0 111.668 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 102.78 2.79 Favored Glycine 0 C--N 1.314 -0.648 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.359 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -66.28 -33.04 74.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.69 0.281 . . . . 0.0 111.005 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 178.8 37.97 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -73.38 135.52 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.684 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -93.1 -60.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.862 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.7 p -146.12 150.47 35.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.183 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.4 138.24 51.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 111.489 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.689 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -103.1 122.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.792 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.45 121.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.546 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD23 ' A' ' 143' ' ' LEU . 48.4 t -79.87 114.43 18.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -79.69 -25.99 41.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.798 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.6 p -79.83 -2.19 42.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.706 0.289 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 77.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.946 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -146.29 -44.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.389 . . . . 0.0 110.736 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.1 mt -113.73 141.66 26.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.862 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.3 Cg_endo -72.06 140.87 35.33 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HG23 ' A' ' 37' ' ' ILE . 38.4 mt -56.43 140.2 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.641 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.38 164.13 20.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.33 119.71 33.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.1 mt -97.44 134.64 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 158.0 43.83 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.19 141.94 32.63 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.572 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 55' ' ' VAL . 26.0 m-20 -80.41 136.39 36.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 111.404 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.622 HD13 ' SG ' ' A' ' 154' ' ' CYS . 46.7 mt -64.31 -45.43 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.071 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -39.42 74.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.442 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.3 mm-40 -68.55 -38.53 80.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.846 HG13 ' HD2' ' A' ' 63' ' ' LYS . 47.5 t -73.1 -37.88 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -30.66 71.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -89.29 -29.8 18.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.124 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.42 119.02 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -103.08 -21.46 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.09 176.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.033 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -77.47 -30.19 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.76 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.0 tp -110.5 151.15 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.846 ' HD2' HG13 ' A' ' 55' ' ' VAL . 8.2 mttp -127.92 -68.45 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -142.02 130.19 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' HD11 ' A' ' 62' ' ' ILE . 11.5 t -125.56 139.14 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 112.086 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.597 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.6 m-90 -100.89 139.4 36.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.199 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 128.76 56.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.45 145.38 46.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.346 -178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.1 -168.5 36.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.067 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.446 ' N ' HD11 ' A' ' 78' ' ' LEU . 25.1 mtm180 -80.28 2.23 25.46 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 t-20 -84.87 133.05 44.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -66.63 -14.05 42.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 0.0 111.901 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.05 17.31 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.902 0.858 . . . . 0.0 108.796 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.18 139.6 1.34 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.779 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.0 m-20 -56.34 -19.0 12.55 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.003 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.6 t80 -129.83 126.98 39.33 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.931 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.45 111.17 23.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -114.52 172.53 6.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.784 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.09 134.05 48.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.675 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -67.32 84.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 83' ' ' ARG . 53.3 mt -100.46 131.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -37.06 69.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.21 -27.85 67.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.005 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.0 mt -96.94 152.2 18.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -99.04 165.27 11.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.773 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -42.84 -53.5 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.387 0.613 . . . . 0.0 109.851 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB2' HG22 ' A' ' 67' ' ' THR . 10.7 ptmt -118.38 81.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.7 t60 -59.34 -45.69 90.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.883 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 34.0 p90 -144.53 160.44 41.12 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.138 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -135.91 143.04 44.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.282 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.3 mt -119.31 127.59 75.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.006 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.32 148.05 32.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 111.635 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.624 HD13 ' CG1' ' A' ' 33' ' ' VAL . 9.4 tp -125.04 123.01 38.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.534 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.56 -165.42 36.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 63.18 90.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 63.6 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -171.35 32.73 0.14 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -106.37 178.88 4.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -120.91 150.59 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -133.06 147.34 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.58 HD22 HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -112.65 125.33 54.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.192 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 48.2 t30 -116.47 115.81 26.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.773 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.735 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -77.89 135.03 37.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 8.5 pt -143.91 34.6 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.83 151.77 19.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.941 0.4 . . . . 0.0 111.457 -179.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -68.58 -31.82 71.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.921 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.62 -19.83 17.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.72 154.52 9.21 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.678 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.7 m -117.5 137.92 52.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.51 148.36 42.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.809 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.43 113.59 18.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.956 177.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 47.74 36.08 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.35 79.91 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.544 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.83 118.67 37.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 110.756 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -73.8 113.44 10.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.809 HG11 HD12 ' A' ' 111' ' ' LEU . 11.7 m -87.41 166.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.262 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.92 126.09 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -52.69 157.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.825 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.6 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 5.0 p-10 34.77 35.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -112.32 145.11 40.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.077 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.649 ' HB3' HD23 ' A' ' 100' ' ' LEU . 15.3 m-80 -80.84 131.87 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm100 -129.24 146.66 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 tp -72.68 118.5 15.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 99' ' ' LEU . 7.6 tt -56.41 153.85 9.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.504 0.668 . . . . 0.0 111.686 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.91 153.02 43.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.465 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.82 125.03 26.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.258 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.57 54.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.283 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.454 ' OD1' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -52.0 166.03 0.18 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.911 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -139.83 135.63 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -111.11 127.0 68.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.742 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.4 141.27 36.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.563 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.78 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.78 43.88 9.7 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -84.68 140.44 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.651 0.739 . . . . 0.0 112.441 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.847 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 145.59 -39.96 1.12 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 50.0 t -126.41 120.02 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.563 -0.818 . . . . 0.0 109.0 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.45 -25.87 4.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.823 0.344 . . . . 0.0 111.442 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.6 t -93.5 6.53 47.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.9 26.01 5.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.627 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.13 138.83 31.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.96 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.49 134.28 53.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.55 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.4 t -108.41 150.3 27.57 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.619 0.723 . . . . 0.0 112.153 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.5 mt -135.75 156.97 47.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.911 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.8 t -125.94 138.61 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 130' ' ' ILE . 32.4 mt -106.34 121.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.966 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.39 114.07 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 124' ' ' LEU . 4.7 mm -84.92 134.0 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.395 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -82.87 125.38 31.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.76 -25.41 62.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -59.15 -45.68 90.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.935 0.397 . . . . 0.0 110.662 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.18 -43.47 87.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -42.77 99.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -59.1 -46.63 87.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.622 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -64.49 -46.11 84.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.987 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -36.16 82.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.045 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.71 -35.47 79.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -32.89 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.59 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.02 140.24 41.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.8 134.94 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -129.48 174.34 9.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -178.43 -37.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.993 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.42 139.22 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.499 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 tp -148.7 143.71 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.96 127.96 67.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -167.66 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.422 2.081 . . . . 0.0 112.244 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.847 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.9 OUTLIER -84.25 173.15 11.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.493 ' H ' HG22 ' B' ' 8' ' ' THR . 10.2 tt0 -102.68 146.3 28.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -136.38 51.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 95.43 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.831 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m 74.55 -59.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -59.79 -44.79 93.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.004 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -59.0 -37.68 77.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.34 -41.37 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -31.83 70.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.38 -35.49 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.803 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -42.0 81.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -67.11 -23.89 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.59 -47.56 79.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 m -77.03 -30.92 55.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 86.07 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.94 151.17 40.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.0 101.86 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -89.38 138.38 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.581 0.705 . . . . 0.0 111.964 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.44 38.31 0.49 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.664 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.42 -45.8 24.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -169.6 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.8 mm -76.71 134.05 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.529 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -93.66 -62.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.073 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.722 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.6 p -146.61 155.96 42.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.189 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -122.7 133.28 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.35 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 68' ' ' PHE . 38.4 t -97.56 122.81 49.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 23.1 mt -122.84 121.99 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.38 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.595 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.8 t -85.18 114.08 22.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.442 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -85.85 -22.87 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.581 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.485 HG21 ' H ' ' A' ' 142' ' ' SER . 42.5 p -79.94 -2.07 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.615 0.245 . . . . 0.0 111.581 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.17 76.64 0.28 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.844 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.702 ' HB2' HD12 ' A' ' 43' ' ' ILE . 12.5 mt-30 -146.89 -43.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.9 mp -118.88 141.87 30.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.999 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.6 138.02 28.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.119 1.879 . . . . 0.0 112.121 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -55.55 136.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.745 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.09 164.1 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.256 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -118.08 119.81 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 111.787 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.722 HD12 ' SG ' ' A' ' 34' ' ' CYS . 5.5 mt -89.84 137.35 32.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.62 157.58 43.74 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -137.66 143.65 41.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.635 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.8 m-20 -74.7 136.09 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.239 0.542 . . . . 0.0 111.119 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.514 HD13 ' SG ' ' A' ' 154' ' ' CYS . 52.9 mt -64.01 -42.1 94.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.102 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.36 -40.1 73.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.967 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.508 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -68.43 -40.87 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.302 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.838 HG11 HD21 ' A' ' 155' ' ' LEU . 45.9 t -64.36 -41.19 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.078 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 56' ' ' LEU . 12.3 tp -71.09 -30.29 66.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.31 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 27.68 9.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.281 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.7 98.99 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.818 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 39.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -139.6 178.25 7.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.0 p -70.86 -20.76 62.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.2 tp -145.94 158.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.326 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.783 ' CE ' HG13 ' A' ' 55' ' ' VAL . 66.6 mttt -93.48 -65.07 1.02 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.215 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 49' ' ' SER . 22.8 ttpt -154.94 119.86 4.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.925 0.393 . . . . 0.0 111.812 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.733 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.8 p -109.85 140.0 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -100.6 139.5 36.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.349 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.05 127.27 55.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -118.99 145.52 45.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.503 -178.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.52 -168.07 39.86 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -90.83 28.95 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.4 t-20 -111.43 136.62 20.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.87 -13.12 38.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.668 2.245 . . . . 0.0 111.736 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -47.45 11.8 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.824 0.821 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.88 140.61 1.0 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.311 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -56.61 -18.91 13.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.883 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 19.6 t80 -129.46 123.65 32.08 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.765 0.317 . . . . 0.0 110.68 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -97.93 121.94 40.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' ILE . 12.4 mt -102.34 -64.04 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.77 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.27 -103.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -179.27 49.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 84' ' ' LEU . 19.2 mt -89.69 141.92 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -64.34 -34.77 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.9 mmt-85 -60.91 -30.49 70.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 81' ' ' ILE . 1.2 mm? -105.81 152.47 23.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 p -98.39 163.32 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.593 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.16 -53.28 4.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.413 0.625 . . . . 0.0 109.67 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -118.99 82.65 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' HD12 ' A' ' 84' ' ' LEU . 13.6 t60 -61.25 -46.94 88.33 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.553 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.5 p90 -143.7 159.14 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.999 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.706 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.0 tt0 -135.5 140.52 44.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.733 ' C ' HG23 ' A' ' 65' ' ' VAL . 77.1 mt -120.12 127.25 75.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.161 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.747 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.812 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp -118.23 123.53 45.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.365 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.89 39.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.592 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 59.16 105.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.09 -177.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 54.35 4.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.416 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.25 -176.07 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -132.32 158.62 41.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.1 mt -127.76 140.68 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.513 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.2 OUTLIER -112.71 121.55 45.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.4 t30 -117.51 116.93 28.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.055 0.455 . . . . 0.0 112.072 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -77.36 134.82 38.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.817 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.4 pt -141.72 39.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.75 149.82 23.42 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.084 0.469 . . . . 0.0 111.943 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.88 -31.34 70.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.862 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.63 -19.96 18.65 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.35 153.82 9.6 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.875 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.6 m -117.66 137.99 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.085 0.554 . . . . 0.0 109.577 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.98 148.57 39.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.53 18.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.482 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 30.5 m-20 44.32 43.51 6.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.494 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.41 -13.59 61.69 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.447 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -103.96 118.47 36.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.983 0.391 . . . . 0.0 110.586 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -72.3 125.63 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.246 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.3 m -95.29 165.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.238 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 mt-10 -69.87 125.11 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.676 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 82.7 tttt -53.49 162.33 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.779 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 36.2 32.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.18 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.49 143.28 43.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.721 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.747 ' OD1' HD21 ' A' ' 92' ' ' LEU . 17.4 m-80 -92.17 133.6 35.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.793 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.6 mm-40 -129.08 150.01 50.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.58 122.91 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.14 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 145' ' ' ILE . 65.8 tp -53.03 156.14 2.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.493 0.663 . . . . 0.0 111.85 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.539 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -124.58 153.53 42.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.285 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.646 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.1 mm-40 -71.22 121.36 18.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.934 0.397 . . . . 0.0 110.405 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.57 24.23 56.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.154 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 38.1 t0 -54.79 170.49 0.17 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.007 0.432 . . . . 0.0 111.249 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 144' ' ' VAL . 20.5 tt0 -145.18 135.46 24.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 145' ' ' ILE . 2.6 mt -113.6 128.16 70.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.3 140.84 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.023 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.9 m -140.13 158.43 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.86 44.21 9.35 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.807 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -85.18 140.44 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.752 0.787 . . . . 0.0 112.47 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 151.39 -39.96 0.79 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.54 120.51 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.042 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 140' ' ' ILE . 9.2 tp10 -50.26 -26.44 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 111.54 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.581 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.5 p -93.61 6.62 47.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -132.49 29.83 4.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -106.32 139.25 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.629 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 142' ' ' SER . 1.5 tt -124.16 134.35 53.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.701 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.528 ' O ' HD22 ' A' ' 143' ' ' LEU . 41.0 t -112.17 150.31 31.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.722 . . . . 0.0 112.499 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -136.02 139.55 43.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.498 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.86 140.15 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 130' ' ' ILE . 16.8 mt -106.18 122.29 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.76 113.74 26.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.367 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.9 127.29 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.57 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.36 124.59 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.68 -27.33 64.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -60.06 -46.05 90.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.762 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 32' ' ' ILE . 1.2 t80 -58.27 -44.03 88.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.073 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -33.86 72.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.981 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -44.65 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.514 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -68.12 -44.06 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.838 HD21 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -64.12 -35.94 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.867 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -45.77 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -79.98 -36.53 35.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.68 31.9 0.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.454 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -124.99 153.74 42.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.22 133.22 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.096 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -158.42 -61.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.476 ' HB3' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -75.52 -46.82 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 162' ' ' ARG . 4.1 mp -102.68 139.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.122 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.917 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.55 129.07 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -69.33 112.26 11.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.55 -170.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.514 2.143 . . . . 0.0 112.223 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.861 HG21 ' HA3' ' A' ' 135' ' ' GLY . 3.3 m -97.34 166.93 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -102.98 163.47 12.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -92.59 129.77 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m 61.6 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.411 HG21 HG22 ' A' ' 136' ' ' VAL . 2.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.7 m -142.42 -54.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -38.94 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -59.0 -36.32 74.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.18 -42.46 96.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 48.8 mm -68.91 -48.18 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.99 -33.56 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.294 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -59.79 -47.1 87.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.935 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.1 p90 -71.9 -47.44 52.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.062 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 52.3 p -65.28 -28.14 69.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.014 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 64.1 -78.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.17 146.21 39.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 104.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.814 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.95 138.3 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 121.708 0.766 . . . . 0.0 111.725 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.5 107.42 0.01 OUTLIER Glycine 0 C--N 1.315 -0.63 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.422 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -27.98 35.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.138 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 177.27 39.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.692 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -74.74 134.25 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.454 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.014 HG12 HD21 ' A' ' 99' ' ' LEU . 2.9 t -91.16 -61.08 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.021 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -146.05 147.01 31.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.378 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.9 121.99 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.8 t -88.77 122.75 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.423 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.71 114.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.89 118.52 31.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -111.66 -12.46 13.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.853 HG21 ' CB ' ' A' ' 142' ' ' SER . 18.0 p -81.05 -2.51 48.4 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.08 85.49 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.809 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 4.4 pt20 -164.3 -49.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.704 HD13 HD22 ' A' ' 78' ' ' LEU . 5.1 mt -132.97 142.5 44.9 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 65.6 Cg_endo -75.69 146.16 29.97 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.201 1.934 . . . . 0.0 111.511 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -50.6 150.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 112.067 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -150.93 158.18 43.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.034 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -117.23 126.22 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.6 mt -101.05 137.62 39.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.75 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.89 158.78 43.68 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.74 141.87 23.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.532 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.888 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -82.35 133.95 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 111.203 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 52' ' ' ILE . 3.5 mp -64.36 -44.61 97.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.465 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -42.14 79.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.319 0.581 . . . . 0.0 110.881 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 18.6 mt-30 -68.55 -36.91 79.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.95 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.8 t -67.14 -46.69 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.93 -29.5 67.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -76.41 -40.16 51.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -62.92 129.66 41.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 31.04 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -123.59 46.49 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 62' ' ' ILE . 6.0 p 63.66 137.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.985 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER 56.49 166.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.289 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.7 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -137.6 -59.22 0.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -148.36 129.37 14.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.685 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.2 t -127.97 139.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.329 0.585 . . . . 0.0 112.333 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.605 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -100.84 139.25 36.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.804 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.72 130.13 55.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -119.34 145.4 46.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.367 -178.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.45 -170.43 37.21 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.777 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 13.8 mtm180 -79.95 2.86 21.86 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -84.94 133.01 44.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.61 0.243 . . . . 0.0 111.144 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.91 -14.51 44.89 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.571 2.181 . . . . 0.0 111.721 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -42.63 18.02 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.831 0.824 . . . . 0.0 108.972 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.39 139.75 1.89 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.914 -1.493 . . . . 0.0 110.826 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.36 -18.26 10.38 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.91 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.8 t80 -129.08 123.94 33.54 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.787 0.327 . . . . 0.0 110.922 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.53 116.67 32.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -99.0 -69.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.12 -92.26 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.317 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.95 55.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.103 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.2 mm -81.67 124.73 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.754 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.55 70.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -28.74 69.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.774 HD13 ' HB ' ' A' ' 81' ' ' ILE . 6.2 mp -97.66 153.31 18.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -96.42 167.31 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.736 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -44.15 -54.93 5.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.266 0.555 . . . . 0.0 109.623 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.612 ' HB2' HD12 ' A' ' 104' ' ' ILE . 17.3 mttp -116.37 82.87 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -59.55 -46.47 88.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.763 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.0 p90 -143.92 157.77 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.008 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.2 tt0 -135.69 141.35 44.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.956 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -116.34 126.73 73.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.853 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -105.51 149.25 26.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.163 0.506 . . . . 0.0 111.858 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 94' ' ' GLY . 2.0 tt -119.44 122.88 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.233 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.614 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -115.84 -166.06 14.6 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.692 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -59.42 172.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 111.038 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.437 ' HA ' HD11 ' A' ' 155' ' ' LEU . 0.9 OUTLIER 57.69 -171.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.4 26.44 19.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.479 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.421 ' OD1' HD11 ' A' ' 123' ' ' LEU . 18.9 m-80 -105.31 135.37 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.014 HD21 HG12 ' A' ' 33' ' ' VAL . 5.7 mp -107.77 160.13 15.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 121' ' ' ASN . 7.8 mt -126.69 142.66 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.425 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.1 OUTLIER -112.79 121.63 45.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.808 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.817 ' HB2' HD11 ' A' ' 92' ' ' LEU . 48.9 t30 -112.24 115.78 29.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.737 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.802 ' OD2' HG23 ' A' ' 116' ' ' VAL . 16.7 p30 -76.43 129.23 36.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.645 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -137.94 38.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.17 152.97 19.29 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.13 0.49 . . . . 0.0 111.663 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.8 m -68.85 -31.6 70.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.24 -19.88 17.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.47 156.07 10.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.675 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.42 137.72 52.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.74 148.19 42.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -124.76 113.55 18.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 48.77 42.07 19.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.33 -6.14 80.82 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.973 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.722 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -106.3 118.83 37.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.275 0.537 . . . . 0.0 110.84 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptp -73.75 127.26 32.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.258 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.802 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -101.12 166.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.203 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 17.5 tt0 -69.77 123.87 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.518 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 2.1 tttt -51.32 165.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p-10 32.82 34.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.322 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.52 145.23 40.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.245 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.77 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.0 m-80 -90.9 129.47 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.15 150.92 50.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.433 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.421 HD11 ' OD1' ' A' ' 98' ' ' ASN . 11.1 tp -72.6 134.24 45.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 145' ' ' ILE . 54.7 tp -65.85 156.42 33.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.48 0.657 . . . . 0.0 111.697 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.39 153.6 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.614 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.666 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.5 tp60 -71.3 118.6 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.33 23.64 62.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.116 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -50.99 172.02 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.871 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.63 135.59 24.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.5 mt -114.32 125.01 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.57 140.4 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.712 ' CG2' HD21 ' A' ' 84' ' ' LEU . 32.7 m -140.31 158.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.94 27.22 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.179 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.0 t -71.02 140.32 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 112.212 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.8 -38.54 1.27 Allowed Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 44.9 t -126.45 124.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.662 -0.769 . . . . 0.0 109.202 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -50.47 -31.07 14.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.587 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 38.0 t -93.45 6.43 48.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -125.54 25.49 7.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.58 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.05 138.94 30.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.016 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 140' ' ' ILE . 6.0 mp -124.46 134.58 53.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.508 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.853 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.54 132.74 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.5 mp -123.23 143.49 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.546 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.871 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.3 t -114.45 132.72 62.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.635 HG21 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -106.42 120.98 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.063 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -104.37 142.2 34.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -110.47 134.07 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.523 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -82.55 131.46 35.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.43 -20.95 60.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.29 87.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.4 -40.48 82.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -65.0 -47.84 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.964 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.08 -46.47 88.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -62.02 -44.36 96.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.949 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -68.99 -39.17 79.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.02 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -58.46 -38.42 77.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -91.74 -36.61 13.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.924 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 44.75 -171.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.565 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.22 152.26 29.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.911 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.09 134.94 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.41 155.98 22.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -65.93 120.23 12.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.57 129.7 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.884 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.77 0.319 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.474 HG23 ' O ' ' B' ' 4' ' ' ILE . 2.3 tt -152.48 121.71 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.95 121.61 84.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.96 174.66 10.9 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.343 2.029 . . . . 0.0 112.386 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.422 HG22 ' N ' ' B' ' 9' ' ' GLN . 15.9 m -157.22 164.14 38.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.422 ' N ' HG22 ' B' ' 8' ' ' THR . 0.0 OUTLIER -93.99 125.49 38.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -90.2 151.31 21.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -105.96 91.94 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.925 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.328 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -127.14 -49.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -47.02 54.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.04 96.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.38 -35.09 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.1 -44.64 88.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.1 mm -66.86 -35.22 74.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.28 -42.92 82.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 0.0 110.353 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -67.26 -23.62 65.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.51 -47.48 79.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.297 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.9 p -76.15 -41.8 48.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -60.79 -46.09 91.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -93.84 143.74 26.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -85.57 126.01 33.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.63 138.19 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.599 0.714 . . . . 0.0 111.718 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.01 35.63 0.78 Allowed Glycine 0 C--N 1.313 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.34 -40.28 96.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 176.23 39.34 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.7 135.29 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.416 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.968 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.42 -59.96 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.012 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.4 p -148.8 153.37 38.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.82 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.416 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -117.97 119.43 34.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.938 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -90.04 122.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 111.184 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.836 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -122.78 126.14 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.156 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.72 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.2 t -81.08 118.58 22.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.579 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.65 HG21 ' OE2' ' A' ' 129' ' ' GLU . 4.1 t -83.52 -27.89 29.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' H ' ' A' ' 142' ' ' SER . 50.6 p -79.88 -2.28 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.461 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.57 77.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.943 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.4 mt-30 -147.35 -43.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.931 HD11 HD21 ' A' ' 141' ' ' LEU . 1.4 mt -112.15 141.26 24.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.51 143.87 43.72 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.177 1.918 . . . . 0.0 112.172 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.836 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -60.13 133.91 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.67 164.44 22.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.68 119.93 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -90.67 126.72 36.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.968 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -131.8 157.07 44.85 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.168 0.985 . . . . 0.0 113.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.99 159.68 40.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.216 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.2 m-20 -84.99 119.86 25.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 151' ' ' PHE . 55.1 mt -64.49 -43.21 96.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.916 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -61.7 -40.82 96.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 0.0 110.668 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.7 mm-40 -68.48 -36.91 79.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.6 t -73.02 -44.33 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 155' ' ' LEU . 3.5 mm? -64.95 -35.28 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -68.1 -51.8 42.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.942 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.03 136.95 36.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 21.46 13.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -167.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -80.04 -25.24 40.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 93' ' ' LEU . 8.3 tp -175.69 158.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 111.148 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -131.31 -49.16 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.538 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -128.3 129.43 46.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.937 0.399 . . . . 0.0 111.844 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.728 HG12 ' HG2' ' A' ' 90' ' ' GLN . 20.6 t -136.17 139.66 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.019 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.707 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.9 m-90 -100.63 138.98 36.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.998 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.25 132.05 55.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.33 145.25 42.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.79 -175.08 39.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.99 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -78.99 -0.43 31.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.85 135.8 39.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.634 0.254 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.83 -9.28 25.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.686 2.257 . . . . 0.0 111.789 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.69 16.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.975 0.893 . . . . 0.0 108.669 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.05 136.5 4.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.651 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -56.49 -18.51 11.71 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.091 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.42 114.75 16.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.723 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -89.16 119.59 29.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.428 ' HA ' HG12 ' A' ' 43' ' ' ILE . 10.0 mp -92.85 -77.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.34 -86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 173.65 48.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 110.929 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 83' ' ' ARG . 4.6 mt -77.47 126.48 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -58.57 -30.69 67.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.58 -49.23 56.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.8 mp -75.45 153.3 37.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 0.0 111.17 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 p -93.45 168.66 10.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.2 m-20 -43.95 -55.39 4.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.344 0.593 . . . . 0.0 109.765 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' THR . 6.1 ptmt -119.66 82.9 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -59.41 -45.85 90.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.981 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.2 p90 -146.36 159.53 43.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.728 ' HG2' HG12 ' A' ' 65' ' ' VAL . 17.1 tt0 -135.84 143.45 45.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.381 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 25.2 mt -116.67 127.4 74.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.2 pt? -116.5 136.73 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.503 . . . . 0.0 112.065 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 6.1 tp -125.0 129.47 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.36 63.02 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.477 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -124.0 -57.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -150.34 37.49 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.83 16.57 63.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 93' ' ' LEU . 37.4 m-20 -133.72 -173.53 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -109.34 153.63 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.848 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.16 147.15 52.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.381 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.661 HD21 HD11 ' A' ' 145' ' ' ILE . 1.3 mt -112.68 124.8 53.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.9 t30 -115.88 115.62 26.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.031 0.443 . . . . 0.0 111.522 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -79.13 136.17 37.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 89' ' ' PHE . 16.6 pt -145.15 39.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.56 159.74 14.74 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.05 0.452 . . . . 0.0 111.804 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.577 ' OG1' HG21 ' B' ' 5' ' ' TPO . 90.3 m -69.06 -37.7 78.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.501 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 9.9 p30 -98.46 -19.91 17.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.55 160.78 10.95 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.695 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.0 m -117.58 137.91 52.28 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.76 148.38 38.44 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.35 18.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.366 177.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 44.27 42.86 5.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.91 -8.51 77.73 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.485 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 118.62 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.9 tptp -74.14 123.05 23.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.29 164.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.261 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.1 tp10 -69.86 126.71 30.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 36.9 tttm -52.63 161.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.377 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.51 34.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.32 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.3 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.153 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.848 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.0 m-80 -84.2 130.05 34.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.754 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.5 mm-40 -129.34 146.66 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.81 135.66 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 145' ' ' ILE . 67.6 tp -66.71 155.85 36.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.401 0.619 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.69 153.11 42.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.41 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.632 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -71.61 114.0 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.63 71.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t0 -56.21 172.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 111.174 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 144' ' ' VAL . 6.9 tt0 -145.19 135.56 24.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -113.68 128.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.614 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.652 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.5 140.71 37.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.8 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.546 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.3 m -140.36 158.64 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.31 43.42 9.53 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.084 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -84.03 140.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.654 0.74 . . . . 0.0 112.275 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.19 -39.5 1.18 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.34 120.03 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -50.42 -26.49 5.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.364 -178.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 136' ' ' VAL . 32.9 m -93.62 6.55 47.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.37 26.11 5.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.652 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.11 138.33 33.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.014 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 HD11 ' A' ' 43' ' ' ILE . 5.6 tp -124.94 134.81 52.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.649 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.3 t -109.89 149.54 29.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.658 0.742 . . . . 0.0 112.364 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -136.36 142.03 43.76 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.713 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.3 t -113.35 140.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 111.007 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 130' ' ' ILE . 23.6 mt -106.08 121.13 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.533 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -107.82 113.13 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.799 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -84.9 130.59 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -75.85 133.69 40.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -73.88 -28.81 61.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -44.48 87.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 4.2 t80 -57.82 -43.99 86.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -41.2 94.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.023 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -58.96 -46.63 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.034 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.419 ' HB3' HD13 ' A' ' 52' ' ' ILE . 13.0 t -58.93 -45.91 89.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.757 HD11 HD21 ' A' ' 56' ' ' LEU . 2.0 mm? -56.59 -47.18 80.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -36.77 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.21 -23.73 64.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -125.86 92.78 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -106.43 130.9 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -76.2 138.36 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 60.97 112.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.09 89.9 3.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.64 137.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.837 0.351 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.863 HG23 ' O2P' ' B' ' 5' ' ' TPO . 15.8 tt -178.56 158.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.863 ' O2P' HG23 ' B' ' 4' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.14 123.33 68.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.41 138.83 27.84 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.434 2.089 . . . . 0.0 112.349 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -78.14 154.39 31.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -76.6 148.79 36.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -169.95 87.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t 60.19 86.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.925 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.781 0.324 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -83.69 67.3 9.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.37 -46.97 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -36.98 84.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 -37.42 86.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.72 96.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.3 mm -67.02 -35.15 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.24 -40.98 78.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -23.87 65.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.43 79.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.235 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -59.59 -42.31 92.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -85.52 67.14 10.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.89 120.98 16.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 105.96 16.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.92 138.32 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.602 0.715 . . . . 0.0 111.759 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -175.81 79.18 0.07 OUTLIER Glycine 0 C--N 1.313 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.558 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.74 -35.67 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.61 38.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -79.76 133.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.563 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.029 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -92.65 -62.57 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.9 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.8 p -141.64 165.14 28.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -124.48 138.21 54.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 111.438 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.701 HG11 ' HE2' ' A' ' 68' ' ' PHE . 2.4 m -108.8 122.63 63.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.627 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -126.94 119.86 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.792 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.773 ' HA ' HD13 ' A' ' 143' ' ' LEU . 16.4 t -83.76 102.34 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.292 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.528 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.2 t -77.27 -25.48 51.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.924 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.619 HG21 ' H ' ' A' ' 142' ' ' SER . 9.9 p -79.9 -2.59 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.515 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.52 79.95 0.19 Allowed Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.068 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' OE1' HD13 ' A' ' 141' ' ' LEU . 5.5 mt-30 -146.97 -39.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -129.11 144.09 51.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.917 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' A' ' 43' ' ' ILE . 38.5 Cg_endo -68.89 141.58 49.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.183 1.922 . . . . 0.0 111.934 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.0 mt -56.49 140.26 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.907 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -135.38 164.11 28.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.87 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.91 119.79 29.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -78.91 135.61 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.029 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.7 156.14 43.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.74 141.74 28.29 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.672 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -75.01 141.73 43.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.162 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mm -64.02 -40.65 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.487 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -56.77 -39.65 74.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.645 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.0 OUTLIER -68.4 -36.93 79.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.8 t -67.47 -42.81 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -39.4 72.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -40.88 97.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 109.59 12.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.45 30.7 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -115.67 -167.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -95.13 44.07 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.862 HD11 ' CG2' ' A' ' 65' ' ' VAL . 6.6 tp -166.07 134.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 55' ' ' VAL . 11.3 mttm -124.4 -58.71 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -148.82 141.37 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.862 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.4 t -136.34 139.24 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.317 0.58 . . . . 0.0 112.247 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.859 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.2 m-90 -109.94 139.13 45.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.982 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.85 127.24 55.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.701 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.25 145.78 41.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.658 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -169.35 35.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.683 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -82.12 5.0 20.99 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.82 128.61 60.01 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.514 0.197 . . . . 0.0 110.668 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.53 -11.8 32.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.223 1.948 . . . . 0.0 111.431 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.23 -42.96 16.62 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.781 0.801 . . . . 0.0 108.974 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.11 136.82 1.45 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.755 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.54 -18.37 11.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.927 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 28.8 t80 -129.43 117.24 20.23 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.03 121.9 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.908 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD12 ' HA2' ' A' ' 69' ' ' GLY . 10.4 mt -100.1 -69.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.26 -95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -178.74 54.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.815 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.9 mt -81.01 126.12 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 -36.79 69.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.2 mmt-85 -68.7 -29.47 67.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.815 ' CD1' HD12 ' A' ' 81' ' ' ILE . 38.9 mt -95.92 152.06 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 p -96.29 165.46 12.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.656 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.3 -53.35 4.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 109.973 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.77 83.04 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -60.12 -47.07 87.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.816 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.22 157.28 43.81 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.854 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HG3' HG23 ' A' ' 67' ' ' THR . 30.2 tt0 -136.05 135.74 39.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.346 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 46.9 mt -109.36 132.06 58.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.825 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' HB2' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -121.72 151.64 40.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 111.576 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 ' CG1' ' A' ' 33' ' ' VAL . 14.6 tp -125.02 122.68 37.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.377 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.7 -153.79 8.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 58.39 -171.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.57 63.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.42 -173.06 38.48 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 63.0 162.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.363 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.862 HD21 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -107.0 160.13 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -127.13 141.57 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 91' ' ' ILE . 21.6 tp -112.88 126.39 55.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.7 t30 -117.06 115.57 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.181 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.78 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -79.66 132.01 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 67' ' ' THR . 22.2 pt -141.35 40.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.64 152.72 20.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.068 0.461 . . . . 0.0 111.882 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -68.77 -31.55 70.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.986 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.12 -19.81 17.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.32 157.43 10.75 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.703 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.873 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.41 148.39 40.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.304 177.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 99.4 m-20 44.93 43.53 7.21 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -9.78 70.0 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.489 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.4 118.53 36.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.056 0.428 . . . . 0.0 110.808 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.873 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.8 tptm -73.7 128.62 35.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.198 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.78 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.8 m -99.47 166.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.212 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.0 126.02 28.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 34.3 tttt -52.36 162.18 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 110.324 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.52 36.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.968 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.89 145.06 40.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.404 ' HB3' HD23 ' A' ' 100' ' ' LEU . 7.5 m-80 -92.12 126.64 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.625 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.07 147.08 50.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.4 tt -72.91 116.39 13.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.919 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 123' ' ' LEU . 1.2 mm? -53.38 167.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.665 0.745 . . . . 0.0 112.019 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.23 153.29 43.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.228 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.9 tp60 -71.55 114.65 9.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.74 26.4 72.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.911 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.8 t0 -60.24 176.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 111.035 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.882 ' CG ' HG22 ' A' ' 144' ' ' VAL . 8.1 mt-10 -145.31 135.71 24.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.263 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 9.1 mt -112.69 126.21 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.495 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.48 141.45 36.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.179 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.4 m -140.26 158.5 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.01 43.79 9.54 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.013 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.4 t -84.08 140.42 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.733 0.777 . . . . 0.0 112.47 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.15 -42.44 0.86 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 138' ' ' SER . 57.5 t -126.53 122.13 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 114.592 -0.804 . . . . 0.0 109.033 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.532 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.36 -24.86 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.727 0.299 . . . . 0.0 111.704 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.26 6.34 48.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 11.6 m-20 -130.75 26.65 4.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.06 139.39 28.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.003 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 43' ' ' ILE . 31.7 tp -122.4 134.43 54.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.619 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.66 137.05 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.07 0.462 . . . . 0.0 111.856 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -131.26 145.05 51.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.172 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.882 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.5 t -111.41 135.65 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.585 HG21 ' CD1' ' A' ' 124' ' ' LEU . 1.3 mm -106.45 122.69 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.581 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -113.13 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.073 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.59 HG23 ' CD1' ' A' ' 99' ' ' LEU . 5.9 mt -84.79 126.48 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.205 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -81.76 115.47 21.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.72 -22.33 65.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.34 -43.56 83.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -38.18 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.694 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -65.08 -33.91 77.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -47.04 87.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.88 -46.02 89.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.062 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -43.96 88.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -35.17 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -24.85 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -123.95 77.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 150.56 46.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 160' ' ' VAL . 11.1 p -84.11 117.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.086 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -109.05 118.86 37.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -99.78 146.22 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.7 128.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.17 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.79 0.329 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -158.24 131.51 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -95.68 132.92 26.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 168.96 22.79 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.482 2.121 . . . . 0.0 112.359 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 97.7 m -137.38 147.07 45.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.713 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.21 175.99 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.59 -171.72 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 4.2 t -99.46 124.09 44.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.897 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -121.55 -48.28 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -65.33 -47.07 77.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -58.92 -36.72 75.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.95 -42.4 93.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -32.74 71.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.1 -35.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.51 -38.02 73.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -67.17 -23.84 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.83 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.81 -47.53 80.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -37.55 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -61.6 -68.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -79.78 139.33 37.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -98.27 130.35 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.56 136.61 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 C-N-CA 123.068 0.547 . . . . 0.0 110.683 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.33 63.4 2.05 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -77.95 -39.31 43.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 177.68 38.42 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.11 136.13 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.479 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.67 -60.16 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.769 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -147.26 150.2 34.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.165 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.89 129.32 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.472 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 48' ' ' LEU . 3.3 m -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.6 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.825 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -131.4 128.23 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.656 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.31 110.04 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.972 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.2 p -87.15 -24.25 24.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.792 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.845 HG21 ' OG ' ' A' ' 142' ' ' SER . 72.5 p -79.91 -2.56 44.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 71.62 78.32 0.47 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.444 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.3 mt-30 -148.56 -40.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.246 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -130.2 141.54 42.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.78 146.03 42.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.23 1.953 . . . . 0.0 112.195 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.825 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -56.02 156.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.844 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.12 164.1 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 p30 -119.58 119.94 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.069 0.461 . . . . 0.0 111.975 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.0 mt -100.77 134.64 43.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.82 158.87 43.63 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.37 149.83 35.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.122 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.704 ' O ' HG23 ' A' ' 55' ' ' VAL . 72.1 m-20 -75.02 120.6 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.483 HD13 ' SG ' ' A' ' 154' ' ' CYS . 46.9 mt -64.53 -42.24 94.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.141 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -40.07 75.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.293 0.568 . . . . 0.0 110.67 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.7 mm100 -68.53 -39.45 81.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.87 HG13 ' HD3' ' A' ' 63' ' ' LYS . 48.8 t -62.63 -43.07 98.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.0 -22.08 62.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.243 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.97 13.0 23.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.616 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.08 137.07 47.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.81 124.31 18.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -48.32 99.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.04 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.571 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.0 tp -173.37 150.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.13 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.87 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.72 -63.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.977 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -145.89 136.59 24.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 62' ' ' ILE . 10.6 t -126.38 138.09 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 112.013 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.551 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -101.85 139.66 37.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.003 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.97 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.61 130.13 55.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.06 145.27 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.16 -167.2 36.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.755 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.0 mtm105 -83.88 3.56 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.9 t-20 -84.93 133.41 43.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 111.019 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -66.06 -14.2 43.33 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.552 2.168 . . . . 0.0 111.676 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.61 16.71 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.946 0.879 . . . . 0.0 108.852 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -44.29 139.8 2.49 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.802 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.5 m-20 -56.4 -18.88 12.49 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.859 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.535 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -129.81 127.78 41.0 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.86 108.0 19.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.772 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 43' ' ' ILE . 26.3 mt -76.7 -166.52 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.17 17.94 53.58 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.25 79.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.397 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.8 mt -112.03 132.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -54.99 -34.68 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.12 -27.37 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 132' ' ' VAL . 40.6 mt -96.64 152.19 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.82 164.77 12.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.661 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.99 -52.82 5.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 109.615 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.72 82.9 1.96 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.77 -45.97 91.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.923 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.4 p90 -143.55 162.52 35.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.436 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.97 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 133.99 38.92 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.202 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.58 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.8 mt -111.56 127.79 68.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.724 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -114.77 146.89 40.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.544 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp -125.0 122.94 38.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.508 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 95' ' ' GLU . . . 147.8 -155.15 26.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 94' ' ' GLY . 1.6 tp10 84.77 -21.79 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.481 0.312 . . . . 0.0 111.699 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -177.46 -46.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.884 0.374 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.51 -32.33 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.355 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -75.13 -172.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -111.13 157.6 19.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.18 146.67 51.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 124' ' ' LEU . 10.7 mt -112.72 124.41 52.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.06 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.673 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.7 t30 -117.52 115.67 25.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.6 p30 -78.35 139.66 38.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.165 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 89' ' ' PHE . 20.6 pt -147.88 40.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.95 152.11 20.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.086 0.47 . . . . 0.0 111.778 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.1 m -68.93 -31.54 70.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.038 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.94 17.57 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.05 155.4 9.81 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.65 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -117.57 137.75 52.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.892 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.41 148.29 41.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.65 18.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.439 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m120 44.65 43.76 6.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.388 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -9.99 69.39 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.437 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -104.64 118.66 37.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.624 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.892 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.1 tptm -74.03 122.57 22.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.224 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -93.64 164.55 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 tp10 -69.82 127.75 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.535 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -53.71 161.03 1.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.922 0.391 . . . . 0.0 110.635 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.53 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.348 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.17 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.122 179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.837 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.9 m-80 -83.97 130.2 34.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.864 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.762 ' O ' HD23 ' A' ' 100' ' ' LEU . 6.5 mm100 -129.46 147.68 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.86 132.9 44.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.853 HD21 HG12 ' A' ' 147' ' ' ILE . 38.0 tp -65.05 154.43 37.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.659 . . . . 0.0 111.61 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.454 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -124.81 153.05 43.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.36 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.73 122.76 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 23.89 49.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.145 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.6 t70 -54.78 170.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.46 . . . . 0.0 111.21 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.1 tt0 -145.17 135.57 24.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.006 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 145' ' ' ILE . 2.3 mt -109.4 128.04 65.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.438 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.37 140.3 38.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.045 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.651 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.37 158.33 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 80.07 42.97 10.16 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -82.83 140.45 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.687 0.756 . . . . 0.0 112.274 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.791 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 145.33 -39.92 1.14 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.48 123.98 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.619 -0.791 . . . . 0.0 109.082 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.27 10.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.412 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.42 6.48 48.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 133' ' ' GLY . 54.3 m-20 -124.34 23.06 8.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.0 139.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 142' ' ' SER . 8.9 tt -122.32 134.72 54.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.845 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.99 128.18 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.087 0.47 . . . . 0.0 111.854 -179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 43' ' ' ILE . 18.6 mt -121.44 137.42 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.03 137.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.816 0.341 . . . . 0.0 111.278 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 130' ' ' ILE . 31.6 mt -106.16 131.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.09 120.36 39.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.853 HG12 HD21 ' A' ' 124' ' ' LEU . 5.7 mt -84.85 131.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.21 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -75.99 118.43 18.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.54 -30.82 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.88 -45.94 90.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.29 -43.12 87.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.96 -45.66 89.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.7 t -60.94 -46.06 92.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 155' ' ' LEU . 3.5 mm? -68.2 -35.76 78.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.03 -41.87 93.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 159' ' ' LYS . 10.5 tt0 -84.7 -31.39 24.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.69 -91.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.692 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' GLN . 18.0 mtmt -73.07 133.82 44.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.848 0.356 . . . . 0.0 110.955 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.05 132.38 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.05 30.4 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.47 114.94 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.0 mt -84.22 113.63 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.038 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.779 0.323 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 4' ' ' ILE . 1.1 tt -141.87 60.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.557 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.16 98.36 5.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.05 -167.5 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.453 2.102 . . . . 0.0 112.308 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.791 HG21 ' HA3' ' A' ' 135' ' ' GLY . 18.6 m -93.75 145.68 24.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.33 121.0 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.93 173.95 6.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 40.4 p -83.83 91.44 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.834 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -139.55 -47.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -70.88 -45.41 64.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -59.02 -46.12 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -35.05 73.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -41.46 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.8 mm -71.92 -35.09 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.16 -38.19 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -67.34 -24.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.671 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.76 79.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.148 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -81.12 -31.56 34.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.852 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 64.34 72.8 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.01 121.0 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -69.88 125.01 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.99 138.34 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.66 0.743 . . . . 0.0 111.776 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.98 90.06 0.26 Allowed Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -36.21 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 178.56 38.32 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.78 133.99 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.458 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.43 -61.7 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.149 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -148.96 150.08 32.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.408 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.51 HH11 HD11 ' A' ' 37' ' ' ILE . 6.0 ttm180 -113.96 138.1 50.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.694 HG11 ' CE1' ' A' ' 76' ' ' TYR . 15.0 p -99.99 122.9 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 45' ' ' ILE . 18.7 mt -130.29 119.41 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.649 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HA ' HD23 ' A' ' 143' ' ' LEU . 40.9 t -79.95 142.07 35.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 144' ' ' VAL . 2.9 p -111.42 -21.29 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.727 ' OG1' HD23 ' A' ' 141' ' ' LEU . 74.8 p -85.09 -2.78 58.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.732 0.301 . . . . 0.0 111.559 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.83 86.91 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.093 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.9 pt20 -159.72 -40.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.084 0.468 . . . . 0.0 111.374 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.572 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 4.3 mt -122.92 139.96 32.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.4 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 70.3 Cg_endo -76.76 146.16 26.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.508 2.139 . . . . 0.0 112.376 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.8 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -55.9 148.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.841 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.06 162.06 37.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.027 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.37 119.91 36.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.092 0.472 . . . . 0.0 111.931 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.0 mt -96.25 137.28 35.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.48 158.7 43.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.52 142.42 33.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.914 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.894 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -74.99 115.8 15.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.072 0.463 . . . . 0.0 111.161 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.38 -44.08 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.077 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.49 -40.73 92.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.0 mm-40 -68.45 -36.93 79.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 51' ' ' ASP . 65.9 t -64.26 -37.85 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mt -70.58 -31.78 68.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -74.75 -50.53 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.915 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.45 116.89 10.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.2 88.25 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.61 176.59 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.67 -57.64 3.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.869 HD11 HG22 ' A' ' 65' ' ' VAL . 9.3 tp -88.82 149.79 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HD2' HG13 ' A' ' 55' ' ' VAL . 9.4 mmtm -126.6 -66.75 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.09 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.3 ttpt -140.65 125.55 18.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.169 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.869 HG22 HD11 ' A' ' 62' ' ' ILE . 6.4 t -123.08 139.48 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.249 0.547 . . . . 0.0 111.752 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.6 m-90 -100.78 139.91 35.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.86 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.19 125.3 51.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.9 m-85 -113.17 145.57 40.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.926 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.9 -173.47 39.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.274 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp-105 -77.43 -1.56 30.83 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.82 134.2 42.16 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.318 . . . . 0.0 111.19 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -68.01 -10.56 29.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.728 2.286 . . . . 0.0 111.967 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.76 -42.87 17.43 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 121.868 0.842 . . . . 0.0 108.914 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 140.3 1.0 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.848 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -56.06 -18.33 9.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.147 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.694 ' CE1' HG11 ' A' ' 36' ' ' VAL . 42.7 t80 -128.88 125.92 38.66 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.42 113.09 26.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.752 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -116.63 175.71 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 81' ' ' ILE . . . -55.5 166.2 3.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.596 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -93.83 92.14 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.013 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 p -54.75 -24.91 24.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.5 mmp_? -74.19 -29.57 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.013 HD12 HD13 ' A' ' 81' ' ' ILE . 30.2 mt -92.2 152.21 19.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.98 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -96.16 163.44 13.1 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.506 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.65 -53.2 3.64 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 109.763 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.9 mttp -118.41 84.28 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -63.93 -45.13 90.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 30.7 p90 -152.67 163.24 40.03 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.189 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.1 mt-30 -135.29 154.94 51.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.494 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mt -123.63 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.167 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.92 148.02 37.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 111.589 -179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.6 tm? -125.14 125.45 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.473 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.604 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -167.54 -163.58 21.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.652 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.61 -168.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.996 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.56 99.28 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.9 51.18 58.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.62 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -147.54 162.71 38.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 110.885 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.94 HD21 HG12 ' A' ' 33' ' ' VAL . 4.4 mp -135.02 152.1 51.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -133.02 145.79 51.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.312 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.933 HD11 HD12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -112.96 131.79 55.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.534 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -119.76 115.57 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.9 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.826 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -78.68 143.21 36.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.062 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.528 HG21 ' OE1' ' A' ' 90' ' ' GLN . 10.2 pt -150.39 36.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.04 152.53 18.65 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.151 0.5 . . . . 0.0 112.19 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.83 -31.44 70.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.852 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.08 -19.84 18.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.508 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.79 158.65 11.69 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.59 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.9 m -117.31 137.67 52.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.58 148.38 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.55 18.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.602 177.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 62.5 m-20 43.63 43.68 4.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.18 -14.22 61.37 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.451 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.39 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 110.517 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.73 128.24 35.38 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.527 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.826 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.4 m -96.25 162.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.834 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.9 mp0 -69.89 127.63 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 49.6 tttm -53.41 161.72 0.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.41 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 9.0 m-80 33.84 35.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.261 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.974 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 45.8 m-80 -89.78 130.21 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.224 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 47.1 mm-40 -129.33 148.66 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.417 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.59 121.5 19.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.351 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 147' ' ' ILE . 66.0 tp -55.27 156.51 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.462 0.649 . . . . 0.0 111.563 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.411 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.63 153.41 42.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.587 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.51 120.39 17.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.76 22.68 62.32 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.679 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.46 170.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.006 0.431 . . . . 0.0 111.237 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.5 tt0 -145.14 135.45 24.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.906 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.491 ' CD1' HD22 ' A' ' 101' ' ' LEU . 19.0 mt -118.36 128.14 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.41 140.77 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.233 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 32.0 m -140.37 158.34 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 112.145 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.13 37.24 11.47 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.815 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -80.53 140.48 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.671 0.748 . . . . 0.0 112.503 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.3 -39.35 0.71 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 138' ' ' SER . 35.4 t -126.35 121.76 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.09 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.54 7.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.502 ' H ' HG12 ' A' ' 136' ' ' VAL . 19.6 t -93.51 6.52 47.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -130.05 29.68 4.9 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.26 138.91 30.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.932 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.727 HD23 ' OG1' ' A' ' 40' ' ' THR . 3.0 mt -124.45 134.38 53.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.728 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -106.02 150.43 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.67 0.748 . . . . 0.0 112.318 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 38' ' ' CYS . 68.4 mt -135.68 147.16 48.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.01 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.413 HG21 ' CG2' ' A' ' 39' ' ' THR . 36.9 t -120.14 139.98 45.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.343 . . . . 0.0 111.061 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.933 HD12 HD11 ' A' ' 101' ' ' LEU . 2.5 mt -106.24 139.09 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.86 116.85 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.94 132.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.189 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.47 113.05 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.78 -27.47 68.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -45.04 89.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.04 -41.4 95.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -44.59 95.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -61.79 -45.85 92.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -66.34 -36.96 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.9 77.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.85 -36.99 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.41 -171.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.585 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -104.43 161.78 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.936 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.34 130.44 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -72.02 149.41 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -34.68 78.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 pt -101.78 139.93 21.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.903 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 9.0 tp -120.33 146.68 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.453 ' P ' ' H ' ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.43 108.8 1.38 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.68 136.85 78.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.437 HG22 ' N ' ' B' ' 9' ' ' GLN . 77.3 m -90.51 162.34 15.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.437 ' N ' HG22 ' B' ' 8' ' ' THR . 24.8 mt-30 -57.06 130.91 48.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -133.18 -178.47 4.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 11.5 m -82.32 99.73 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.938 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -108.54 -34.83 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.55 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -71.87 -47.14 55.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.82 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -61.95 -36.05 80.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.41 -37.69 81.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.682 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 22' ' ' LYS . 6.3 mt -66.09 -33.09 74.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.727 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.19 -35.51 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.53 -46.11 84.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.58 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.813 ' HE2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -67.08 -23.67 65.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.605 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.55 79.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -75.55 -31.51 60.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.93 91.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -90.59 144.92 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.36 112.06 23.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.07 138.32 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.584 0.707 . . . . 0.0 111.823 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.27 29.19 9.11 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.445 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -67.11 -36.69 82.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.18 38.89 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.5 mm -73.08 135.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.67 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.95 -60.58 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.6 p -149.42 151.14 33.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.084 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.84 134.66 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.383 -179.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 48' ' ' LEU . 26.6 t -101.48 122.68 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.98 123.12 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.561 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.9 t -83.15 119.09 24.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.369 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -25.49 32.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 142' ' ' SER . 58.6 p -79.94 -2.3 43.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.446 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.67 77.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.024 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.827 ' OE1' HD11 ' A' ' 141' ' ' LEU . 10.0 mt-30 -146.03 -44.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 110.773 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.063 HD13 HD22 ' A' ' 78' ' ' LEU . 5.4 mt -109.12 141.17 22.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -72.97 133.56 20.05 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.79 138.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.563 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 162.99 28.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.553 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -115.57 119.66 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.999 0.428 . . . . 0.0 111.659 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 36' ' ' VAL . 3.0 mt -95.12 133.63 38.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.71 158.49 43.85 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.4 145.96 35.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.817 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.8 m-20 -74.97 120.56 20.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.563 . . . . 0.0 111.366 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 151' ' ' PHE . 18.0 mt -65.35 -38.81 83.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.153 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 p -60.33 -43.28 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.11 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.65 -36.79 79.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG22 ' HG2' ' A' ' 63' ' ' LYS . 45.8 t -69.87 -46.78 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.998 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -32.25 71.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -82.4 -46.79 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.56 129.07 41.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 80.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.8 -174.57 2.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.23 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.612 HD11 HG22 ' A' ' 65' ' ' VAL . 8.2 tp -130.15 145.52 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.709 ' HG2' HG22 ' A' ' 55' ' ' VAL . 4.3 mppt? -114.82 -59.16 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.998 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -154.97 138.36 15.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -130.77 139.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.323 0.582 . . . . 0.0 112.148 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.2 m-90 -102.67 139.42 38.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.062 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -111.72 129.31 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.744 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 1.1 m-85 -120.12 145.22 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.49 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -166.86 35.16 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 12.2 mtm105 -80.94 4.52 19.18 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.68 130.54 52.73 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.533 0.206 . . . . 0.0 110.917 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.3 Cg_exo -65.33 -14.71 46.46 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.415 2.077 . . . . 0.0 111.594 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -44.12 15.62 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.929 0.871 . . . . 0.0 108.873 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -38.88 139.7 0.43 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.815 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.3 m-20 -56.35 -19.13 13.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CD2' HD21 ' A' ' 78' ' ' LEU . 1.2 t80 -130.21 119.73 23.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.695 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -89.67 109.14 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.063 HD22 HD13 ' A' ' 43' ' ' ILE . 8.8 mt -106.03 162.39 13.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.833 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.55 129.4 49.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.093 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -62.93 79.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.831 0.348 . . . . 0.0 111.09 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 83' ' ' ARG . 32.7 mm -105.0 139.64 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.7 m -60.08 -31.6 70.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.77 -29.82 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.217 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.596 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.3 mp -102.39 152.65 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 162.24 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.878 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.14 -52.1 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.757 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CB ' HD12 ' A' ' 104' ' ' ILE . 40.0 mttt -119.18 80.89 1.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.7 t-80 -61.14 -45.87 92.89 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.786 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 39.1 p90 -147.75 159.97 43.23 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.992 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG2' HG12 ' A' ' 65' ' ' VAL . 28.6 tt0 -136.18 141.88 44.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.744 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 58.7 mt -116.49 127.59 74.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.943 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -111.29 151.46 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.9 tp -125.07 122.76 38.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.68 -138.81 2.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.595 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 68.74 -67.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.704 0.288 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -178.03 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.11 28.28 2.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.418 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -131.34 174.62 9.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -117.45 159.66 22.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.796 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.1 mt -133.07 146.91 52.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.315 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 145' ' ' ILE . 1.3 mt -112.67 123.66 50.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.481 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.9 t30 -117.15 115.66 25.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.4 p30 -79.21 140.51 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' CB ' ' A' ' 87' ' ' LYS . 10.3 pt -143.46 30.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.554 0.216 . . . . 0.0 111.577 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.512 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.3 t -89.96 158.31 17.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.447 0.641 . . . . 0.0 112.243 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 m -69.68 -49.17 56.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.499 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.28 3.04 56.31 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.43 157.4 23.75 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.053 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 HG22 ' CG2' ' A' ' 130' ' ' ILE . 7.4 m -117.82 137.92 52.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.811 -0.694 . . . . 0.0 109.215 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.31 148.8 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD13 ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -123.83 113.47 18.58 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.197 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 44.14 42.91 5.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.86 -14.09 61.21 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.501 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -103.42 118.5 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.54 124.56 24.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.373 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.7 m -96.57 163.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.039 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 tm-20 -69.85 127.03 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.3 tttm -53.68 160.98 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.964 0.411 . . . . 0.0 110.611 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.89 34.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.288 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.19 40.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.114 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.8 m-80 -88.49 131.7 34.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.874 ' O ' HD23 ' A' ' 100' ' ' LEU . 41.2 mm-40 -129.29 151.92 49.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.69 136.04 45.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.708 0.289 . . . . 0.0 110.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.735 HD22 ' HB2' ' A' ' 99' ' ' LEU . 28.1 tp -62.94 152.66 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.575 0.702 . . . . 0.0 111.521 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.4 152.51 44.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.653 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.46 121.36 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.36 25.29 60.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.983 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' HD13 ' A' ' 111' ' ' LEU . 25.0 t70 -49.88 165.19 0.08 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.258 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 tt0 -144.33 135.47 25.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 145' ' ' ILE . 3.1 mt -114.39 128.27 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.608 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.9 m -104.03 141.57 35.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.607 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.6 m -140.52 158.72 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.95 9.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -84.25 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.585 0.707 . . . . 0.0 112.13 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.691 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 144.27 -37.05 1.43 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 24.9 t -126.16 119.13 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.446 -0.877 . . . . 0.0 108.814 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -29.39 9.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.2 p -93.46 6.46 48.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.85 27.53 5.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.608 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.49 138.67 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.65 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.827 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -124.51 134.43 53.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.558 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.507 ' H ' HG21 ' A' ' 40' ' ' THR . 36.1 t -106.54 149.43 27.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.791 0.805 . . . . 0.0 112.221 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.56 HD21 HD12 ' A' ' 43' ' ' ILE . 77.1 mt -136.12 143.74 44.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.597 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.37 138.03 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.2 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 101' ' ' LEU . 23.9 mt -106.13 131.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 120.2 39.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.678 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.732 HG12 HD21 ' A' ' 124' ' ' LEU . 5.4 mt -84.84 131.18 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.55 107.19 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -59.61 -26.91 65.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -59.12 -45.7 90.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.016 0.436 . . . . 0.0 110.611 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' CE1' HG13 ' A' ' 52' ' ' ILE . 2.2 t80 -58.11 -44.1 87.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.909 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -65.13 -39.4 92.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -59.06 -43.31 91.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.07 -42.64 80.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -66.82 -43.15 84.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.94 -40.93 86.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -83.74 -36.67 23.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.53 86.05 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.444 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -76.18 122.55 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.33 132.28 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -110.68 -33.03 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.959 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.25 127.28 40.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.96 120.28 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.91 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.823 0.344 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tt -137.45 133.38 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -64.72 111.57 6.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.15 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.478 2.119 . . . . 0.0 112.17 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.691 HG21 ' HA3' ' A' ' 135' ' ' GLY . 1.8 m -99.53 167.87 10.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.26 147.07 29.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.09 50.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.85 104.32 16.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.937 -179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -112.33 67.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -46.99 79.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -58.98 -39.33 81.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -59.47 -39.23 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -31.92 73.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -73.01 -35.44 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.6 -42.75 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.37 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -67.18 -23.68 65.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.633 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.79 -47.4 80.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -32.18 69.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 64.63 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.96 149.04 24.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -84.62 142.11 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 136.7 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.131 0 CA-C-O 121.144 0.497 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.54 44.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.345 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' HG2' HD11 ' A' ' 32' ' ' ILE . 7.3 pt-20 -68.04 -39.6 83.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 179.04 38.04 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.14 136.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.295 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.976 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -90.85 -59.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.866 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.712 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.4 p -146.24 165.2 29.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.523 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.34 138.27 51.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.395 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 68' ' ' PHE . 41.1 t -109.24 122.73 64.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.878 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.861 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -127.15 121.03 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.465 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.6 t -79.98 105.58 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.438 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -71.35 -25.1 62.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.874 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.83 -2.26 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.529 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.0 0.26 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.995 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -146.05 -44.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.695 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.0 mt -112.01 141.78 25.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.1 Cg_endo -70.73 138.69 35.26 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.107 1.872 . . . . 0.0 112.293 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.861 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.83 146.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.647 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 164.23 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -127.58 119.65 26.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.457 . . . . 0.0 111.636 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 8.3 mp -91.35 132.56 36.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.475 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.976 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.95 155.8 46.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.314 1.054 . . . . 0.0 113.638 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.24 141.92 29.06 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.676 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -79.5 143.69 34.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 0.0 111.271 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.05 -43.97 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.717 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m -55.95 -37.2 68.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.781 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.35 -36.82 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.971 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.806 HG22 ' HG2' ' A' ' 63' ' ' LYS . 49.8 t -70.75 -44.67 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.234 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.95 -27.4 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.998 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -53.01 17.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.95 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.93 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.35 73.85 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 59.29 100.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -178.71 -63.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 65' ' ' VAL . 7.4 tp -178.77 130.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.806 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -102.74 -62.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.035 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -155.2 140.04 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.624 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 62' ' ' ILE . 5.6 t -126.32 134.66 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.233 0.54 . . . . 0.0 111.601 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.0 140.07 36.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.246 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.634 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 130.5 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.8 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -120.31 145.51 47.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.713 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 162.06 -167.82 36.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.954 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.3 mtp180 -83.83 3.35 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 5.6 t-20 -84.85 133.12 44.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -12.91 37.54 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.547 2.165 . . . . 0.0 111.678 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.79 -44.09 15.95 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.914 0.864 . . . . 0.0 108.822 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.64 138.89 2.39 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.943 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.35 -18.86 12.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.094 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.3 t80 -129.8 123.99 32.29 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 111.392 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.38 107.93 18.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.713 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -110.32 78.91 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.31 -117.04 2.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.851 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -176.71 92.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.063 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 23.1 mm -109.63 129.86 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -38.28 67.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.093 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -63.43 -28.05 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.877 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 78' ' ' LEU . 27.8 mt -97.48 152.11 19.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.97 162.9 13.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.723 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.11 -52.27 4.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 0.0 109.655 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.8 mtpm? -117.87 83.9 2.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -64.89 -45.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.198 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.4 p90 -150.3 162.03 41.3 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.206 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.634 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.6 mt-30 -135.65 155.71 50.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.401 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.1 mt -126.28 132.35 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.029 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -128.66 144.67 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.998 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -125.1 131.11 53.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.142 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . -166.77 -155.24 8.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.498 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 58.22 -165.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.53 56.37 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.798 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . 107.74 -169.02 14.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.461 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.27 171.38 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.698 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -127.03 160.09 32.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 122' ' ' GLN . 12.2 mt -131.33 142.48 50.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.777 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.79 126.22 53.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.738 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.548 ' HB2' HD21 ' A' ' 92' ' ' LEU . 46.7 t30 -116.8 115.69 26.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -77.4 143.2 38.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.815 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' CG ' ' A' ' 90' ' ' GLN . 9.6 pt -149.6 36.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.612 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.74 151.97 19.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.11 0.481 . . . . 0.0 111.934 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.78 -31.45 70.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.854 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.61 -19.79 18.08 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.38 156.43 10.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.89 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.9 m -117.42 137.74 52.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.52 148.39 38.0 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.5 18.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.461 177.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 44.33 43.27 5.91 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.53 64.02 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.518 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -104.72 118.49 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.62 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.58 127.24 31.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.411 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -97.46 164.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.3 tt0 -69.89 126.71 30.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 13.5 tttm -53.28 161.42 0.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 0.0 110.593 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 35.33 33.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.438 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.44 145.14 40.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.936 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.654 ' HB3' HD22 ' A' ' 100' ' ' LEU . 63.6 m-80 -90.48 130.07 36.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.838 ' O ' HD23 ' A' ' 100' ' ' LEU . 46.8 mm-40 -129.1 148.82 51.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 tp -72.51 116.31 12.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 145' ' ' ILE . 67.2 tp -53.46 157.54 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.406 0.622 . . . . 0.0 111.729 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.5 t -124.26 153.3 41.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.339 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.5 tp60 -71.47 123.51 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.3 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.28 21.81 54.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.131 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.87 175.25 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.05 135.62 24.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 145' ' ' ILE . 14.7 mt -114.48 126.14 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.462 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.563 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.5 140.07 38.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.3 158.35 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.122 0.487 . . . . 0.0 112.278 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.04 27.42 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.141 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.4 t -71.37 140.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.681 0.753 . . . . 0.0 112.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.92 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 152.76 -37.48 0.77 Allowed Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 41.6 t -126.25 131.99 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.805 -0.697 . . . . 0.0 109.3 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -40.1 51.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 6.47 48.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 8.2 t0 -119.64 28.44 8.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.563 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.26 139.65 28.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.987 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.0 tt -123.48 134.35 53.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.0 t -110.06 150.64 28.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 112.36 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.0 mt -135.55 156.8 48.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -125.02 137.12 58.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 130' ' ' ILE . 35.3 mt -106.34 123.45 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 115.1 28.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.512 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -82.73 113.95 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.684 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -29.53 70.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.015 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -46.09 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.793 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.47 -44.01 93.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.01 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -33.93 76.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -46.92 87.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -66.61 -46.15 76.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.798 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -65.59 -39.9 92.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.953 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.21 -42.03 94.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -83.4 -37.04 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 42.16 35.96 0.65 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 132.44 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.49 141.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -163.86 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.99 97.36 7.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.95 140.04 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.768 0.318 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.72 137.92 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.625 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -58.58 110.07 2.33 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 -168.36 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.509 2.139 . . . . 0.0 112.363 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.92 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -90.15 146.63 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 91.73 3.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -167.28 160.25 13.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -117.02 94.12 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.905 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.3 p -124.47 -64.84 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -42.83 66.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -59.27 -39.81 84.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -40.68 91.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.84 96.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mm -67.78 -34.88 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.265 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -57.06 -36.11 70.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -67.33 -23.92 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.768 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.8 -47.59 79.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.298 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -70.72 -44.15 67.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -156.08 137.24 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.62 132.63 42.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.2 107.7 18.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.29 138.39 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.63 0.728 . . . . 0.0 111.736 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.25 3.21 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.449 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.02 -44.49 26.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.14 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -73.12 136.86 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.466 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -92.35 -59.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.843 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' A' ' 99' ' ' LEU . 4.1 p -146.67 165.46 29.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.506 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.25 138.07 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.366 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 36' ' ' VAL . 11.8 p -105.42 122.67 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.565 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.72 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -129.51 119.44 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.551 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -79.91 108.04 13.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.379 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.594 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -72.17 -25.89 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.72 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.86 -2.22 42.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.532 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.01 76.17 0.27 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HB2' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -145.73 -44.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.799 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.6 mt -111.72 141.35 24.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.759 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.7 Cg_endo -72.18 137.58 29.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.217 1.945 . . . . 0.0 112.355 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.72 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.07 136.98 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.51 164.3 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.48 119.71 34.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 111.843 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.0 mp -94.24 126.59 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.949 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.38 156.67 47.94 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.038 0.923 . . . . 0.0 113.309 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.33 145.74 26.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.089 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.803 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.3 m-20 -75.09 128.67 36.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG13 ' CE1' ' A' ' 151' ' ' PHE . 85.0 mt -64.51 -45.03 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.223 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -56.98 -40.18 76.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.718 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.52 -36.96 79.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.673 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 51' ' ' ASP . 42.0 t -71.42 -38.85 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 HD22 ' NZ ' ' A' ' 159' ' ' LYS . 7.7 tp -69.4 -30.21 68.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -54.21 6.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.48 117.51 14.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -123.27 -3.81 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.409 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -40.6 2.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.9 157.73 15.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.962 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 150.35 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.715 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -87.87 -68.24 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -155.08 136.9 14.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -130.08 139.11 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.196 0.522 . . . . 0.0 111.843 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.825 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.3 m-90 -105.27 139.54 39.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.259 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.79 132.19 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -119.3 145.61 45.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.353 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.63 -167.88 35.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.029 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtp-105 -81.1 3.31 23.83 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.8 t-20 -84.8 132.22 46.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.534 0.207 . . . . 0.0 111.102 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.24 -14.19 43.17 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.686 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.05 -42.98 16.83 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.872 0.844 . . . . 0.0 109.026 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.41 138.92 1.16 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.109 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.8 m-20 -56.47 -18.94 13.0 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.147 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 43' ' ' ILE . 14.2 t80 -129.63 114.16 15.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.741 0.305 . . . . 0.0 111.04 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.22 107.88 19.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.555 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD13 ' CA ' ' A' ' 69' ' ' GLY . 10.7 mp -79.78 -80.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.6 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.345 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.57 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 111.195 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp -84.34 119.18 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -54.81 -29.85 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.241 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.5 mmp_? -68.51 -26.94 65.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 81' ' ' ILE . 10.6 mt -102.71 151.18 22.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.047 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -94.1 164.12 13.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.568 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -41.59 -52.44 3.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.48 0.657 . . . . 0.0 109.832 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.96 82.51 1.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.4 t60 -60.91 -47.15 87.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.767 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.1 p90 -143.99 159.21 42.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.7 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 67' ' ' THR . 25.9 tt0 -136.19 138.52 42.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.0 mt -112.56 128.67 69.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.064 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -113.31 143.26 44.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.852 HD22 HG11 ' A' ' 33' ' ' VAL . 22.9 tp -122.05 129.86 52.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.375 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' HA2' ' HZ3' ' A' ' 63' ' ' LYS . . . 163.18 -119.2 0.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 63.92 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.992 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.11 37.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.45 24.95 8.0 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.529 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.767 ' O ' HD12 ' A' ' 93' ' ' LEU . 23.4 m-20 -128.9 -177.6 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -119.27 143.81 47.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.4 mm? -126.49 145.43 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.549 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.558 HD21 HD13 ' A' ' 124' ' ' LEU . 14.8 mt -112.51 124.09 51.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.872 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD23 ' A' ' 92' ' ' LEU . 51.7 t30 -118.01 115.58 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.856 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.6 p30 -76.43 139.98 41.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 67' ' ' THR . 17.8 pt -148.12 39.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 152.32 20.11 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.034 0.445 . . . . 0.0 111.548 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.86 -31.55 70.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.942 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.24 -19.82 17.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.69 156.48 10.17 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.945 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.43 137.95 52.17 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.839 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.89 148.62 38.38 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.17 113.51 18.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.455 177.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 27.8 m-20 44.09 43.26 5.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.66 -13.58 62.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.392 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.58 118.51 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.083 0.442 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.65 127.09 31.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.532 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.856 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.4 m -95.95 164.46 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.5 mt-10 -69.85 124.91 25.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.2 tttt -53.0 162.79 0.58 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.6 m-80 33.97 35.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.151 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.11 145.06 40.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.075 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.98 129.15 35.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.763 ' O ' HD13 ' A' ' 100' ' ' LEU . 40.5 mm-40 -129.29 146.83 51.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.804 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.73 125.3 27.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.841 HD11 HG21 ' A' ' 145' ' ' ILE . 66.2 tp -58.15 155.37 11.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.418 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.1 t -124.83 153.04 43.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 122.48 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.3 22.02 57.86 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.93 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.69 170.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.13 135.49 24.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.072 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.623 HD11 HD11 ' A' ' 145' ' ' ILE . 20.7 mt -118.37 128.04 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.445 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.599 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.43 141.52 36.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.5 m -140.21 158.33 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.029 0.442 . . . . 0.0 112.104 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.25 43.69 8.5 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.9 t -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.707 0.765 . . . . 0.0 112.498 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' ' CG2' ' B' ' 8' ' ' THR . . . 151.79 -37.74 0.82 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.38 120.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.037 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.26 -29.52 9.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.763 0.316 . . . . 0.0 111.459 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 52.8 p -93.45 6.56 47.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -130.67 30.59 4.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.599 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.11 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.614 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt -122.17 134.49 54.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.635 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.4 t -108.52 150.58 27.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.304 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.9 mt -135.8 147.85 48.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.783 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 39' ' ' THR . 29.3 t -119.92 139.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.841 HG21 HD11 ' A' ' 124' ' ' LEU . 31.8 mt -106.09 128.62 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.56 114.86 26.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 124' ' ' LEU . 5.1 mt -84.75 134.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.894 0.378 . . . . 0.0 111.439 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -84.32 110.09 18.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -62.07 -26.0 68.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.99 90.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.896 0.379 . . . . 0.0 110.75 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CE1' HG13 ' A' ' 52' ' ' ILE . 5.5 t80 -59.42 -44.2 92.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.983 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -65.25 -38.5 90.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.065 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -59.51 -43.91 93.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.94 -41.66 82.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD22 HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.972 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.97 -38.72 91.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -88.4 -36.73 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.039 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 44.96 -172.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.49 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.525 ' NZ ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -121.26 153.31 37.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.025 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.88 138.38 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.51 149.2 44.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -66.07 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.4 pt -95.71 127.84 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.905 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.18 137.79 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.608 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -94.02 105.79 19.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 173.66 14.12 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.444 2.096 . . . . 0.0 112.43 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.404 ' CG2' ' HA3' ' A' ' 135' ' ' GLY . 5.8 m -150.96 147.74 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.75 176.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -129.88 151.88 49.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.75 156.67 24.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.868 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.748 0.309 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 16' ' ' GLN . 5.3 t -68.16 -51.65 43.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' N ' HG23 ' A' ' 15' ' ' THR . 9.9 pt20 -72.2 -40.04 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.811 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 2.4 mtt-85 -58.99 -35.98 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -37.29 80.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.36 -33.44 75.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.16 -35.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.742 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.43 -41.5 80.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -67.13 -23.79 65.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.75 -47.46 80.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.281 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m -69.31 -47.0 65.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -147.38 137.97 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -95.8 132.56 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -80.06 106.65 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.54 136.75 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 123.105 0.562 . . . . 0.0 110.763 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.23 70.75 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.606 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.09 -36.28 15.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.887 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 174.6 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.19 135.38 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 113.668 -1.605 . . . . 0.0 112.554 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.72 -60.13 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.917 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -145.34 161.84 38.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.402 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.53 138.04 53.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG21 ' HE2' ' A' ' 68' ' ' PHE . 29.8 m -110.85 122.68 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.655 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.84 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.45 122.56 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.66 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.85 99.94 7.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.206 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -68.24 -24.33 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.928 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.498 HG21 ' H ' ' A' ' 142' ' ' SER . 59.7 p -79.92 -2.21 42.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.603 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.81 78.01 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.878 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -147.33 -43.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -115.82 142.49 29.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.8 Cg_endo -70.12 139.03 38.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.104 1.869 . . . . 0.0 112.191 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -56.61 145.93 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.825 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.44 164.18 28.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.006 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.99 120.04 30.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 0.0 112.06 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.767 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -90.26 126.78 35.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.982 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.92 157.0 47.91 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.036 0.922 . . . . 0.0 113.45 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.15 154.0 40.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.042 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -85.09 138.72 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.103 0.477 . . . . 0.0 111.308 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.76 HD13 ' SG ' ' A' ' 154' ' ' CYS . 97.1 mt -64.35 -44.53 97.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.984 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -36.52 69.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.286 0.565 . . . . 0.0 110.538 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.53 -36.9 79.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.456 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 51' ' ' ASP . 60.7 t -72.0 -46.72 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -27.37 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.924 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -73.55 -46.18 49.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.63 136.83 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -104.32 90.05 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 44.29 46.12 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.45 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.709 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.0 m -138.01 53.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 61' ' ' SER . 8.9 tp 52.41 158.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.832 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -140.2 -64.92 0.47 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.195 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -141.81 134.2 28.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.546 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.9 t -131.29 139.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.127 0.489 . . . . 0.0 111.859 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.767 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.4 m-90 -102.82 139.32 38.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.013 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.58 127.2 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 177.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -110.81 145.56 37.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.773 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.68 ' C ' HD21 ' A' ' 78' ' ' LEU . . . 160.59 178.52 34.65 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.697 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.599 ' N ' HD21 ' A' ' 78' ' ' LEU . 14.9 mtp180 -68.25 -6.72 25.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 4.1 t-20 -84.51 133.69 43.92 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.7 0.286 . . . . 0.0 111.19 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.8 Cg_exo -70.03 -5.9 17.47 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.588 2.192 . . . . 0.0 111.654 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.68 -42.81 17.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -43.88 137.14 3.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.14 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.34 -19.21 13.49 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 57.2 t80 -130.54 130.55 44.26 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.386 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.53 ' C ' HD13 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -109.91 136.44 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.44 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.888 HD13 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -109.59 -53.0 2.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.08 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.62 -115.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.761 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -154.17 65.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.297 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.8 mp -103.45 120.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.765 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.92 -24.97 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.42 -17.37 61.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.362 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 81' ' ' ILE . 34.5 mt -107.24 150.26 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.99 164.26 12.43 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.0 m-20 -43.0 -52.12 5.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.423 0.63 . . . . 0.0 109.777 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' CB ' HD12 ' A' ' 104' ' ' ILE . 11.9 mttm -121.44 82.76 1.98 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 11.6 t60 -62.38 -46.19 89.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.892 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 17.5 p90 -150.36 157.72 43.37 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.58 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.7 tt0 -135.84 140.07 43.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.485 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.573 ' C ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -117.93 131.55 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.349 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.736 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -116.13 145.47 43.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.508 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.8 tm? -125.25 127.73 47.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.534 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.631 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 163.45 -134.92 3.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.694 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 68.97 -67.11 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.922 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -171.46 45.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.19 -27.49 16.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.64 158.06 34.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -107.13 151.29 25.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.5 mp -132.76 144.65 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.99 128.51 56.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.416 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.6 t30 -118.86 119.17 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.853 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.675 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.4 p30 -79.81 137.8 37.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.986 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' CB ' ' A' ' 87' ' ' LYS . 13.6 pt -145.56 30.99 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -88.73 158.18 18.27 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.053 0.454 . . . . 0.0 111.553 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -68.94 -36.28 77.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.659 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.93 17.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.546 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.8 157.34 9.68 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.07 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.61 137.97 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.208 0.603 . . . . 0.0 109.42 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -114.3 148.57 37.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.51 18.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.492 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 78.0 m-20 44.34 43.22 5.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.33 -10.85 67.5 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.43 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -104.83 118.59 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.016 0.436 . . . . 0.0 110.69 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.5 tptt -72.97 119.12 16.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.675 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -88.7 166.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.177 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.5 mm-40 -69.93 128.01 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.521 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -55.13 158.0 3.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.577 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 0.9 OUTLIER 38.34 32.77 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.791 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.2 145.07 40.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.868 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.736 ' OD1' HD11 ' A' ' 92' ' ' LEU . 13.2 m-20 -95.38 133.79 38.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.981 0.419 . . . . 0.0 110.959 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.7 mm-40 -129.07 152.07 49.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.547 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.47 123.92 24.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.829 0.347 . . . . 0.0 110.306 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 145' ' ' ILE . 65.1 tp -54.49 155.88 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.535 0.683 . . . . 0.0 111.682 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.77 153.1 42.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 120.95 18.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.928 0.394 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 23.66 59.51 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.231 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.5 t0 -54.83 172.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.9 mt-10 -145.3 135.61 24.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.4 mt -114.09 126.14 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -104.63 142.75 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.341 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.568 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.54 158.58 24.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.082 0.467 . . . . 0.0 112.254 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.04 43.54 8.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.053 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.537 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.6 t -85.1 140.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.76 0.791 . . . . 0.0 112.428 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.32 -40.96 0.86 Allowed Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.55 120.82 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.075 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -50.52 -24.96 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.731 0.301 . . . . 0.0 111.48 -178.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 t -93.5 6.44 48.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -132.13 27.86 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 138.82 31.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.56 134.32 53.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.556 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.498 ' H ' HG21 ' A' ' 40' ' ' THR . 46.7 t -108.96 150.31 27.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.6 0.714 . . . . 0.0 112.192 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.9 mt -135.67 148.36 48.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.549 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.0 t -116.92 138.12 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 124' ' ' LEU . 1.3 mm -106.37 121.11 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.086 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 117.63 34.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.795 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -84.98 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.553 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -79.13 119.17 21.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.919 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.26 -18.7 63.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -58.76 -45.13 90.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 110.699 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -42.28 85.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.989 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -37.17 77.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.57 -47.3 79.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.99 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.76 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -68.21 -45.82 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -35.94 71.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.41 -38.76 92.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.42 -29.28 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.0 101.94 7.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.15 156.21 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.62 136.89 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.91 167.78 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -73.97 106.28 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 163' ' ' ILE . 5.2 tp -82.78 120.94 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.811 HG23 ' O2P' ' B' ' 5' ' ' TPO . 17.8 tt -140.32 147.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.811 ' O2P' HG23 ' B' ' 4' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -57.01 109.65 1.87 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.18 163.6 3.26 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.45 2.1 . . . . 0.0 112.188 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.463 HG23 ' NH1' ' A' ' 83' ' ' ARG . 3.7 m -86.68 154.24 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.39 83.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -136.15 75.47 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 17.9 t -98.8 89.2 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.804 0.335 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -90.46 -53.81 4.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -66.24 -44.34 84.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -58.96 -38.26 78.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -40.71 90.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' LEU . 11.9 tp -61.47 -31.92 71.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.7 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.79 -35.38 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.31 82.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.423 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -67.08 -23.83 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.647 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.239 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.3 m -78.05 -37.67 46.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -66.52 79.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -94.87 134.23 37.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.31 102.05 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.75 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.41 138.39 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.657 0.741 . . . . 0.0 111.901 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.78 29.3 1.15 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.41 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -83.35 -23.55 32.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.747 0.308 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -175.08 33.38 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -88.41 95.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.4 -177.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -51.84 -64.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.1 p -147.9 164.9 32.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 125.72 36.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 19.4 t -88.84 122.85 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.398 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -126.19 117.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.0 t -79.94 119.96 23.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.494 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.59 -25.59 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.736 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 9.1 p -79.85 -2.6 44.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.44 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.33 76.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.973 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.551 ' HB2' HD12 ' A' ' 43' ' ' ILE . 4.7 mt-30 -144.06 -43.65 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.7 mp -122.69 142.71 38.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.02 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.67 140.66 36.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.057 1.838 . . . . 0.0 111.799 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -53.61 127.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.882 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -118.0 160.62 21.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.854 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.93 120.35 38.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.031 0.443 . . . . 0.0 112.124 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.7 mt -101.1 136.38 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.175 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.73 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.09 158.26 44.04 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -141.68 141.87 33.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.585 -1.643 . . . . 0.0 110.585 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.7 m-20 -84.43 135.35 34.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.727 HD13 ' SG ' ' A' ' 154' ' ' CYS . 17.4 mt -64.36 -45.49 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.153 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -57.45 -40.0 77.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.607 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.2 mm-40 -68.54 -37.22 79.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.685 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.3 t -71.93 -41.36 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.877 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 tp -71.04 -29.83 65.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -80.33 -51.01 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -63.0 112.28 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.74 62.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.91 -178.62 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.838 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.3 m -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.032 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.8 tp -138.08 154.85 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.228 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -112.39 -64.23 1.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.025 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -143.16 133.57 24.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.249 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -132.08 139.3 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.341 0.591 . . . . 0.0 112.026 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.553 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -101.34 139.12 37.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.208 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.24 130.46 55.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -120.15 145.44 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.377 -178.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.82 -166.8 35.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.839 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 20.5 mtm180 -83.83 5.05 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.921 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 57.2 t30 -84.82 132.13 47.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.028 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.16 -14.97 48.05 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.471 2.114 . . . . 0.0 111.541 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.921 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.74 -42.94 17.38 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 138.04 3.48 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.722 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -56.59 -18.23 11.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.831 178.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.7 t80 -126.41 120.59 30.18 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.93 116.28 31.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD13 HD13 ' A' ' 84' ' ' LEU . 29.6 mt -89.3 -170.08 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.15 14.98 59.3 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.841 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 63.88 78.55 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 111.487 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.831 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.9 mt -102.99 132.43 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.807 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -55.11 -28.63 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -78.6 -47.37 17.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.16 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.831 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.7 mt -72.73 150.73 42.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -95.9 164.24 12.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.806 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.94 -52.51 5.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.485 0.66 . . . . 0.0 109.771 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.7 mttt -119.93 81.92 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.1 t60 -62.48 -46.14 89.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.711 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -144.22 159.62 42.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.789 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 30.3 tt0 -135.94 142.65 44.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.61 ' O ' HG13 ' A' ' 65' ' ' VAL . 57.0 mt -116.94 128.06 74.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -111.67 147.99 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 111.714 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.406 HD22 HG11 ' A' ' 33' ' ' VAL . 24.5 tp -125.14 122.89 38.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.7 -159.25 30.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.55 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.13 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.76 -70.71 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.37 42.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -131.86 -177.58 4.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.852 HD13 HD22 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -106.92 148.49 28.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.0 mp -133.01 147.27 52.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.64 125.32 54.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.43 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.1 t30 -115.13 115.66 27.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 111.522 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.5 p30 -79.33 135.17 36.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.056 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 16.3 pt -142.72 40.04 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 157.18 16.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.998 0.427 . . . . 0.0 111.629 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.9 m -68.98 -35.03 76.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.601 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.62 -20.03 17.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.561 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.02 161.33 11.26 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.597 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.4 m -117.64 137.94 52.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.08 148.5 38.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.38 18.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.191 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.47 42.81 5.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.76 77.22 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.484 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.69 118.58 36.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.14 131.43 41.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.213 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -103.66 166.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.87 126.18 28.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.557 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 83.6 tttt -53.36 162.14 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 110.727 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.9 m-80 34.63 34.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.243 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 145.09 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.149 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.61 ' HB3' HD23 ' A' ' 100' ' ' LEU . 76.1 m-20 -85.87 131.0 34.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.3 mm-40 -129.35 145.69 51.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.619 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.82 114.32 10.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.339 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.852 HD22 HD13 ' A' ' 99' ' ' LEU . 63.5 tp -53.7 157.74 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.613 . . . . 0.0 111.53 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.3 153.17 42.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.077 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.764 ' HA ' HD13 ' A' ' 147' ' ' ILE . 5.2 mm100 -71.28 125.26 26.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.589 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.6 19.22 47.75 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.327 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.4 t70 -58.41 172.88 0.42 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.9 tt0 -145.19 135.58 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -107.65 128.15 63.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.67 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.25 138.09 41.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 28.3 m -140.33 158.53 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.37 28.71 29.5 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.136 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.5 t -69.91 140.45 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.607 0.718 . . . . 0.0 112.357 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.53 0.97 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 138' ' ' SER . 51.8 t -126.39 128.72 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.629 -0.785 . . . . 0.0 109.07 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.53 -36.12 32.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.313 . . . . 0.0 111.75 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.474 ' H ' HG12 ' A' ' 136' ' ' VAL . 24.4 m -93.4 6.31 48.58 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.5 t0 -120.31 26.51 9.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.67 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -106.9 139.58 27.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.042 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.4 tt -120.41 134.59 55.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.707 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.639 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -112.2 134.63 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.474 . . . . 0.0 111.843 -179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.732 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.3 mm? -129.73 135.02 47.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.607 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.72 136.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.701 ' CD1' HG22 ' A' ' 36' ' ' VAL . 4.1 mm -106.11 137.26 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.176 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.2 124.31 51.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.764 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -99.4 130.76 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 111.663 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -82.5 116.65 22.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -62.84 -22.81 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -58.89 -45.24 90.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.752 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.0 -40.47 80.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -65.01 -34.02 77.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.943 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -38.31 86.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.021 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.727 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -62.54 -46.06 90.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.74 83.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.99 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.59 -47.39 85.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.987 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -81.26 -35.15 31.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 42.43 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.549 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.55 144.88 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.71 138.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.6 115.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -32.08 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.74 138.51 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.864 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.769 0.319 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.72 133.86 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -80.18 140.22 53.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.76 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.05 -169.79 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.322 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.04 158.69 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.02 156.18 16.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 92.41 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -101.0 98.99 9.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.9 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.785 0.326 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.469 ' HB ' ' CB ' ' A' ' 18' ' ' PHE . 3.2 p 56.01 52.24 10.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.032 0.444 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.31 86.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.91 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -68.94 -35.89 77.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.28 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' CB ' ' HB ' ' A' ' 15' ' ' THR . 3.1 t80 -60.54 -44.78 95.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -45.24 86.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 HG23 ' CE2' ' A' ' 23' ' ' PHE . 39.8 mm -63.54 -47.26 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.9 -33.58 74.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.2 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -56.07 -47.12 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.949 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CE2' HG23 ' A' ' 20' ' ' ILE . 5.8 p90 -71.85 -47.12 55.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -57.92 -47.13 83.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.944 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -177.53 5.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.44 157.99 16.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.63 138.09 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.09 138.32 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.644 0.735 . . . . 0.0 111.819 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.56 44.36 0.06 OUTLIER Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.19 -38.86 60.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER 177.54 38.49 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.44 133.55 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-N 113.846 -1.525 . . . . 0.0 112.393 -177.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.26 -61.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.203 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.429 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.8 p -149.02 146.22 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.287 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -113.95 138.03 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 111.398 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 25.0 t -101.47 122.95 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.855 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.848 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -123.9 126.13 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.553 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.9 t -95.33 107.85 19.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.5 p -88.16 -20.02 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.756 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.71 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.9 -2.52 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 111.401 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.57 76.04 0.52 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.795 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -146.7 -42.15 0.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' A' ' 44' ' ' PRO . 12.4 mt -131.1 142.51 45.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.11 146.02 40.39 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.239 1.959 . . . . 0.0 112.102 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 37' ' ' ILE . 34.7 mt -56.34 148.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.897 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.01 159.51 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.051 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.18 119.76 35.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.025 0.441 . . . . 0.0 112.061 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -95.54 137.49 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.58 158.76 43.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.04 141.81 36.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.655 -1.612 . . . . 0.0 110.695 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.5 m-20 -76.83 134.24 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -64.27 -42.65 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.759 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -57.02 -38.66 73.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm-40 -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.498 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG11 HD21 ' A' ' 155' ' ' LEU . 43.2 t -70.62 -41.66 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.006 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.06 -31.46 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -50.24 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.27 112.87 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -29.67 15.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.7 174.31 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 m 61.34 -168.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.995 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 92' ' ' LEU . 6.4 tp -101.34 144.04 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' HG22 ' A' ' 55' ' ' VAL . 12.6 mptt -65.89 -71.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.957 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 35.0 ttpt -149.22 121.19 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.625 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 91' ' ' ILE . 10.6 p -107.53 139.88 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.707 0.765 . . . . 0.0 112.519 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.561 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.5 m-90 -100.59 139.05 36.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.99 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.4 127.01 55.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.679 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -113.57 145.36 41.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.47 -178.134 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.63 -175.71 39.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.779 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 28.4 mtm180 -74.97 -1.59 23.3 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t-20 -84.65 132.09 47.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.594 0.235 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.0 Cg_exo -68.52 -8.28 22.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 111.669 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.84 -42.91 17.24 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.916 0.865 . . . . 0.0 108.693 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.68 138.2 1.46 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.66 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -56.46 -19.24 14.3 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.984 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 52.8 t80 -130.21 126.39 37.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -101.49 137.62 39.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.665 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -124.59 -68.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.185 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 78' ' ' LEU . . . -168.3 -127.9 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 2.1 p30 -159.76 65.7 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 83' ' ' ARG . 35.2 mt -89.7 127.75 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.82 -24.92 25.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.238 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.779 ' NH1' HG23 ' B' ' 8' ' ' THR . 2.0 mmm180 -78.27 -48.23 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.9 mt -72.84 152.25 41.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.904 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.0 p -95.71 164.53 12.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.29 -53.3 5.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.382 0.611 . . . . 0.0 109.757 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.76 81.1 1.64 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.397 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.3 t60 -60.0 -45.61 92.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.916 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.6 p90 -145.53 159.48 43.05 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.791 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.3 tt0 -135.99 141.39 44.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.472 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 65' ' ' VAL . 51.4 mt -118.15 129.91 73.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.809 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD12 HD13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -111.5 140.94 45.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.003 0.43 . . . . 0.0 111.729 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.7 tm? -121.27 131.94 54.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.662 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 147.05 -162.99 28.66 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.627 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 62.7 105.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.931 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.51 -80.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.05 37.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -125.06 -173.85 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -120.11 150.36 40.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -132.6 145.3 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 130' ' ' ILE . 2.2 tp -112.8 127.01 56.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.219 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 90' ' ' GLN . 45.5 t30 -117.12 115.42 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.283 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.7 p30 -79.89 137.59 36.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.742 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 67' ' ' THR . 19.7 pt -146.44 40.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 157.84 16.17 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 120.957 0.408 . . . . 0.0 111.409 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -68.82 -34.77 76.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.61 -19.8 17.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.01 160.32 11.18 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.39 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.66 137.86 52.37 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.73 148.78 39.4 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.29 113.38 18.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.423 176.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 45.75 42.52 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.318 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.97 -3.37 87.03 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.626 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.51 118.54 36.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.052 0.426 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.5 tptt -76.33 121.06 22.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.121 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -97.32 164.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.231 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 mt-10 -69.9 126.98 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 46.0 tttm -52.96 161.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.942 0.401 . . . . 0.0 110.634 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 35.05 34.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.312 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.36 145.08 40.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.729 ' HB3' HD23 ' A' ' 100' ' ' LEU . 17.4 m-80 -86.11 130.01 34.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 28.6 mm-40 -129.48 146.77 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 119.32 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.797 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -52.93 156.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.396 0.617 . . . . 0.0 111.654 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.597 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.61 153.32 42.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.802 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.699 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.6 mm-40 -71.57 122.76 21.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.306 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.52 48.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.315 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t70 -53.03 174.01 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.01 135.53 24.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 145' ' ' ILE . 7.2 mt -110.72 123.21 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.755 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.64 140.12 38.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.15 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.32 158.71 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.982 0.42 . . . . 0.0 112.129 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 36.36 13.72 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.0 t -80.13 140.36 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 111.917 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.79 -30.11 2.69 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 82.9 t -126.46 118.55 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.425 -0.887 . . . . 0.0 108.708 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -50.73 -35.68 32.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.33 6.73 47.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -125.52 29.3 6.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.13 139.36 29.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.59 134.43 55.01 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.71 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -111.25 132.49 54.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 0.0 111.686 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.4 mt -125.01 150.22 46.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.377 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.4 t -117.5 140.24 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 111.349 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 130' ' ' ILE . 13.1 mt -106.22 121.74 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.99 110.96 22.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.491 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.99 133.93 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.47 105.78 16.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.711 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -58.38 -30.73 67.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -59.26 -45.23 91.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.85 -41.79 83.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.034 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -62.57 -35.92 81.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -63.64 -40.35 96.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.54 -44.36 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.964 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.669 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -69.09 -39.63 78.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.028 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -48.07 77.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -37.03 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.5 37.32 0.95 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -125.02 150.14 47.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.01 125.73 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.11 100.74 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.03 173.91 10.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 15.7 pt -79.23 130.62 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.434 HG23 ' O ' ' B' ' 4' ' ' ILE . 0.5 OUTLIER 42.67 93.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.617 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.504 ' P ' ' H ' ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.53 122.99 83.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.15 176.46 7.79 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.432 2.088 . . . . 0.0 112.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.779 HG23 ' NH1' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -94.04 169.62 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 146.2 24.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.66 156.58 47.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t 60.63 85.34 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -140.98 -59.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -71.94 -38.54 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.05 -39.65 82.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.912 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 10.9 t80 -60.25 -39.25 86.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.694 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -31.9 72.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.82 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.63 -46.18 84.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.358 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -67.31 -23.95 65.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.61 -47.76 78.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.289 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.23 -22.64 61.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.012 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 62.43 169.26 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.949 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 132.83 53.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -91.8 107.27 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.07 138.35 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.635 0.731 . . . . 0.0 111.759 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.92 41.6 0.12 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.474 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.47 -47.35 56.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 177.92 40.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.5 mm -85.38 95.75 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.936 -1.483 . . . . 0.0 112.677 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 99' ' ' LEU . 3.1 t -45.58 -62.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.0 p -152.08 165.2 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.723 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -124.3 138.44 54.39 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.824 0.345 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -104.08 122.91 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.86 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -126.83 118.88 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.659 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.743 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -79.92 102.31 9.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.169 179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 t -67.84 -20.65 65.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.269 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 142' ' ' SER . 73.2 p -79.74 -2.41 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.47 75.88 0.26 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.831 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.77 -42.99 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.743 HD12 ' SG ' ' A' ' 38' ' ' CYS . 4.5 mt -112.41 142.82 27.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.881 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.655 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.35 135.18 26.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.223 1.948 . . . . 0.0 111.972 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.86 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -55.51 141.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.755 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.06 164.1 28.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HB3' HG21 ' A' ' 32' ' ' ILE . 4.5 m-20 -119.84 119.55 33.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.036 0.446 . . . . 0.0 111.986 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.3 mp -86.3 129.02 34.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.691 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.86 154.32 49.5 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -148.48 148.22 30.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.045 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 55' ' ' VAL . 19.3 m-20 -79.62 125.33 29.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.162 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -40.98 87.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.143 0.497 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 47.9 mm-40 -68.42 -36.97 79.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.878 HG13 ' HG3' ' A' ' 63' ' ' LYS . 57.6 t -72.02 -40.88 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.097 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.6 tp -71.07 -29.97 65.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -49.96 10.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.66 133.29 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -110.47 -21.43 12.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -52.09 167.61 0.12 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.23 126.29 27.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 94' ' ' GLY . 1.3 tp 54.09 172.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.878 ' HG3' HG13 ' A' ' 55' ' ' VAL . 12.5 mmtp -132.09 -63.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.7 OUTLIER -134.44 124.35 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -124.64 138.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 112.071 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -103.65 139.07 39.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.774 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.87 126.22 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 0.0 109.931 177.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.0 m-85 -107.58 145.77 32.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.53 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 167.12 -175.1 42.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.848 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -81.45 -4.82 56.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.86 137.18 38.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.325 . . . . 0.0 111.199 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.9 -5.97 16.96 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.779 2.319 . . . . 0.0 111.818 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.2 17.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.014 0.912 . . . . 0.0 108.621 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.36 137.61 4.67 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.514 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -56.34 -18.55 11.19 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.014 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 32.5 t80 -129.43 120.16 25.01 Favored 'General case' 0 C--N 1.338 0.078 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.811 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.26 112.14 23.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.743 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.727 ' CD2' HD13 ' A' ' 43' ' ' ILE . 60.9 mt -85.52 -79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.238 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.59 -108.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.39 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -166.54 46.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 111.258 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 84' ' ' LEU . 7.0 mt -84.3 122.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.72 -29.64 53.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.117 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.561 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.794 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD12 HD12 ' A' ' 81' ' ' ILE . 24.5 mt -72.92 149.93 42.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.267 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 76.2 p -95.0 165.93 12.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.893 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.666 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.34 -53.65 4.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.828 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.608 ' HB2' HD12 ' A' ' 104' ' ' ILE . 9.7 mttt -120.79 82.7 1.95 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.2 t60 -60.42 -46.2 90.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.817 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 10.2 p90 -148.51 158.65 44.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.278 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.695 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.3 tt0 -136.03 141.29 44.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.42 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -114.23 127.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -113.25 145.15 41.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.13 0.491 . . . . 0.0 112.012 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 99' ' ' LEU . 17.8 tp -125.21 123.0 38.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 62' ' ' ILE . . . 129.73 119.94 2.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.617 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -177.3 -39.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.812 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.83 -42.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.807 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.04 39.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.509 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.64 -175.21 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.672 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -106.95 158.42 17.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.06 143.56 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -112.59 122.99 49.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.88 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.765 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.2 t30 -114.94 115.72 27.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.542 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -77.72 138.94 39.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.7 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.47 38.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.41 157.71 15.85 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.076 0.465 . . . . 0.0 111.533 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -69.07 -33.78 74.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.557 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -19.92 17.43 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.48 160.15 11.2 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.456 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.082 0.553 . . . . 0.0 109.535 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.54 148.36 38.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.56 18.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.372 177.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 4.0 m120 44.29 43.34 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.43 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.41 -9.75 72.05 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.433 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.4 tptt -73.6 122.85 22.93 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.206 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.9 m -93.58 164.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.215 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.6 pm0 -69.89 124.06 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.583 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.7 tttm -51.87 161.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.04 0.448 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.6 32.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.497 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.64 145.13 40.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.12 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.856 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.3 m-80 -87.34 131.04 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.864 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.3 mm-40 -129.2 150.01 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.71 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.63 133.18 44.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.023 HD11 HG21 ' A' ' 145' ' ' ILE . 65.4 tp -64.74 155.5 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.51 0.672 . . . . 0.0 111.689 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.85 152.9 43.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.511 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' HD12 ' A' ' 147' ' ' ILE . 5.3 mm-40 -71.88 124.05 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.328 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.02 22.68 43.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.088 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t70 -53.01 172.05 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.939 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -145.05 135.8 24.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 143' ' ' LEU . 15.6 mt -114.66 124.81 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.999 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.621 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.78 141.65 36.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' CD2' ' A' ' 88' ' ' HIS . 23.0 m -140.44 158.74 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.32 43.5 9.46 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.251 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.7 t -84.28 140.35 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.595 0.712 . . . . 0.0 112.336 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 144.2 -39.17 1.27 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.4 119.64 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.455 -0.872 . . . . 0.0 108.917 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.4 tt0 -50.39 -26.45 4.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.8 0.334 . . . . 0.0 111.455 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.45 6.49 47.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.7 25.48 5.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.19 138.75 31.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.17 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.61 134.57 52.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.157 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.2 t -109.96 150.36 28.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.676 0.751 . . . . 0.0 112.381 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.572 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -135.25 154.06 51.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.782 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.939 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -126.1 137.89 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.023 HG21 HD11 ' A' ' 124' ' ' LEU . 1.6 mm -106.32 120.91 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.837 0.351 . . . . 0.0 110.817 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.33 112.68 24.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.717 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -86.01 133.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.361 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -77.49 135.2 38.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.713 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -32.56 71.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -60.29 -46.0 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.757 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -59.61 -43.97 93.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.033 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -45.86 87.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -47.17 86.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.74 -45.99 73.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -60.84 -35.89 77.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.823 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -42.84 92.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.73 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 159' ' ' LYS . 5.8 mm100 -84.78 -30.17 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.16 -91.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.658 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 157' ' ' GLN . 14.1 mttt -84.18 151.88 24.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.9 131.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -114.86 158.05 22.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -98.94 104.8 16.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.0 pt -84.59 133.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.876 0.369 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 19.0 tt -173.81 157.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.602 HG22 ' O2P' ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -74.41 111.65 13.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.8 161.08 42.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.547 HG21 ' HA3' ' A' ' 135' ' ' GLY . 25.4 m -81.85 144.65 30.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -86.68 174.6 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -93.27 144.87 24.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 131.96 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.859 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -71.81 0.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pm0 -63.82 -33.32 75.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.95 -39.46 94.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.21 -35.45 75.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.475 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 16' ' ' GLN . 34.6 mt -65.99 -33.3 75.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.672 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.07 -35.61 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.667 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -42.15 82.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.451 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -67.1 -23.77 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.687 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.66 -47.41 79.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -31.08 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.79 159.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.01 120.95 12.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.51 102.8 15.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.95 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -82.01 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.709 0.766 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.5 68.53 0.07 OUTLIER Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -38.52 21.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-80 179.39 38.03 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.22 135.46 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.5 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.92 -60.41 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.925 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.597 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.9 p -150.15 147.42 27.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.24 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.443 HH11 HD11 ' A' ' 37' ' ' ILE . 3.1 ttm180 -113.95 132.8 55.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.25 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.1 m -95.08 122.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.7 mt -127.36 125.66 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.263 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HA ' HD23 ' A' ' 143' ' ' LEU . 5.4 t -89.4 109.84 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.491 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -82.6 -24.76 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.776 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.67 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.2 p -79.92 -2.71 44.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.712 0.291 . . . . 0.0 111.496 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 77.5 0.3 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.965 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -147.46 -39.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -126.44 141.69 40.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.7 Cg_endo -72.09 145.66 44.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.171 1.914 . . . . 0.0 112.139 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.8 mt -60.82 149.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.711 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -142.71 164.08 31.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.092 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.92 119.89 35.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 111.881 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.5 mt -97.65 137.21 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.13 158.78 43.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.94 141.98 25.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.845 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 m-20 -76.55 126.09 30.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.325 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.787 HD13 ' SG ' ' A' ' 154' ' ' CYS . 62.0 mt -64.65 -45.24 95.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.188 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -60.79 -39.44 88.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 0.0 110.634 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 33.5 mm-40 -68.48 -36.87 79.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.728 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 51' ' ' ASP . 57.8 t -71.43 -37.85 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.18 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -27.82 64.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.393 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -93.44 -23.29 18.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.327 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.82 119.36 9.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.018 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.96 64.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -145.94 173.97 11.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -55.21 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.703 HD13 HD12 ' A' ' 92' ' ' LEU . 9.7 tp -123.91 156.96 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -107.5 -75.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt -121.68 133.89 54.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.42 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.643 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -131.96 139.16 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.245 0.545 . . . . 0.0 111.852 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.11 139.26 37.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.006 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.51 129.04 56.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -118.46 145.29 45.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.523 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.63 -169.05 37.0 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.762 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.434 ' HG3' HD11 ' A' ' 78' ' ' LEU . 20.3 mtm180 -80.76 3.57 21.91 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.915 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 56.7 t30 -84.76 132.56 45.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 0.0 111.134 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.19 -14.16 43.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.45 2.1 . . . . 0.0 111.637 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.78 -42.73 17.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.861 0.838 . . . . 0.0 108.909 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.42 139.02 1.14 Allowed 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.021 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 m-20 -56.3 -18.99 12.3 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.977 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.0 t80 -129.8 123.09 30.09 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 120.731 0.3 . . . . 0.0 111.083 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.07 107.9 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -111.14 177.35 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.29 131.77 50.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.618 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -70.97 88.26 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.4 mt -106.33 135.08 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.06 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.27 -31.87 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.091 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.25 -49.26 57.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.189 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 81' ' ' ILE . 25.6 mt -74.54 151.21 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.996 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 p -95.38 164.15 12.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.61 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.55 -52.63 4.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.424 0.631 . . . . 0.0 109.648 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.97 82.35 1.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -60.88 -46.13 91.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.761 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.7 p90 -143.46 160.0 41.37 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.907 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.97 142.33 44.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.462 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.645 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.6 mt -117.67 131.52 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.805 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.703 HD12 HD13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -118.93 140.21 50.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.049 0.452 . . . . 0.0 111.96 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.719 HD22 HG11 ' A' ' 33' ' ' VAL . 10.4 tp -125.19 122.9 38.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.237 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.07 -130.71 2.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.941 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.35 172.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.398 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 59.49 167.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.981 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.66 21.22 42.36 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.637 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -108.98 -177.15 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.828 0.346 . . . . 0.0 110.801 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -124.48 160.06 29.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.6 mt -125.84 141.01 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.099 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.69 122.24 47.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.386 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -113.95 115.69 28.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.978 0.418 . . . . 0.0 111.404 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.6 p30 -78.59 137.52 37.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.002 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -145.93 40.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.13 161.07 13.9 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.01 0.433 . . . . 0.0 111.712 -179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.485 HG22 ' HB3' ' B' ' 7' ' ' PRO . 88.6 m -69.05 -38.63 79.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.799 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -20.1 17.22 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.55 161.02 10.96 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.609 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.2 m -117.59 137.97 52.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.565 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.888 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.97 148.56 36.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.5 18.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.219 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 44.52 43.24 6.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.87 -10.86 68.65 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.514 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -104.61 118.5 36.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.888 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.5 tptm -73.5 131.11 41.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.228 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -102.79 165.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.193 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.5 tt0 -69.9 126.4 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.573 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.0 tttp -53.75 162.5 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 110.619 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.32 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.111 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.53 145.07 40.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.109 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.685 ' HB3' HD22 ' A' ' 100' ' ' LEU . 78.3 m-20 -88.75 130.71 35.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.968 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.846 ' O ' HD23 ' A' ' 100' ' ' LEU . 37.3 mm-40 -129.12 147.56 50.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.4 tm? -72.6 119.23 16.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.48 HD21 ' CG1' ' A' ' 147' ' ' ILE . 65.6 tp -54.68 157.79 2.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 111.537 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.438 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.31 153.25 42.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.26 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.31 122.41 20.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.458 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.62 23.01 54.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.138 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.7 t70 -57.41 173.86 0.24 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' VAL . 59.9 tt0 -145.13 135.61 24.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.041 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 145' ' ' ILE . 2.8 mp -109.24 127.37 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.62 139.01 40.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.29 37.41 15.02 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.15 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.3 t -77.58 140.39 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.671 0.748 . . . . 0.0 112.202 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 143.82 -39.59 1.26 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 138' ' ' SER . 42.9 t -126.45 123.89 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.078 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.32 -29.59 10.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.808 0.337 . . . . 0.0 111.454 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.543 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.7 m -93.41 6.51 47.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.15 23.02 8.55 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -106.8 139.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.24 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 142' ' ' SER . 6.7 tt -124.4 134.65 53.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.702 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -110.92 129.12 55.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.177 0.513 . . . . 0.0 111.606 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 20.9 mt -122.53 136.78 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.677 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -110.85 140.17 31.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.331 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.622 ' CD1' HD11 ' A' ' 130' ' ' ILE . 25.3 mt -105.97 136.39 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.82 111.78 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.86 128.65 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.482 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -75.87 134.82 40.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -74.03 -29.43 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.204 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -59.57 -45.64 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.441 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.1 t80 -63.06 -42.69 99.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.21 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -50.03 67.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.277 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -59.37 -36.94 76.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.108 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.787 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.0 t -68.0 -45.98 72.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.71 -35.94 77.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.797 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.54 -39.63 91.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.93 -36.99 15.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.834 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 44.44 -171.5 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.583 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.73 115.36 13.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.877 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG21 ' CG2' ' A' ' 163' ' ' ILE . 28.9 m -70.32 138.45 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -40.15 43.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -146.6 123.85 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.406 ' CG2' HG21 ' A' ' 160' ' ' VAL . 2.9 pt -93.67 130.46 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.825 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.505 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.555 HG23 ' O ' ' B' ' 4' ' ' ILE . 20.0 tt -130.4 114.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.67 119.3 57.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 106' ' ' THR . 86.8 Cg_endo -78.3 55.73 5.51 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 112.552 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 135' ' ' GLY . 13.9 m 61.66 149.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.947 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -56.47 175.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -88.29 132.03 34.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -116.86 130.13 56.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.86 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -106.84 -58.41 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.83 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -36.04 74.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -36.95 85.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -45.02 77.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.789 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.8 mm -66.83 -35.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.075 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.05 -43.03 81.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.2 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -67.14 -23.87 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.403 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.57 -47.43 79.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -41.44 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -59.08 -66.62 0.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -83.8 130.99 34.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.13 124.8 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.07 138.36 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.713 0.768 . . . . 0.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 57.26 2.34 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.542 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.82 -43.42 94.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -177.19 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.737 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -76.03 135.2 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 113.617 -1.629 . . . . 0.0 112.696 -177.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.79 -61.09 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.86 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.1 p -144.52 145.98 32.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.076 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 138.13 50.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.493 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 36' ' ' VAL . 11.9 p -105.33 122.69 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -129.39 118.44 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.514 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -79.98 115.22 19.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.369 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -82.57 -26.0 32.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.885 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 67.1 p -79.9 -2.24 42.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.722 0.296 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.16 76.29 0.3 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.98 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -146.02 -43.76 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mt -114.13 141.3 26.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.1 Cg_endo -72.98 135.48 23.28 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.21 1.94 . . . . 0.0 112.198 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.75 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -55.47 134.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.04 164.29 20.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.49 119.83 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.214 0.531 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -97.38 131.53 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.988 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.85 159.0 44.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -178.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.83 141.76 30.52 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.475 178.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.804 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -82.75 147.16 28.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 111.436 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 mt -64.18 -45.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.069 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.8 t -56.53 -40.32 74.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.873 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.5 -36.8 79.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.444 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 51' ' ' ASP . 40.7 t -69.79 -41.8 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.2 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 159' ' ' LYS . 1.4 mp -71.03 -28.34 64.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -49.03 38.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.23 116.81 22.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.54 -20.03 8.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.297 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -106.12 -70.66 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.062 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 177.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.898 HD11 ' HB2' ' A' ' 92' ' ' LEU . 1.3 tt -75.02 147.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.977 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -81.81 -78.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.338 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 ttpt -143.56 139.41 29.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 111.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.1 t -133.34 139.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.226 0.536 . . . . 0.0 112.007 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -103.42 139.08 39.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.99 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.93 130.24 56.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -120.05 145.27 47.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.49 -167.1 35.04 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.49 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.75 1.96 21.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.56 127.01 67.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.464 0.174 . . . . 0.0 110.948 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.9 Cg_exo -63.85 -14.33 42.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.317 2.012 . . . . 0.0 111.47 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -42.17 17.95 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.738 0.78 . . . . 0.0 108.925 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.09 138.61 1.07 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.592 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 t70 -56.35 -18.63 11.48 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.164 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' CE2' HG21 ' A' ' 43' ' ' ILE . 16.0 t80 -129.75 116.06 18.21 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -89.15 107.94 19.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.586 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD13 ' A' ' 84' ' ' LEU . 57.0 mt -71.87 -76.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.87 -98.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.465 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -162.89 53.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.334 . . . . 0.0 111.167 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -93.02 117.67 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -28.98 56.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.12 -47.88 40.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.01 HD12 HD13 ' A' ' 81' ' ' ILE . 16.1 mt -72.78 146.5 46.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.2 p -94.29 163.52 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.723 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.55 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -41.43 -52.11 3.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.589 0.709 . . . . 0.0 110.007 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -121.34 81.37 1.78 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.9 t60 -61.21 -46.49 90.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.609 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.8 p90 -144.86 157.15 44.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.722 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 67' ' ' THR . 26.5 tt0 -136.15 138.92 42.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.5 mt -113.0 127.86 70.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.678 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.898 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -110.01 149.23 30.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.493 . . . . 0.0 111.836 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.673 HD12 HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -123.31 123.85 41.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.117 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -160.44 -174.21 29.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.716 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 61.74 18.51 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.636 0.255 . . . . 0.0 111.22 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 50.73 89.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.281 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.01 -65.42 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.661 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -56.38 134.13 53.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 111.109 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.815 HD21 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -109.95 153.38 24.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.764 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.0 mm? -133.17 145.29 50.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.943 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 124' ' ' LEU . 13.9 mt -112.73 122.91 49.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.596 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.8 t30 -115.62 115.72 26.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 112.013 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.874 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.1 p30 -77.0 134.66 38.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.0 pt -142.0 39.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.62 159.7 14.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.956 0.408 . . . . 0.0 111.778 -178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.0 m -68.88 -37.97 79.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -19.77 17.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.71 162.97 11.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.432 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.35 137.85 52.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.894 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.11 148.36 35.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.578 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.19 113.43 18.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.302 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 5.0 m120 42.75 44.1 3.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.527 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.65 -13.55 63.84 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -103.26 118.56 37.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.6 tptm -73.49 124.2 25.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.487 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.874 HG23 ' OD2' ' A' ' 103' ' ' ASP . 19.1 m -91.53 161.88 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.3 pt-20 -69.82 123.07 20.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.499 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 72.0 tttt -50.08 161.65 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 34.15 35.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.332 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.21 145.05 40.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.387 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -84.78 125.43 32.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.718 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.572 ' O ' HD13 ' A' ' 100' ' ' LEU . 36.0 mm-40 -129.54 147.16 51.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -77.28 115.18 16.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.122 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.43 162.5 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 111.912 -179.159 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.507 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.93 153.41 42.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.421 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.37 119.92 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.543 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.39 56.89 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.434 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.578 ' OD2' HD13 ' A' ' 111' ' ' LEU . 12.7 t70 -60.55 -179.01 0.1 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.946 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.28 135.64 24.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.296 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.866 HG13 HD11 ' A' ' 145' ' ' ILE . 3.7 mt -113.72 127.72 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.579 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.46 141.09 36.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.28 158.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 43.52 8.71 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.026 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.494 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.3 t -84.35 140.42 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.663 0.744 . . . . 0.0 112.396 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.06 -38.81 0.83 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.42 123.15 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.166 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.4 -29.83 11.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.556 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.7 m -93.57 6.41 48.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -127.56 27.43 5.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.579 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 139.25 29.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.032 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.21 134.43 53.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.512 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -108.71 150.51 27.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.597 0.713 . . . . 0.0 112.145 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.4 mt -135.66 158.13 45.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.946 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.0 t -126.52 130.53 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.888 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.866 HD11 HG13 ' A' ' 130' ' ' ILE . 1.1 mp -105.64 120.8 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.29 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.29 112.17 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.586 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.515 ' CD1' HD22 ' A' ' 124' ' ' LEU . 5.2 mt -84.79 131.06 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 117.44 17.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.846 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -33.69 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.036 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -59.95 -45.81 91.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.91 -42.73 85.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.084 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -34.86 74.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -61.13 -43.49 98.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -62.47 -45.91 90.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 96' ' ' ASP . 1.1 mm? -67.27 -36.01 80.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -62.52 -36.61 83.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -91.97 -36.51 13.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.983 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 44.94 -172.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.593 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 56' ' ' LEU . 2.1 tttp -77.74 156.85 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 160' ' ' VAL . 27.7 m -101.63 121.05 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.88 -170.02 2.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 30.61 3.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.57 112.15 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.878 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p30 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.809 0.338 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 tt -165.59 139.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.76 124.76 77.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.28 139.22 34.65 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.503 2.135 . . . . 0.0 112.345 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.89 168.64 10.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -71.29 129.85 39.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -151.8 133.17 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.2 98.25 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.919 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.5 m -155.7 -50.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -64.58 -44.83 89.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -35.96 74.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -44.23 94.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -44.68 94.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -65.87 -35.0 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -57.14 -36.94 71.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -67.24 -23.9 65.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.53 79.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -36.15 82.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 60.1 84.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -99.12 139.75 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -84.4 103.61 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.94 138.34 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.631 0.729 . . . . 0.0 111.76 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 94.04 2.33 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.504 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -80.22 -34.06 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.953 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 178.61 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -74.02 133.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.465 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.74 -60.81 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.646 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 p -146.55 147.59 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.178 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.08 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' CE2' ' A' ' 68' ' ' PHE . 28.5 t -105.49 122.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.859 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -126.87 121.17 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.449 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' HD21 ' A' ' 141' ' ' LEU . 17.8 t -79.87 115.73 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -87.01 -25.05 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.742 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' H ' ' A' ' 142' ' ' SER . 30.4 p -79.89 -2.13 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.599 0.238 . . . . 0.0 111.441 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.36 76.99 0.26 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.897 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -147.26 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -122.17 142.08 35.93 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.0 Cg_endo -72.43 145.05 41.99 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.148 1.899 . . . . 0.0 112.228 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.859 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -56.61 147.35 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.49 161.38 35.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.198 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -118.63 119.74 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 111.707 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.4 mt -99.11 132.56 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.35 158.58 43.9 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.58 141.74 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.501 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -83.5 134.39 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.245 0.545 . . . . 0.0 111.331 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.5 -45.09 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.906 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.4 -39.18 86.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.0 110.585 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm100 -68.49 -36.81 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.579 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 51' ' ' ASP . 65.7 t -65.88 -48.21 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.801 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.05 -32.85 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -77.72 -42.55 33.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.95 120.16 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.975 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.34 70.21 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -145.58 171.4 14.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.2 p -71.13 -30.65 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 65' ' ' VAL . 9.3 tp -114.66 147.54 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.577 ' HD2' HG13 ' A' ' 55' ' ' VAL . 9.1 mmpt? -103.91 -66.66 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.5 ttpt -150.72 131.46 14.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.79 139.14 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.239 0.542 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.2 m-90 -102.81 139.44 38.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.15 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.38 128.88 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -118.35 145.34 45.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.477 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.709 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 161.02 -166.59 35.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.644 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.4 mtm180 -84.34 5.42 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.4 t-20 -84.95 132.47 45.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.72 -14.79 46.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.449 2.099 . . . . 0.0 111.462 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -43.31 16.96 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.854 0.835 . . . . 0.0 108.76 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.05 138.96 1.92 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.739 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.35 -18.86 12.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.922 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.5 t80 -129.78 125.23 35.3 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.778 0.323 . . . . 0.0 111.257 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -103.28 112.84 25.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.614 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.709 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -119.29 72.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.26 -131.87 19.83 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.919 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.69 84.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.046 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -96.59 128.6 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -28.77 63.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.63 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -74.13 -27.76 61.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.059 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.971 HD12 HD13 ' A' ' 81' ' ' ILE . 17.5 mt -99.5 152.12 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.956 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.8 p -94.96 166.65 11.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.533 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.564 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.58 -53.85 5.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.353 0.597 . . . . 0.0 109.596 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.566 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.14 83.75 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -60.33 -46.27 90.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.8 p90 -144.59 160.27 41.43 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.171 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.78 141.32 44.77 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.196 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.5 mt -117.3 132.18 67.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.027 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.93 151.59 27.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.087 0.47 . . . . 0.0 111.612 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.574 HD13 ' C ' ' A' ' 93' ' ' LEU . 2.6 tm? -125.05 122.9 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -99.91 165.44 19.87 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.711 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -58.66 -30.37 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.757 0.313 . . . . 0.0 111.05 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.07 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.95 29.7 8.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' C ' HD12 ' A' ' 99' ' ' LEU . 77.8 m-20 -133.73 -178.31 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.826 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 33' ' ' VAL . 5.8 mp -132.23 160.11 37.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.6 mt -129.67 143.92 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -112.66 127.47 56.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.538 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.5 t30 -118.9 115.5 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 0.0 111.493 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -78.84 138.37 38.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -145.74 40.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 150.94 21.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.037 0.446 . . . . 0.0 111.798 -178.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.451 ' OG1' HG21 ' B' ' 5' ' ' TPO . 52.4 m -68.62 -31.56 70.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.769 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.14 -19.71 17.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.34 10.61 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.53 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.19 137.71 52.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.76 148.58 39.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.59 18.61 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.349 177.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 43.97 43.44 5.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.45 -12.55 64.65 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.485 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.42 118.53 36.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 110.56 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.83 130.63 41.52 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.501 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.866 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.1 m -100.05 163.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 pm0 -69.98 124.69 24.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.9 tttt -50.99 161.01 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 111.012 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.37 34.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.401 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.37 145.16 40.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.8 ' HB3' HD22 ' A' ' 100' ' ' LEU . 24.9 m-80 -85.49 128.55 34.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.34 147.53 51.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.705 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.4 tt -72.89 120.1 18.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.31 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -56.81 157.54 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.291 0.567 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.38 153.24 42.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.452 ' HG2' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 121.8 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.357 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.95 24.57 54.55 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.19 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.8 t70 -57.72 175.6 0.18 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.902 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.6 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.035 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 145' ' ' ILE . 6.7 mt -113.14 128.19 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.383 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.651 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.19 138.88 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.805 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.26 158.41 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.35 21.46 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.936 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.0 t -75.07 140.43 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.661 0.743 . . . . 0.0 112.428 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.26 -37.8 0.85 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.38 123.26 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.96 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -32.54 16.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.783 0.325 . . . . 0.0 111.585 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.461 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 3.6 t0 -125.86 29.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.651 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.29 139.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 142' ' ' SER . 4.4 tt -124.4 134.41 53.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.577 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD23 ' A' ' 141' ' ' LEU . 45.7 t -112.71 150.27 31.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.481 0.658 . . . . 0.0 112.424 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HZ ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -134.1 148.5 51.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.14 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.6 t -114.04 135.5 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 130' ' ' ILE . 27.9 mt -106.3 122.79 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 120.57 42.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.55 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.583 HG12 HD21 ' A' ' 124' ' ' LEU . 6.1 mt -84.59 134.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.826 0.346 . . . . 0.0 111.322 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.29 123.37 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.8 -17.97 62.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -57.44 -44.4 84.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.51 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.494 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -58.7 -44.11 90.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.711 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -65.21 -33.93 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.85 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -46.31 71.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -59.89 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 151' ' ' PHE . 4.3 mm? -59.94 -39.1 84.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.803 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -78.5 -37.07 44.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 42.43 44.03 3.31 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.488 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.27 114.01 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.73 131.9 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.18 -176.7 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.36 167.84 15.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.7 126.4 40.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.863 0.363 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.14 142.38 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' TPO . . . . . 0.632 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -90.05 107.59 20.38 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.11 -169.08 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.444 2.096 . . . . 0.0 112.389 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -157.2 157.76 34.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -93.17 142.3 27.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -122.25 151.24 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 16.2 m 60.43 179.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.894 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -59.01 -39.08 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -39.11 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.81 -31.98 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.99 -35.53 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.38 -45.34 84.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -67.07 -23.78 65.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.581 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.63 -47.62 79.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -76.4 136.09 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.533 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.944 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.32 -60.0 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.803 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.4 p -145.97 165.27 29.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.281 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.44 122.79 34.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.386 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.659 HG11 ' HE2' ' A' ' 68' ' ' PHE . 5.4 m -90.35 122.86 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.922 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.833 HG23 HG12 ' A' ' 45' ' ' ILE . 20.4 mt -126.34 120.46 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.444 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.746 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.3 t -80.83 121.31 25.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -26.17 19.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.379 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' H ' ' A' ' 142' ' ' SER . 40.2 p -79.87 -2.18 42.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.579 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.32 76.49 0.29 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.807 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -146.32 -42.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -117.72 141.26 28.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.8 141.06 36.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.152 1.902 . . . . 0.0 112.167 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.833 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -55.9 133.56 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.82 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -127.1 164.05 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.137 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.85 119.78 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.814 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -87.18 130.45 34.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.463 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.944 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.91 155.99 48.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.287 1.041 . . . . 0.0 113.497 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.226 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 16.4 ttpt . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.9 p -111.35 140.08 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.814 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.6 m-90 -100.67 139.34 36.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.107 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 131.41 55.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -120.2 145.58 46.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.659 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.45 -169.18 36.18 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.768 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.0 mtm180 -81.95 3.75 25.26 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.744 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.6 t-20 -84.82 132.65 45.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.572 0.225 . . . . 0.0 111.007 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.88 -13.3 39.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.514 2.143 . . . . 0.0 111.63 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.92 17.41 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.914 0.864 . . . . 0.0 108.847 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.54 137.52 3.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.805 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -18.09 11.01 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.226 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 9.8 t80 -129.06 119.43 24.19 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.031 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.97 111.41 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.547 ' HA ' HG12 ' A' ' 43' ' ' ILE . 1.7 mt -88.07 -65.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.06 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.169 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.4 p30 178.78 54.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 111.007 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 34.1 mm -75.06 126.66 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 p -54.94 -40.83 70.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.277 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -68.81 -44.9 72.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -72.99 150.07 42.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -95.69 166.83 11.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.78 -53.15 6.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 109.805 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HB2' HG22 ' A' ' 67' ' ' THR . 9.7 ptmt -120.9 81.83 1.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.7 t60 -60.4 -46.15 91.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.829 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.8 p90 -142.45 160.2 40.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.077 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.712 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.99 143.87 45.05 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.713 ' C ' HG23 ' A' ' 65' ' ' VAL . 69.9 mt -120.03 125.68 74.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.632 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.9 pt? -114.17 137.3 51.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.787 HD22 HG11 ' A' ' 33' ' ' VAL . 18.9 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.307 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.8 mp -133.14 147.13 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.224 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 145' ' ' ILE . 8.2 mp -112.62 125.66 54.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD22 ' A' ' 92' ' ' LEU . 41.1 t30 -116.69 115.63 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.8 p30 -80.44 132.6 35.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.808 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -139.57 41.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.95 157.76 16.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.018 0.437 . . . . 0.0 111.473 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -68.84 -36.35 78.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.445 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -19.84 17.34 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.46 161.45 11.25 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.489 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.0 m -117.6 137.99 52.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.6 148.38 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -124.33 113.54 18.37 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 45.78 42.75 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.37 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.84 -5.5 84.87 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.493 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.39 118.72 37.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.108 0.454 . . . . 0.0 110.868 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.4 tptm -75.11 126.91 32.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.327 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -101.52 165.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tt0 -69.86 125.92 28.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 47.9 tttm -52.12 161.82 0.56 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.91 0.386 . . . . 0.0 110.558 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.63 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.281 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.23 145.07 40.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.251 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.481 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.4 m120 -86.67 130.13 34.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.8 mm-40 -129.39 147.89 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.477 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.5 tt -72.8 135.99 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.331 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.848 HD21 HG12 ' A' ' 147' ' ' ILE . 63.4 tp -65.62 155.23 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.463 0.649 . . . . 0.0 111.733 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.95 153.12 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.515 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 123.13 21.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.139 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.38 46.15 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.063 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.5 t70 -52.14 170.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.02 135.56 24.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 145' ' ' ILE . 11.3 mt -113.52 126.68 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.48 138.57 40.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.745 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.8 m -140.27 158.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.84 31.49 23.62 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.6 t -73.41 140.36 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.604 0.716 . . . . 0.0 112.217 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.01 -39.33 0.88 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 21.6 t -126.23 128.31 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.017 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.4 -35.42 28.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.38 6.55 47.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.92 27.32 8.16 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.12 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.172 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -124.35 134.48 53.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.434 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.588 ' C ' HD22 ' A' ' 143' ' ' LEU . 41.6 t -112.61 150.41 31.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.671 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.746 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.91 152.4 50.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.379 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.9 t -119.82 140.08 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.34 . . . . 0.0 111.334 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 130' ' ' ILE . 47.7 mt -106.32 121.0 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -109.11 114.38 28.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.512 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.848 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.86 132.76 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.551 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.8 179.768 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -38.88 86.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -35.45 77.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.843 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -42.17 88.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.22 -35.14 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.22 -43.35 82.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.853 0.359 . . . . 0.0 110.377 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.428 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.47 79.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.827 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -75.35 135.04 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.561 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.26 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.838 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -146.49 147.21 30.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.326 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 128.17 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.265 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.5 m -94.58 122.9 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.798 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -123.15 111.38 29.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.655 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.04 106.42 18.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -97.76 -10.76 24.29 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.682 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.1 p -79.94 -2.59 44.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.408 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.45 84.26 0.69 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.432 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.928 ' NE2' HD13 ' A' ' 141' ' ' LEU . 15.1 pt20 -161.72 -47.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.422 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.58 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.6 mt -134.16 142.79 44.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.711 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' HG23 ' A' ' 43' ' ' ILE . 63.4 Cg_endo -75.92 146.01 29.03 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.255 1.97 . . . . 0.0 111.794 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 36.9 mt -52.24 136.77 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.969 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -132.08 161.89 32.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 120.02 36.68 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.712 HD11 HG13 ' A' ' 36' ' ' VAL . 4.1 mt -96.04 136.96 35.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 159.07 43.91 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -178.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.709 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.7 ttpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.848 0.356 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.5 t -132.55 139.48 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.22 0.533 . . . . 0.0 111.761 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -100.88 137.67 38.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.69 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.01 127.48 56.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.25 145.53 42.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.66 -173.06 35.63 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.663 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 14.3 mtm105 -77.79 4.87 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 11.4 t-20 -84.97 131.91 47.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 0.0 111.043 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 Cg_exo -66.07 -14.21 43.35 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.362 2.041 . . . . 0.0 111.573 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.01 -42.61 17.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.946 0.879 . . . . 0.0 109.014 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.65 138.19 1.44 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.096 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.39 -18.21 10.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' A' ' 36' ' ' VAL . 6.6 t80 -128.48 112.22 14.12 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.79 0.328 . . . . 0.0 111.222 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -90.46 118.28 29.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.415 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -126.95 172.4 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.33 137.09 45.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.577 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -71.51 81.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 83' ' ' ARG . 27.8 mm -88.9 127.31 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.955 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -55.04 -24.93 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.665 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.03 -46.07 15.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.157 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 132' ' ' VAL . 42.3 mt -72.7 152.18 41.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.036 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.4 p -95.88 166.03 11.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.693 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.607 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.14 -53.77 6.17 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 109.614 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.36 81.85 1.75 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -59.54 -45.89 90.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.764 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.2 p90 -145.45 157.61 43.98 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.772 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -136.06 141.06 44.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.606 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 65' ' ' VAL . 53.6 mt -116.53 129.69 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.022 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -117.13 140.83 49.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.105 0.479 . . . . 0.0 111.602 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.803 HD22 HG11 ' A' ' 33' ' ' VAL . 9.8 tp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.258 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.748 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.822 0.344 . . . . 0.0 110.749 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.1 mp -133.03 145.09 50.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.591 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 145' ' ' ILE . 10.5 mp -112.74 122.05 46.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.01 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.582 ' HB2' HD21 ' A' ' 92' ' ' LEU . 57.4 t30 -116.77 115.63 25.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 111.56 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.1 p30 -78.31 135.91 37.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.0 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -143.84 39.08 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.98 160.4 14.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.043 0.449 . . . . 0.0 111.5 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.1 m -68.96 -36.46 77.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.615 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.49 -20.06 17.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.34 162.07 11.55 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.201 -0.999 . . . . 0.0 113.481 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.69 137.84 52.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.852 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.72 148.39 36.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.46 18.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.198 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.39 42.85 5.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.358 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.37 -5.08 85.33 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.464 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -104.86 118.51 36.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 0.0 110.738 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.852 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.0 tptp -75.67 126.04 30.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.156 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.789 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.2 m -102.69 163.13 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.289 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.91 127.1 31.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.7 tttp -52.44 163.44 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.197 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 35.43 35.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.948 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -112.03 137.2 50.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.107 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.466 ' HB3' HD23 ' A' ' 100' ' ' LEU . 19.2 m120 -80.4 130.54 35.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 27.2 mm-40 -129.54 146.9 51.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 tp -72.85 136.13 45.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -63.72 157.45 24.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.48 0.657 . . . . 0.0 112.006 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.475 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.44 153.37 43.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.217 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.456 ' OE1' HD12 ' A' ' 147' ' ' ILE . 15.2 mm100 -71.55 115.6 10.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.38 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.26 30.02 63.8 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.702 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.457 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.1 t70 -55.23 174.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.973 0.416 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.907 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.21 135.47 24.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.015 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 10.4 mt -111.33 126.3 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.549 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.564 HG22 ' CG2' ' A' ' 140' ' ' ILE . 8.2 m -104.87 137.66 42.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.0 m -140.32 158.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 112.181 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.59 16.26 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.17 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.8 t -74.53 140.41 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.684 0.754 . . . . 0.0 112.172 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.23 -41.07 1.08 Allowed Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 43.1 t -126.5 123.14 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.541 -0.83 . . . . 0.0 108.929 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.29 -28.05 7.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.427 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -93.64 6.53 48.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.62 24.37 7.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.564 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.47 138.23 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.928 HD13 ' NE2' ' A' ' 42' ' ' GLN . 9.9 mt -125.19 134.77 52.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.339 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.682 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -104.65 139.07 40.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.213 0.53 . . . . 0.0 111.897 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.2 mp -125.06 152.51 44.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.154 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.907 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.5 t -120.77 134.18 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.869 0.366 . . . . 0.0 111.618 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 36.3 mt -106.31 121.74 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -110.24 119.02 37.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.599 HD13 HD22 ' A' ' 124' ' ' LEU . 5.9 mt -84.71 134.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 t30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.784 0.326 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -60.54 -42.21 96.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 -38.05 80.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.9 -32.27 72.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.675 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.11 -35.5 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.734 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -39.98 77.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.446 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -67.1 -23.8 65.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.794 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.68 -47.34 80.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.224 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.832 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.711 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -75.11 134.49 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.262 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.75 -61.58 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.421 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.453 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.2 p -155.19 138.03 15.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.443 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -113.99 138.45 50.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.3 t -96.13 132.14 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.388 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.788 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.71 116.89 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 108.99 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.245 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.4 p -93.61 -20.12 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.035 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.852 HG21 ' OG ' ' A' ' 142' ' ' SER . 48.9 p -79.82 -2.99 45.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 111.499 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 74.27 75.37 0.78 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.562 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 8.8 mt-30 -147.95 -41.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.676 0.274 . . . . 0.0 111.223 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.6 mt -134.01 141.49 39.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.2 Cg_endo -73.99 146.07 36.6 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.179 1.919 . . . . 0.0 111.92 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.788 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -56.13 151.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.187 0.517 . . . . 0.0 111.956 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 2.0 ttt-85 -149.69 159.18 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.26 121.59 40.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 112.333 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD11 ' HZ ' ' A' ' 68' ' ' PHE . 8.1 mt -94.56 137.76 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.005 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 158.17 43.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.117 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.0 ttpt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.652 0.263 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.8 t -127.45 139.47 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.312 0.577 . . . . 0.0 112.186 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.636 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -107.78 138.56 43.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -110.69 126.23 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.746 ' CE2' HG21 ' A' ' 36' ' ' VAL . 2.5 m-85 -107.37 145.78 32.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.818 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.9 -178.58 40.54 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.782 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -78.16 -3.38 42.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 136.83 38.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.27 -6.12 17.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.796 2.331 . . . . 0.0 111.736 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.27 14.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.956 0.884 . . . . 0.0 108.684 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.07 139.23 2.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.457 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -18.62 10.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.174 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.1 t80 -129.36 131.65 46.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.04 131.09 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -133.18 -178.58 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.45 135.64 39.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -69.93 89.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' H ' ' A' ' 83' ' ' ARG . 25.2 mt -104.35 127.75 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -54.98 -25.02 26.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.325 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -75.62 -46.74 29.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.227 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 132' ' ' VAL . 39.8 mt -72.74 151.68 42.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.748 0.309 . . . . 0.0 111.306 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -95.56 166.16 11.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.893 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.22 -54.39 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 109.858 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.9 mttp -118.82 82.84 1.92 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -60.87 -46.79 89.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.652 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 p90 -147.71 159.31 43.94 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.278 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.4 tt0 -135.95 141.46 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 65' ' ' VAL . 41.4 mt -114.37 132.33 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.251 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 121' ' ' ASN . 0.5 OUTLIER -122.0 144.46 48.88 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 111.341 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.762 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.544 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 110.821 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.9 mt -133.13 140.38 47.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.249 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -112.56 126.08 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.202 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -115.8 115.49 26.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.784 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.68 140.81 38.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.7 pt -149.22 38.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.51 159.04 15.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.007 0.432 . . . . 0.0 111.625 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.1 m -69.02 -34.96 76.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.647 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 -19.97 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.71 162.81 12.04 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.533 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.9 m -117.53 137.81 52.32 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.71 148.36 38.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.526 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.14 113.48 18.4 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.361 177.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 44.28 42.88 5.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -10.39 71.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.474 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.96 118.54 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.09 0.445 . . . . 0.0 110.656 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.34 130.91 41.2 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.56 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.784 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -101.87 164.58 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.851 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 tt0 -69.98 126.67 30.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.499 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 tttt -52.69 161.6 0.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.545 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.02 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.293 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.0 40.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.114 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.631 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.4 m120 -89.86 126.67 35.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.76 ' O ' HD23 ' A' ' 100' ' ' LEU . 39.4 mm-40 -129.3 147.28 51.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.834 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.9 120.95 19.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.984 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 101' ' ' LEU . 1.3 mm? -57.83 165.51 1.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.756 0.789 . . . . 0.0 112.076 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.38 153.18 43.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.195 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.489 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.63 120.36 17.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.94 26.39 60.7 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.246 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.1 t0 -60.82 178.54 0.23 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.914 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.7 mt-10 -144.99 135.57 24.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -112.64 126.92 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.457 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.49 141.63 36.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.101 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.41 158.53 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.99 9.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.192 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -83.69 140.37 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.646 0.736 . . . . 0.0 112.228 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.46 -39.29 1.31 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.52 120.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.592 -0.804 . . . . 0.0 108.97 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 mt-10 -50.29 -26.75 5.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.41 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.42 6.49 48.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.32 24.32 6.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.403 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 142' ' ' SER . 7.9 tt -123.32 134.78 54.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.196 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.852 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -111.98 128.7 56.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.078 0.466 . . . . 0.0 111.605 -179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.7 mt -123.01 149.1 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.777 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.914 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.9 t -113.84 138.03 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.056 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 124' ' ' LEU . 1.4 mm -106.39 120.91 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.411 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -108.33 131.09 55.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -102.98 132.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.4 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.888 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -36.04 82.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -60.57 -40.05 90.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -61.13 -43.54 98.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mm -71.59 -34.99 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.23 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.493 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -23.86 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.57 -47.6 79.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.296 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.832 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -73.38 135.52 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.684 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -93.1 -60.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.862 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.7 p -146.12 150.47 35.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.183 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.4 138.24 51.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 111.489 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.689 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -103.1 122.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.792 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.45 121.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.546 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD23 ' A' ' 143' ' ' LEU . 48.4 t -79.87 114.43 18.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -79.69 -25.99 41.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.798 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.6 p -79.83 -2.19 42.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.706 0.289 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 77.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.946 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -146.29 -44.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.389 . . . . 0.0 110.736 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.1 mt -113.73 141.66 26.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.862 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.3 Cg_endo -72.06 140.87 35.33 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HG23 ' A' ' 37' ' ' ILE . 38.4 mt -56.43 140.2 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.641 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.38 164.13 20.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.33 119.71 33.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.1 mt -97.44 134.64 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 158.0 43.83 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.572 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.743 0.306 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.673 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.5 t -125.56 139.14 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 112.086 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.597 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.6 m-90 -100.89 139.4 36.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.199 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 128.76 56.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.45 145.38 46.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.346 -178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.1 -168.5 36.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.067 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.446 ' N ' HD11 ' A' ' 78' ' ' LEU . 25.1 mtm180 -80.28 2.23 25.46 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 t-20 -84.87 133.05 44.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -66.63 -14.05 42.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 0.0 111.901 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.05 17.31 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.902 0.858 . . . . 0.0 108.796 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.18 139.6 1.34 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.779 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.0 m-20 -56.34 -19.0 12.55 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.003 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.6 t80 -129.83 126.98 39.33 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.931 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.45 111.17 23.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -114.52 172.53 6.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.784 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.09 134.05 48.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.675 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -67.32 84.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 83' ' ' ARG . 53.3 mt -100.46 131.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -37.06 69.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.21 -27.85 67.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.005 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.0 mt -96.94 152.2 18.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -99.04 165.27 11.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.773 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -42.84 -53.5 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.387 0.613 . . . . 0.0 109.851 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB2' HG22 ' A' ' 67' ' ' THR . 10.7 ptmt -118.38 81.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.7 t60 -59.34 -45.69 90.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.883 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 34.0 p90 -144.53 160.44 41.12 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.138 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -135.91 143.04 44.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.282 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.3 mt -119.31 127.59 75.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.006 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.32 148.05 32.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 111.635 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.624 HD13 ' CG1' ' A' ' 33' ' ' VAL . 9.4 tp . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.534 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -133.06 147.34 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.58 HD22 HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -112.65 125.33 54.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.192 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 48.2 t30 -116.47 115.81 26.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.773 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.735 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -77.89 135.03 37.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 8.5 pt -143.91 34.6 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.83 151.77 19.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.941 0.4 . . . . 0.0 111.457 -179.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -68.58 -31.82 71.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.921 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.62 -19.83 17.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.72 154.52 9.21 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.678 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.7 m -117.5 137.92 52.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.51 148.36 42.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.809 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.43 113.59 18.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.956 177.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 47.74 36.08 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.35 79.91 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.544 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.83 118.67 37.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 110.756 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -73.8 113.44 10.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.809 HG11 HD12 ' A' ' 111' ' ' LEU . 11.7 m -87.41 166.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.262 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.92 126.09 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -52.69 157.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.825 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.6 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 4.0 p30 34.77 35.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -112.32 145.11 40.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.077 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.649 ' HB3' HD23 ' A' ' 100' ' ' LEU . 11.5 m120 -80.84 131.87 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.24 146.66 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 tp -72.68 118.5 15.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 99' ' ' LEU . 7.6 tt -56.41 153.85 9.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.504 0.668 . . . . 0.0 111.686 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.91 153.02 43.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.465 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -71.82 125.03 26.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.258 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.57 54.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.283 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.454 ' OD1' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -52.0 166.03 0.18 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.911 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -139.83 135.63 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -111.11 127.0 68.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.742 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.4 141.27 36.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.563 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.78 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.78 43.88 9.7 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -84.68 140.44 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.651 0.739 . . . . 0.0 112.441 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.59 -39.96 1.12 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 50.0 t -126.41 120.02 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.563 -0.818 . . . . 0.0 109.0 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.45 -25.87 4.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.823 0.344 . . . . 0.0 111.442 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.6 t -93.5 6.53 47.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.9 26.01 5.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.627 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.13 138.83 31.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.96 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.49 134.28 53.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.55 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.4 t -108.41 150.3 27.57 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.619 0.723 . . . . 0.0 112.153 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.5 mt -135.75 156.97 47.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.911 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.8 t -125.94 138.61 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 130' ' ' ILE . 32.4 mt -106.34 121.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.966 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.39 114.07 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 124' ' ' LEU . 4.7 mm -84.92 134.0 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.395 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.818 0.342 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -59.0 -37.68 77.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.34 -41.37 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -31.83 70.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.38 -35.49 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.803 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -42.0 81.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -67.11 -23.89 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.59 -47.56 79.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.859 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.8 mm -76.71 134.05 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.529 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -93.66 -62.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.073 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.722 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.6 p -146.61 155.96 42.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.189 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -122.7 133.28 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.35 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 68' ' ' PHE . 38.4 t -97.56 122.81 49.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 23.1 mt -122.84 121.99 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.38 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.595 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.8 t -85.18 114.08 22.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.442 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -85.85 -22.87 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.581 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.485 HG21 ' H ' ' A' ' 142' ' ' SER . 42.5 p -79.94 -2.07 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.615 0.245 . . . . 0.0 111.581 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.17 76.64 0.28 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.844 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.702 ' HB2' HD12 ' A' ' 43' ' ' ILE . 12.5 mt-30 -146.89 -43.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.9 mp -118.88 141.87 30.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.999 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.6 138.02 28.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.119 1.879 . . . . 0.0 112.121 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -55.55 136.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.745 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.09 164.1 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.256 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -118.08 119.81 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 111.787 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.722 HD12 ' SG ' ' A' ' 34' ' ' CYS . 5.5 mt -89.84 137.35 32.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.62 157.58 43.74 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.635 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 49' ' ' SER . 22.8 ttpt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.925 0.393 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.733 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.8 p -109.85 140.0 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -100.6 139.5 36.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.349 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.05 127.27 55.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -118.99 145.52 45.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.503 -178.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.52 -168.07 39.86 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -90.83 28.95 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.4 t-20 -111.43 136.62 20.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.87 -13.12 38.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.668 2.245 . . . . 0.0 111.736 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -47.45 11.8 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.824 0.821 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.88 140.61 1.0 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.311 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -56.61 -18.91 13.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.883 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 19.6 t80 -129.46 123.65 32.08 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.765 0.317 . . . . 0.0 110.68 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -97.93 121.94 40.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' ILE . 12.4 mt -102.34 -64.04 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.77 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.27 -103.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -179.27 49.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 84' ' ' LEU . 19.2 mt -89.69 141.92 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -64.34 -34.77 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.9 mmt-85 -60.91 -30.49 70.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 81' ' ' ILE . 1.2 mm? -105.81 152.47 23.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 p -98.39 163.32 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.593 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.16 -53.28 4.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.413 0.625 . . . . 0.0 109.67 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -118.99 82.65 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' HD12 ' A' ' 84' ' ' LEU . 13.6 t60 -61.25 -46.94 88.33 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.553 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.5 p90 -143.7 159.14 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.999 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.706 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.0 tt0 -135.5 140.52 44.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.733 ' C ' HG23 ' A' ' 65' ' ' VAL . 77.1 mt -120.12 127.25 75.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.161 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.747 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.812 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.365 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.1 mt -127.76 140.68 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.513 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.2 OUTLIER -112.71 121.55 45.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.4 t30 -117.51 116.93 28.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.055 0.455 . . . . 0.0 112.072 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -77.36 134.82 38.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.817 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.4 pt -141.72 39.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.75 149.82 23.42 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.084 0.469 . . . . 0.0 111.943 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.88 -31.34 70.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.862 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.63 -19.96 18.65 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.35 153.82 9.6 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.875 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.6 m -117.66 137.99 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.085 0.554 . . . . 0.0 109.577 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.98 148.57 39.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.53 18.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.482 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 30.5 m-20 44.32 43.51 6.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.494 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.41 -13.59 61.69 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.447 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -103.96 118.47 36.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.983 0.391 . . . . 0.0 110.586 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -72.3 125.63 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.246 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.3 m -95.29 165.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.238 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 mt-10 -69.87 125.11 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.676 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 82.7 tttt -53.49 162.33 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.779 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 36.2 32.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.18 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.49 143.28 43.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.721 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.747 ' OD1' HD21 ' A' ' 92' ' ' LEU . 17.4 m-80 -92.17 133.6 35.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.793 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.6 mm-40 -129.08 150.01 50.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.58 122.91 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.14 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 145' ' ' ILE . 65.8 tp -53.03 156.14 2.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.493 0.663 . . . . 0.0 111.85 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.539 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -124.58 153.53 42.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.285 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.646 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.22 121.36 18.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.934 0.397 . . . . 0.0 110.405 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.57 24.23 56.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.154 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 38.1 t0 -54.79 170.49 0.17 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.007 0.432 . . . . 0.0 111.249 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 144' ' ' VAL . 20.5 tt0 -145.18 135.46 24.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 145' ' ' ILE . 2.6 mt -113.6 128.16 70.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.3 140.84 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.023 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.9 m -140.13 158.43 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.86 44.21 9.35 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.807 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -85.18 140.44 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.752 0.787 . . . . 0.0 112.47 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.39 -39.96 0.79 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.54 120.51 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.042 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 140' ' ' ILE . 9.2 tp10 -50.26 -26.44 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 111.54 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.581 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.5 p -93.61 6.62 47.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -132.49 29.83 4.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -106.32 139.25 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.629 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 142' ' ' SER . 1.5 tt -124.16 134.35 53.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.701 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.528 ' O ' HD22 ' A' ' 143' ' ' LEU . 41.0 t -112.17 150.31 31.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.722 . . . . 0.0 112.499 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -136.02 139.55 43.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.498 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.86 140.15 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 130' ' ' ILE . 16.8 mt -106.18 122.29 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.76 113.74 26.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.367 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.9 127.29 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.57 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -59.0 -36.32 74.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.18 -42.46 96.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 48.8 mm -68.91 -48.18 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.99 -33.56 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.294 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -59.79 -47.1 87.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.935 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.1 p90 -71.9 -47.44 52.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.062 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 52.3 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.014 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.692 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -74.74 134.25 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.454 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.014 HG12 HD21 ' A' ' 99' ' ' LEU . 2.9 t -91.16 -61.08 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.021 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -146.05 147.01 31.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.378 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.9 121.99 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.8 t -88.77 122.75 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.423 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.71 114.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.89 118.52 31.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -111.66 -12.46 13.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.853 HG21 ' CB ' ' A' ' 142' ' ' SER . 18.0 p -81.05 -2.51 48.4 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.08 85.49 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.809 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 4.4 pt20 -164.3 -49.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.704 HD13 HD22 ' A' ' 78' ' ' LEU . 5.1 mt -132.97 142.5 44.9 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 65.6 Cg_endo -75.69 146.16 29.97 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.201 1.934 . . . . 0.0 111.511 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -50.6 150.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 112.067 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -150.93 158.18 43.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.034 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -117.23 126.22 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.6 mt -101.05 137.62 39.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.75 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.89 158.78 43.68 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.532 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt . . . . . 0 CA--C 1.523 -0.096 0 CA-C-O 120.732 0.301 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.2 t -127.97 139.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.329 0.585 . . . . 0.0 112.333 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.605 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -100.84 139.25 36.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.804 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.72 130.13 55.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -119.34 145.4 46.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.367 -178.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.45 -170.43 37.21 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.777 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 13.8 mtm180 -79.95 2.86 21.86 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -84.94 133.01 44.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.61 0.243 . . . . 0.0 111.144 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.91 -14.51 44.89 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.571 2.181 . . . . 0.0 111.721 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -42.63 18.02 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.831 0.824 . . . . 0.0 108.972 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.39 139.75 1.89 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.914 -1.493 . . . . 0.0 110.826 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.36 -18.26 10.38 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.91 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.8 t80 -129.08 123.94 33.54 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.787 0.327 . . . . 0.0 110.922 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -105.53 116.67 32.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -99.0 -69.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.12 -92.26 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.317 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 177.95 55.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.103 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.2 mm -81.67 124.73 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.754 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.55 70.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -28.74 69.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.774 HD13 ' HB ' ' A' ' 81' ' ' ILE . 6.2 mp -97.66 153.31 18.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -96.42 167.31 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.736 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -44.15 -54.93 5.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.266 0.555 . . . . 0.0 109.623 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.612 ' HB2' HD12 ' A' ' 104' ' ' ILE . 17.3 mttp -116.37 82.87 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -59.55 -46.47 88.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.763 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.0 p90 -143.92 157.77 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.008 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.2 tt0 -135.69 141.35 44.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.956 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -116.34 126.73 73.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.853 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -105.51 149.25 26.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.163 0.506 . . . . 0.0 111.858 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 50' ' ' ALA . 2.0 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.233 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.014 HD21 HG12 ' A' ' 33' ' ' VAL . 5.7 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.788 0.328 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 121' ' ' ASN . 7.8 mt -126.69 142.66 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.425 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.1 OUTLIER -112.79 121.63 45.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.808 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.817 ' HB2' HD11 ' A' ' 92' ' ' LEU . 48.9 t30 -112.24 115.78 29.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.737 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.802 ' OD2' HG23 ' A' ' 116' ' ' VAL . 16.7 p30 -76.43 129.23 36.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.645 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -137.94 38.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.17 152.97 19.29 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.13 0.49 . . . . 0.0 111.663 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.8 m -68.85 -31.6 70.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.24 -19.88 17.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.47 156.07 10.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.675 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.42 137.72 52.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.74 148.19 42.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -124.76 113.55 18.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 48.77 42.07 19.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.33 -6.14 80.82 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.973 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.722 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -106.3 118.83 37.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.275 0.537 . . . . 0.0 110.84 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptp -73.75 127.26 32.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.258 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.802 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -101.12 166.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.203 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 17.5 tt0 -69.77 123.87 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.518 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 2.1 tttt -51.32 165.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 p30 32.82 34.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.322 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.52 145.23 40.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.245 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.77 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.5 m120 -90.9 129.47 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.15 150.92 50.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.433 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 tp -72.6 134.24 45.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 145' ' ' ILE . 54.7 tp -65.85 156.42 33.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.48 0.657 . . . . 0.0 111.697 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.39 153.6 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.614 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.666 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.5 tp60 -71.3 118.6 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.33 23.64 62.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.116 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -50.99 172.02 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.871 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.63 135.59 24.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.5 mt -114.32 125.01 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.57 140.4 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.712 ' CG2' HD21 ' A' ' 84' ' ' LEU . 32.7 m -140.31 158.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.94 27.22 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.179 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.0 t -71.02 140.32 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 112.212 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.8 -38.54 1.27 Allowed Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 44.9 t -126.45 124.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.662 -0.769 . . . . 0.0 109.202 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -50.47 -31.07 14.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.587 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 38.0 t -93.45 6.43 48.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -125.54 25.49 7.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.58 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.05 138.94 30.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.016 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 140' ' ' ILE . 6.0 mp -124.46 134.58 53.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.508 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.853 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.54 132.74 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.5 mp -123.23 143.49 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.546 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.871 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.3 t -114.45 132.72 62.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.635 HG21 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -106.42 120.98 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.063 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -104.37 142.2 34.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -110.47 134.07 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.523 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.955 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.776 0.322 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.04 96.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.38 -35.09 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.1 -44.64 88.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.1 mm -66.86 -35.22 74.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.28 -42.92 82.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 0.0 110.353 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -67.26 -23.62 65.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.51 -47.48 79.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.297 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.9 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.7 135.29 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.416 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.968 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.42 -59.96 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.012 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.4 p -148.8 153.37 38.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.82 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.416 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -117.97 119.43 34.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.938 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -90.04 122.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 111.184 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.836 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -122.78 126.14 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.156 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.72 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.2 t -81.08 118.58 22.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.579 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.65 HG21 ' OE2' ' A' ' 129' ' ' GLU . 4.1 t -83.52 -27.89 29.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' H ' ' A' ' 142' ' ' SER . 50.6 p -79.88 -2.28 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.461 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.57 77.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.943 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.4 mt-30 -147.35 -43.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.931 HD11 HD21 ' A' ' 141' ' ' LEU . 1.4 mt -112.15 141.26 24.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.51 143.87 43.72 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.177 1.918 . . . . 0.0 112.172 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.836 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -60.13 133.91 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.67 164.44 22.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.68 119.93 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -90.67 126.72 36.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.968 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -131.8 157.07 44.85 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.168 0.985 . . . . 0.0 113.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.216 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.937 0.399 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.728 HG12 ' HG2' ' A' ' 90' ' ' GLN . 20.6 t -136.17 139.66 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.019 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.707 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.9 m-90 -100.63 138.98 36.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.998 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -112.25 132.05 55.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.33 145.25 42.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.79 -175.08 39.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.99 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -78.99 -0.43 31.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.85 135.8 39.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.634 0.254 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.83 -9.28 25.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.686 2.257 . . . . 0.0 111.789 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.69 16.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.975 0.893 . . . . 0.0 108.669 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.05 136.5 4.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.651 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -56.49 -18.51 11.71 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.091 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.42 114.75 16.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.723 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -89.16 119.59 29.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.428 ' HA ' HG12 ' A' ' 43' ' ' ILE . 10.0 mp -92.85 -77.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.34 -86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 173.65 48.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 110.929 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 83' ' ' ARG . 4.6 mt -77.47 126.48 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -58.57 -30.69 67.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.58 -49.23 56.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.8 mp -75.45 153.3 37.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 0.0 111.17 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 p -93.45 168.66 10.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.2 m-20 -43.95 -55.39 4.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.344 0.593 . . . . 0.0 109.765 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' THR . 6.1 ptmt -119.66 82.9 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -59.41 -45.85 90.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.981 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.2 p90 -146.36 159.53 43.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.728 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.84 143.45 45.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.381 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 25.2 mt -116.67 127.4 74.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 92' ' ' LEU . 2.2 pt? -116.5 136.73 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.503 . . . . 0.0 112.065 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 6.1 tp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.52 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.848 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.16 147.15 52.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.381 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.661 HD21 HD11 ' A' ' 145' ' ' ILE . 1.3 mt -112.68 124.8 53.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.9 t30 -115.88 115.62 26.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.031 0.443 . . . . 0.0 111.522 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -79.13 136.17 37.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 89' ' ' PHE . 16.6 pt -145.15 39.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.56 159.74 14.74 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.05 0.452 . . . . 0.0 111.804 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.3 m -69.06 -37.7 78.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.501 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 9.9 p30 -98.46 -19.91 17.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.55 160.78 10.95 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.695 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.0 m -117.58 137.91 52.28 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.76 148.38 38.44 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.35 18.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.366 177.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 44.27 42.86 5.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.91 -8.51 77.73 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.485 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 118.62 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.9 tptp -74.14 123.05 23.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.29 164.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.261 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.1 tp10 -69.86 126.71 30.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 36.9 tttm -52.63 161.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.377 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.51 34.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.32 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.3 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.153 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.848 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.3 m120 -84.2 130.05 34.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.754 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.5 mm-40 -129.34 146.66 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.81 135.66 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 145' ' ' ILE . 67.6 tp -66.71 155.85 36.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.401 0.619 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.69 153.11 42.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.41 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.632 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 114.0 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.63 71.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t0 -56.21 172.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 111.174 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 144' ' ' VAL . 6.9 tt0 -145.19 135.56 24.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -113.68 128.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.614 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.652 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.5 140.71 37.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.8 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.546 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.3 m -140.36 158.64 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.31 43.42 9.53 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.084 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -84.03 140.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.654 0.74 . . . . 0.0 112.275 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.19 -39.5 1.18 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.34 120.03 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -50.42 -26.49 5.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.364 -178.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 136' ' ' VAL . 32.9 m -93.62 6.55 47.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.37 26.11 5.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.652 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.11 138.33 33.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.014 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 HD11 ' A' ' 43' ' ' ILE . 5.6 tp -124.94 134.81 52.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.649 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.3 t -109.89 149.54 29.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.658 0.742 . . . . 0.0 112.364 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -136.36 142.03 43.76 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.713 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.3 t -113.35 140.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 111.007 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 130' ' ' ILE . 23.6 mt -106.08 121.13 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.533 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -107.82 113.13 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.799 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -84.9 130.59 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -36.98 84.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 -37.42 86.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.72 96.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.3 mm -67.02 -35.15 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.24 -40.98 78.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -23.87 65.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.43 79.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.235 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -79.76 133.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.563 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.029 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -92.65 -62.57 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.9 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.8 p -141.64 165.14 28.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -124.48 138.21 54.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 111.438 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.701 HG11 ' HE2' ' A' ' 68' ' ' PHE . 2.4 m -108.8 122.63 63.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.627 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -126.94 119.86 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.792 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.773 ' HA ' HD13 ' A' ' 143' ' ' LEU . 16.4 t -83.76 102.34 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.292 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.528 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.2 t -77.27 -25.48 51.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.924 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.619 HG21 ' H ' ' A' ' 142' ' ' SER . 9.9 p -79.9 -2.59 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.515 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.52 79.95 0.19 Allowed Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.068 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.552 ' NE2' HD13 ' A' ' 141' ' ' LEU . 1.5 mt-30 -146.97 -39.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -129.11 144.09 51.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.917 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' A' ' 43' ' ' ILE . 38.5 Cg_endo -68.89 141.58 49.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.183 1.922 . . . . 0.0 111.934 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.0 mt -56.49 140.26 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.907 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -135.38 164.11 28.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.87 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.91 119.79 29.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -78.91 135.61 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.029 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.7 156.14 43.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.672 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.671 0.272 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.4 t -136.34 139.24 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.317 0.58 . . . . 0.0 112.247 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.859 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.2 m-90 -109.94 139.13 45.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.982 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.85 127.24 55.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.701 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.25 145.78 41.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.658 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -169.35 35.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.683 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -82.12 5.0 20.99 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.82 128.61 60.01 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.514 0.197 . . . . 0.0 110.668 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.53 -11.8 32.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.223 1.948 . . . . 0.0 111.431 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.23 -42.96 16.62 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.781 0.801 . . . . 0.0 108.974 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.11 136.82 1.45 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.755 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.54 -18.37 11.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.927 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 28.8 t80 -129.43 117.24 20.23 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.03 121.9 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.908 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD12 ' HA2' ' A' ' 69' ' ' GLY . 10.4 mt -100.1 -69.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.26 -95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -178.74 54.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.815 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.9 mt -81.01 126.12 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 -36.79 69.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.2 mmt-85 -68.7 -29.47 67.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.815 ' CD1' HD12 ' A' ' 81' ' ' ILE . 38.9 mt -95.92 152.06 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 p -96.29 165.46 12.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.656 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.3 -53.35 4.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 109.973 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.77 83.04 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -60.12 -47.07 87.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.816 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.22 157.28 43.81 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.854 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.05 135.74 39.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.346 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 46.9 mt -109.36 132.06 58.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.825 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -121.72 151.64 40.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 111.576 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 ' CG1' ' A' ' 33' ' ' VAL . 14.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.377 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.862 HD21 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -127.13 141.57 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 91' ' ' ILE . 21.6 tp -112.88 126.39 55.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.7 t30 -117.06 115.57 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.181 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.78 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -79.66 132.01 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 67' ' ' THR . 22.2 pt -141.35 40.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.64 152.72 20.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.068 0.461 . . . . 0.0 111.882 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -68.77 -31.55 70.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.986 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.12 -19.81 17.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.32 157.43 10.75 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.703 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.873 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.41 148.39 40.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.304 177.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 99.4 m-20 44.93 43.53 7.21 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -9.78 70.0 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.489 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.4 118.53 36.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.056 0.428 . . . . 0.0 110.808 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.873 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.8 tptm -73.7 128.62 35.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.198 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.78 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.8 m -99.47 166.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.212 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.0 126.02 28.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 34.3 tttt -52.36 162.18 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 110.324 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.968 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.89 145.06 40.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.519 HD22 HD21 ' A' ' 92' ' ' LEU . 6.6 m120 -92.12 126.64 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.625 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.07 147.08 50.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.4 tt -72.91 116.39 13.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.919 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 123' ' ' LEU . 1.2 mm? -53.38 167.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.665 0.745 . . . . 0.0 112.019 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.23 153.29 43.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.228 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.9 tp60 -71.55 114.65 9.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.74 26.4 72.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.911 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.8 t0 -60.24 176.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 111.035 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.882 ' CG ' HG22 ' A' ' 144' ' ' VAL . 8.1 mt-10 -145.31 135.71 24.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.263 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 9.1 mt -112.69 126.21 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.495 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.48 141.45 36.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.179 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.4 m -140.26 158.5 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.01 43.79 9.54 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.013 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.4 t -84.08 140.42 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.733 0.777 . . . . 0.0 112.47 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.15 -42.44 0.86 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 138' ' ' SER . 57.5 t -126.53 122.13 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 114.592 -0.804 . . . . 0.0 109.033 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.532 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.36 -24.86 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.727 0.299 . . . . 0.0 111.704 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.26 6.34 48.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 11.6 m-20 -130.75 26.65 4.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.06 139.39 28.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.003 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.552 HD13 ' NE2' ' A' ' 42' ' ' GLN . 31.7 tp -122.4 134.43 54.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.619 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.66 137.05 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.07 0.462 . . . . 0.0 111.856 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -131.26 145.05 51.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.172 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.882 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.5 t -111.41 135.65 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.585 HG21 ' CD1' ' A' ' 124' ' ' LEU . 1.3 mm -106.45 122.69 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.581 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -113.13 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.073 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.59 HG23 ' CD1' ' A' ' 99' ' ' LEU . 5.9 mt -84.79 126.48 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.205 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 -179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.832 0.348 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -58.92 -36.72 75.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.95 -42.4 93.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -32.74 71.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.1 -35.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.51 -38.02 73.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -67.17 -23.84 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.83 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.81 -47.53 80.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.11 136.13 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.479 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.67 -60.16 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.769 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -147.26 150.2 34.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.165 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.89 129.32 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.472 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 48' ' ' LEU . 3.3 m -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.6 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.825 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -131.4 128.23 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.656 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.31 110.04 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.972 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.2 p -87.15 -24.25 24.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.792 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.845 HG21 ' OG ' ' A' ' 142' ' ' SER . 72.5 p -79.91 -2.56 44.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 71.62 78.32 0.47 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.444 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.3 mt-30 -148.56 -40.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.246 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -130.2 141.54 42.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.78 146.03 42.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.23 1.953 . . . . 0.0 112.195 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.825 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -56.02 156.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.844 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.12 164.1 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 p30 -119.58 119.94 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.069 0.461 . . . . 0.0 111.975 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.0 mt -100.77 134.64 43.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.82 158.87 43.63 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.122 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.738 0.304 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.524 HG13 ' C ' ' A' ' 91' ' ' ILE . 10.6 t -126.38 138.09 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 112.013 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.551 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -101.85 139.66 37.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.003 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.97 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.61 130.13 55.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.06 145.27 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.16 -167.2 36.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.755 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.0 mtm105 -83.88 3.56 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.9 t-20 -84.93 133.41 43.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 111.019 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -66.06 -14.2 43.33 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.552 2.168 . . . . 0.0 111.676 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.61 16.71 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.946 0.879 . . . . 0.0 108.852 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -44.29 139.8 2.49 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.802 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.5 m-20 -56.4 -18.88 12.49 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.859 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.535 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -129.81 127.78 41.0 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.86 108.0 19.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.772 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 43' ' ' ILE . 26.3 mt -76.7 -166.52 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.17 17.94 53.58 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.25 79.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.397 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.8 mt -112.03 132.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -54.99 -34.68 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.12 -27.37 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 132' ' ' VAL . 40.6 mt -96.64 152.19 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.82 164.77 12.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.661 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.99 -52.82 5.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 109.615 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.72 82.9 1.96 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.77 -45.97 91.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.923 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.4 p90 -143.55 162.52 35.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.436 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.97 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 133.99 38.92 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.202 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.58 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.8 mt -111.56 127.79 68.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.724 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -114.77 146.89 40.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.544 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.508 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.901 0.381 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.18 146.67 51.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 124' ' ' LEU . 10.7 mt -112.72 124.41 52.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.06 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.673 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.7 t30 -117.52 115.67 25.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.6 p30 -78.35 139.66 38.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.165 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 89' ' ' PHE . 20.6 pt -147.88 40.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.95 152.11 20.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.086 0.47 . . . . 0.0 111.778 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.1 m -68.93 -31.54 70.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.038 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.94 17.57 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.05 155.4 9.81 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.65 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -117.57 137.75 52.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.892 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.41 148.29 41.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.65 18.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.439 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.65 43.76 6.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.388 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -9.99 69.39 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.437 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -104.64 118.66 37.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.624 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.892 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.1 tptm -74.03 122.57 22.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.224 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -93.64 164.55 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 tp10 -69.82 127.75 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.535 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -53.71 161.03 1.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.922 0.391 . . . . 0.0 110.635 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.53 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.348 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.17 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.122 179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.837 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.3 m120 -83.97 130.2 34.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.864 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.762 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.6 mm-40 -129.46 147.68 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.86 132.9 44.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.853 HD21 HG12 ' A' ' 147' ' ' ILE . 38.0 tp -65.05 154.43 37.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.659 . . . . 0.0 111.61 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.454 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -124.81 153.05 43.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.36 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 122.76 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 23.89 49.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.145 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.6 t70 -54.78 170.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.46 . . . . 0.0 111.21 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.1 tt0 -145.17 135.57 24.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.006 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 145' ' ' ILE . 2.3 mt -109.4 128.04 65.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.438 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.37 140.3 38.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.045 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.651 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.37 158.33 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 80.07 42.97 10.16 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -82.83 140.45 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.687 0.756 . . . . 0.0 112.274 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.33 -39.92 1.14 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.48 123.98 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.619 -0.791 . . . . 0.0 109.082 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.27 10.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.412 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.42 6.48 48.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 133' ' ' GLY . 54.3 m-20 -124.34 23.06 8.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.0 139.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 142' ' ' SER . 8.9 tt -122.32 134.72 54.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.845 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.99 128.18 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.087 0.47 . . . . 0.0 111.854 -179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 43' ' ' ILE . 18.6 mt -121.44 137.42 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.03 137.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.816 0.341 . . . . 0.0 111.278 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 130' ' ' ILE . 31.6 mt -106.16 131.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.09 120.36 39.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.853 HG12 HD21 ' A' ' 124' ' ' LEU . 5.7 mt -84.85 131.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.21 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -59.02 -46.12 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -35.05 73.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -41.46 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.8 mm -71.92 -35.09 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.16 -38.19 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -67.34 -24.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.671 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.76 79.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.148 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.852 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.78 133.99 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.458 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.43 -61.7 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.149 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -148.96 150.08 32.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.408 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.51 HH11 HD11 ' A' ' 37' ' ' ILE . 6.0 ttm180 -113.96 138.1 50.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.694 HG11 ' CE1' ' A' ' 76' ' ' TYR . 15.0 p -99.99 122.9 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 45' ' ' ILE . 18.7 mt -130.29 119.41 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.649 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HA ' HD23 ' A' ' 143' ' ' LEU . 40.9 t -79.95 142.07 35.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 144' ' ' VAL . 2.9 p -111.42 -21.29 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.727 ' OG1' HD23 ' A' ' 141' ' ' LEU . 74.8 p -85.09 -2.78 58.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.732 0.301 . . . . 0.0 111.559 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.83 86.91 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.093 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.9 pt20 -159.72 -40.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.084 0.468 . . . . 0.0 111.374 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.572 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 4.3 mt -122.92 139.96 32.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.4 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 70.3 Cg_endo -76.76 146.16 26.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.508 2.139 . . . . 0.0 112.376 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.8 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -55.9 148.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.841 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.06 162.06 37.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.027 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.37 119.91 36.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.092 0.472 . . . . 0.0 111.931 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.0 mt -96.25 137.28 35.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.48 158.7 43.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.785 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.914 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.3 ttpt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.734 0.302 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.4 t -123.08 139.48 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.249 0.547 . . . . 0.0 111.752 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.6 m-90 -100.78 139.91 35.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.86 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.19 125.3 51.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.9 m-85 -113.17 145.57 40.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.926 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.9 -173.47 39.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.274 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp-105 -77.43 -1.56 30.83 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.82 134.2 42.16 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.318 . . . . 0.0 111.19 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -68.01 -10.56 29.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.728 2.286 . . . . 0.0 111.967 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.76 -42.87 17.43 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 121.868 0.842 . . . . 0.0 108.914 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 140.3 1.0 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.848 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -56.06 -18.33 9.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.147 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.694 ' CE1' HG11 ' A' ' 36' ' ' VAL . 42.7 t80 -128.88 125.92 38.66 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.42 113.09 26.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.752 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -116.63 175.71 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 81' ' ' ILE . . . -55.5 166.2 3.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.596 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -93.83 92.14 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.013 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 p -54.75 -24.91 24.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.5 mmp_? -74.19 -29.57 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.013 HD12 HD13 ' A' ' 81' ' ' ILE . 30.2 mt -92.2 152.21 19.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.98 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -96.16 163.44 13.1 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.506 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.65 -53.2 3.64 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 109.763 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.9 mttp -118.41 84.28 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -63.93 -45.13 90.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 30.7 p90 -152.67 163.24 40.03 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.189 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.655 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.1 mt-30 -135.29 154.94 51.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.494 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mt -123.63 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.167 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.92 148.02 37.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 111.589 -179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.584 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.6 tm? . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.473 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.94 HD21 HG12 ' A' ' 33' ' ' VAL . 4.4 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.819 0.343 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -133.02 145.79 51.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.312 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.933 HD11 HD12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -112.96 131.79 55.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.534 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -119.76 115.57 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.9 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.826 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -78.68 143.21 36.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.062 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.528 HG21 ' OE1' ' A' ' 90' ' ' GLN . 10.2 pt -150.39 36.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.04 152.53 18.65 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.151 0.5 . . . . 0.0 112.19 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.83 -31.44 70.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.852 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.08 -19.84 18.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.508 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.79 158.65 11.69 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.59 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.9 m -117.31 137.67 52.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.58 148.38 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.55 18.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.602 177.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 62.5 m-20 43.63 43.68 4.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.18 -14.22 61.37 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.451 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.39 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 110.517 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.73 128.24 35.38 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.527 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.826 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.4 m -96.25 162.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.834 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.9 mp0 -69.89 127.63 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 49.6 tttm -53.41 161.72 0.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.41 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 9.0 m-80 33.84 35.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.261 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.974 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 27.3 m120 -89.78 130.21 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.224 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 47.1 mm-40 -129.33 148.66 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.417 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.59 121.5 19.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.351 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 147' ' ' ILE . 66.0 tp -55.27 156.51 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.462 0.649 . . . . 0.0 111.563 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.411 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.63 153.41 42.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.587 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.51 120.39 17.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.76 22.68 62.32 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.679 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.46 170.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.006 0.431 . . . . 0.0 111.237 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.5 tt0 -145.14 135.45 24.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.906 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.491 ' CD1' HD22 ' A' ' 101' ' ' LEU . 19.0 mt -118.36 128.14 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.41 140.77 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.233 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 32.0 m -140.37 158.34 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 112.145 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.13 37.24 11.47 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.815 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -80.53 140.48 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.671 0.748 . . . . 0.0 112.503 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.3 -39.35 0.71 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 138' ' ' SER . 35.4 t -126.35 121.76 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.09 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.54 7.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.502 ' H ' HG12 ' A' ' 136' ' ' VAL . 19.6 t -93.51 6.52 47.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -130.05 29.68 4.9 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.26 138.91 30.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.932 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.727 HD23 ' OG1' ' A' ' 40' ' ' THR . 3.0 mt -124.45 134.38 53.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.728 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -106.02 150.43 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.67 0.748 . . . . 0.0 112.318 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 38' ' ' CYS . 68.4 mt -135.68 147.16 48.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.01 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.413 HG21 ' CG2' ' A' ' 39' ' ' THR . 36.9 t -120.14 139.98 45.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.343 . . . . 0.0 111.061 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.933 HD12 HD11 ' A' ' 101' ' ' LEU . 2.5 mt -106.24 139.09 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.86 116.85 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.94 132.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.189 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.55 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.865 0.364 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -61.95 -36.05 80.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.41 -37.69 81.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.682 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 22' ' ' LYS . 6.3 mt -66.09 -33.09 74.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.727 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.19 -35.51 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.53 -46.11 84.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.58 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.813 ' HE2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -67.08 -23.67 65.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.605 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.55 79.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.5 mm -73.08 135.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.67 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.95 -60.58 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.6 p -149.42 151.14 33.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.084 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.84 134.66 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.383 -179.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 48' ' ' LEU . 26.6 t -101.48 122.68 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.98 123.12 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.561 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.9 t -83.15 119.09 24.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.369 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -25.49 32.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 142' ' ' SER . 58.6 p -79.94 -2.3 43.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.446 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.67 77.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.024 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.827 ' OE1' HD11 ' A' ' 141' ' ' LEU . 10.0 mt-30 -146.03 -44.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 110.773 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.063 HD13 HD22 ' A' ' 78' ' ' LEU . 5.4 mt -109.12 141.17 22.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -72.97 133.56 20.05 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.79 138.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.563 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 162.99 28.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.553 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -115.57 119.66 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.999 0.428 . . . . 0.0 111.659 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 36' ' ' VAL . 3.0 mt -95.12 133.63 38.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.71 158.49 43.85 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.817 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.763 0.316 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -130.77 139.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.323 0.582 . . . . 0.0 112.148 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.2 m-90 -102.67 139.42 38.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.062 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -111.72 129.31 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.744 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 1.1 m-85 -120.12 145.22 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.49 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -166.86 35.16 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 12.2 mtm105 -80.94 4.52 19.18 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.68 130.54 52.73 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.533 0.206 . . . . 0.0 110.917 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.3 Cg_exo -65.33 -14.71 46.46 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.415 2.077 . . . . 0.0 111.594 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -44.12 15.62 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.929 0.871 . . . . 0.0 108.873 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -38.88 139.7 0.43 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.815 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.3 m-20 -56.35 -19.13 13.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CD2' HD21 ' A' ' 78' ' ' LEU . 1.2 t80 -130.21 119.73 23.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.695 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -89.67 109.14 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.063 HD22 HD13 ' A' ' 43' ' ' ILE . 8.8 mt -106.03 162.39 13.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.833 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.55 129.4 49.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.093 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -62.93 79.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.831 0.348 . . . . 0.0 111.09 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 83' ' ' ARG . 32.7 mm -105.0 139.64 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.7 m -60.08 -31.6 70.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.77 -29.82 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.217 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.596 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.3 mp -102.39 152.65 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 162.24 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.878 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.14 -52.1 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.757 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CB ' HD12 ' A' ' 104' ' ' ILE . 40.0 mttt -119.18 80.89 1.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.618 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 16.1 t60 -61.14 -45.87 92.89 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.786 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 39.1 p90 -147.75 159.97 43.23 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.992 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.5 tt0 -136.18 141.88 44.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.744 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 58.7 mt -116.49 127.59 74.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.943 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -111.29 151.46 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.9 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.814 0.34 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.1 mt -133.07 146.91 52.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.315 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 145' ' ' ILE . 1.3 mt -112.67 123.66 50.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.481 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.9 t30 -117.15 115.66 25.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.4 p30 -79.21 140.51 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' CB ' ' A' ' 87' ' ' LYS . 10.3 pt -143.46 30.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.554 0.216 . . . . 0.0 111.577 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -89.96 158.31 17.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.447 0.641 . . . . 0.0 112.243 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 m -69.68 -49.17 56.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.499 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.28 3.04 56.31 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.43 157.4 23.75 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.053 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 HG22 ' CG2' ' A' ' 130' ' ' ILE . 7.4 m -117.82 137.92 52.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.811 -0.694 . . . . 0.0 109.215 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.31 148.8 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.433 HD13 ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -123.83 113.47 18.58 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.197 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 44.14 42.91 5.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.86 -14.09 61.21 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.501 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -103.42 118.5 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.54 124.56 24.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.373 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.7 m -96.57 163.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.039 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 tm-20 -69.85 127.03 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.3 tttm -53.68 160.98 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.964 0.411 . . . . 0.0 110.611 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.89 34.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.288 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.19 40.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.114 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.7 m120 -88.49 131.7 34.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.874 ' O ' HD23 ' A' ' 100' ' ' LEU . 41.2 mm-40 -129.29 151.92 49.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.69 136.04 45.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.708 0.289 . . . . 0.0 110.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.735 HD22 ' HB2' ' A' ' 99' ' ' LEU . 28.1 tp -62.94 152.66 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.575 0.702 . . . . 0.0 111.521 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.4 152.51 44.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.653 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.46 121.36 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.36 25.29 60.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.983 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' HD13 ' A' ' 111' ' ' LEU . 25.0 t70 -49.88 165.19 0.08 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.258 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 tt0 -144.33 135.47 25.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 145' ' ' ILE . 3.1 mt -114.39 128.27 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.608 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.9 m -104.03 141.57 35.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.618 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.6 m -140.52 158.72 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.95 9.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -84.25 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.585 0.707 . . . . 0.0 112.13 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.27 -37.05 1.43 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 24.9 t -126.16 119.13 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.446 -0.877 . . . . 0.0 108.814 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -29.39 9.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.2 p -93.46 6.46 48.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.85 27.53 5.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.608 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.49 138.67 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.65 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.827 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -124.51 134.43 53.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.558 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.507 ' H ' HG21 ' A' ' 40' ' ' THR . 36.1 t -106.54 149.43 27.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.791 0.805 . . . . 0.0 112.221 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.56 HD21 HD12 ' A' ' 43' ' ' ILE . 77.1 mt -136.12 143.74 44.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.597 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.37 138.03 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.2 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 101' ' ' LEU . 23.9 mt -106.13 131.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 120.2 39.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.678 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.732 HG12 HD21 ' A' ' 124' ' ' LEU . 5.4 mt -84.84 131.18 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.876 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.838 0.351 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -58.98 -39.33 81.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -59.47 -39.23 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -31.92 73.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -73.01 -35.44 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.6 -42.75 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.37 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -67.18 -23.68 65.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.633 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.79 -47.4 80.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.776 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.14 136.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.295 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.976 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -90.85 -59.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.866 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.712 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.4 p -146.24 165.2 29.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.523 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.34 138.27 51.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.395 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 68' ' ' PHE . 41.1 t -109.24 122.73 64.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.878 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.861 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -127.15 121.03 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.465 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.6 t -79.98 105.58 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.438 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -71.35 -25.1 62.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.874 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.83 -2.26 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.529 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.0 0.26 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.995 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' NE2' HD12 ' A' ' 141' ' ' LEU . 7.7 mt-30 -146.05 -44.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.695 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.0 mt -112.01 141.78 25.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.1 Cg_endo -70.73 138.69 35.26 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.107 1.872 . . . . 0.0 112.293 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.861 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.83 146.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.647 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 164.23 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -127.58 119.65 26.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.457 . . . . 0.0 111.636 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 8.3 mp -91.35 132.56 36.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.475 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.976 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.95 155.8 46.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.314 1.054 . . . . 0.0 113.638 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.676 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.816 0.341 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 92' ' ' LEU . 5.6 t -126.32 134.66 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.233 0.54 . . . . 0.0 111.601 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.0 140.07 36.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.246 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.634 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 130.5 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.8 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -120.31 145.51 47.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.713 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 162.06 -167.82 36.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.954 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.3 mtp180 -83.83 3.35 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 5.6 t-20 -84.85 133.12 44.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -12.91 37.54 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.547 2.165 . . . . 0.0 111.678 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.79 -44.09 15.95 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.914 0.864 . . . . 0.0 108.822 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.64 138.89 2.39 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.943 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.35 -18.86 12.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.094 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.3 t80 -129.8 123.99 32.29 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 111.392 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.38 107.93 18.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.713 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -110.32 78.91 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.31 -117.04 2.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.851 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -176.71 92.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.063 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 23.1 mm -109.63 129.86 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -38.28 67.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.093 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -63.43 -28.05 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.877 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 78' ' ' LEU . 27.8 mt -97.48 152.11 19.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.97 162.9 13.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.723 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.11 -52.27 4.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 0.0 109.655 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.8 mtpm? -117.87 83.9 2.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -64.89 -45.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.198 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.4 p90 -150.3 162.03 41.3 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.206 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.634 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.6 mt-30 -135.65 155.71 50.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.401 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.1 mt -126.28 132.35 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.029 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -128.66 144.67 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.998 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.142 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.698 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.705 0.288 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 122' ' ' GLN . 12.2 mt -131.33 142.48 50.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.777 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.79 126.22 53.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.738 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.548 ' HB2' HD21 ' A' ' 92' ' ' LEU . 46.7 t30 -116.8 115.69 26.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -77.4 143.2 38.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.815 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' CG ' ' A' ' 90' ' ' GLN . 9.6 pt -149.6 36.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.612 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.74 151.97 19.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.11 0.481 . . . . 0.0 111.934 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.78 -31.45 70.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.854 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.61 -19.79 18.08 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.38 156.43 10.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.89 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.9 m -117.42 137.74 52.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.52 148.39 38.0 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.5 18.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.461 177.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 44.33 43.27 5.91 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.53 64.02 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.518 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -104.72 118.49 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.62 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.58 127.24 31.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.411 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -97.46 164.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.3 tt0 -69.89 126.71 30.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 13.5 tttm -53.28 161.42 0.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 0.0 110.593 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.33 33.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.438 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.44 145.14 40.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.936 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.654 ' HB3' HD22 ' A' ' 100' ' ' LEU . 28.1 m120 -90.48 130.07 36.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.838 ' O ' HD23 ' A' ' 100' ' ' LEU . 46.8 mm-40 -129.1 148.82 51.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 tp -72.51 116.31 12.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 145' ' ' ILE . 67.2 tp -53.46 157.54 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.406 0.622 . . . . 0.0 111.729 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.5 t -124.26 153.3 41.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.339 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.5 tp60 -71.47 123.51 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.3 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.28 21.81 54.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.131 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.87 175.25 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.05 135.62 24.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 145' ' ' ILE . 14.7 mt -114.48 126.14 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.462 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.563 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.5 140.07 38.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.494 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.3 158.35 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.122 0.487 . . . . 0.0 112.278 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.04 27.42 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.141 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.4 t -71.37 140.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.681 0.753 . . . . 0.0 112.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.76 -37.48 0.77 Allowed Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 41.6 t -126.25 131.99 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.805 -0.697 . . . . 0.0 109.3 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -40.1 51.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 6.47 48.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 8.2 t0 -119.64 28.44 8.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.563 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.26 139.65 28.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.987 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.401 HD12 ' NE2' ' A' ' 42' ' ' GLN . 9.0 tt -123.48 134.35 53.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.522 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.0 t -110.06 150.64 28.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 112.36 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.0 mt -135.55 156.8 48.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -125.02 137.12 58.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 130' ' ' ILE . 35.3 mt -106.34 123.45 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 115.1 28.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.512 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 26.5 t30 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.684 179.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.852 0.358 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -59.27 -39.81 84.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -40.68 91.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.84 96.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mm -67.78 -34.88 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.265 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -57.06 -36.11 70.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -67.33 -23.92 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.768 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.8 -47.59 79.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.298 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -73.12 136.86 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.466 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -92.35 -59.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.843 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' A' ' 99' ' ' LEU . 4.1 p -146.67 165.46 29.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.506 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.25 138.07 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.366 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 36' ' ' VAL . 11.8 p -105.42 122.67 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.565 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.72 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -129.51 119.44 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.551 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.558 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -79.91 108.04 13.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.379 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.594 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -72.17 -25.89 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.72 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.86 -2.22 42.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.532 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.01 76.17 0.27 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.9 mt-30 -145.73 -44.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.799 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.6 mt -111.72 141.35 24.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.759 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.7 Cg_endo -72.18 137.58 29.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.217 1.945 . . . . 0.0 112.355 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.72 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.07 136.98 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.51 164.3 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.48 119.71 34.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 111.843 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.0 mp -94.24 126.59 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.949 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.38 156.67 47.94 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.038 0.923 . . . . 0.0 113.309 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.089 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.856 0.36 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -130.08 139.11 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.196 0.522 . . . . 0.0 111.843 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.825 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.3 m-90 -105.27 139.54 39.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.259 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.79 132.19 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -119.3 145.61 45.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.353 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.63 -167.88 35.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.029 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtp-105 -81.1 3.31 23.83 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.8 t-20 -84.8 132.22 46.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.534 0.207 . . . . 0.0 111.102 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.7 Cg_exo -66.24 -14.19 43.17 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.686 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.05 -42.98 16.83 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.872 0.844 . . . . 0.0 109.026 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.41 138.92 1.16 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.109 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.8 m-20 -56.47 -18.94 13.0 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.147 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 43' ' ' ILE . 14.2 t80 -129.63 114.16 15.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.741 0.305 . . . . 0.0 111.04 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.22 107.88 19.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.555 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD13 ' CA ' ' A' ' 69' ' ' GLY . 10.7 mp -79.78 -80.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.6 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.345 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.57 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 111.195 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp -84.34 119.18 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -54.81 -29.85 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.241 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.5 mmp_? -68.51 -26.94 65.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 81' ' ' ILE . 10.6 mt -102.71 151.18 22.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.047 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -94.1 164.12 13.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.568 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -41.59 -52.44 3.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.48 0.657 . . . . 0.0 109.832 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.96 82.51 1.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.4 t60 -60.91 -47.15 87.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.767 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.1 p90 -143.99 159.21 42.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.7 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -136.19 138.52 42.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.0 mt -112.56 128.67 69.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.064 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -113.31 143.26 44.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.852 HD22 HG11 ' A' ' 33' ' ' VAL . 22.9 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.375 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.4 mm? -126.49 145.43 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.549 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.558 HD21 HD13 ' A' ' 124' ' ' LEU . 14.8 mt -112.51 124.09 51.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.872 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD23 ' A' ' 92' ' ' LEU . 51.7 t30 -118.01 115.58 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.856 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.6 p30 -76.43 139.98 41.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 67' ' ' THR . 17.8 pt -148.12 39.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 152.32 20.11 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.034 0.445 . . . . 0.0 111.548 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.86 -31.55 70.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.942 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.24 -19.82 17.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.69 156.48 10.17 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.945 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.43 137.95 52.17 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.839 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.89 148.62 38.38 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.17 113.51 18.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.455 177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 27.8 m-20 44.09 43.26 5.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.66 -13.58 62.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.392 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.58 118.51 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.083 0.442 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.65 127.09 31.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.532 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.856 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.4 m -95.95 164.46 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.5 mt-10 -69.85 124.91 25.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.2 tttt -53.0 162.79 0.58 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.6 m-80 33.97 35.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.151 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.11 145.06 40.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.075 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.483 HD22 HD21 ' A' ' 92' ' ' LEU . 5.1 m120 -87.98 129.15 35.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.763 ' O ' HD13 ' A' ' 100' ' ' LEU . 40.5 mm-40 -129.29 146.83 51.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.804 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.73 125.3 27.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.841 HD11 HG21 ' A' ' 145' ' ' ILE . 66.2 tp -58.15 155.37 11.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.418 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.1 t -124.83 153.04 43.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 122.48 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.3 22.02 57.86 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.93 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.69 170.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.13 135.49 24.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.072 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.623 HD11 HD11 ' A' ' 145' ' ' ILE . 20.7 mt -118.37 128.04 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.445 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.599 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.43 141.52 36.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.5 m -140.21 158.33 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.029 0.442 . . . . 0.0 112.104 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.25 43.69 8.5 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.9 t -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.707 0.765 . . . . 0.0 112.498 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.79 -37.74 0.82 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.38 120.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.037 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.26 -29.52 9.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.763 0.316 . . . . 0.0 111.459 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 52.8 p -93.45 6.56 47.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -130.67 30.59 4.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.599 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.11 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.614 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt -122.17 134.49 54.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.635 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.4 t -108.52 150.58 27.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.304 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.9 mt -135.8 147.85 48.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.783 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 39' ' ' THR . 29.3 t -119.92 139.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.841 HG21 HD11 ' A' ' 124' ' ' LEU . 31.8 mt -106.09 128.62 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.56 114.86 26.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 124' ' ' LEU . 5.1 mt -84.75 134.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.894 0.378 . . . . 0.0 111.439 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.799 0.333 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -58.99 -35.98 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -37.29 80.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.36 -33.44 75.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.16 -35.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.742 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.43 -41.5 80.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -67.13 -23.79 65.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.75 -47.46 80.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.281 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.925 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.19 135.38 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 113.668 -1.605 . . . . 0.0 112.554 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.72 -60.13 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.917 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -145.34 161.84 38.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.402 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.53 138.04 53.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG21 ' HE2' ' A' ' 68' ' ' PHE . 29.8 m -110.85 122.68 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.655 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.84 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.45 122.56 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.66 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.85 99.94 7.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.206 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -68.24 -24.33 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.928 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.498 HG21 ' H ' ' A' ' 142' ' ' SER . 59.7 p -79.92 -2.21 42.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.603 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.81 78.01 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.878 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -147.33 -43.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -115.82 142.49 29.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.8 Cg_endo -70.12 139.03 38.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.104 1.869 . . . . 0.0 112.191 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -56.61 145.93 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.825 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.44 164.18 28.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.006 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.99 120.04 30.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 0.0 112.06 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.767 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -90.26 126.78 35.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.982 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.92 157.0 47.91 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.036 0.922 . . . . 0.0 113.45 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.874 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.042 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 111.546 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.9 t -131.29 139.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.127 0.489 . . . . 0.0 111.859 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.767 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.4 m-90 -102.82 139.32 38.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.013 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.58 127.2 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 177.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -110.81 145.56 37.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.773 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.68 ' C ' HD21 ' A' ' 78' ' ' LEU . . . 160.59 178.52 34.65 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.697 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.599 ' N ' HD21 ' A' ' 78' ' ' LEU . 14.9 mtp180 -68.25 -6.72 25.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 4.1 t-20 -84.51 133.69 43.92 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.7 0.286 . . . . 0.0 111.19 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.8 Cg_exo -70.03 -5.9 17.47 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.588 2.192 . . . . 0.0 111.654 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.68 -42.81 17.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -43.88 137.14 3.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.14 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.34 -19.21 13.49 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 57.2 t80 -130.54 130.55 44.26 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.386 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.53 ' C ' HD13 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -109.91 136.44 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.44 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.888 ' N ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -109.59 -53.0 2.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.08 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.62 -115.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.761 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -154.17 65.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.297 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.8 mp -103.45 120.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.765 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.92 -24.97 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.42 -17.37 61.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.362 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 81' ' ' ILE . 34.5 mt -107.24 150.26 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.99 164.26 12.43 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.0 m-20 -43.0 -52.12 5.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.423 0.63 . . . . 0.0 109.777 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' CB ' HD12 ' A' ' 104' ' ' ILE . 11.9 mttm -121.44 82.76 1.98 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 11.6 t60 -62.38 -46.19 89.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.892 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 17.5 p90 -150.36 157.72 43.37 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.58 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.9 tt0 -135.84 140.07 43.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.485 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.573 ' C ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -117.93 131.55 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.349 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.736 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -116.13 145.47 43.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.508 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.598 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.8 tm? . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.534 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.744 0.307 . . . . 0.0 110.691 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.5 mp -132.76 144.65 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.99 128.51 56.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.416 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.6 t30 -118.86 119.17 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.853 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.675 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.4 p30 -79.81 137.8 37.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.986 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' CB ' ' A' ' 87' ' ' LYS . 13.6 pt -145.56 30.99 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -88.73 158.18 18.27 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.053 0.454 . . . . 0.0 111.553 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -68.94 -36.28 77.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.659 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.93 17.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.546 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.8 157.34 9.68 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.07 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.61 137.97 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.208 0.603 . . . . 0.0 109.42 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -114.3 148.57 37.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.51 18.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.492 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 78.0 m-20 44.34 43.22 5.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.33 -10.85 67.5 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.43 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -104.83 118.59 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.016 0.436 . . . . 0.0 110.69 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.5 tptt -72.97 119.12 16.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.675 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -88.7 166.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.177 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.5 mm-40 -69.93 128.01 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.521 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -55.13 158.0 3.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.577 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER 38.34 32.77 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.791 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.2 145.07 40.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.868 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.736 ' OD1' HD11 ' A' ' 92' ' ' LEU . 13.2 m-20 -95.38 133.79 38.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.981 0.419 . . . . 0.0 110.959 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.7 mm-40 -129.07 152.07 49.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.547 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.47 123.92 24.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.829 0.347 . . . . 0.0 110.306 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 145' ' ' ILE . 65.1 tp -54.49 155.88 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.535 0.683 . . . . 0.0 111.682 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.77 153.1 42.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 120.95 18.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.928 0.394 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 23.66 59.51 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.231 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.5 t0 -54.83 172.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.9 mt-10 -145.3 135.61 24.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.4 mt -114.09 126.14 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -104.63 142.75 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.341 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.568 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.54 158.58 24.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.082 0.467 . . . . 0.0 112.254 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.04 43.54 8.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.053 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.537 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.6 t -85.1 140.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.76 0.791 . . . . 0.0 112.428 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.32 -40.96 0.86 Allowed Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.55 120.82 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.075 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -50.52 -24.96 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.731 0.301 . . . . 0.0 111.48 -178.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 t -93.5 6.44 48.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -132.13 27.86 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 138.82 31.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.56 134.32 53.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.556 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.498 ' H ' HG21 ' A' ' 40' ' ' THR . 46.7 t -108.96 150.31 27.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.6 0.714 . . . . 0.0 112.192 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.9 mt -135.67 148.36 48.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.549 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.0 t -116.92 138.12 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 124' ' ' LEU . 1.3 mm -106.37 121.11 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.086 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 117.63 34.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.795 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -84.98 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.553 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.919 179.809 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.333 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -58.96 -38.26 78.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -40.71 90.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' LEU . 11.9 tp -61.47 -31.92 71.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.7 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.79 -35.38 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.31 82.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.423 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -67.08 -23.83 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.647 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.239 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.796 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -88.41 95.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.4 -177.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -51.84 -64.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.1 p -147.9 164.9 32.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 125.72 36.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 19.4 t -88.84 122.85 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.398 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -126.19 117.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.0 t -79.94 119.96 23.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.494 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.59 -25.59 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.736 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 9.1 p -79.85 -2.6 44.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.44 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.33 76.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.973 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.551 ' HB2' HD12 ' A' ' 43' ' ' ILE . 4.7 mt-30 -144.06 -43.65 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.632 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.7 mp -122.69 142.71 38.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.02 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.67 140.66 36.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.057 1.838 . . . . 0.0 111.799 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -53.61 127.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.882 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -118.0 160.62 21.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.854 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.93 120.35 38.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.031 0.443 . . . . 0.0 112.124 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.7 mt -101.1 136.38 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.175 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.73 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.09 158.26 44.04 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.714 0 CA-C-N 113.585 -1.643 . . . . 0.0 110.585 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -132.08 139.3 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.341 0.591 . . . . 0.0 112.026 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.553 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -101.34 139.12 37.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.208 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.24 130.46 55.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -120.15 145.44 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.377 -178.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.82 -166.8 35.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.839 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 20.5 mtm180 -83.83 5.05 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 11.0 t-20 -84.82 132.13 47.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.028 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 20.3 Cg_exo -65.16 -14.97 48.05 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.471 2.114 . . . . 0.0 111.541 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.94 17.38 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 138.04 3.48 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.722 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -56.59 -18.23 11.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.831 178.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.7 t80 -126.41 120.59 30.18 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.93 116.28 31.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.54 HD13 HD13 ' A' ' 84' ' ' LEU . 29.6 mt -89.3 -170.08 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.15 14.98 59.3 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.841 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 63.88 78.55 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 111.487 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.831 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.9 mt -102.99 132.43 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.807 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -55.11 -28.63 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -78.6 -47.37 17.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.16 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.831 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.7 mt -72.73 150.73 42.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -95.9 164.24 12.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.806 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.94 -52.51 5.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.485 0.66 . . . . 0.0 109.771 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.7 mttt -119.93 81.92 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.1 t60 -62.48 -46.14 89.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.711 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -144.22 159.62 42.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.789 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.8 tt0 -135.94 142.65 44.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.61 ' O ' HG13 ' A' ' 65' ' ' VAL . 57.0 mt -116.94 128.06 74.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -111.67 147.99 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 111.714 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.406 HD22 HG11 ' A' ' 33' ' ' VAL . 24.5 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.852 HD13 HD22 ' A' ' 124' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.0 mp -133.01 147.27 52.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.64 125.32 54.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.43 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.1 t30 -115.13 115.66 27.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 111.522 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.5 p30 -79.33 135.17 36.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.056 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 16.3 pt -142.72 40.04 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 157.18 16.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.998 0.427 . . . . 0.0 111.629 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.9 m -68.98 -35.03 76.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.601 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.62 -20.03 17.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.561 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.02 161.33 11.26 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.597 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.4 m -117.64 137.94 52.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.08 148.5 38.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.38 18.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.191 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.47 42.81 5.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.76 77.22 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.484 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.69 118.58 36.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.14 131.43 41.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.213 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -103.66 166.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.87 126.18 28.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.557 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 83.6 tttt -53.36 162.14 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 110.727 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.9 m-80 34.63 34.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.243 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 145.09 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.149 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.61 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.4 m120 -85.87 131.0 34.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.3 mm-40 -129.35 145.69 51.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.619 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.82 114.32 10.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.339 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.852 HD22 HD13 ' A' ' 99' ' ' LEU . 63.5 tp -53.7 157.74 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.613 . . . . 0.0 111.53 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.3 153.17 42.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.077 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.764 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.7 mm-40 -71.28 125.26 26.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.589 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.6 19.22 47.75 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.327 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.4 t70 -58.41 172.88 0.42 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.9 tt0 -145.19 135.58 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -107.65 128.15 63.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.67 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.25 138.09 41.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 28.3 m -140.33 158.53 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.37 28.71 29.5 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.136 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.5 t -69.91 140.45 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.607 0.718 . . . . 0.0 112.357 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.53 0.97 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 138' ' ' SER . 51.8 t -126.39 128.72 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.629 -0.785 . . . . 0.0 109.07 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.53 -36.12 32.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.313 . . . . 0.0 111.75 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.474 ' H ' HG12 ' A' ' 136' ' ' VAL . 24.4 m -93.4 6.31 48.58 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.5 t0 -120.31 26.51 9.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.67 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -106.9 139.58 27.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.042 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.4 tt -120.41 134.59 55.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.707 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.639 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -112.2 134.63 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.474 . . . . 0.0 111.843 -179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.732 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.3 mm? -129.73 135.02 47.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.607 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.72 136.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.701 ' CD1' HG22 ' A' ' 36' ' ' VAL . 4.1 mm -106.11 137.26 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.176 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.2 124.31 51.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.764 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -99.4 130.76 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 111.663 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.768 0.318 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -68.94 -35.89 77.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.28 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.54 -44.78 95.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -45.24 86.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 HG23 ' CE2' ' A' ' 23' ' ' PHE . 39.8 mm -63.54 -47.26 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.9 -33.58 74.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.2 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -56.07 -47.12 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.949 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CE2' HG23 ' A' ' 20' ' ' ILE . 5.8 p90 -71.85 -47.12 55.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.44 133.55 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-N 113.846 -1.525 . . . . 0.0 112.393 -177.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.26 -61.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.203 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.429 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.8 p -149.02 146.22 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.287 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -113.95 138.03 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 111.398 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 25.0 t -101.47 122.95 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.855 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.848 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -123.9 126.13 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.553 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.9 t -95.33 107.85 19.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.5 p -88.16 -20.02 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.756 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.71 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.9 -2.52 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 111.401 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.57 76.04 0.52 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.795 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -146.7 -42.15 0.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' A' ' 44' ' ' PRO . 12.4 mt -131.1 142.51 45.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.11 146.02 40.39 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.239 1.959 . . . . 0.0 112.102 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 37' ' ' ILE . 34.7 mt -56.34 148.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.897 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.01 159.51 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.051 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.18 119.76 35.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.025 0.441 . . . . 0.0 112.061 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -95.54 137.49 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.58 158.76 43.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 113.655 -1.612 . . . . 0.0 110.695 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 35.0 ttpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.041 0.448 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 91' ' ' ILE . 10.6 p -107.53 139.88 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.707 0.765 . . . . 0.0 112.519 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.561 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.5 m-90 -100.59 139.05 36.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.99 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.4 127.01 55.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.679 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -113.57 145.36 41.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.47 -178.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.63 -175.71 39.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.779 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 28.4 mtm180 -74.97 -1.59 23.3 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t-20 -84.65 132.09 47.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.594 0.235 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.0 Cg_exo -68.52 -8.28 22.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 111.669 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.84 -42.91 17.24 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.916 0.865 . . . . 0.0 108.693 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.68 138.2 1.46 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.66 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -56.46 -19.24 14.3 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.984 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 52.8 t80 -130.21 126.39 37.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -101.49 137.62 39.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.665 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -124.59 -68.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.185 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 78' ' ' LEU . . . -168.3 -127.9 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 2.1 p30 -159.76 65.7 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 83' ' ' ARG . 35.2 mt -89.7 127.75 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.82 -24.92 25.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.238 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.0 mmm180 -78.27 -48.23 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.9 mt -72.84 152.25 41.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.904 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.0 p -95.71 164.53 12.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.29 -53.3 5.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.382 0.611 . . . . 0.0 109.757 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.76 81.1 1.64 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.3 t60 -60.0 -45.61 92.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.916 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.6 p90 -145.53 159.48 43.05 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.791 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.3 tt0 -135.99 141.39 44.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.472 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 65' ' ' VAL . 51.4 mt -118.15 129.91 73.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.809 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.5 140.94 45.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.003 0.43 . . . . 0.0 111.729 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.605 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.7 tm? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 110.837 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -132.6 145.3 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 130' ' ' ILE . 2.2 tp -112.8 127.01 56.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.219 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 90' ' ' GLN . 45.5 t30 -117.12 115.42 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.283 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.7 p30 -79.89 137.59 36.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.742 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 67' ' ' THR . 19.7 pt -146.44 40.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 157.84 16.17 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 120.957 0.408 . . . . 0.0 111.409 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -68.82 -34.77 76.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.61 -19.8 17.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.01 160.32 11.18 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.39 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.66 137.86 52.37 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.73 148.78 39.4 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.29 113.38 18.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.423 176.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 45.75 42.52 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.318 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.97 -3.37 87.03 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.626 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.51 118.54 36.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.052 0.426 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.5 tptt -76.33 121.06 22.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.121 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -97.32 164.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.231 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 mt-10 -69.9 126.98 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 46.0 tttm -52.96 161.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.942 0.401 . . . . 0.0 110.634 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.05 34.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.312 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.36 145.08 40.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.729 ' HB3' HD23 ' A' ' 100' ' ' LEU . 11.0 m120 -86.11 130.01 34.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 28.6 mm-40 -129.48 146.77 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 119.32 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.797 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -52.93 156.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.396 0.617 . . . . 0.0 111.654 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.597 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.61 153.32 42.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.802 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.699 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.57 122.76 21.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.306 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.52 48.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.315 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t70 -53.03 174.01 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.01 135.53 24.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 145' ' ' ILE . 7.2 mt -110.72 123.21 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.755 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.64 140.12 38.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.15 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.32 158.71 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.982 0.42 . . . . 0.0 112.129 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 36.36 13.72 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.0 t -80.13 140.36 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 111.917 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.79 -30.11 2.69 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 82.9 t -126.46 118.55 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.425 -0.887 . . . . 0.0 108.708 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -50.73 -35.68 32.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.33 6.73 47.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -125.52 29.3 6.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.13 139.36 29.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.59 134.43 55.01 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.71 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -111.25 132.49 54.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 0.0 111.686 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.4 mt -125.01 150.22 46.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.377 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.4 t -117.5 140.24 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 111.349 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 130' ' ' ILE . 13.1 mt -106.22 121.74 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.99 110.96 22.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.491 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.99 133.93 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.1 t30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.711 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.745 0.307 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.05 -39.65 82.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.912 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 10.9 t80 -60.25 -39.25 86.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.694 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -31.9 72.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.82 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.63 -46.18 84.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.358 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -67.31 -23.95 65.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.61 -47.76 78.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.289 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.5 mm -85.38 95.75 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.936 -1.483 . . . . 0.0 112.677 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 99' ' ' LEU . 3.1 t -45.58 -62.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.0 p -152.08 165.2 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.723 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -124.3 138.44 54.39 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.824 0.345 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -104.08 122.91 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.86 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -126.83 118.88 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.659 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.743 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -79.92 102.31 9.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.169 179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 t -67.84 -20.65 65.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.269 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 142' ' ' SER . 73.2 p -79.74 -2.41 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.47 75.88 0.26 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.831 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -145.77 -42.99 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.743 HD12 ' SG ' ' A' ' 38' ' ' CYS . 4.5 mt -112.41 142.82 27.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.881 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.655 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.35 135.18 26.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.223 1.948 . . . . 0.0 111.972 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.86 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -55.51 141.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.755 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.06 164.1 28.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HB3' HG21 ' A' ' 32' ' ' ILE . 4.5 m-20 -119.84 119.55 33.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.036 0.446 . . . . 0.0 111.986 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.3 mp -86.3 129.02 34.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.691 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.86 154.32 49.5 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.045 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.695 0.283 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -124.64 138.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 112.071 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -103.65 139.07 39.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.774 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.87 126.22 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 0.0 109.931 177.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.0 m-85 -107.58 145.77 32.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.53 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 167.12 -175.1 42.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.848 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -81.45 -4.82 56.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.86 137.18 38.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.325 . . . . 0.0 111.199 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.9 -5.97 16.96 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.779 2.319 . . . . 0.0 111.818 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.2 17.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.014 0.912 . . . . 0.0 108.621 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.36 137.61 4.67 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.514 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -56.34 -18.55 11.19 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.014 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 32.5 t80 -129.43 120.16 25.01 Favored 'General case' 0 C--N 1.338 0.078 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.811 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.26 112.14 23.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.743 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.727 ' CD2' HD13 ' A' ' 43' ' ' ILE . 60.9 mt -85.52 -79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.238 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.59 -108.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.39 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -166.54 46.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 111.258 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 84' ' ' LEU . 7.0 mt -84.3 122.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.72 -29.64 53.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.117 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.561 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.794 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD12 HD12 ' A' ' 81' ' ' ILE . 24.5 mt -72.92 149.93 42.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.267 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 76.2 p -95.0 165.93 12.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.893 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.666 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.34 -53.65 4.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.828 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.608 ' HB2' HD12 ' A' ' 104' ' ' ILE . 9.7 mttt -120.79 82.7 1.95 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.2 t60 -60.42 -46.2 90.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.817 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 10.2 p90 -148.51 158.65 44.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.278 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.695 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.1 tt0 -136.03 141.29 44.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.42 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -114.23 127.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -113.25 145.15 41.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.13 0.491 . . . . 0.0 112.012 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 99' ' ' LEU . 17.8 tp . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.281 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.672 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.711 0.291 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.06 143.56 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -112.59 122.99 49.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.88 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.765 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.2 t30 -114.94 115.72 27.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.542 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -77.72 138.94 39.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.7 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.47 38.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.41 157.71 15.85 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.076 0.465 . . . . 0.0 111.533 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -69.07 -33.78 74.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.557 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -19.92 17.43 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.48 160.15 11.2 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.456 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.082 0.553 . . . . 0.0 109.535 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.54 148.36 38.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.56 18.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.372 177.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.4 m-80 44.29 43.34 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.43 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.41 -9.75 72.05 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.433 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.4 tptt -73.6 122.85 22.93 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.206 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.9 m -93.58 164.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.215 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.6 pm0 -69.89 124.06 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.583 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.7 tttm -51.87 161.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.04 0.448 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.6 32.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.497 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.64 145.13 40.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.12 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.856 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.4 m120 -87.34 131.04 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.864 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.3 mm-40 -129.2 150.01 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.71 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.63 133.18 44.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.023 HD11 HG21 ' A' ' 145' ' ' ILE . 65.4 tp -64.74 155.5 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.51 0.672 . . . . 0.0 111.689 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.85 152.9 43.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.511 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.88 124.05 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.328 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.02 22.68 43.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.088 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t70 -53.01 172.05 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.939 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -145.05 135.8 24.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 143' ' ' LEU . 15.6 mt -114.66 124.81 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.999 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.621 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.78 141.65 36.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' CD2' ' A' ' 88' ' ' HIS . 23.0 m -140.44 158.74 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.32 43.5 9.46 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.251 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.7 t -84.28 140.35 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.595 0.712 . . . . 0.0 112.336 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.2 -39.17 1.27 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.4 119.64 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.455 -0.872 . . . . 0.0 108.917 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.4 tt0 -50.39 -26.45 4.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.8 0.334 . . . . 0.0 111.455 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.45 6.49 47.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.7 25.48 5.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.19 138.75 31.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.17 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.61 134.57 52.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.157 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.2 t -109.96 150.36 28.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.676 0.751 . . . . 0.0 112.381 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.572 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -135.25 154.06 51.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.782 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.939 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -126.1 137.89 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.023 HG21 HD11 ' A' ' 124' ' ' LEU . 1.6 mm -106.32 120.91 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.837 0.351 . . . . 0.0 110.817 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.33 112.68 24.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.717 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -86.01 133.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.361 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.713 179.836 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pm0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.891 0.377 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.95 -39.46 94.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.21 -35.45 75.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.475 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 16' ' ' GLN . 34.6 mt -65.99 -33.3 75.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.672 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.07 -35.61 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.667 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -42.15 82.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.451 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -67.1 -23.77 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.687 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.66 -47.41 79.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.732 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-80 . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.22 135.46 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.5 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.92 -60.41 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.925 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.597 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.9 p -150.15 147.42 27.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.24 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.443 HH11 HD11 ' A' ' 37' ' ' ILE . 3.1 ttm180 -113.95 132.8 55.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.25 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.1 m -95.08 122.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.7 mt -127.36 125.66 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.263 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HA ' HD23 ' A' ' 143' ' ' LEU . 5.4 t -89.4 109.84 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.491 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -82.6 -24.76 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.776 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.67 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.2 p -79.92 -2.71 44.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.712 0.291 . . . . 0.0 111.496 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 77.5 0.3 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.965 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -147.46 -39.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -126.44 141.69 40.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.7 Cg_endo -72.09 145.66 44.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.171 1.914 . . . . 0.0 112.139 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.8 mt -60.82 149.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.711 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -142.71 164.08 31.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.092 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.92 119.89 35.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 111.881 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.5 mt -97.65 137.21 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.13 158.78 43.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.845 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.882 0.372 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.643 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -131.96 139.16 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.245 0.545 . . . . 0.0 111.852 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.11 139.26 37.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.006 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.51 129.04 56.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -118.46 145.29 45.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.523 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.63 -169.05 37.0 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.762 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.434 ' HG3' HD11 ' A' ' 78' ' ' LEU . 20.3 mtm180 -80.76 3.57 21.91 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.765 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.8 t-20 -84.76 132.56 45.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 0.0 111.134 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.19 -14.16 43.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.45 2.1 . . . . 0.0 111.637 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.78 -42.73 17.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.861 0.838 . . . . 0.0 108.909 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.42 139.02 1.14 Allowed 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.021 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 m-20 -56.3 -18.99 12.3 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.977 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.0 t80 -129.8 123.09 30.09 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 120.731 0.3 . . . . 0.0 111.083 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.07 107.9 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -111.14 177.35 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.29 131.77 50.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.618 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -70.97 88.26 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.4 mt -106.33 135.08 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.06 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.27 -31.87 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.091 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.25 -49.26 57.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.189 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 81' ' ' ILE . 25.6 mt -74.54 151.21 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.996 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 p -95.38 164.15 12.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.61 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.55 -52.63 4.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.424 0.631 . . . . 0.0 109.648 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.97 82.35 1.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -60.88 -46.13 91.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.761 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.7 p90 -143.46 160.0 41.37 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.907 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.97 142.33 44.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.462 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.645 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.6 mt -117.67 131.52 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.805 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD21 HD22 ' A' ' 121' ' ' ASN . 0.9 OUTLIER -118.93 140.21 50.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.049 0.452 . . . . 0.0 111.96 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.719 HD22 HG11 ' A' ' 33' ' ' VAL . 10.4 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.237 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.803 0.335 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.6 mt -125.84 141.01 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.099 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.69 122.24 47.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.386 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -113.95 115.69 28.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.978 0.418 . . . . 0.0 111.404 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.6 p30 -78.59 137.52 37.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.002 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -145.93 40.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.13 161.07 13.9 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.01 0.433 . . . . 0.0 111.712 -179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.6 m -69.05 -38.63 79.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.799 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -20.1 17.22 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.55 161.02 10.96 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.609 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.2 m -117.59 137.97 52.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.565 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.888 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.97 148.56 36.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.5 18.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.219 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 44.52 43.24 6.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.87 -10.86 68.65 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.514 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -104.61 118.5 36.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.888 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.5 tptm -73.5 131.11 41.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.228 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -102.79 165.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.193 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.5 tt0 -69.9 126.4 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.573 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.0 tttp -53.75 162.5 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 110.619 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.32 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.111 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.53 145.07 40.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.109 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.685 ' HB3' HD22 ' A' ' 100' ' ' LEU . 24.8 m120 -88.75 130.71 35.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.968 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.846 ' O ' HD23 ' A' ' 100' ' ' LEU . 37.3 mm-40 -129.12 147.56 50.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.4 tm? -72.6 119.23 16.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.48 HD21 ' CG1' ' A' ' 147' ' ' ILE . 65.6 tp -54.68 157.79 2.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 111.537 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.438 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.31 153.25 42.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.26 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.31 122.41 20.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.458 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.62 23.01 54.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.138 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.7 t70 -57.41 173.86 0.24 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' VAL . 59.9 tt0 -145.13 135.61 24.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.041 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 145' ' ' ILE . 2.8 mp -109.24 127.37 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.62 139.01 40.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.29 37.41 15.02 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.15 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.3 t -77.58 140.39 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.671 0.748 . . . . 0.0 112.202 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.82 -39.59 1.26 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 138' ' ' SER . 42.9 t -126.45 123.89 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.078 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.32 -29.59 10.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.808 0.337 . . . . 0.0 111.454 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.543 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.7 m -93.41 6.51 47.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.15 23.02 8.55 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -106.8 139.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.24 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 142' ' ' SER . 6.7 tt -124.4 134.65 53.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.702 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -110.92 129.12 55.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.177 0.513 . . . . 0.0 111.606 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 20.9 mt -122.53 136.78 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.677 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -110.85 140.17 31.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.331 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.622 ' CD1' HD11 ' A' ' 130' ' ' ILE . 25.3 mt -105.97 136.39 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.82 111.78 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.86 128.65 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.482 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.801 0.334 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -36.04 74.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -36.95 85.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -45.02 77.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.789 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.8 mm -66.83 -35.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.075 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.05 -43.03 81.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.2 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -67.14 -23.87 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.403 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.57 -47.43 79.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.737 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -76.03 135.2 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 113.617 -1.629 . . . . 0.0 112.696 -177.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.79 -61.09 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.86 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.1 p -144.52 145.98 32.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.076 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 138.13 50.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.493 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 36' ' ' VAL . 11.9 p -105.33 122.69 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -129.39 118.44 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.514 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -79.98 115.22 19.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.369 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -82.57 -26.0 32.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.885 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 67.1 p -79.9 -2.24 42.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.722 0.296 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.16 76.29 0.3 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.98 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -146.02 -43.76 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mt -114.13 141.3 26.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.1 Cg_endo -72.98 135.48 23.28 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.21 1.94 . . . . 0.0 112.198 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.75 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -55.47 134.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.04 164.29 20.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.49 119.83 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.214 0.531 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -97.38 131.53 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.988 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.85 159.0 44.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -178.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.84 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.475 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG12 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -133.34 139.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.226 0.536 . . . . 0.0 112.007 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -103.42 139.08 39.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.99 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.93 130.24 56.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -120.05 145.27 47.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.49 -167.1 35.04 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.49 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.75 1.96 21.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.56 127.01 67.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.464 0.174 . . . . 0.0 110.948 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.9 Cg_exo -63.85 -14.33 42.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.317 2.012 . . . . 0.0 111.47 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -42.17 17.95 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.738 0.78 . . . . 0.0 108.925 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.09 138.61 1.07 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.592 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 t70 -56.35 -18.63 11.48 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.164 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' CE2' HG21 ' A' ' 43' ' ' ILE . 16.0 t80 -129.75 116.06 18.21 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -89.15 107.94 19.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.586 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD13 ' A' ' 84' ' ' LEU . 57.0 mt -71.87 -76.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.87 -98.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.465 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -162.89 53.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.334 . . . . 0.0 111.167 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -93.02 117.67 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -28.98 56.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.12 -47.88 40.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.01 HD12 HD13 ' A' ' 81' ' ' ILE . 16.1 mt -72.78 146.5 46.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.2 p -94.29 163.52 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.723 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.55 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -41.43 -52.11 3.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.589 0.709 . . . . 0.0 110.007 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -121.34 81.37 1.78 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.9 t60 -61.21 -46.49 90.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.609 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.8 p90 -144.86 157.15 44.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.722 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.8 tt0 -136.15 138.92 42.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.5 mt -113.0 127.86 70.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.678 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -110.01 149.23 30.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.493 . . . . 0.0 111.836 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.673 HD12 HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.117 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.815 HD21 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.732 0.301 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.0 mm? -133.17 145.29 50.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.943 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 124' ' ' LEU . 13.9 mt -112.73 122.91 49.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.596 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.8 t30 -115.62 115.72 26.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 112.013 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.874 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.1 p30 -77.0 134.66 38.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.0 pt -142.0 39.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.62 159.7 14.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.956 0.408 . . . . 0.0 111.778 -178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.0 m -68.88 -37.97 79.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -19.77 17.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.71 162.97 11.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.432 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.35 137.85 52.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.894 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.11 148.36 35.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.578 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.19 113.43 18.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.302 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 16.4 m-80 42.75 44.1 3.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.527 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.65 -13.55 63.84 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -103.26 118.56 37.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.6 tptm -73.49 124.2 25.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.487 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.874 HG23 ' OD2' ' A' ' 103' ' ' ASP . 19.1 m -91.53 161.88 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.3 pt-20 -69.82 123.07 20.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.499 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 72.0 tttt -50.08 161.65 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.15 35.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.332 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.21 145.05 40.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.387 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.56 HD22 HD21 ' A' ' 92' ' ' LEU . 7.6 m120 -84.78 125.43 32.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.718 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.572 ' O ' HD13 ' A' ' 100' ' ' LEU . 36.0 mm-40 -129.54 147.16 51.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -77.28 115.18 16.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.122 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.43 162.5 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 111.912 -179.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.507 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.93 153.41 42.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.421 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.37 119.92 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.543 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.39 56.89 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.434 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.578 ' OD2' HD13 ' A' ' 111' ' ' LEU . 12.7 t70 -60.55 -179.01 0.1 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.946 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.28 135.64 24.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.296 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.866 HG13 HD11 ' A' ' 145' ' ' ILE . 3.7 mt -113.72 127.72 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.579 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.46 141.09 36.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.28 158.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 43.52 8.71 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.026 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.494 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.3 t -84.35 140.42 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.663 0.744 . . . . 0.0 112.396 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.06 -38.81 0.83 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.42 123.15 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.166 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.4 -29.83 11.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.556 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.7 m -93.57 6.41 48.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -127.56 27.43 5.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.579 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 139.25 29.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.032 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.21 134.43 53.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.512 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -108.71 150.51 27.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.597 0.713 . . . . 0.0 112.145 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.4 mt -135.66 158.13 45.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.946 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.0 t -126.52 130.53 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.888 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.866 HD11 HG13 ' A' ' 130' ' ' ILE . 1.1 mp -105.64 120.8 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.29 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.29 112.17 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.586 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.515 ' CD1' HD22 ' A' ' 124' ' ' LEU . 5.2 mt -84.79 131.06 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.846 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.814 0.34 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -35.96 74.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -44.23 94.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -44.68 94.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -65.87 -35.0 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -57.14 -36.94 71.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -67.24 -23.9 65.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.53 79.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -74.02 133.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.465 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.74 -60.81 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.646 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 p -146.55 147.59 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.178 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.08 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' CE2' ' A' ' 68' ' ' PHE . 28.5 t -105.49 122.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.859 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -126.87 121.17 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.449 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' HD21 ' A' ' 141' ' ' LEU . 17.8 t -79.87 115.73 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -87.01 -25.05 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.742 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' H ' ' A' ' 142' ' ' SER . 30.4 p -79.89 -2.13 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.599 0.238 . . . . 0.0 111.441 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.36 76.99 0.26 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.897 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -147.26 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -122.17 142.08 35.93 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.0 Cg_endo -72.43 145.05 41.99 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.148 1.899 . . . . 0.0 112.228 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.859 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -56.61 147.35 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.49 161.38 35.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.198 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -118.63 119.74 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 111.707 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.4 mt -99.11 132.56 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.35 158.58 43.9 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.501 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.5 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.712 0.291 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.79 139.14 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.239 0.542 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.2 m-90 -102.81 139.44 38.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.15 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.38 128.88 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -118.35 145.34 45.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.477 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.709 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 161.02 -166.59 35.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.644 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.4 mtm180 -84.34 5.42 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.4 t-20 -84.95 132.47 45.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.72 -14.79 46.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.449 2.099 . . . . 0.0 111.462 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -43.31 16.96 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.854 0.835 . . . . 0.0 108.76 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.05 138.96 1.92 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.739 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.35 -18.86 12.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.922 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.5 t80 -129.78 125.23 35.3 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.778 0.323 . . . . 0.0 111.257 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -103.28 112.84 25.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.614 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.709 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -119.29 72.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.26 -131.87 19.83 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.919 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.69 84.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.046 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -96.59 128.6 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -28.77 63.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.63 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -74.13 -27.76 61.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.059 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.971 HD12 HD13 ' A' ' 81' ' ' ILE . 17.5 mt -99.5 152.12 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.956 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.8 p -94.96 166.65 11.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.533 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.564 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.58 -53.85 5.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.353 0.597 . . . . 0.0 109.596 179.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.566 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.14 83.75 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -60.33 -46.27 90.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.8 p90 -144.59 160.27 41.43 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.171 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.78 141.32 44.77 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.196 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.5 mt -117.3 132.18 67.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.027 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.93 151.59 27.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.087 0.47 . . . . 0.0 111.612 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.574 ' C ' HD13 ' A' ' 93' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 33' ' ' VAL . 5.8 mp . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.72 0.295 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.6 mt -129.67 143.92 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -112.66 127.47 56.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.538 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.5 t30 -118.9 115.5 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 0.0 111.493 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -78.84 138.37 38.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -145.74 40.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 150.94 21.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.037 0.446 . . . . 0.0 111.798 -178.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -68.62 -31.56 70.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.769 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.14 -19.71 17.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.34 10.61 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.53 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.19 137.71 52.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.76 148.58 39.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.59 18.61 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.349 177.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 43.97 43.44 5.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.45 -12.55 64.65 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.485 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.42 118.53 36.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 110.56 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.83 130.63 41.52 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.501 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.866 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.1 m -100.05 163.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 pm0 -69.98 124.69 24.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.9 tttt -50.99 161.01 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 111.012 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 34.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.401 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.37 145.16 40.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.8 ' HB3' HD22 ' A' ' 100' ' ' LEU . 14.6 m120 -85.49 128.55 34.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.34 147.53 51.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.705 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.4 tt -72.89 120.1 18.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.31 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -56.81 157.54 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.291 0.567 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.38 153.24 42.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.452 ' HG2' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 121.8 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.357 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.95 24.57 54.55 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.19 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.8 t70 -57.72 175.6 0.18 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.902 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.6 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.035 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 145' ' ' ILE . 6.7 mt -113.14 128.19 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.383 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.651 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.19 138.88 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.805 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.26 158.41 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.35 21.46 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.936 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.0 t -75.07 140.43 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.661 0.743 . . . . 0.0 112.428 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.26 -37.8 0.85 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.38 123.26 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.96 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -32.54 16.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.783 0.325 . . . . 0.0 111.585 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.461 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 3.6 t0 -125.86 29.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.651 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.29 139.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 142' ' ' SER . 4.4 tt -124.4 134.41 53.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.577 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD23 ' A' ' 141' ' ' LEU . 45.7 t -112.71 150.27 31.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.481 0.658 . . . . 0.0 112.424 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HZ ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -134.1 148.5 51.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.14 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.6 t -114.04 135.5 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 130' ' ' ILE . 27.9 mt -106.3 122.79 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 120.57 42.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.55 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.583 HG12 HD21 ' A' ' 124' ' ' LEU . 6.1 mt -84.59 134.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.826 0.346 . . . . 0.0 111.322 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.77 0.319 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -128.73 -61.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.88 -42.56 69.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -59.01 -39.08 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -39.11 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.718 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.81 -31.98 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.99 -35.53 48.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -57.38 -45.34 84.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -67.07 -23.78 65.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.581 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.63 -47.62 79.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.22 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m -80.85 -38.34 28.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -99.07 76.2 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.82 135.69 37.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -66.46 101.88 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.9 mm -86.99 138.47 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.711 0.767 . . . . 0.0 111.826 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.52 36.61 0.73 Allowed Glycine 0 C--N 1.314 -0.668 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.626 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -44.05 97.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 178.6 38.53 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -76.4 136.09 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.533 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.944 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.32 -60.0 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.803 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.4 p -145.97 165.27 29.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.281 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -127.44 122.79 34.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 111.386 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.659 HG11 ' HE2' ' A' ' 68' ' ' PHE . 5.4 m -90.35 122.86 42.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.922 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.833 HG23 HG12 ' A' ' 45' ' ' ILE . 20.4 mt -126.34 120.46 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.444 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.746 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.3 t -80.83 121.31 25.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -26.17 19.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.379 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' H ' ' A' ' 142' ' ' SER . 40.2 p -79.87 -2.18 42.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.579 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.32 76.49 0.29 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.807 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -146.32 -42.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -117.72 141.26 28.74 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.8 141.06 36.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.152 1.902 . . . . 0.0 112.167 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.833 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -55.9 133.56 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.82 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -127.1 164.05 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.137 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.85 119.78 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.814 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -87.18 130.45 34.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.463 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.944 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.91 155.99 48.35 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.287 1.041 . . . . 0.0 113.497 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.69 165.84 31.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.226 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.6 m-20 -81.31 126.73 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.123 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.563 HD13 ' SG ' ' A' ' 154' ' ' CYS . 56.1 mt -64.42 -43.31 96.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.896 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -62.51 -40.11 95.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.333 0.587 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 28.9 mm-40 -68.48 -36.92 79.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.683 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 51' ' ' ASP . 53.3 t -73.08 -42.48 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.009 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.89 -39.35 72.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -75.19 -40.84 59.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.93 126.02 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 33.12 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -147.94 153.6 39.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.1 t 61.19 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.77 HD13 HD12 ' A' ' 92' ' ' LEU . 6.0 tp -179.02 161.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.657 0.265 . . . . 0.0 111.141 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.45 -68.53 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.718 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 49' ' ' SER . 16.4 ttpt -145.91 117.91 8.27 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.9 p -111.35 140.08 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.814 ' CD2' HD23 ' A' ' 48' ' ' LEU . 16.6 m-90 -100.67 139.34 36.5 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.107 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.597 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 131.41 55.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -120.2 145.58 46.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.659 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.45 -169.18 36.18 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.768 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.0 mtm180 -81.95 3.75 25.26 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.744 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.6 t-20 -84.82 132.65 45.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.572 0.225 . . . . 0.0 111.007 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.88 -13.3 39.18 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.514 2.143 . . . . 0.0 111.63 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.92 17.41 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.914 0.864 . . . . 0.0 108.847 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.54 137.52 3.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.805 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -18.09 11.01 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.226 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 9.8 t80 -129.06 119.43 24.19 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.031 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.97 111.41 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.547 ' HA ' HG12 ' A' ' 43' ' ' ILE . 1.7 mt -88.07 -65.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.06 -90.63 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.169 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.4 p30 178.78 54.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 111.007 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 34.1 mm -75.06 126.66 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 p -54.94 -40.83 70.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.277 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -68.81 -44.9 72.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -72.99 150.07 42.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -95.69 166.83 11.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.714 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.78 -53.15 6.15 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 109.805 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HB2' HG22 ' A' ' 67' ' ' THR . 9.7 ptmt -120.9 81.83 1.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.7 t60 -60.4 -46.15 91.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.829 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.8 p90 -142.45 160.2 40.74 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.077 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.712 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.99 143.87 45.05 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.94 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.713 ' C ' HG23 ' A' ' 65' ' ' VAL . 69.9 mt -120.03 125.68 74.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.632 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.77 HD12 HD13 ' A' ' 62' ' ' ILE . 1.9 pt? -114.17 137.3 51.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.787 HD22 HG11 ' A' ' 33' ' ' VAL . 18.9 tp -110.94 128.76 55.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.307 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.99 -130.68 1.31 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.294 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.05 -165.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.313 . . . . 0.0 110.978 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.74 53.6 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 155' ' ' LEU . . . 93.68 40.62 4.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.0 165.05 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -107.51 156.96 18.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.82 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.8 mp -133.14 147.13 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.224 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 145' ' ' ILE . 8.2 mp -112.62 125.66 54.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.365 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD22 ' A' ' 92' ' ' LEU . 41.1 t30 -116.69 115.63 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.8 p30 -80.44 132.6 35.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.808 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -139.57 41.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.95 157.76 16.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.018 0.437 . . . . 0.0 111.473 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.539 ' OG1' HG21 ' B' ' 5' ' ' TPO . 85.6 m -68.84 -36.35 78.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.445 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.62 -19.84 17.34 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.46 161.45 11.25 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.489 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.0 m -117.6 137.99 52.25 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.6 148.38 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -124.33 113.54 18.37 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 45.78 42.75 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.37 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.84 -5.5 84.87 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.493 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.39 118.72 37.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.108 0.454 . . . . 0.0 110.868 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.4 tptm -75.11 126.91 32.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.327 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.0 m -101.52 165.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tt0 -69.86 125.92 28.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.444 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 47.9 tttm -52.12 161.82 0.56 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.91 0.386 . . . . 0.0 110.558 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.63 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.281 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.23 145.07 40.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.251 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.481 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.4 m120 -86.67 130.13 34.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.008 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.8 mm-40 -129.39 147.89 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.477 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.5 tt -72.8 135.99 45.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.331 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.848 HD21 HG12 ' A' ' 147' ' ' ILE . 63.4 tp -65.62 155.23 36.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.463 0.649 . . . . 0.0 111.733 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.95 153.12 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.515 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 123.13 21.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.139 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.38 46.15 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.063 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.5 t70 -52.14 170.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.985 0.421 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.906 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.02 135.56 24.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 145' ' ' ILE . 11.3 mt -113.52 126.68 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.48 138.57 40.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.745 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.8 m -140.27 158.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.84 31.49 23.62 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.6 t -73.41 140.36 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.604 0.716 . . . . 0.0 112.217 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 150.01 -39.33 0.88 Allowed Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 21.6 t -126.23 128.31 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.017 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.4 -35.42 28.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.38 6.55 47.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -121.92 27.32 8.16 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.12 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.172 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -124.35 134.48 53.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.434 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.588 ' C ' HD22 ' A' ' 143' ' ' LEU . 41.6 t -112.61 150.41 31.43 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.671 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.746 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.91 152.4 50.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.379 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.906 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.9 t -119.82 140.08 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.34 . . . . 0.0 111.334 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 130' ' ' ILE . 47.7 mt -106.32 121.0 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -109.11 114.38 28.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.512 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.848 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.86 132.76 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.551 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.21 111.41 15.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.8 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.58 -28.72 65.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -45.87 90.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -43.18 88.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.054 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.2 -37.17 76.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.563 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.1 t -63.75 -46.03 87.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.428 HD22 ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -62.61 -40.83 98.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.834 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -59.47 -34.12 72.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.96 -33.49 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p30 42.45 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.547 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 147.2 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.1 m -96.34 134.34 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.188 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -97.37 105.53 17.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.09 136.45 47.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.089 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.717 ' O ' HG22 ' B' ' 4' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.593 0.235 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.717 HG22 ' O ' ' B' ' 3' ' ' ASN . 6.3 tt 52.47 161.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.822 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.539 HG21 ' OG1' ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.65 128.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.66 125.84 10.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.384 2.056 . . . . 0.0 112.439 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.623 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -78.95 175.22 10.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.5 ' H ' HG22 ' B' ' 8' ' ' THR . 49.1 mt-30 -67.07 173.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -161.78 130.79 4.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 68.7 m -89.55 109.45 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -158.27 -55.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -69.45 -47.08 65.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -38.88 86.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -35.45 77.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.843 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.43 -42.17 88.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.22 -35.14 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.22 -43.35 82.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.853 0.359 . . . . 0.0 110.377 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.428 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.47 79.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.178 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -64.85 -38.78 92.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.827 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -92.93 75.1 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.7 131.43 37.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -67.24 111.78 4.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.03 138.41 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.692 0.758 . . . . 0.0 111.703 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.62 69.0 1.23 Allowed Glycine 0 C--N 1.314 -0.664 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.456 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -39.08 70.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 179.62 37.81 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -75.35 135.04 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.561 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.26 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.838 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.7 p -146.49 147.21 30.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.326 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.99 128.17 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.265 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.5 m -94.58 122.9 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.798 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.827 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -123.15 111.38 29.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.655 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.04 106.42 18.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.031 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.7 p -97.76 -10.76 24.29 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.682 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.1 p -79.94 -2.59 44.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.408 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.45 84.26 0.69 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.432 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.928 ' NE2' HD13 ' A' ' 141' ' ' LEU . 15.1 pt20 -161.72 -47.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.858 0.361 . . . . 0.0 111.422 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.58 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.6 mt -134.16 142.79 44.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.711 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD2' HG23 ' A' ' 43' ' ' ILE . 63.4 Cg_endo -75.92 146.01 29.03 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.255 1.97 . . . . 0.0 111.794 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.827 HG12 HG23 ' A' ' 37' ' ' ILE . 36.9 mt -52.24 136.77 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.969 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -132.08 161.89 32.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 p30 -117.77 120.02 36.68 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.712 HD11 HG13 ' A' ' 36' ' ' VAL . 4.1 mt -96.04 136.96 35.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 159.07 43.91 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -178.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -152.14 141.96 21.98 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.709 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -85.65 135.03 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.159 0.504 . . . . 0.0 111.126 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.5 mp -64.19 -39.99 87.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -41.6 78.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.668 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.1 mt-30 -68.68 -37.02 79.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.697 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.6 t -62.96 -48.18 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.727 HD12 ' N ' ' A' ' 57' ' ' LYS . 4.4 pp -70.93 -28.03 64.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.134 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.727 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -80.05 -26.93 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.052 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 63' ' ' LYS . 1.3 tp10 -62.82 99.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.29 93.57 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.82 95.87 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.32 -168.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.841 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.558 HD11 HD13 ' A' ' 92' ' ' LEU . 8.7 tp -104.24 8.27 9.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG3' HG13 ' A' ' 55' ' ' VAL . 3.3 mmtt 61.2 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.322 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 62' ' ' ILE . 8.7 ttpt -155.07 136.47 14.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.848 0.356 . . . . 0.0 111.454 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.5 t -132.55 139.48 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.22 0.533 . . . . 0.0 111.761 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -100.88 137.67 38.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.69 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.01 127.48 56.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.25 145.53 42.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.999 -178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.66 -173.06 35.63 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.663 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 14.3 mtm105 -77.79 4.87 10.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 11.4 t-20 -84.97 131.91 47.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 0.0 111.043 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 Cg_exo -66.07 -14.21 43.35 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.362 2.041 . . . . 0.0 111.573 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.01 -42.61 17.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.946 0.879 . . . . 0.0 109.014 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.65 138.19 1.44 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.096 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.8 m-20 -56.39 -18.21 10.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' A' ' 36' ' ' VAL . 6.6 t80 -128.48 112.22 14.12 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 120.79 0.328 . . . . 0.0 111.222 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -90.46 118.28 29.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.415 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -126.95 172.4 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.33 137.09 45.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.577 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -71.51 81.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 111.138 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.665 HG22 ' H ' ' A' ' 83' ' ' ARG . 27.8 mm -88.9 127.31 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.955 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -55.04 -24.93 27.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.665 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.03 -46.07 15.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.157 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 132' ' ' VAL . 42.3 mt -72.7 152.18 41.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.036 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.4 p -95.88 166.03 11.99 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.693 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.607 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.14 -53.77 6.17 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 109.614 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -118.36 81.85 1.75 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -59.54 -45.89 90.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.764 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.2 p90 -145.45 157.61 43.98 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.772 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -136.06 141.06 44.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.606 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 65' ' ' VAL . 53.6 mt -116.53 129.69 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.022 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -117.13 140.83 49.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.105 0.479 . . . . 0.0 111.602 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.803 HD22 HG11 ' A' ' 33' ' ' VAL . 9.8 tp -125.24 123.0 38.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.258 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.1 -140.28 6.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.559 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 69.11 -67.19 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.964 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.87 -47.19 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 177.79 -35.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.521 ' O ' HD12 ' A' ' 93' ' ' LEU . 6.7 p-10 -59.74 179.8 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.748 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.52 156.33 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.1 mp -133.03 145.09 50.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.591 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 145' ' ' ILE . 10.5 mp -112.74 122.05 46.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.01 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.582 ' HB2' HD21 ' A' ' 92' ' ' LEU . 57.4 t30 -116.77 115.63 25.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 111.56 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.1 p30 -78.31 135.91 37.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.0 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -143.84 39.08 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.98 160.4 14.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.043 0.449 . . . . 0.0 111.5 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.1 m -68.96 -36.46 77.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.615 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.49 -20.06 17.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.34 162.07 11.55 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.201 -0.999 . . . . 0.0 113.481 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.69 137.84 52.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.852 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.72 148.39 36.51 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.46 18.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.198 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.39 42.85 5.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.358 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.37 -5.08 85.33 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.464 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -104.86 118.51 36.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 0.0 110.738 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.852 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.0 tptp -75.67 126.04 30.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.156 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.789 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.2 m -102.69 163.13 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.289 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.91 127.1 31.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.7 tttp -52.44 163.44 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.197 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 35.43 35.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.948 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -112.03 137.2 50.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.107 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.466 ' HB3' HD23 ' A' ' 100' ' ' LEU . 19.2 m120 -80.4 130.54 35.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 27.2 mm-40 -129.54 146.9 51.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 tp -72.85 136.13 45.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -63.72 157.45 24.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.48 0.657 . . . . 0.0 112.006 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.475 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -125.44 153.37 43.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.217 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.456 ' OE1' HD12 ' A' ' 147' ' ' ILE . 15.2 mm100 -71.55 115.6 10.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.899 0.38 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.26 30.02 63.8 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.702 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.457 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.1 t70 -55.23 174.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.973 0.416 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.907 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.21 135.47 24.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.015 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 10.4 mt -111.33 126.3 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.549 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.564 HG22 ' CG2' ' A' ' 140' ' ' ILE . 8.2 m -104.87 137.66 42.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.054 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.0 m -140.32 158.71 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.033 0.444 . . . . 0.0 112.181 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.29 31.59 16.26 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.17 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.8 t -74.53 140.41 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.684 0.754 . . . . 0.0 112.172 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' B' ' 8' ' ' THR . . . 145.23 -41.07 1.08 Allowed Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 43.1 t -126.5 123.14 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.541 -0.83 . . . . 0.0 108.929 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -50.29 -28.05 7.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.821 0.343 . . . . 0.0 111.427 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -93.64 6.53 48.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.62 24.37 7.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.564 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.47 138.23 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.928 HD13 ' NE2' ' A' ' 42' ' ' GLN . 9.9 mt -125.19 134.77 52.25 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.339 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.682 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -104.65 139.07 40.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.213 0.53 . . . . 0.0 111.897 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.2 mp -125.06 152.51 44.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.154 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.907 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.5 t -120.77 134.18 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.869 0.366 . . . . 0.0 111.618 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 36.3 mt -106.31 121.74 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -110.24 119.02 37.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.805 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.599 HD13 HD22 ' A' ' 124' ' ' LEU . 5.9 mt -84.71 134.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.291 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -81.66 126.35 31.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.79 -24.45 61.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -57.9 -43.84 86.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.534 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 1.1 t80 -57.9 -40.99 81.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.734 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -33.96 77.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -46.27 80.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -65.85 -43.19 89.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -36.03 82.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.81 -39.44 85.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -91.42 -34.54 14.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.002 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 p30 44.85 -172.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.619 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 151.13 46.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.926 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.1 p -72.97 117.63 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.035 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -134.12 -48.2 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.61 177.36 7.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.5 mp -89.6 114.98 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.898 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.691 ' O ' HG22 ' B' ' 4' ' ' ILE . 5.9 m-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.519 0.199 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.691 HG22 ' O ' ' B' ' 3' ' ' ASN . 9.3 tp 52.04 157.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.999 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -79.84 143.01 57.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 -176.76 2.67 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.532 2.155 . . . . 0.0 112.256 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.453 HG22 ' HA3' ' A' ' 135' ' ' GLY . 25.5 m -163.49 111.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 58.88 97.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -139.8 148.5 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 t -163.43 164.53 24.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -124.03 -44.31 2.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -63.64 -47.1 82.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -60.54 -42.21 96.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.946 0.403 . . . . 0.0 110.76 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 -38.05 80.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.9 -32.27 72.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.675 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.11 -35.5 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.734 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.53 -39.98 77.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.446 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -67.1 -23.8 65.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.794 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.68 -47.34 80.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.224 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -36.51 49.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.832 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.67 81.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 150.82 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.57 129.14 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.27 138.34 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 121.715 0.769 . . . . 0.0 111.809 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.68 66.79 3.85 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 32' ' ' ILE . 3.9 pt-20 -65.02 -39.18 93.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.167 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 177.11 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.711 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -75.11 134.49 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 113.854 -1.521 . . . . 0.0 112.262 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -92.75 -61.58 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.421 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.453 ' SG ' HD12 ' A' ' 48' ' ' LEU . 17.2 p -155.19 138.03 15.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.443 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.543 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -113.99 138.45 50.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.3 t -96.13 132.14 41.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.388 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.788 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.71 116.89 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.18 108.99 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.245 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.4 p -93.61 -20.12 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.035 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.852 HG21 ' OG ' ' A' ' 142' ' ' SER . 48.9 p -79.82 -2.99 45.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 111.499 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 74.27 75.37 0.78 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.562 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 8.8 mt-30 -147.95 -41.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.676 0.274 . . . . 0.0 111.223 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.6 mt -134.01 141.49 39.82 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.2 Cg_endo -73.99 146.07 36.6 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.179 1.919 . . . . 0.0 111.92 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.788 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -56.13 151.51 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.187 0.517 . . . . 0.0 111.956 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 2.0 ttt-85 -149.69 159.18 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.26 121.59 40.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 112.333 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD11 ' HZ ' ' A' ' 68' ' ' PHE . 8.1 mt -94.56 137.76 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.005 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 158.17 43.94 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.55 143.44 35.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.117 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 31.5 m-20 -86.2 114.02 22.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.479 . . . . 0.0 111.263 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -64.38 -41.44 92.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.376 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 t -56.74 -38.26 72.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.307 0.575 . . . . 0.0 110.802 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.0 mm-40 -68.49 -36.83 79.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.73 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.63 -50.08 69.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.025 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -57.49 -28.1 63.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.02 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.8 -32.82 40.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.73 123.2 40.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 88.55 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.65 172.35 18.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.54 29.86 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.409 HD11 ' CG2' ' A' ' 65' ' ' VAL . 7.6 tp -151.38 145.45 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HD3' HD23 ' A' ' 93' ' ' LEU . 10.0 mttp -119.66 -67.07 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.0 ttpt -153.76 142.78 21.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.8 t -127.45 139.47 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.312 0.577 . . . . 0.0 112.186 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.636 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.6 m-90 -107.78 138.56 43.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -110.69 126.23 54.31 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.746 ' CE2' HG21 ' A' ' 36' ' ' VAL . 2.5 m-85 -107.37 145.78 32.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.818 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.9 -178.58 40.54 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.782 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -78.16 -3.38 42.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 136.83 38.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.27 -6.12 17.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.796 2.331 . . . . 0.0 111.736 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.27 14.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.956 0.884 . . . . 0.0 108.684 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.07 139.23 2.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.457 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -18.62 10.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.174 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.1 t80 -129.36 131.65 46.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.74 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.04 131.09 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -133.18 -178.58 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.45 135.64 39.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -69.93 89.43 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.757 0.313 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.661 HG22 ' H ' ' A' ' 83' ' ' ARG . 25.2 mt -104.35 127.75 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -54.98 -25.02 26.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.325 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -75.62 -46.74 29.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.227 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 132' ' ' VAL . 39.8 mt -72.74 151.68 42.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.748 0.309 . . . . 0.0 111.306 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -95.56 166.16 11.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.893 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.22 -54.39 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 109.858 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 3.9 mttp -118.82 82.84 1.92 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.5 t60 -60.87 -46.79 89.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.652 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 15.6 p90 -147.71 159.31 43.94 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.278 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.4 tt0 -135.95 141.46 44.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 65' ' ' VAL . 41.4 mt -114.37 132.33 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.251 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 121' ' ' ASN . 0.5 OUTLIER -122.0 144.46 48.88 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 111.341 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.762 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.4 tp -125.12 123.0 38.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.508 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.64 -132.63 1.49 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.553 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 62.38 -80.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.021 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.39 42.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.27 -30.29 8.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.68 162.16 21.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.302 . . . . 0.0 110.965 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.544 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -106.97 150.68 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.821 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.9 mt -133.13 140.38 47.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.249 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -112.56 126.08 54.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.202 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -115.8 115.49 26.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.784 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -78.68 140.81 38.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.808 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.7 pt -149.22 38.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.51 159.04 15.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.007 0.432 . . . . 0.0 111.625 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.1 m -69.02 -34.96 76.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.647 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 -19.97 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.543 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.71 162.81 12.04 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.533 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.9 m -117.53 137.81 52.32 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.71 148.36 38.38 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.526 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.14 113.48 18.4 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.361 177.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 44.28 42.88 5.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -10.39 71.28 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.474 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -104.96 118.54 36.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.09 0.445 . . . . 0.0 110.656 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.34 130.91 41.2 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.56 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.784 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -101.87 164.58 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.851 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 tt0 -69.98 126.67 30.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.499 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 tttt -52.69 161.6 0.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.545 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.02 34.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.293 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.0 40.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.114 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.631 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.4 m120 -89.86 126.67 35.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.76 ' O ' HD23 ' A' ' 100' ' ' LEU . 39.4 mm-40 -129.3 147.28 51.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.834 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.9 120.95 19.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.984 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 101' ' ' LEU . 1.3 mm? -57.83 165.51 1.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.756 0.789 . . . . 0.0 112.076 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.38 153.18 43.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.195 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.489 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.63 120.36 17.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.94 26.39 60.7 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.246 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.1 t0 -60.82 178.54 0.23 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.914 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.7 mt-10 -144.99 135.57 24.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.5 mt -112.64 126.92 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.457 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.605 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.49 141.63 36.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.101 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.538 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.41 158.53 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.5 42.99 9.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.192 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -83.69 140.37 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.646 0.736 . . . . 0.0 112.228 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.662 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 143.46 -39.29 1.31 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.52 120.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.592 -0.804 . . . . 0.0 108.97 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 mt-10 -50.29 -26.75 5.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.41 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.42 6.49 48.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.32 24.32 6.29 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.5 28.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.403 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 142' ' ' SER . 7.9 tt -123.32 134.78 54.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.196 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.852 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -111.98 128.7 56.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.078 0.466 . . . . 0.0 111.605 -179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.7 mt -123.01 149.1 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.777 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.914 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.9 t -113.84 138.03 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.056 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 124' ' ' LEU . 1.4 mm -106.39 120.91 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.411 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -108.33 131.09 55.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -102.98 132.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -84.03 116.63 22.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.45 -24.51 67.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -45.83 90.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.72 -42.17 83.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.975 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -64.9 -35.45 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.3 t -67.2 -44.61 79.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -47.6 81.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.51 -38.57 77.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -69.81 -27.04 64.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -115.61 65.32 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 130.46 39.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 123.92 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.063 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -127.89 142.08 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.935 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -124.79 137.63 54.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pp -100.56 132.62 45.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.932 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.751 0.31 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 4' ' ' ILE . 1.0 OUTLIER -140.99 120.12 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.618 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -61.09 110.17 2.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.04 -168.7 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.361 2.04 . . . . 0.0 112.323 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.662 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.4 OUTLIER -104.94 174.98 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.489 ' H ' HG22 ' B' ' 8' ' ' THR . 19.6 mt-30 -82.16 76.64 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -121.23 149.3 43.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.954 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.85 79.98 0.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.514 ' OXT' HG22 ' B' ' 12' ' ' THR . 29.5 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.818 0.342 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 m 60.76 30.04 19.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -72.08 -47.04 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -36.04 82.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.785 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -60.57 -40.05 90.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -61.13 -43.54 98.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mm -71.59 -34.99 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.23 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.493 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -23.86 65.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.57 -47.6 79.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.296 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -75.43 -35.97 60.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.832 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 50.9 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -74.85 124.2 26.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -77.91 103.36 7.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.04 138.42 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.689 0.757 . . . . 0.0 111.668 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 102.78 2.79 Favored Glycine 0 C--N 1.314 -0.648 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.359 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -66.28 -33.04 74.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.69 0.281 . . . . 0.0 111.005 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 178.8 37.97 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.6 mm -73.38 135.52 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.684 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -93.1 -60.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.862 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.7 p -146.12 150.47 35.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.183 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.4 138.24 51.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.922 0.391 . . . . 0.0 111.489 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.689 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -103.1 122.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.792 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -127.45 121.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.546 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD23 ' A' ' 143' ' ' LEU . 48.4 t -79.87 114.43 18.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -79.69 -25.99 41.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.798 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' HB3' ' A' ' 142' ' ' SER . 72.6 p -79.83 -2.19 42.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.706 0.289 . . . . 0.0 111.548 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 77.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.946 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -146.29 -44.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.389 . . . . 0.0 110.736 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.1 mt -113.73 141.66 26.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.862 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.3 Cg_endo -72.06 140.87 35.33 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.304 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.792 HG12 HG23 ' A' ' 37' ' ' ILE . 38.4 mt -56.43 140.2 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.641 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.38 164.13 20.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.33 119.71 33.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.1 mt -97.44 134.64 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.56 158.0 43.83 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.19 141.94 32.63 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.572 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 55' ' ' VAL . 26.0 m-20 -80.41 136.39 36.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 0.0 111.404 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.622 HD13 ' SG ' ' A' ' 154' ' ' CYS . 46.7 mt -64.31 -45.43 96.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.071 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -39.42 74.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.442 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.3 mm-40 -68.55 -38.53 80.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.626 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.846 HG13 ' HD2' ' A' ' 63' ' ' LYS . 47.5 t -73.1 -37.88 53.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.89 -30.66 71.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -89.29 -29.8 18.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.124 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -72.42 119.02 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -103.08 -21.46 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.09 176.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.033 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -77.47 -30.19 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.76 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.0 tp -110.5 151.15 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.846 ' HD2' HG13 ' A' ' 55' ' ' VAL . 8.2 mttp -127.92 -68.45 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.93 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -142.02 130.19 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' HD11 ' A' ' 62' ' ' ILE . 11.5 t -125.56 139.14 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.2 0.524 . . . . 0.0 112.086 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.597 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.6 m-90 -100.89 139.4 36.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.199 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 128.76 56.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.45 145.38 46.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.346 -178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.1 -168.5 36.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.067 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.446 ' N ' HD11 ' A' ' 78' ' ' LEU . 25.1 mtm180 -80.28 2.23 25.46 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 t-20 -84.87 133.05 44.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.667 0.27 . . . . 0.0 111.113 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -66.63 -14.05 42.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 0.0 111.901 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.05 17.31 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.902 0.858 . . . . 0.0 108.796 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.18 139.6 1.34 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.779 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.0 m-20 -56.34 -19.0 12.55 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.003 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.6 t80 -129.83 126.98 39.33 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.931 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.45 111.17 23.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.935 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -114.52 172.53 6.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.784 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.09 134.05 48.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.675 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -67.32 84.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 83' ' ' ARG . 53.3 mt -100.46 131.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -37.06 69.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.21 -27.85 67.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.005 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.0 mt -96.94 152.2 18.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.904 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -99.04 165.27 11.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.773 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -42.84 -53.5 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.387 0.613 . . . . 0.0 109.851 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB2' HG22 ' A' ' 67' ' ' THR . 10.7 ptmt -118.38 81.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.7 t60 -59.34 -45.69 90.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.883 -176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 34.0 p90 -144.53 160.44 41.12 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.138 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -135.91 143.04 44.75 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.282 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.3 mt -119.31 127.59 75.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.006 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.32 148.05 32.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 111.635 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.624 HD13 ' CG1' ' A' ' 33' ' ' VAL . 9.4 tp -125.04 123.01 38.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.534 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.56 -165.42 36.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 63.18 90.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.0 t0 63.6 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -171.35 32.73 0.14 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -106.37 178.88 4.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -120.91 150.59 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -133.06 147.34 52.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.58 HD22 HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -112.65 125.33 54.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.192 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 48.2 t30 -116.47 115.81 26.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.773 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.735 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -77.89 135.03 37.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.851 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 8.5 pt -143.91 34.6 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.83 151.77 19.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 120.941 0.4 . . . . 0.0 111.457 -179.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.5 m -68.58 -31.82 71.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.921 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.62 -19.83 17.34 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.72 154.52 9.21 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.678 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.7 m -117.5 137.92 52.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.51 148.36 42.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.809 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.43 113.59 18.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.956 177.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 47.74 36.08 5.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.37 0.35 79.91 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.544 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.83 118.67 37.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 110.756 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.4 tptm -73.8 113.44 10.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.809 HG11 HD12 ' A' ' 111' ' ' LEU . 11.7 m -87.41 166.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.262 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.92 126.09 28.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.362 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -52.69 157.43 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.953 0.406 . . . . 0.0 110.825 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.6 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 4.0 p30 34.77 35.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.224 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -112.32 145.11 40.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.077 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.649 ' HB3' HD23 ' A' ' 100' ' ' LEU . 11.5 m120 -80.84 131.87 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.24 146.66 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.318 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 tp -72.68 118.5 15.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.811 HD13 HD13 ' A' ' 99' ' ' LEU . 7.6 tt -56.41 153.85 9.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.504 0.668 . . . . 0.0 111.686 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.91 153.02 43.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.465 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -71.82 125.03 26.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.258 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.57 54.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.283 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.454 ' OD1' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -52.0 166.03 0.18 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.911 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -139.83 135.63 33.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -111.11 127.0 68.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.742 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.4 141.27 36.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.07 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.563 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.78 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.78 43.88 9.7 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 140' ' ' ILE . 77.3 t -84.68 140.44 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-O 121.651 0.739 . . . . 0.0 112.441 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.847 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 145.59 -39.96 1.12 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 50.0 t -126.41 120.02 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.563 -0.818 . . . . 0.0 109.0 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.45 -25.87 4.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.823 0.344 . . . . 0.0 111.442 -178.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.6 t -93.5 6.53 47.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -129.9 26.01 5.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.627 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.13 138.83 31.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.96 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.49 134.28 53.08 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.55 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.4 t -108.41 150.3 27.57 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.619 0.723 . . . . 0.0 112.153 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.5 mt -135.75 156.97 47.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.911 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.8 t -125.94 138.61 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 130' ' ' ILE . 32.4 mt -106.34 121.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.966 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.39 114.07 27.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 124' ' ' LEU . 4.7 mm -84.92 134.0 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.395 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -82.87 125.38 31.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.76 -25.41 62.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -59.15 -45.68 90.33 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.935 0.397 . . . . 0.0 110.662 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.18 -43.47 87.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.944 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -42.77 99.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -59.1 -46.63 87.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.622 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -64.49 -46.11 84.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.987 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -36.16 82.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.045 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.71 -35.47 79.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -32.89 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.59 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.02 140.24 41.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.8 134.94 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -129.48 174.34 9.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -178.43 -37.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.993 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.42 139.22 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 tp -148.7 143.71 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.96 127.96 67.44 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -167.66 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.422 2.081 . . . . 0.0 112.244 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.847 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.9 OUTLIER -84.25 173.15 11.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.493 ' H ' HG22 ' B' ' 8' ' ' THR . 10.2 tt0 -102.68 146.3 28.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -136.38 51.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m 63.66 95.43 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.831 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m 74.55 -59.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.16 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -59.79 -44.79 93.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.004 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -59.0 -37.68 77.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.837 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.34 -41.37 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -31.83 70.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.38 -35.49 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.803 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -42.0 81.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -67.11 -23.89 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.59 -47.56 79.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 m -77.03 -30.92 55.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.61 86.07 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.94 151.17 40.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.0 101.86 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -89.38 138.38 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.581 0.705 . . . . 0.0 111.964 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.44 38.31 0.49 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.664 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.42 -45.8 24.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -169.6 33.13 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.734 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.8 mm -76.71 134.05 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.529 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -93.66 -62.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.073 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.722 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.6 p -146.61 155.96 42.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.189 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -122.7 133.28 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.35 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 68' ' ' PHE . 38.4 t -97.56 122.81 49.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.925 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 23.1 mt -122.84 121.99 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.38 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.595 ' HA ' HD13 ' A' ' 143' ' ' LEU . 41.8 t -85.18 114.08 22.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.442 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -85.85 -22.87 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.581 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.485 HG21 ' H ' ' A' ' 142' ' ' SER . 42.5 p -79.94 -2.07 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.615 0.245 . . . . 0.0 111.581 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.17 76.64 0.28 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.844 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.702 ' HB2' HD12 ' A' ' 43' ' ' ILE . 12.5 mt-30 -146.89 -43.48 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.9 mp -118.88 141.87 30.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.999 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.6 138.02 28.68 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.119 1.879 . . . . 0.0 112.121 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -55.55 136.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.745 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.09 164.1 26.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.256 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -118.08 119.81 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 111.787 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.722 HD12 ' SG ' ' A' ' 34' ' ' CYS . 5.5 mt -89.84 137.35 32.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.62 157.58 43.74 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -137.66 143.65 41.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.635 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.8 m-20 -74.7 136.09 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.239 0.542 . . . . 0.0 111.119 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.514 HD13 ' SG ' ' A' ' 154' ' ' CYS . 52.9 mt -64.01 -42.1 94.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.102 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.36 -40.1 73.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.967 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.508 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -68.43 -40.87 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.302 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.838 HG11 HD21 ' A' ' 155' ' ' LEU . 45.9 t -64.36 -41.19 91.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.078 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 56' ' ' LEU . 12.3 tp -71.09 -30.29 66.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.31 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 27.68 9.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.281 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.7 98.99 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.818 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 39.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -139.6 178.25 7.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.0 p -70.86 -20.76 62.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.2 tp -145.94 158.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.326 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.783 ' CE ' HG13 ' A' ' 55' ' ' VAL . 66.6 mttt -93.48 -65.07 1.02 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.215 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' CE ' ' O ' ' A' ' 49' ' ' SER . 22.8 ttpt -154.94 119.86 4.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.925 0.393 . . . . 0.0 111.812 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.733 HG23 ' C ' ' A' ' 91' ' ' ILE . 11.8 p -109.85 140.0 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.524 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.9 m-90 -100.6 139.5 36.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.349 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.05 127.27 55.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -118.99 145.52 45.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.503 -178.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.52 -168.07 39.86 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -90.83 28.95 1.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.335 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.4 t-20 -111.43 136.62 20.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -65.87 -13.12 38.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.668 2.245 . . . . 0.0 111.736 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.9 -47.45 11.8 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.824 0.821 . . . . 0.0 109.295 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.88 140.61 1.0 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.311 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -56.61 -18.91 13.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.883 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 19.6 t80 -129.46 123.65 32.08 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.765 0.317 . . . . 0.0 110.68 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -97.93 121.94 40.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.129 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 43' ' ' ILE . 12.4 mt -102.34 -64.04 1.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.77 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.27 -103.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.473 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -179.27 49.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 84' ' ' LEU . 19.2 mt -89.69 141.92 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -64.34 -34.77 78.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.9 mmt-85 -60.91 -30.49 70.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.991 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 81' ' ' ILE . 1.2 mm? -105.81 152.47 23.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 p -98.39 163.32 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.524 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.593 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.16 -53.28 4.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.413 0.625 . . . . 0.0 109.67 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -118.99 82.65 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' HD12 ' A' ' 84' ' ' LEU . 13.6 t60 -61.25 -46.94 88.33 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.553 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.5 p90 -143.7 159.14 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.999 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.706 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.0 tt0 -135.5 140.52 44.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.042 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.733 ' C ' HG23 ' A' ' 65' ' ' VAL . 77.1 mt -120.12 127.25 75.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.161 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.747 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.812 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp -118.23 123.53 45.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.365 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.89 39.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.592 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 59.16 105.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.09 -177.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.33 54.35 4.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.416 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.25 -176.07 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -132.32 158.62 41.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.1 mt -127.76 140.68 51.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.513 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.719 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.2 OUTLIER -112.71 121.55 45.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.545 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.4 t30 -117.51 116.93 28.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.055 0.455 . . . . 0.0 112.072 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.8 p30 -77.36 134.82 38.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.817 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.4 pt -141.72 39.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.75 149.82 23.42 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.084 0.469 . . . . 0.0 111.943 -178.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.5 m -68.88 -31.34 70.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.862 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.63 -19.96 18.65 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.35 153.82 9.6 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.875 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.6 m -117.66 137.99 52.28 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.085 0.554 . . . . 0.0 109.577 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -115.98 148.57 39.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.53 18.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.482 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 111' ' ' LEU . 30.5 m-20 44.32 43.51 6.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.494 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.41 -13.59 61.69 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.447 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -103.96 118.47 36.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.983 0.391 . . . . 0.0 110.586 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -72.3 125.63 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.246 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.3 m -95.29 165.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.238 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 mt-10 -69.87 125.11 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.676 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 82.7 tttt -53.49 162.33 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.779 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 36.2 32.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.18 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.49 143.28 43.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.721 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.747 ' OD1' HD21 ' A' ' 92' ' ' LEU . 17.4 m-80 -92.17 133.6 35.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.793 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.6 mm-40 -129.08 150.01 50.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.49 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.58 122.91 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.14 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 145' ' ' ILE . 65.8 tp -53.03 156.14 2.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.493 0.663 . . . . 0.0 111.85 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.539 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -124.58 153.53 42.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.285 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.646 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.22 121.36 18.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.934 0.397 . . . . 0.0 110.405 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.57 24.23 56.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.154 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 38.1 t0 -54.79 170.49 0.17 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.007 0.432 . . . . 0.0 111.249 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 144' ' ' VAL . 20.5 tt0 -145.18 135.46 24.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 145' ' ' ILE . 2.6 mt -113.6 128.16 70.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.3 140.84 37.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.023 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.9 m -140.13 158.43 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.86 44.21 9.35 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.807 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -85.18 140.44 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.752 0.787 . . . . 0.0 112.47 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 151.39 -39.96 0.79 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.54 120.51 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.042 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 140' ' ' ILE . 9.2 tp10 -50.26 -26.44 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.792 0.33 . . . . 0.0 111.54 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.581 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.5 p -93.61 6.62 47.67 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -132.49 29.83 4.2 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -106.32 139.25 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.629 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 142' ' ' SER . 1.5 tt -124.16 134.35 53.34 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.701 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.528 ' O ' HD22 ' A' ' 143' ' ' LEU . 41.0 t -112.17 150.31 31.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.615 0.722 . . . . 0.0 112.499 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.595 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -136.02 139.55 43.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.498 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.86 140.15 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.794 HD11 HD11 ' A' ' 130' ' ' ILE . 16.8 mt -106.18 122.29 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.76 113.74 26.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.367 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.646 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.9 127.29 40.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.57 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.36 124.59 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.863 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.68 -27.33 64.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.088 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -60.06 -46.05 90.84 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.762 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 32' ' ' ILE . 1.2 t80 -58.27 -44.03 88.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.073 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -33.86 72.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.981 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -44.65 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.514 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -68.12 -44.06 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.838 HD21 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -64.12 -35.94 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.867 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.24 -45.77 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.022 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -79.98 -36.53 35.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.68 31.9 0.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.454 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -124.99 153.74 42.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.22 133.22 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.096 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -158.42 -61.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.476 ' HB3' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -75.52 -46.82 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 162' ' ' ARG . 4.1 mp -102.68 139.27 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.122 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.917 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.55 129.07 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.047 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -69.33 112.26 11.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.55 -170.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.514 2.143 . . . . 0.0 112.223 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.861 HG21 ' HA3' ' A' ' 135' ' ' GLY . 3.3 m -97.34 166.93 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -102.98 163.47 12.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -92.59 129.77 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m 61.6 114.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.411 HG21 HG22 ' A' ' 136' ' ' VAL . 2.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.7 m -142.42 -54.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -38.94 80.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -59.0 -36.32 74.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.18 -42.46 96.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.856 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 48.8 mm -68.91 -48.18 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.99 -33.56 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.294 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -59.79 -47.1 87.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.935 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.1 p90 -71.9 -47.44 52.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.062 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.533 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 52.3 p -65.28 -28.14 69.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.014 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 64.1 -78.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.17 146.21 39.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 104.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.814 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.95 138.3 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-O 121.708 0.766 . . . . 0.0 111.725 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.5 107.42 0.01 OUTLIER Glycine 0 C--N 1.315 -0.63 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.422 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -27.98 35.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.717 0.294 . . . . 0.0 111.138 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 177.27 39.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.692 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -74.74 134.25 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 113.698 -1.592 . . . . 0.0 112.454 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.014 HG12 HD21 ' A' ' 99' ' ' LEU . 2.9 t -91.16 -61.08 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.021 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -146.05 147.01 31.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.378 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.9 121.99 45.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.8 t -88.77 122.75 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.423 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.71 114.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 1.3 m -92.89 118.52 31.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -111.66 -12.46 13.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.853 HG21 ' CB ' ' A' ' 142' ' ' SER . 18.0 p -81.05 -2.51 48.4 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.08 85.49 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.809 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 4.4 pt20 -164.3 -49.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.704 HD13 HD22 ' A' ' 78' ' ' LEU . 5.1 mt -132.97 142.5 44.9 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 65.6 Cg_endo -75.69 146.16 29.97 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.201 1.934 . . . . 0.0 111.511 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -50.6 150.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 112.067 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -150.93 158.18 43.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.034 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -117.23 126.22 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.6 mt -101.05 137.62 39.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.75 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.002 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.89 158.78 43.68 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.74 141.87 23.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.532 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.888 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -82.35 133.95 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 111.203 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 52' ' ' ILE . 3.5 mp -64.36 -44.61 97.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.465 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -42.14 79.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.319 0.581 . . . . 0.0 110.881 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 5.4 mt-30 -68.55 -36.91 79.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.95 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.8 t -67.14 -46.69 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.037 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.93 -29.5 67.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -76.41 -40.16 51.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -62.92 129.66 41.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 31.04 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -123.59 46.49 2.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 62' ' ' ILE . 6.0 p 63.66 137.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.985 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER 56.49 166.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.289 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.7 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -137.6 -59.22 0.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -148.36 129.37 14.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.685 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.2 t -127.97 139.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.329 0.585 . . . . 0.0 112.333 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.605 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -100.84 139.25 36.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.804 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.72 130.13 55.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -119.34 145.4 46.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.367 -178.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.45 -170.43 37.21 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.777 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 13.8 mtm180 -79.95 2.86 21.86 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.528 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -84.94 133.01 44.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.61 0.243 . . . . 0.0 111.144 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.9 Cg_exo -65.91 -14.51 44.89 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.571 2.181 . . . . 0.0 111.721 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -42.63 18.02 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.831 0.824 . . . . 0.0 108.972 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.39 139.75 1.89 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 113.914 -1.493 . . . . 0.0 110.826 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.36 -18.26 10.38 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.91 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.8 t80 -129.08 123.94 33.54 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 120.787 0.327 . . . . 0.0 110.922 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -105.53 116.67 32.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -99.0 -69.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.024 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.12 -92.26 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.317 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 177.95 55.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.103 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.774 ' HB ' HD13 ' A' ' 84' ' ' LEU . 29.2 mm -81.67 124.73 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.754 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.55 70.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.218 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -28.74 69.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.774 HD13 ' HB ' ' A' ' 81' ' ' ILE . 6.2 mp -97.66 153.31 18.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 0.0 110.942 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -96.42 167.31 11.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.736 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -44.15 -54.93 5.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.266 0.555 . . . . 0.0 109.623 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.612 ' HB2' HD12 ' A' ' 104' ' ' ILE . 17.3 mttp -116.37 82.87 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -59.55 -46.47 88.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.763 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.0 p90 -143.92 157.77 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.008 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.2 tt0 -135.69 141.35 44.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.956 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.5 mt -116.34 126.73 73.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.853 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -105.51 149.25 26.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.163 0.506 . . . . 0.0 111.858 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 94' ' ' GLY . 2.0 tt -119.44 122.88 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.233 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.614 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -115.84 -166.06 14.6 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.692 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -59.42 172.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 111.038 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.437 ' HA ' HD11 ' A' ' 155' ' ' LEU . 0.9 OUTLIER 57.69 -171.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.4 26.44 19.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.479 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.421 ' OD1' HD11 ' A' ' 123' ' ' LEU . 18.9 m-80 -105.31 135.37 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.014 HD21 HG12 ' A' ' 33' ' ' VAL . 5.7 mp -107.77 160.13 15.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 121' ' ' ASN . 7.8 mt -126.69 142.66 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.425 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.1 OUTLIER -112.79 121.63 45.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.808 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.817 ' HB2' HD11 ' A' ' 92' ' ' LEU . 48.9 t30 -112.24 115.78 29.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.737 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.802 ' OD2' HG23 ' A' ' 116' ' ' VAL . 16.7 p30 -76.43 129.23 36.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.645 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -137.94 38.83 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.17 152.97 19.29 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.13 0.49 . . . . 0.0 111.663 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.8 m -68.85 -31.6 70.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.24 -19.88 17.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.47 156.07 10.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.675 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.42 137.72 52.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -117.74 148.19 42.26 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -124.76 113.55 18.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 48.77 42.07 19.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.33 -6.14 80.82 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.973 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.722 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -106.3 118.83 37.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.275 0.537 . . . . 0.0 110.84 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptp -73.75 127.26 32.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.258 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.802 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -101.12 166.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.203 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 17.5 tt0 -69.77 123.87 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.518 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 2.1 tttt -51.32 165.0 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.8 p30 32.82 34.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.322 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.52 145.23 40.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.245 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.77 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.5 m120 -90.9 129.47 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.15 150.92 50.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.433 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.421 HD11 ' OD1' ' A' ' 98' ' ' ASN . 11.1 tp -72.6 134.24 45.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.635 HD11 HG21 ' A' ' 145' ' ' ILE . 54.7 tp -65.85 156.42 33.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.48 0.657 . . . . 0.0 111.697 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.634 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.39 153.6 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.614 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.666 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.5 tp60 -71.3 118.6 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.441 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.33 23.64 62.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.116 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -50.99 172.02 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.871 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.63 135.59 24.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.5 mt -114.32 125.01 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.57 140.4 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.055 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.712 ' CG2' HD21 ' A' ' 84' ' ' LEU . 32.7 m -140.31 158.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.94 27.22 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.179 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.0 t -71.02 140.32 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.572 0.701 . . . . 0.0 112.212 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.8 -38.54 1.27 Allowed Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 44.9 t -126.45 124.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.662 -0.769 . . . . 0.0 109.202 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -50.47 -31.07 14.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.587 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 38.0 t -93.45 6.43 48.22 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -125.54 25.49 7.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.58 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.05 138.94 30.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.016 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 140' ' ' ILE . 6.0 mp -124.46 134.58 53.02 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.508 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.853 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -105.54 132.74 51.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.5 mp -123.23 143.49 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.546 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.871 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.3 t -114.45 132.72 62.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.796 0.331 . . . . 0.0 111.032 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.635 HG21 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -106.42 120.98 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.063 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -104.37 142.2 34.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.628 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -110.47 134.07 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.881 0.372 . . . . 0.0 111.523 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -82.55 131.46 35.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.955 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.43 -20.95 60.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -44.29 87.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.4 -40.48 82.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -65.0 -47.84 76.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.964 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -59.08 -46.47 88.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -62.02 -44.36 96.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.949 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -68.99 -39.17 79.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.02 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -58.46 -38.42 77.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.01 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -91.74 -36.61 13.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.924 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.0 p30 44.75 -171.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.565 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.22 152.26 29.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.911 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.4 m -97.09 134.94 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.41 155.98 22.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -65.93 120.23 12.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.57 129.7 52.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.884 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.77 0.319 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.474 ' O ' HG23 ' B' ' 4' ' ' ILE . 2.3 tt -152.48 121.71 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -70.95 121.61 84.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.96 174.66 10.9 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.343 2.029 . . . . 0.0 112.386 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.422 HG22 ' N ' ' B' ' 9' ' ' GLN . 15.9 m -157.22 164.14 38.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.422 ' N ' HG22 ' B' ' 8' ' ' THR . 0.0 OUTLIER -93.99 125.49 38.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -90.2 151.31 21.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -105.96 91.94 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.925 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.328 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 t -127.14 -49.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -47.02 54.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.04 96.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.38 -35.09 74.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.1 -44.64 88.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.1 mm -66.86 -35.22 74.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.28 -42.92 82.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 0.0 110.353 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -67.26 -23.62 65.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.51 -47.48 79.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.297 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.9 p -76.15 -41.8 48.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -60.79 -46.09 91.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -93.84 143.74 26.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -85.57 126.01 33.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.63 138.19 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.599 0.714 . . . . 0.0 111.718 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.01 35.63 0.78 Allowed Glycine 0 C--N 1.313 -0.718 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.34 -40.28 96.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 176.23 39.34 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.7 135.29 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.628 -1.624 . . . . 0.0 112.416 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.968 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.42 -59.96 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.012 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.4 p -148.8 153.37 38.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.82 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.416 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -117.97 119.43 34.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.938 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 68' ' ' PHE . 59.7 t -90.04 122.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 111.184 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.836 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -122.78 126.14 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.156 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.72 ' HA ' HD13 ' A' ' 143' ' ' LEU . 47.2 t -81.08 118.58 22.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.579 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.65 HG21 ' OE2' ' A' ' 129' ' ' GLU . 4.1 t -83.52 -27.89 29.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' H ' ' A' ' 142' ' ' SER . 50.6 p -79.88 -2.28 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.461 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.57 77.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.943 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.4 mt-30 -147.35 -43.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.996 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.931 HD11 HD21 ' A' ' 141' ' ' LEU . 1.4 mt -112.15 141.26 24.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.51 143.87 43.72 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.177 1.918 . . . . 0.0 112.172 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.836 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -60.13 133.91 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -128.67 164.44 22.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.68 119.93 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -90.67 126.72 36.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.968 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -131.8 157.07 44.85 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.168 0.985 . . . . 0.0 113.613 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.99 159.68 40.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.216 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.2 m-20 -84.99 119.86 25.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 151' ' ' PHE . 55.1 mt -64.49 -43.21 96.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.916 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -61.7 -40.82 96.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 0.0 110.668 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.7 mm-40 -68.48 -36.91 79.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.6 t -73.02 -44.33 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.757 HD21 HD11 ' A' ' 155' ' ' LEU . 3.5 mm? -64.95 -35.28 80.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -68.1 -51.8 42.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.942 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -81.03 136.95 36.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 21.46 13.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -167.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 p -80.04 -25.24 40.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 93' ' ' LEU . 8.3 tp -175.69 158.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 111.148 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -131.31 -49.16 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.538 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -128.3 129.43 46.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.937 0.399 . . . . 0.0 111.844 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.728 HG12 ' HG2' ' A' ' 90' ' ' GLN . 20.6 t -136.17 139.66 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.019 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.707 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.9 m-90 -100.63 138.98 36.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.998 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -112.25 132.05 55.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -114.33 145.25 42.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.79 -175.08 39.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.99 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -78.99 -0.43 31.1 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.85 135.8 39.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.634 0.254 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.83 -9.28 25.08 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.686 2.257 . . . . 0.0 111.789 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.98 -43.69 16.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.975 0.893 . . . . 0.0 108.669 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.05 136.5 4.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.651 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -56.49 -18.51 11.71 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.091 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 7.0 t80 -129.42 114.75 16.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.723 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -89.16 119.59 29.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.428 ' HA ' HG12 ' A' ' 43' ' ' ILE . 10.0 mp -92.85 -77.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.34 -86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 173.65 48.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 110.929 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HG22 ' H ' ' A' ' 83' ' ' ARG . 4.6 mt -77.47 126.48 37.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -58.57 -30.69 67.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.58 -49.23 56.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.8 mp -75.45 153.3 37.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 0.0 111.17 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 p -93.45 168.66 10.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.2 m-20 -43.95 -55.39 4.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.344 0.593 . . . . 0.0 109.765 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' THR . 6.1 ptmt -119.66 82.9 1.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -59.41 -45.85 90.36 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.981 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 21.2 p90 -146.36 159.53 43.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.97 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.728 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.84 143.45 45.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.381 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 25.2 mt -116.67 127.4 74.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.623 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 92' ' ' LEU . 2.2 pt? -116.5 136.73 52.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.503 . . . . 0.0 112.065 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 6.1 tp -125.0 129.47 50.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.326 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.36 63.02 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.477 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -124.0 -57.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 110.906 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -150.34 37.49 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.83 16.57 63.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.452 ' O ' HD12 ' A' ' 93' ' ' LEU . 37.4 m-20 -133.72 -173.53 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' HG ' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -109.34 153.63 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.848 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.16 147.15 52.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.381 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.661 HD21 HD11 ' A' ' 145' ' ' ILE . 1.3 mt -112.68 124.8 53.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.9 t30 -115.88 115.62 26.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.031 0.443 . . . . 0.0 111.522 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.808 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -79.13 136.17 37.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.057 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 89' ' ' PHE . 16.6 pt -145.15 39.61 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.56 159.74 14.74 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.05 0.452 . . . . 0.0 111.804 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.577 ' OG1' HG21 ' B' ' 5' ' ' TPO . 90.3 m -69.06 -37.7 78.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.501 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 9.9 p30 -98.46 -19.91 17.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.55 160.78 10.95 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.695 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.0 m -117.58 137.91 52.28 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.76 148.38 38.44 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.35 18.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.366 177.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 44.27 42.86 5.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.91 -8.51 77.73 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.485 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.3 118.62 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.9 tptp -74.14 123.05 23.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.808 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.29 164.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.261 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.1 tp10 -69.86 126.71 30.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 36.9 tttm -52.63 161.05 0.77 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.891 0.377 . . . . 0.0 110.713 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.51 34.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.32 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.3 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.153 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.848 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.3 m120 -84.2 130.05 34.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.058 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.754 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.5 mm-40 -129.34 146.66 51.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.379 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -72.81 135.66 45.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 145' ' ' ILE . 67.6 tp -66.71 155.85 36.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.401 0.619 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.69 153.11 42.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.41 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.632 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 114.0 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.202 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.63 71.57 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t0 -56.21 172.09 0.23 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 111.174 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 144' ' ' VAL . 6.9 tt0 -145.19 135.56 24.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.928 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -113.68 128.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.614 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.652 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.5 140.71 37.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.8 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.546 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.3 m -140.36 158.64 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.31 43.42 9.53 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.084 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -84.03 140.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.654 0.74 . . . . 0.0 112.275 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.19 -39.5 1.18 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.34 120.03 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -50.42 -26.49 5.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.364 -178.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 136' ' ' VAL . 32.9 m -93.62 6.55 47.9 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.37 26.11 5.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.652 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.11 138.33 33.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.014 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 HD11 ' A' ' 43' ' ' ILE . 5.6 tp -124.94 134.81 52.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.46 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.649 ' C ' HD22 ' A' ' 143' ' ' LEU . 39.3 t -109.89 149.54 29.73 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.658 0.742 . . . . 0.0 112.364 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -136.36 142.03 43.76 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.713 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.3 t -113.35 140.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.75 0.309 . . . . 0.0 111.007 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.917 HD11 HD11 ' A' ' 130' ' ' ILE . 23.6 mt -106.08 121.13 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.533 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -107.82 113.13 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.799 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.5 mp -84.9 130.59 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.501 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -75.85 133.69 40.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -73.88 -28.81 61.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -44.48 87.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.963 0.411 . . . . 0.0 110.485 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 4.2 t80 -57.82 -43.99 86.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -41.2 94.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.023 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -58.96 -46.63 87.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.034 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.419 ' HB3' HD13 ' A' ' 52' ' ' ILE . 13.0 t -58.93 -45.91 89.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.757 HD11 HD21 ' A' ' 56' ' ' LEU . 2.0 mm? -56.59 -47.18 80.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -36.77 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.21 -23.73 64.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -125.86 92.78 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -106.43 130.9 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -76.2 138.36 20.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 60.97 112.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.09 89.9 3.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.64 137.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.837 0.351 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.863 HG23 ' O2P' ' B' ' 5' ' ' TPO . 15.8 tt -178.56 158.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.863 ' O2P' HG23 ' B' ' 4' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.14 123.33 68.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.41 138.83 27.84 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.434 2.089 . . . . 0.0 112.349 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -78.14 154.39 31.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -76.6 148.79 36.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -169.95 87.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t 60.19 86.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.925 179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.781 0.324 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -83.69 67.3 9.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.37 -46.97 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.56 -36.98 84.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.6 -37.42 86.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.72 96.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.3 mm -67.02 -35.15 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.24 -40.98 78.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -23.87 65.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.52 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.43 79.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.235 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -59.59 -42.31 92.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -85.52 67.14 10.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.89 120.98 16.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 105.96 16.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.92 138.32 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.602 0.715 . . . . 0.0 111.759 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -175.81 79.18 0.07 OUTLIER Glycine 0 C--N 1.313 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.558 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.74 -35.67 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.61 38.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -79.76 133.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.563 -177.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.029 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -92.65 -62.57 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.9 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.8 p -141.64 165.14 28.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.274 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 146' ' ' PHE . 0.0 OUTLIER -124.48 138.21 54.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 111.438 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.701 HG11 ' HE2' ' A' ' 68' ' ' PHE . 2.4 m -108.8 122.63 63.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.627 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -126.94 119.86 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.792 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.773 ' HA ' HD13 ' A' ' 143' ' ' LEU . 16.4 t -83.76 102.34 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 110.292 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.528 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.2 t -77.27 -25.48 51.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.924 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.619 HG21 ' H ' ' A' ' 142' ' ' SER . 9.9 p -79.9 -2.59 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.515 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.52 79.95 0.19 Allowed Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.068 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.552 ' NE2' HD13 ' A' ' 141' ' ' LEU . 1.5 mt-30 -146.97 -39.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.897 0.379 . . . . 0.0 110.896 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -129.11 144.09 51.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.917 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' A' ' 43' ' ' ILE . 38.5 Cg_endo -68.89 141.58 49.31 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.183 1.922 . . . . 0.0 111.934 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.0 mt -56.49 140.26 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.907 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 43.1 mtt-85 -135.38 164.11 28.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.87 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.91 119.79 29.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -78.91 135.61 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.029 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.7 156.14 43.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.74 141.74 28.29 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.672 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -75.01 141.73 43.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.162 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.7 mm -64.02 -40.65 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.487 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -56.77 -39.65 74.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.645 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.0 OUTLIER -68.4 -36.93 79.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.8 t -67.47 -42.81 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -39.4 72.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -40.88 97.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.24 109.59 12.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.45 30.7 3.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -115.67 -167.18 1.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -95.13 44.07 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.862 HD11 ' CG2' ' A' ' 65' ' ' VAL . 6.6 tp -166.07 134.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 55' ' ' VAL . 11.3 mttm -124.4 -58.71 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -148.82 141.37 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.862 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.4 t -136.34 139.24 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.317 0.58 . . . . 0.0 112.247 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.859 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.2 m-90 -109.94 139.13 45.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.982 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.85 127.24 55.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.701 ' HE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.25 145.78 41.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.658 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -169.35 35.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.683 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -82.12 5.0 20.99 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.82 128.61 60.01 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.514 0.197 . . . . 0.0 110.668 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.53 -11.8 32.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.223 1.948 . . . . 0.0 111.431 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.23 -42.96 16.62 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.781 0.801 . . . . 0.0 108.974 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.11 136.82 1.45 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.755 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.54 -18.37 11.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.927 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 28.8 t80 -129.43 117.24 20.23 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.03 121.9 35.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.908 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD12 ' HA2' ' A' ' 69' ' ' GLY . 10.4 mt -100.1 -69.61 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.26 -95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -178.74 54.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.815 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.9 mt -81.01 126.12 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 -36.79 69.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.2 mmt-85 -68.7 -29.47 67.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.016 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.815 ' CD1' HD12 ' A' ' 81' ' ' ILE . 38.9 mt -95.92 152.06 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.8 p -96.29 165.46 12.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.656 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.3 -53.35 4.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.397 0.618 . . . . 0.0 109.973 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.77 83.04 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -60.12 -47.07 87.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.816 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.22 157.28 43.81 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.854 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.05 135.74 39.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.346 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 46.9 mt -109.36 132.06 58.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.825 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -121.72 151.64 40.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.952 0.406 . . . . 0.0 111.576 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 ' CG1' ' A' ' 33' ' ' VAL . 14.6 tp -125.02 122.68 37.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.377 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.7 -153.79 8.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 58.39 -171.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.57 63.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.42 -173.06 38.48 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 63.0 162.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.363 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.862 HD21 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -107.0 160.13 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.1 mp -127.13 141.57 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 91' ' ' ILE . 21.6 tp -112.88 126.39 55.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.7 t30 -117.06 115.57 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.07 0.462 . . . . 0.0 111.181 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.78 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -79.66 132.01 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 67' ' ' THR . 22.2 pt -141.35 40.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.64 152.72 20.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.068 0.461 . . . . 0.0 111.882 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -68.77 -31.55 70.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.986 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -98.12 -19.81 17.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.32 157.43 10.75 Favored Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.703 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.873 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.41 148.39 40.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.304 177.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 99.4 m-20 44.93 43.53 7.21 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -9.78 70.0 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.489 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -105.4 118.53 36.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.056 0.428 . . . . 0.0 110.808 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.873 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.8 tptm -73.7 128.62 35.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.198 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.78 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.8 m -99.47 166.87 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.212 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -70.0 126.02 28.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 34.3 tttt -52.36 162.18 0.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 110.324 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.52 36.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.968 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.89 145.06 40.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.519 HD22 HD21 ' A' ' 92' ' ' LEU . 6.6 m120 -92.12 126.64 37.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.625 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.07 147.08 50.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.4 tt -72.91 116.39 13.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.919 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 123' ' ' LEU . 1.2 mm? -53.38 167.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.665 0.745 . . . . 0.0 112.019 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.23 153.29 43.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.228 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.9 tp60 -71.55 114.65 9.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.74 26.4 72.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.911 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.8 t0 -60.24 176.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 111.035 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.882 ' CG ' HG22 ' A' ' 144' ' ' VAL . 8.1 mt-10 -145.31 135.71 24.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.263 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 9.1 mt -112.69 126.21 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.495 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.48 141.45 36.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.179 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 29.4 m -140.26 158.5 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.01 43.79 9.54 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.013 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.4 t -84.08 140.42 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.733 0.777 . . . . 0.0 112.47 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.15 -42.44 0.86 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 138' ' ' SER . 57.5 t -126.53 122.13 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 114.592 -0.804 . . . . 0.0 109.033 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.532 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.36 -24.86 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.727 0.299 . . . . 0.0 111.704 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.26 6.34 48.41 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 11.6 m-20 -130.75 26.65 4.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.06 139.39 28.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.003 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.552 HD13 ' NE2' ' A' ' 42' ' ' GLN . 31.7 tp -122.4 134.43 54.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.619 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.66 137.05 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.07 0.462 . . . . 0.0 111.856 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -131.26 145.05 51.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.172 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.882 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.5 t -111.41 135.65 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.585 HG21 ' CD1' ' A' ' 124' ' ' LEU . 1.3 mm -106.45 122.69 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.581 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -113.13 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.073 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.59 HG23 ' CD1' ' A' ' 99' ' ' LEU . 5.9 mt -84.79 126.48 40.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.205 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -81.76 115.47 21.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.72 -22.33 65.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.34 -43.56 83.51 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -38.18 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.694 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -65.08 -33.91 77.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.876 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -47.04 87.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.88 -46.02 89.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.062 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -43.96 88.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -35.17 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.715 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -24.85 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.93 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -123.95 77.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.949 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 150.56 46.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 160' ' ' VAL . 11.1 p -84.11 117.51 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.086 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -109.05 118.86 37.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -99.78 146.22 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.7 128.17 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.17 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.79 0.329 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -158.24 131.51 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -95.68 132.92 26.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 168.96 22.79 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.482 2.121 . . . . 0.0 112.359 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 97.7 m -137.38 147.07 45.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.713 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.21 175.99 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.59 -171.72 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 4.2 t -99.46 124.09 44.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.897 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -121.55 -48.28 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -65.33 -47.07 77.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -58.92 -36.72 75.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -59.95 -42.4 93.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -32.74 71.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.1 -35.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -57.51 -38.02 73.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.465 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -67.17 -23.84 65.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.83 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.81 -47.53 80.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -37.55 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -61.6 -68.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -79.78 139.33 37.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -98.27 130.35 44.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.56 136.61 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 C-N-CA 123.068 0.547 . . . . 0.0 110.683 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.33 63.4 2.05 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -77.95 -39.31 43.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 177.68 38.42 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.11 136.13 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.479 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.67 -60.16 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.769 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.6 p -147.26 150.2 34.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.165 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.89 129.32 56.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.472 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 48' ' ' LEU . 3.3 m -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.6 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.825 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -131.4 128.23 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.656 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.31 110.04 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.972 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.2 p -87.15 -24.25 24.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.792 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.845 HG21 ' OG ' ' A' ' 142' ' ' SER . 72.5 p -79.91 -2.56 44.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.737 0.303 . . . . 0.0 111.606 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 71.62 78.32 0.47 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.444 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.3 mt-30 -148.56 -40.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.246 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -130.2 141.54 42.26 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.78 146.03 42.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.23 1.953 . . . . 0.0 112.195 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.825 HG12 HG23 ' A' ' 37' ' ' ILE . 33.9 mt -56.02 156.84 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.844 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.12 164.1 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.359 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.2 p30 -119.58 119.94 35.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.069 0.461 . . . . 0.0 111.975 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.688 HD12 ' SG ' ' A' ' 34' ' ' CYS . 3.0 mt -100.77 134.64 43.44 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.82 158.87 43.63 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.37 149.83 35.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.791 -1.549 . . . . 0.0 111.122 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.704 ' O ' HG23 ' A' ' 55' ' ' VAL . 72.1 m-20 -75.02 120.6 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.483 HD13 ' SG ' ' A' ' 154' ' ' CYS . 46.9 mt -64.53 -42.24 94.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.141 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -40.07 75.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.293 0.568 . . . . 0.0 110.67 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.7 mm100 -68.53 -39.45 81.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.637 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.87 HG13 ' HD3' ' A' ' 63' ' ' LYS . 48.8 t -62.63 -43.07 98.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.0 -22.08 62.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.243 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.97 13.0 23.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.616 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.08 137.07 47.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.862 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.81 124.31 18.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.7 mtt85 -48.32 99.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.04 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.571 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.0 tp -173.37 150.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.13 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.87 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.72 -63.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.977 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -145.89 136.59 24.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 62' ' ' ILE . 10.6 t -126.38 138.09 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 112.013 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.551 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.4 m-90 -101.85 139.66 37.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.003 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.97 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.61 130.13 55.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.06 145.27 47.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.16 -167.2 36.7 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.755 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 4.0 mtm105 -83.88 3.56 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.9 t-20 -84.93 133.41 43.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 111.019 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -66.06 -14.2 43.33 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.552 2.168 . . . . 0.0 111.676 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.61 16.71 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.946 0.879 . . . . 0.0 108.852 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -44.29 139.8 2.49 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.802 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 5.5 m-20 -56.4 -18.88 12.49 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.859 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.535 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -129.81 127.78 41.0 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.86 108.0 19.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.772 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 43' ' ' ILE . 26.3 mt -76.7 -166.52 0.68 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.17 17.94 53.58 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.25 79.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.397 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 31.8 mt -112.03 132.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -54.99 -34.68 63.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.324 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.12 -27.37 64.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 132' ' ' VAL . 40.6 mt -96.64 152.19 18.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.07 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.82 164.77 12.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.661 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.99 -52.82 5.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 109.615 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.72 82.9 1.96 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.77 -45.97 91.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.923 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.4 p90 -143.55 162.52 35.65 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.436 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.97 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 133.99 38.92 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.202 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.58 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.8 mt -111.56 127.79 68.5 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.724 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -114.77 146.89 40.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.544 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp -125.0 122.94 38.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.508 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 95' ' ' GLU . . . 147.8 -155.15 26.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.501 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 94' ' ' GLY . 1.6 tp10 84.77 -21.79 0.23 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.481 0.312 . . . . 0.0 111.699 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -177.46 -46.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.884 0.374 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.51 -32.33 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.355 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -75.13 -172.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.77 0.319 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -111.13 157.6 19.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.1 mt -133.18 146.67 51.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 124' ' ' LEU . 10.7 mt -112.72 124.41 52.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.06 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.673 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.7 t30 -117.52 115.67 25.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.807 ' OD2' HG23 ' A' ' 116' ' ' VAL . 7.6 p30 -78.35 139.66 38.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.165 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 89' ' ' PHE . 20.6 pt -147.88 40.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.95 152.11 20.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.086 0.47 . . . . 0.0 111.778 -178.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.1 m -68.93 -31.54 70.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.038 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.94 17.57 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.05 155.4 9.81 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.65 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -117.57 137.75 52.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.892 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -117.41 148.29 41.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.65 18.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.439 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.65 43.76 6.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.388 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -9.99 69.39 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.437 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -104.64 118.66 37.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.624 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.892 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 3.1 tptm -74.03 122.57 22.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.224 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.807 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -93.64 164.55 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 tp10 -69.82 127.75 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.535 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -53.71 161.03 1.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.922 0.391 . . . . 0.0 110.635 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.53 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.348 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.35 145.17 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.122 179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.837 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.3 m120 -83.97 130.2 34.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.864 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.762 ' O ' HD23 ' A' ' 100' ' ' LEU . 30.6 mm-40 -129.46 147.68 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.456 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.86 132.9 44.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.245 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.853 HD21 HG12 ' A' ' 147' ' ' ILE . 38.0 tp -65.05 154.43 37.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.485 0.659 . . . . 0.0 111.61 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.454 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -124.81 153.05 43.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.36 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 122.76 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.892 0.377 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 23.89 49.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.145 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.6 t70 -54.78 170.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.065 0.46 . . . . 0.0 111.21 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 6.1 tt0 -145.17 135.57 24.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.006 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 145' ' ' ILE . 2.3 mt -109.4 128.04 65.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.438 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.37 140.3 38.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.045 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.651 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.37 158.33 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 80.07 42.97 10.16 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -82.83 140.45 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.687 0.756 . . . . 0.0 112.274 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.791 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 145.33 -39.92 1.14 Allowed Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.48 123.98 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 114.619 -0.791 . . . . 0.0 109.082 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.27 10.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.785 0.326 . . . . 0.0 111.412 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.42 6.48 48.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 133' ' ' GLY . 54.3 m-20 -124.34 23.06 8.39 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.5 mt -107.0 139.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.39 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 142' ' ' SER . 8.9 tt -122.32 134.72 54.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.233 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.845 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.99 128.18 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.087 0.47 . . . . 0.0 111.854 -179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 43' ' ' ILE . 18.6 mt -121.44 137.42 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.03 137.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.816 0.341 . . . . 0.0 111.278 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.922 HD11 HD11 ' A' ' 130' ' ' ILE . 31.6 mt -106.16 131.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.09 120.36 39.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.853 HG12 HD21 ' A' ' 124' ' ' LEU . 5.7 mt -84.85 131.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.21 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -75.99 118.43 18.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.54 -30.82 71.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.88 -45.94 90.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.29 -43.12 87.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -38.02 89.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.96 -45.66 89.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.974 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.7 t -60.94 -46.06 92.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 155' ' ' LEU . 3.5 mm? -68.2 -35.76 78.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.03 -41.87 93.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 159' ' ' LYS . 10.5 tt0 -84.7 -31.39 24.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.69 -91.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.692 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' GLN . 18.0 mtmt -73.07 133.82 44.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.848 0.356 . . . . 0.0 110.955 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.05 132.38 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.05 30.4 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.47 114.94 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.0 mt -84.22 113.63 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.038 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.779 0.323 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 4' ' ' ILE . 1.1 tt -141.87 60.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.557 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -98.16 98.36 5.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.05 -167.5 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.453 2.102 . . . . 0.0 112.308 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.791 HG21 ' HA3' ' A' ' 135' ' ' GLY . 18.6 m -93.75 145.68 24.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.33 121.0 24.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.93 173.95 6.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 40.4 p -83.83 91.44 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.834 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.898 0.38 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.8 t -139.55 -47.65 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -70.88 -45.41 64.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -59.02 -46.12 88.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -35.05 73.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -41.46 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.8 mm -71.92 -35.09 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.16 -38.19 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -67.34 -24.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.671 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.76 79.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.148 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -81.12 -31.56 34.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.852 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 64.34 72.8 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.01 121.0 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -69.88 125.01 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.99 138.34 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.66 0.743 . . . . 0.0 111.776 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.98 90.06 0.26 Allowed Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -36.21 17.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.908 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 178.56 38.32 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.728 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.78 133.99 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.458 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.43 -61.7 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.149 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.6 p -148.96 150.08 32.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.408 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.51 HH11 HD11 ' A' ' 37' ' ' ILE . 6.0 ttm180 -113.96 138.1 50.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.848 0.356 . . . . 0.0 111.147 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.694 HG11 ' CE1' ' A' ' 76' ' ' TYR . 15.0 p -99.99 122.9 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 45' ' ' ILE . 18.7 mt -130.29 119.41 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.649 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HA ' HD23 ' A' ' 143' ' ' LEU . 40.9 t -79.95 142.07 35.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 144' ' ' VAL . 2.9 p -111.42 -21.29 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.727 ' OG1' HD23 ' A' ' 141' ' ' LEU . 74.8 p -85.09 -2.78 58.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.732 0.301 . . . . 0.0 111.559 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.83 86.91 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.093 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.9 pt20 -159.72 -40.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.084 0.468 . . . . 0.0 111.374 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.572 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 4.3 mt -122.92 139.96 32.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.4 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 70.3 Cg_endo -76.76 146.16 26.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.508 2.139 . . . . 0.0 112.376 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.8 HG12 HG23 ' A' ' 37' ' ' ILE . 37.4 mt -55.9 148.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.841 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.06 162.06 37.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.027 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.37 119.91 36.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.092 0.472 . . . . 0.0 111.931 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 10.0 mt -96.25 137.28 35.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.48 158.7 43.63 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.52 142.42 33.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.914 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.894 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -74.99 115.8 15.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.072 0.463 . . . . 0.0 111.161 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.38 -44.08 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.077 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.49 -40.73 92.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.349 0.595 . . . . 0.0 110.706 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.0 mm-40 -68.45 -36.93 79.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 51' ' ' ASP . 65.9 t -64.26 -37.85 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mt -70.58 -31.78 68.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -74.75 -50.53 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.915 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.45 116.89 10.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.2 88.25 5.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.61 176.59 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.67 -57.64 3.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.869 HD11 HG22 ' A' ' 65' ' ' VAL . 9.3 tp -88.82 149.79 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HD2' HG13 ' A' ' 55' ' ' VAL . 9.4 mmtm -126.6 -66.75 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.09 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.3 ttpt -140.65 125.55 18.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.169 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.869 HG22 HD11 ' A' ' 62' ' ' ILE . 6.4 t -123.08 139.48 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.249 0.547 . . . . 0.0 111.752 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.6 m-90 -100.78 139.91 35.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.86 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.655 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.19 125.3 51.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.9 m-85 -113.17 145.57 40.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.926 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.9 -173.47 39.12 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.274 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 11.8 mtp-105 -77.43 -1.56 30.83 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.82 134.2 42.16 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.769 0.318 . . . . 0.0 111.19 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -68.01 -10.56 29.26 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.728 2.286 . . . . 0.0 111.967 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.76 -42.87 17.43 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 121.868 0.842 . . . . 0.0 108.914 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.68 140.3 1.0 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.848 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -56.06 -18.33 9.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.147 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.694 ' CE1' HG11 ' A' ' 36' ' ' VAL . 42.7 t80 -128.88 125.92 38.66 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.739 0.304 . . . . 0.0 110.88 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.42 113.09 26.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.752 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -116.63 175.71 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' O ' HD12 ' A' ' 81' ' ' ILE . . . -55.5 166.2 3.43 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.596 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -93.83 92.14 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.013 HD13 HD12 ' A' ' 84' ' ' LEU . 4.3 mp -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 p -54.75 -24.91 24.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.5 mmp_? -74.19 -29.57 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.013 HD12 HD13 ' A' ' 81' ' ' ILE . 30.2 mt -92.2 152.21 19.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.98 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.4 p -96.16 163.44 13.1 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.506 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.65 -53.2 3.64 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 109.763 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.51 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.9 mttp -118.41 84.28 2.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -63.93 -45.13 90.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HA ' HG12 ' A' ' 104' ' ' ILE . 30.7 p90 -152.67 163.24 40.03 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.189 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.1 mt-30 -135.29 154.94 51.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.494 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mt -123.63 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.167 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.92 148.02 37.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 111.589 -179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.6 tm? -125.14 125.45 43.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.473 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.604 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -167.54 -163.58 21.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.652 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.61 -168.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.996 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.56 99.28 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.9 51.18 58.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.62 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -147.54 162.71 38.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 0.0 110.885 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.94 HD21 HG12 ' A' ' 33' ' ' VAL . 4.4 mp -135.02 152.1 51.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -133.02 145.79 51.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.312 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.933 HD11 HD12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -112.96 131.79 55.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.534 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -119.76 115.57 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.9 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.826 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -78.68 143.21 36.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.062 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.528 HG21 ' OE1' ' A' ' 90' ' ' GLN . 10.2 pt -150.39 36.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.04 152.53 18.65 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.151 0.5 . . . . 0.0 112.19 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.83 -31.44 70.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.852 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.08 -19.84 18.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.508 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.79 158.65 11.69 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.59 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.9 m -117.31 137.67 52.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.58 148.38 39.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.55 18.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.602 177.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 62.5 m-20 43.63 43.68 4.88 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.18 -14.22 61.37 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.451 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.39 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 110.517 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.73 128.24 35.38 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.527 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.826 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.4 m -96.25 162.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.834 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.9 mp0 -69.89 127.63 33.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.397 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 49.6 tttm -53.41 161.72 0.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.41 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 9.0 m-80 33.84 35.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.261 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.974 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.687 ' HB3' HD23 ' A' ' 100' ' ' LEU . 27.3 m120 -89.78 130.21 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.224 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 47.1 mm-40 -129.33 148.66 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.417 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.59 121.5 19.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.351 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 147' ' ' ILE . 66.0 tp -55.27 156.51 4.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.462 0.649 . . . . 0.0 111.563 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.411 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.63 153.41 42.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.587 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.51 120.39 17.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.76 22.68 62.32 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.679 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.46 170.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.006 0.431 . . . . 0.0 111.237 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.5 tt0 -145.14 135.45 24.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.906 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.491 ' CD1' HD22 ' A' ' 101' ' ' LEU . 19.0 mt -118.36 128.14 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.8 m -104.41 140.77 37.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.233 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 32.0 m -140.37 158.34 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 112.145 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.13 37.24 11.47 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.815 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -80.53 140.48 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.671 0.748 . . . . 0.0 112.503 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.3 -39.35 0.71 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 138' ' ' SER . 35.4 t -126.35 121.76 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.09 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.54 7.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.502 ' H ' HG12 ' A' ' 136' ' ' VAL . 19.6 t -93.51 6.52 47.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -130.05 29.68 4.9 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.567 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.26 138.91 30.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.932 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.727 HD23 ' OG1' ' A' ' 40' ' ' THR . 3.0 mt -124.45 134.38 53.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.728 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -106.02 150.43 25.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.67 0.748 . . . . 0.0 112.318 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 38' ' ' CYS . 68.4 mt -135.68 147.16 48.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.01 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.413 HG21 ' CG2' ' A' ' 39' ' ' THR . 36.9 t -120.14 139.98 45.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.343 . . . . 0.0 111.061 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.933 HD12 HD11 ' A' ' 101' ' ' LEU . 2.5 mt -106.24 139.09 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.86 116.85 25.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.94 132.47 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.189 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.47 113.05 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.78 -27.47 68.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.49 -45.04 89.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.554 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -57.82 -43.06 85.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.04 -41.4 95.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.5 -44.59 95.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -61.79 -45.85 92.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -66.34 -36.96 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.9 77.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.85 -36.99 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.4 p30 44.41 -171.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.585 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -104.43 161.78 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.936 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.34 130.44 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -72.02 149.41 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -34.68 78.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 pt -101.78 139.93 21.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.1 mtt180 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.903 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.82 0.343 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 9.0 tp -120.33 146.68 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.453 ' H ' ' P ' ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.43 108.8 1.38 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.936 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.68 136.85 78.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.437 HG22 ' N ' ' B' ' 9' ' ' GLN . 77.3 m -90.51 162.34 15.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.437 ' N ' HG22 ' B' ' 8' ' ' THR . 24.8 mt-30 -57.06 130.91 48.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -133.18 -178.47 4.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 11.5 m -82.32 99.73 9.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.938 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -108.54 -34.83 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.55 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -71.87 -47.14 55.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.82 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -61.95 -36.05 80.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.41 -37.69 81.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.682 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD23 ' HE2' ' A' ' 22' ' ' LYS . 6.3 mt -66.09 -33.09 74.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.727 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.19 -35.51 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.53 -46.11 84.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.58 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.813 ' HE2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -67.08 -23.67 65.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.605 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.55 79.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.227 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -75.55 -31.51 60.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.93 91.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -90.59 144.92 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.36 112.06 23.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.07 138.32 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.584 0.707 . . . . 0.0 111.823 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.27 29.19 9.11 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.445 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -67.11 -36.69 82.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.18 38.89 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.5 mm -73.08 135.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.67 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.95 -60.58 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 48' ' ' LEU . 5.6 p -149.42 151.14 33.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.084 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.84 134.66 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.758 0.313 . . . . 0.0 111.383 -179.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 48' ' ' LEU . 26.6 t -101.48 122.68 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.98 123.12 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.561 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.9 t -83.15 119.09 24.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.369 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -25.49 32.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.866 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 142' ' ' SER . 58.6 p -79.94 -2.3 43.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.649 0.261 . . . . 0.0 111.446 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.67 77.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.024 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.827 ' OE1' HD11 ' A' ' 141' ' ' LEU . 10.0 mt-30 -146.03 -44.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 110.773 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.063 HD13 HD22 ' A' ' 78' ' ' LEU . 5.4 mt -109.12 141.17 22.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -72.97 133.56 20.05 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.79 138.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.563 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.21 162.99 28.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.553 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -115.57 119.66 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.999 0.428 . . . . 0.0 111.659 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.752 HD11 HG23 ' A' ' 36' ' ' VAL . 3.0 mt -95.12 133.63 38.73 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.71 158.49 43.85 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.4 145.96 35.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.817 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.8 m-20 -74.97 120.56 20.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.563 . . . . 0.0 111.366 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 151' ' ' PHE . 18.0 mt -65.35 -38.81 83.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.153 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 p -60.33 -43.28 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.11 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.65 -36.79 79.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.907 0.384 . . . . 0.0 110.423 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG22 ' HG2' ' A' ' 63' ' ' LYS . 45.8 t -69.87 -46.78 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.998 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -32.25 71.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -82.4 -46.79 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.56 129.07 41.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 80.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.8 -174.57 2.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.23 41.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.612 HD11 HG22 ' A' ' 65' ' ' VAL . 8.2 tp -130.15 145.52 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.086 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.709 ' HG2' HG22 ' A' ' 55' ' ' VAL . 4.3 mppt? -114.82 -59.16 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.998 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -154.97 138.36 15.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -130.77 139.18 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.323 0.582 . . . . 0.0 112.148 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.2 m-90 -102.67 139.42 38.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.062 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -111.72 129.31 56.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.744 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 1.1 m-85 -120.12 145.22 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.49 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.84 -166.86 35.16 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 12.2 mtm105 -80.94 4.52 19.18 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.68 130.54 52.73 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.533 0.206 . . . . 0.0 110.917 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 20.3 Cg_exo -65.33 -14.71 46.46 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.415 2.077 . . . . 0.0 111.594 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -44.12 15.62 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.929 0.871 . . . . 0.0 108.873 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -38.88 139.7 0.43 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.815 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.3 m-20 -56.35 -19.13 13.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.851 ' CD2' HD21 ' A' ' 78' ' ' LEU . 1.2 t80 -130.21 119.73 23.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.695 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.6 t-160 -89.67 109.14 20.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.063 HD22 HD13 ' A' ' 43' ' ' ILE . 8.8 mt -106.03 162.39 13.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.833 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.55 129.4 49.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.093 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -62.93 79.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.831 0.348 . . . . 0.0 111.09 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 83' ' ' ARG . 32.7 mm -105.0 139.64 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.7 m -60.08 -31.6 70.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.371 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.662 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.77 -29.82 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.217 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.596 HD13 ' HB ' ' A' ' 81' ' ' ILE . 5.3 mp -102.39 152.65 20.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 162.24 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.878 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -43.14 -52.1 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.757 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CB ' HD12 ' A' ' 104' ' ' ILE . 40.0 mttt -119.18 80.89 1.62 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.618 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 16.1 t60 -61.14 -45.87 92.89 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.786 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 39.1 p90 -147.75 159.97 43.23 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.992 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.5 tt0 -136.18 141.88 44.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.744 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 58.7 mt -116.49 127.59 74.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.943 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -111.29 151.46 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.9 tp -125.07 122.76 38.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.68 -138.81 2.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.595 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 68.74 -67.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.704 0.288 . . . . 0.0 110.928 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -178.03 -66.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.11 28.28 2.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.418 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -131.34 174.62 9.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -117.45 159.66 22.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.796 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.1 mt -133.07 146.91 52.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.315 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 145' ' ' ILE . 1.3 mt -112.67 123.66 50.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.481 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.9 t30 -117.15 115.66 25.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 111.595 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.4 p30 -79.21 140.51 37.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.555 HD12 ' CB ' ' A' ' 87' ' ' LYS . 10.3 pt -143.46 30.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.554 0.216 . . . . 0.0 111.577 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.3 t -89.96 158.31 17.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.447 0.641 . . . . 0.0 112.243 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 m -69.68 -49.17 56.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.499 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.28 3.04 56.31 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.43 157.4 23.75 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.053 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 HG22 ' CG2' ' A' ' 130' ' ' ILE . 7.4 m -117.82 137.92 52.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.811 -0.694 . . . . 0.0 109.215 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.31 148.8 31.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD13 ' OD1' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -123.83 113.47 18.58 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.197 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 44.14 42.91 5.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.86 -14.09 61.21 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.501 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -103.42 118.5 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.54 124.56 24.52 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.373 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.7 m -96.57 163.71 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.039 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 tm-20 -69.85 127.03 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.505 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.3 tttm -53.68 160.98 1.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.964 0.411 . . . . 0.0 110.611 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.89 34.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.288 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.19 40.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.114 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.7 m120 -88.49 131.7 34.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.874 ' O ' HD23 ' A' ' 100' ' ' LEU . 41.2 mm-40 -129.29 151.92 49.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.69 136.04 45.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.708 0.289 . . . . 0.0 110.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.735 HD22 ' HB2' ' A' ' 99' ' ' LEU . 28.1 tp -62.94 152.66 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.575 0.702 . . . . 0.0 111.521 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.4 152.51 44.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.653 179.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.46 121.36 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.36 25.29 60.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.983 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' HD13 ' A' ' 111' ' ' LEU . 25.0 t70 -49.88 165.19 0.08 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.258 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 tt0 -144.33 135.47 25.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 145' ' ' ILE . 3.1 mt -114.39 128.27 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.608 HG22 ' CG2' ' A' ' 140' ' ' ILE . 5.9 m -104.03 141.57 35.97 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.618 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 19.6 m -140.52 158.72 24.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.95 9.15 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.3 t -84.25 140.47 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.585 0.707 . . . . 0.0 112.13 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.691 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 144.27 -37.05 1.43 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 24.9 t -126.16 119.13 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.446 -0.877 . . . . 0.0 108.814 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -29.39 9.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.2 p -93.46 6.46 48.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.467 ' CB ' ' HD3' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -126.85 27.53 5.99 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.608 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.49 138.67 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.65 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.827 HD11 ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -124.51 134.43 53.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.558 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.507 ' H ' HG21 ' A' ' 40' ' ' THR . 36.1 t -106.54 149.43 27.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.791 0.805 . . . . 0.0 112.221 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.56 HD21 HD12 ' A' ' 43' ' ' ILE . 77.1 mt -136.12 143.74 44.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.597 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.37 138.03 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.2 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 101' ' ' LEU . 23.9 mt -106.13 131.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 120.2 39.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.678 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.732 HG12 HD21 ' A' ' 124' ' ' LEU . 5.4 mt -84.84 131.18 34.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -83.55 107.19 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -59.61 -26.91 65.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -59.12 -45.7 90.23 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.016 0.436 . . . . 0.0 110.611 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' CE1' HG13 ' A' ' 52' ' ' ILE . 2.2 t80 -58.11 -44.1 87.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.909 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -65.13 -39.4 92.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -59.06 -43.31 91.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.07 -42.64 80.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -66.82 -43.15 84.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.94 -40.93 86.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -83.74 -36.67 23.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.53 86.05 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.444 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -76.18 122.55 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.33 132.28 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -110.68 -33.03 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.959 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.25 127.28 40.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.96 120.28 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.91 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.823 0.344 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tt -137.45 133.38 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -64.72 111.57 6.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.15 -170.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.478 2.119 . . . . 0.0 112.17 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.691 HG21 ' HA3' ' A' ' 135' ' ' GLY . 1.8 m -99.53 167.87 10.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.26 147.07 29.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.09 50.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.85 104.32 16.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.937 -179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -112.33 67.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.86 -46.99 79.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -58.98 -39.33 81.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -59.47 -39.23 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -31.92 73.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -73.01 -35.44 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.878 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.6 -42.75 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 110.37 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -67.18 -23.68 65.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.633 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.79 -47.4 80.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -32.18 69.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 64.63 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.96 149.04 24.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -84.62 142.11 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 136.7 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.131 0 CA-C-O 121.144 0.497 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.54 44.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.345 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' HG2' HD11 ' A' ' 32' ' ' ILE . 7.3 pt-20 -68.04 -39.6 83.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 111.08 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 179.04 38.04 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.14 136.48 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.295 -177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.976 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -90.85 -59.1 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.866 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.712 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.4 p -146.24 165.2 29.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.523 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.34 138.27 51.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.395 -179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 68' ' ' PHE . 41.1 t -109.24 122.73 64.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.878 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.861 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -127.15 121.03 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.465 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.6 t -79.98 105.58 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.85 0.357 . . . . 0.0 110.438 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -71.35 -25.1 62.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.874 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.83 -2.26 42.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.529 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.0 0.26 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.995 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' NE2' HD12 ' A' ' 141' ' ' LEU . 7.7 mt-30 -146.05 -44.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.398 . . . . 0.0 110.695 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 78' ' ' LEU . 4.0 mt -112.01 141.78 25.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.1 Cg_endo -70.73 138.69 35.26 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.107 1.872 . . . . 0.0 112.293 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.861 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.83 146.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.647 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.58 164.23 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -127.58 119.65 26.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.457 . . . . 0.0 111.636 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 8.3 mp -91.35 132.56 36.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.475 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.976 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.95 155.8 46.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.314 1.054 . . . . 0.0 113.638 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.24 141.92 29.06 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.676 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -79.5 143.69 34.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 0.0 111.271 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mt -64.05 -43.97 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.717 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m -55.95 -37.2 68.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.781 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.35 -36.82 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.971 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.806 HG22 ' HG2' ' A' ' 63' ' ' LYS . 49.8 t -70.75 -44.67 76.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.234 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.95 -27.4 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.998 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -53.01 17.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.95 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.93 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.35 73.85 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 59.29 100.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -178.71 -63.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 65' ' ' VAL . 7.4 tp -178.77 130.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.806 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -102.74 -62.17 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.035 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -155.2 140.04 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 0.0 111.624 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 62' ' ' ILE . 5.6 t -126.32 134.66 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.233 0.54 . . . . 0.0 111.601 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.0 140.07 36.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.246 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.634 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.66 130.5 55.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.8 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -120.31 145.51 47.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 -179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.713 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 162.06 -167.82 36.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.954 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.3 mtp180 -83.83 3.35 34.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 5.6 t-20 -84.85 133.12 44.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -12.91 37.54 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.547 2.165 . . . . 0.0 111.678 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.79 -44.09 15.95 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.914 0.864 . . . . 0.0 108.822 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.64 138.89 2.39 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.943 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.35 -18.86 12.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.094 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.474 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 9.3 t80 -129.8 123.99 32.29 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 111.392 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.38 107.93 18.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.713 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -110.32 78.91 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.371 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 46.31 -117.04 2.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.851 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -176.71 92.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.063 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 23.1 mm -109.63 129.86 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -38.28 67.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.093 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -63.43 -28.05 69.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.877 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 78' ' ' LEU . 27.8 mt -97.48 152.11 19.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.97 162.9 13.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.723 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.11 -52.27 4.35 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 0.0 109.655 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.8 mtpm? -117.87 83.9 2.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -64.89 -45.35 86.29 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.198 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.4 p90 -150.3 162.03 41.3 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.206 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.634 ' CD ' HG23 ' A' ' 67' ' ' THR . 13.6 mt-30 -135.65 155.71 50.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.401 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.1 mt -126.28 132.35 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.029 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -128.66 144.67 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.998 -179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -125.1 131.11 53.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.142 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . -166.77 -155.24 8.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.498 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 58.22 -165.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -85.53 56.37 3.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.808 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.798 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . 107.74 -169.02 14.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.461 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.27 171.38 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.698 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -127.03 160.09 32.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.838 HD23 ' O ' ' A' ' 122' ' ' GLN . 12.2 mt -131.33 142.48 50.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.777 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.79 126.22 53.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.738 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.548 ' HB2' HD21 ' A' ' 92' ' ' LEU . 46.7 t30 -116.8 115.69 26.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -77.4 143.2 38.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.815 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' CG ' ' A' ' 90' ' ' GLN . 9.6 pt -149.6 36.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.612 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.74 151.97 19.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.11 0.481 . . . . 0.0 111.934 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.0 m -68.78 -31.45 70.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.854 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.61 -19.79 18.08 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.38 156.43 10.44 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.89 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.9 m -117.42 137.74 52.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.52 148.39 38.0 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.5 18.39 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.461 177.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 44.33 43.27 5.91 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.1 -12.53 64.02 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.518 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -104.72 118.49 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.005 0.431 . . . . 0.0 110.62 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.58 127.24 31.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.411 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -97.46 164.21 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.3 tt0 -69.89 126.71 30.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.536 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 13.5 tttm -53.28 161.42 0.92 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 0.0 110.593 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.33 33.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.438 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.44 145.14 40.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.936 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.654 ' HB3' HD22 ' A' ' 100' ' ' LEU . 28.1 m120 -90.48 130.07 36.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.838 ' O ' HD23 ' A' ' 100' ' ' LEU . 46.8 mm-40 -129.1 148.82 51.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.7 tp -72.51 116.31 12.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 145' ' ' ILE . 67.2 tp -53.46 157.54 2.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.406 0.622 . . . . 0.0 111.729 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.5 t -124.26 153.3 41.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.339 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.5 tp60 -71.47 123.51 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.3 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.28 21.81 54.53 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.131 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.87 175.25 0.09 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.05 135.62 24.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.354 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 145' ' ' ILE . 14.7 mt -114.48 126.14 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.462 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.563 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.5 140.07 38.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.251 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.3 158.35 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.122 0.487 . . . . 0.0 112.278 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.82 28.04 27.42 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.141 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.4 t -71.37 140.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 121.681 0.753 . . . . 0.0 112.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.92 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 152.76 -37.48 0.77 Allowed Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 41.6 t -126.25 131.99 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.805 -0.697 . . . . 0.0 109.3 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -40.1 51.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 6.47 48.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 8.2 t0 -119.64 28.44 8.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.563 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -107.26 139.65 28.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.987 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.401 HD12 ' NE2' ' A' ' 42' ' ' GLN . 9.0 tt -123.48 134.35 53.91 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.522 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.0 t -110.06 150.64 28.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.575 0.702 . . . . 0.0 112.36 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.0 mt -135.55 156.8 48.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.9 t -125.02 137.12 58.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.087 HD11 HD11 ' A' ' 130' ' ' ILE . 35.3 mt -106.34 123.45 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 115.1 28.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.512 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -82.73 113.95 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.684 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -29.53 70.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.015 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -46.09 91.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.793 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -59.47 -44.01 93.11 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.01 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -33.93 76.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -46.92 87.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -66.61 -46.15 76.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.998 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.798 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -65.59 -39.9 92.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.953 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.21 -42.03 94.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -83.4 -37.04 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.16 35.96 0.65 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.521 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 132.44 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.49 141.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -163.86 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.962 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.99 97.36 7.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.95 140.04 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.867 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.768 0.318 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.72 137.92 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.625 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -58.58 110.07 2.33 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 -168.36 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.509 2.139 . . . . 0.0 112.363 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.92 HG21 ' HA3' ' A' ' 135' ' ' GLY . 0.5 OUTLIER -90.15 146.63 24.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.62 91.73 3.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -167.28 160.25 13.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -117.02 94.12 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.905 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.3 p -124.47 -64.84 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -42.83 66.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -59.27 -39.81 84.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -40.68 91.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.84 96.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mm -67.78 -34.88 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.265 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -57.06 -36.11 70.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -67.33 -23.92 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.768 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.8 -47.59 79.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.298 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -70.72 -44.15 67.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -156.08 137.24 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.62 132.63 42.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.2 107.7 18.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.29 138.39 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.63 0.728 . . . . 0.0 111.736 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.25 3.21 Favored Glycine 0 C--N 1.314 -0.669 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.449 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.02 -44.49 26.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 177.14 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.1 mm -73.12 136.86 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.466 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -92.35 -59.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.843 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' A' ' 99' ' ' LEU . 4.1 p -146.67 165.46 29.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.506 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.25 138.07 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.357 . . . . 0.0 111.366 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 36' ' ' VAL . 11.8 p -105.42 122.67 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.565 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.72 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -129.51 119.44 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.551 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.4 t -79.91 108.04 13.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.379 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.594 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -72.17 -25.89 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.72 -179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.5 p -79.86 -2.22 42.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.532 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.01 76.17 0.27 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.923 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.9 mt-30 -145.73 -44.49 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.799 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.6 mt -111.72 141.35 24.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.759 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.7 Cg_endo -72.18 137.58 29.02 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.217 1.945 . . . . 0.0 112.355 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.72 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.07 136.98 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.51 164.3 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.31 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.48 119.71 34.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.957 0.408 . . . . 0.0 111.843 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.0 mp -94.24 126.59 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.949 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.38 156.67 47.94 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.038 0.923 . . . . 0.0 113.309 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.33 145.74 26.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.699 -1.591 . . . . 0.0 111.089 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.803 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.3 m-20 -75.09 128.67 36.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 111.128 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG13 ' CE1' ' A' ' 151' ' ' PHE . 85.0 mt -64.51 -45.03 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.223 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -56.98 -40.18 76.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.305 0.574 . . . . 0.0 110.718 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.3 mm-40 -68.52 -36.96 79.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.673 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 51' ' ' ASP . 42.0 t -71.42 -38.85 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.187 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 HD22 ' NZ ' ' A' ' 159' ' ' LYS . 7.7 tp -69.4 -30.21 68.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.94 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -54.21 6.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -72.48 117.51 14.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -123.27 -3.81 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.409 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -40.6 2.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.34 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.9 157.73 15.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.962 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 150.35 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.715 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -87.87 -68.24 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.971 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -155.08 136.9 14.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -130.08 139.11 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.196 0.522 . . . . 0.0 111.843 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.825 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.3 m-90 -105.27 139.54 39.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.259 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.79 132.19 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -119.3 145.61 45.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.353 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.63 -167.88 35.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.029 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 9.4 mtp-105 -81.1 3.31 23.83 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.8 t-20 -84.8 132.22 46.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.534 0.207 . . . . 0.0 111.102 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.7 Cg_exo -66.24 -14.19 43.17 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.686 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.05 -42.98 16.83 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.872 0.844 . . . . 0.0 109.026 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.41 138.92 1.16 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.109 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.8 m-20 -56.47 -18.94 13.0 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.147 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 43' ' ' ILE . 14.2 t80 -129.63 114.16 15.69 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.741 0.305 . . . . 0.0 111.04 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.22 107.88 19.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.555 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD13 ' CA ' ' A' ' 69' ' ' GLY . 10.7 mp -79.78 -80.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.6 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.345 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.57 47.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.9 0.381 . . . . 0.0 111.195 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.928 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp -84.34 119.18 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -54.81 -29.85 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.241 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.5 mmp_? -68.51 -26.94 65.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.022 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.928 HD12 HD13 ' A' ' 81' ' ' ILE . 10.6 mt -102.71 151.18 22.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.047 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -94.1 164.12 13.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.568 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -41.59 -52.44 3.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.48 0.657 . . . . 0.0 109.832 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.96 82.51 1.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.4 t60 -60.91 -47.15 87.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.767 -177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.1 p90 -143.99 159.21 42.98 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.7 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -136.19 138.52 42.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.0 mt -112.56 128.67 69.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.064 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -113.31 143.26 44.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.852 HD22 HG11 ' A' ' 33' ' ' VAL . 22.9 tp -122.05 129.86 52.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.375 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' HA2' ' HZ3' ' A' ' 63' ' ' LYS . . . 163.18 -119.2 0.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 63.92 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.992 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.11 37.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.45 24.95 8.0 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.529 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.767 ' O ' HD12 ' A' ' 93' ' ' LEU . 23.4 m-20 -128.9 -177.6 4.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.653 HD13 HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -119.27 143.81 47.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.4 mm? -126.49 145.43 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.549 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.558 HD21 HD13 ' A' ' 124' ' ' LEU . 14.8 mt -112.51 124.09 51.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.872 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.634 ' HB2' HD23 ' A' ' 92' ' ' LEU . 51.7 t30 -118.01 115.58 25.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.856 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.6 p30 -76.43 139.98 41.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 67' ' ' THR . 17.8 pt -148.12 39.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.623 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 152.32 20.11 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.034 0.445 . . . . 0.0 111.548 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.86 -31.55 70.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.942 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.24 -19.82 17.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.623 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.69 156.48 10.17 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.325 -0.941 . . . . 0.0 113.945 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.43 137.95 52.17 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.839 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -114.89 148.62 38.38 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.17 113.51 18.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.455 177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 27.8 m-20 44.09 43.26 5.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.66 -13.58 62.15 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.392 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.58 118.51 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.083 0.442 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.65 127.09 31.47 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.532 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.856 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.4 m -95.95 164.46 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.5 mt-10 -69.85 124.91 25.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.525 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.2 tttt -53.0 162.79 0.58 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 110.615 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.6 m-80 33.97 35.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.151 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.11 145.06 40.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.075 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.483 HD22 HD21 ' A' ' 92' ' ' LEU . 5.1 m120 -87.98 129.15 35.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.763 ' O ' HD13 ' A' ' 100' ' ' LEU . 40.5 mm-40 -129.29 146.83 51.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.804 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.73 125.3 27.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.841 HD11 HG21 ' A' ' 145' ' ' ILE . 66.2 tp -58.15 155.37 11.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.418 ' H ' HD12 ' A' ' 124' ' ' LEU . 1.1 t -124.83 153.04 43.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.503 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 122.48 20.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.3 22.02 57.86 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.93 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.69 170.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.13 135.49 24.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.072 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.623 HD11 HD11 ' A' ' 145' ' ' ILE . 20.7 mt -118.37 128.04 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.445 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.599 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.43 141.52 36.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 30.5 m -140.21 158.33 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.029 0.442 . . . . 0.0 112.104 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.25 43.69 8.5 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.9 t -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 121.707 0.765 . . . . 0.0 112.498 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' ' CG2' ' B' ' 8' ' ' THR . . . 151.79 -37.74 0.82 Allowed Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.38 120.44 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.037 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.26 -29.52 9.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.763 0.316 . . . . 0.0 111.459 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 52.8 p -93.45 6.56 47.75 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -130.67 30.59 4.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -178.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.599 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.11 139.13 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.614 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt -122.17 134.49 54.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.635 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB3' HG23 ' A' ' 40' ' ' THR . 39.4 t -108.52 150.58 27.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 112.304 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.9 mt -135.8 147.85 48.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.783 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 39' ' ' THR . 29.3 t -119.92 139.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.841 HG21 HD11 ' A' ' 124' ' ' LEU . 31.8 mt -106.09 128.62 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -114.56 114.86 26.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 124' ' ' LEU . 5.1 mt -84.75 134.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.894 0.378 . . . . 0.0 111.439 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -84.32 110.09 18.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -62.07 -26.0 68.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -45.99 90.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.896 0.379 . . . . 0.0 110.75 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CE1' HG13 ' A' ' 52' ' ' ILE . 5.5 t80 -59.42 -44.2 92.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.983 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -65.25 -38.5 90.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.065 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -59.51 -43.91 93.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.94 -41.66 82.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD22 HG23 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.972 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.97 -38.72 91.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -88.4 -36.73 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.039 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 44.96 -172.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.49 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.525 ' NZ ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -121.26 153.31 37.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.025 -179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.88 138.38 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.51 149.2 44.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -66.07 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.4 pt -95.71 127.84 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.905 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 tt -100.18 137.79 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.608 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -94.02 105.79 19.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.029 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.5 173.66 14.12 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.444 2.096 . . . . 0.0 112.43 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.404 ' CG2' ' HA3' ' A' ' 135' ' ' GLY . 5.8 m -150.96 147.74 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.815 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.75 176.83 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -129.88 151.88 49.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.75 156.67 24.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.868 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.748 0.309 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 16' ' ' GLN . 5.3 t -68.16 -51.65 43.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' N ' HG23 ' A' ' 15' ' ' THR . 9.9 pt20 -72.2 -40.04 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.811 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 2.4 mtt-85 -58.99 -35.98 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.822 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -37.29 80.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.36 -33.44 75.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.579 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.16 -35.46 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.742 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.43 -41.5 80.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -67.13 -23.79 65.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.75 -47.46 80.02 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.281 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 m -69.31 -47.0 65.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.925 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -147.38 137.97 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -95.8 132.56 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -80.06 106.65 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.938 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.54 136.75 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 123.105 0.562 . . . . 0.0 110.763 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.23 70.75 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.606 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.09 -36.28 15.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.77 0.319 . . . . 0.0 110.887 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 174.6 39.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.19 135.38 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 113.668 -1.605 . . . . 0.0 112.554 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.72 -60.13 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.917 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -145.34 161.84 38.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.402 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.53 138.04 53.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG21 ' HE2' ' A' ' 68' ' ' PHE . 29.8 m -110.85 122.68 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.655 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.84 HG23 HG12 ' A' ' 45' ' ' ILE . 14.6 mt -124.45 122.56 64.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.66 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HA ' HD23 ' A' ' 143' ' ' LEU . 46.8 t -79.85 99.94 7.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.206 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -68.24 -24.33 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.928 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.498 HG21 ' H ' ' A' ' 142' ' ' SER . 59.7 p -79.92 -2.21 42.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.603 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.81 78.01 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.878 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -147.33 -43.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -115.82 142.49 29.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.95 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.8 Cg_endo -70.12 139.03 38.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.104 1.869 . . . . 0.0 112.191 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.84 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -56.61 145.93 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.825 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.44 164.18 28.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.006 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.99 120.04 30.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 0.0 112.06 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.767 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -90.26 126.78 35.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.982 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.92 157.0 47.91 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.036 0.922 . . . . 0.0 113.45 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.15 154.0 40.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.042 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -85.09 138.72 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.103 0.477 . . . . 0.0 111.308 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.76 HD13 ' SG ' ' A' ' 154' ' ' CYS . 97.1 mt -64.35 -44.53 97.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.984 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.7 -36.52 69.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.286 0.565 . . . . 0.0 110.538 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 5.8 mm-40 -68.53 -36.9 79.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.456 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 51' ' ' ASP . 60.7 t -72.0 -46.72 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -27.37 63.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.924 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -73.55 -46.18 49.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.63 136.83 49.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -104.32 90.05 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 44.29 46.12 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.45 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.709 ' O ' HG22 ' A' ' 62' ' ' ILE . 2.0 m -138.01 53.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 61' ' ' SER . 8.9 tp 52.41 158.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.832 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -140.2 -64.92 0.47 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.195 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -141.81 134.2 28.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 111.546 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.9 t -131.29 139.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.127 0.489 . . . . 0.0 111.859 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.767 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.4 m-90 -102.82 139.32 38.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.013 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.58 127.2 55.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 177.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.1 m-85 -110.81 145.56 37.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.773 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.68 ' C ' HD21 ' A' ' 78' ' ' LEU . . . 160.59 178.52 34.65 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.697 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.599 ' N ' HD21 ' A' ' 78' ' ' LEU . 14.9 mtp180 -68.25 -6.72 25.27 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 4.1 t-20 -84.51 133.69 43.92 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.7 0.286 . . . . 0.0 111.19 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.8 Cg_exo -70.03 -5.9 17.47 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.588 2.192 . . . . 0.0 111.654 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.68 -42.81 17.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -43.88 137.14 3.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.14 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.34 -19.21 13.49 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 57.2 t80 -130.54 130.55 44.26 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.386 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.53 ' C ' HD13 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -109.91 136.44 49.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.44 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.888 ' N ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -109.59 -53.0 2.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.08 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.62 -115.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.761 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -154.17 65.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.297 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.8 mp -103.45 120.87 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.765 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.92 -24.97 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.42 -17.37 61.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.362 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 81' ' ' ILE . 34.5 mt -107.24 150.26 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.053 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.99 164.26 12.43 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.656 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.0 m-20 -43.0 -52.12 5.37 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.423 0.63 . . . . 0.0 109.777 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' CB ' HD12 ' A' ' 104' ' ' ILE . 11.9 mttm -121.44 82.76 1.98 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 11.6 t60 -62.38 -46.19 89.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.892 -176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.526 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 17.5 p90 -150.36 157.72 43.37 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.58 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.9 tt0 -135.84 140.07 43.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.485 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.573 ' C ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -117.93 131.55 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.349 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.736 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -116.13 145.47 43.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.028 0.442 . . . . 0.0 111.508 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.8 tm? -125.25 127.73 47.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.534 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.631 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 163.45 -134.92 3.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.694 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 68.97 -67.11 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.714 0.292 . . . . 0.0 110.922 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -171.46 45.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.19 -27.49 16.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.492 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -74.64 158.06 34.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -107.13 151.29 25.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.691 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.5 mp -132.76 144.65 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.99 128.51 56.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.416 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 52.6 t30 -118.86 119.17 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 0.0 111.853 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.675 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.4 p30 -79.81 137.8 37.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.986 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' CB ' ' A' ' 87' ' ' LYS . 13.6 pt -145.56 30.99 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -88.73 158.18 18.27 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.053 0.454 . . . . 0.0 111.553 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -68.94 -36.28 77.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.659 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.93 17.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.546 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.8 157.34 9.68 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.07 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.61 137.97 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.208 0.603 . . . . 0.0 109.42 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -114.3 148.57 37.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.51 18.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.492 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 78.0 m-20 44.34 43.22 5.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.33 -10.85 67.5 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.43 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -104.83 118.59 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.016 0.436 . . . . 0.0 110.69 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.5 tptt -72.97 119.12 16.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.194 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.675 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -88.7 166.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.177 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 120' ' ' SER . 16.5 mm-40 -69.93 128.01 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.521 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -55.13 158.0 3.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.577 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 0.7 OUTLIER 38.34 32.77 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.791 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.2 145.07 40.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.868 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.736 ' OD1' HD11 ' A' ' 92' ' ' LEU . 13.2 m-20 -95.38 133.79 38.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.981 0.419 . . . . 0.0 110.959 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.7 mm-40 -129.07 152.07 49.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.547 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.47 123.92 24.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.829 0.347 . . . . 0.0 110.306 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 145' ' ' ILE . 65.1 tp -54.49 155.88 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.535 0.683 . . . . 0.0 111.682 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.77 153.1 42.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 120.95 18.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.928 0.394 . . . . 0.0 110.164 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 23.66 59.51 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.231 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.5 t0 -54.83 172.8 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.845 0.355 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 6.9 mt-10 -145.3 135.61 24.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.4 mt -114.09 126.14 71.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.1 m -104.63 142.75 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.341 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.568 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.4 m -140.54 158.58 24.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.082 0.467 . . . . 0.0 112.254 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.04 43.54 8.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.053 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.537 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.6 t -85.1 140.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.76 0.791 . . . . 0.0 112.428 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.32 -40.96 0.86 Allowed Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.55 120.82 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.075 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -50.52 -24.96 3.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.731 0.301 . . . . 0.0 111.48 -178.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.615 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 t -93.5 6.44 48.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -132.13 27.86 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.59 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 138.82 31.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.831 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.56 134.32 53.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.556 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.498 ' H ' HG21 ' A' ' 40' ' ' THR . 46.7 t -108.96 150.31 27.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.6 0.714 . . . . 0.0 112.192 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' CYS . 71.9 mt -135.67 148.36 48.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.549 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 15.0 t -116.92 138.12 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 124' ' ' LEU . 1.3 mm -106.37 121.11 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.086 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 117.63 34.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.795 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -84.98 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.553 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -79.13 119.17 21.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.919 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -70.26 -18.7 63.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -58.76 -45.13 90.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 110.699 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -42.28 85.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.989 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -37.17 77.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.57 -47.3 79.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.99 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.76 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -68.21 -45.82 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -35.94 71.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.41 -38.76 92.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.42 -29.28 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.0 101.94 7.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.15 156.21 35.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.62 136.89 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.91 167.78 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -73.97 106.28 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 163' ' ' ILE . 5.2 tp -82.78 120.94 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.811 HG23 ' O2P' ' B' ' 5' ' ' TPO . 17.8 tt -140.32 147.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.811 ' O2P' HG23 ' B' ' 4' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -57.01 109.65 1.87 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.008 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.18 163.6 3.26 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.45 2.1 . . . . 0.0 112.188 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.463 HG23 ' NH1' ' A' ' 83' ' ' ARG . 3.7 m -86.68 154.24 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.39 83.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -136.15 75.47 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 17.9 t -98.8 89.2 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.804 0.335 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -90.46 -53.81 4.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -66.24 -44.34 84.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -58.96 -38.26 78.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.13 -40.71 90.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' LEU . 11.9 tp -61.47 -31.92 71.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.7 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.79 -35.38 49.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.31 82.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.423 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -67.08 -23.83 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.647 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.239 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.3 m -78.05 -37.67 46.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -66.52 79.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -94.87 134.23 37.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.964 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.31 102.05 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.75 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.41 138.39 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.657 0.741 . . . . 0.0 111.901 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.78 29.3 1.15 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.41 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -83.35 -23.55 32.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.747 0.308 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -175.08 33.38 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -88.41 95.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.911 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.4 -177.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -51.84 -64.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.1 p -147.9 164.9 32.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.864 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.95 125.72 36.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.962 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 19.4 t -88.84 122.85 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.969 0.414 . . . . 0.0 111.398 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -126.19 117.64 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.097 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.0 t -79.94 119.96 23.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.494 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.59 -25.59 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.736 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 9.1 p -79.85 -2.6 44.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.701 0.286 . . . . 0.0 111.44 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.33 76.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.973 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.551 ' HB2' HD12 ' A' ' 43' ' ' ILE . 4.7 mt-30 -144.06 -43.65 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.7 mp -122.69 142.71 38.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.02 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.9 Cg_endo -71.67 140.66 36.24 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.057 1.838 . . . . 0.0 111.799 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 39.2 mt -53.61 127.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.882 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -118.0 160.62 21.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.854 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.93 120.35 38.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.031 0.443 . . . . 0.0 112.124 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.7 mt -101.1 136.38 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.175 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.73 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.09 158.26 44.04 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -141.68 141.87 33.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.585 -1.643 . . . . 0.0 110.585 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.7 m-20 -84.43 135.35 34.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.727 HD13 ' SG ' ' A' ' 154' ' ' CYS . 17.4 mt -64.36 -45.49 95.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.153 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.4 m -57.45 -40.0 77.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.607 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.2 mm-40 -68.54 -37.22 79.78 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.685 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.3 t -71.93 -41.36 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.877 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 tp -71.04 -29.83 65.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -80.33 -51.01 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -63.0 112.28 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.74 62.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.91 -178.62 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.838 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.3 m -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.032 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.8 tp -138.08 154.85 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.228 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -112.39 -64.23 1.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.025 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -143.16 133.57 24.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.249 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -132.08 139.3 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.341 0.591 . . . . 0.0 112.026 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.553 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -101.34 139.12 37.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.208 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -110.24 130.46 55.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -120.15 145.44 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.377 -178.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.82 -166.8 35.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.839 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 20.5 mtm180 -83.83 5.05 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 11.0 t-20 -84.82 132.13 47.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.028 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 20.3 Cg_exo -65.16 -14.97 48.05 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.471 2.114 . . . . 0.0 111.541 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -42.94 17.38 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.55 138.04 3.48 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.722 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -56.59 -18.23 11.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.831 178.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.7 t80 -126.41 120.59 30.18 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.93 116.28 31.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD13 HD13 ' A' ' 84' ' ' LEU . 29.6 mt -89.3 -170.08 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.15 14.98 59.3 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.841 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER 63.88 78.55 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 111.487 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.831 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.9 mt -102.99 132.43 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.807 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 p -55.11 -28.63 53.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -78.6 -47.37 17.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.16 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.831 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.7 mt -72.73 150.73 42.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 m -95.9 164.24 12.81 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.806 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.94 -52.51 5.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.485 0.66 . . . . 0.0 109.771 179.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.7 mttt -119.93 81.92 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.1 t60 -62.48 -46.14 89.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.711 -177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.3 p90 -144.22 159.62 42.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.789 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.8 tt0 -135.94 142.65 44.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.61 ' O ' HG13 ' A' ' 65' ' ' VAL . 57.0 mt -116.94 128.06 74.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -111.67 147.99 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 111.714 -179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.406 HD22 HG11 ' A' ' 33' ' ' VAL . 24.5 tp -125.14 122.89 38.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.7 -159.25 30.43 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.55 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.13 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.76 -70.71 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 164.37 42.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -131.86 -177.58 4.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.852 HD13 HD22 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -106.92 148.49 28.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.0 mp -133.01 147.27 52.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.64 125.32 54.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.43 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.1 t30 -115.13 115.66 27.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 111.522 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.5 p30 -79.33 135.17 36.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.056 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 16.3 pt -142.72 40.04 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 157.18 16.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.998 0.427 . . . . 0.0 111.629 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.9 m -68.98 -35.03 76.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.601 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.62 -20.03 17.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.561 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.02 161.33 11.26 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.597 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.4 m -117.64 137.94 52.3 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.08 148.5 38.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.38 18.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.191 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.47 42.81 5.8 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.08 -8.76 77.22 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.484 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.69 118.58 36.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.14 131.43 41.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.213 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -103.66 166.08 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.197 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.87 126.18 28.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.557 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 83.6 tttt -53.36 162.14 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.952 0.406 . . . . 0.0 110.727 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.9 m-80 34.63 34.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.243 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.5 145.09 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.149 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.61 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.4 m120 -85.87 131.0 34.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.803 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.3 mm-40 -129.35 145.69 51.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.619 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.82 114.32 10.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.339 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.852 HD22 HD13 ' A' ' 99' ' ' LEU . 63.5 tp -53.7 157.74 2.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.386 0.613 . . . . 0.0 111.53 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.3 153.17 42.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.077 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.764 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.7 mm-40 -71.28 125.26 26.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 110.589 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.6 19.22 47.75 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.327 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.4 t70 -58.41 172.88 0.42 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.9 tt0 -145.19 135.58 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -107.65 128.15 63.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.67 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.25 138.09 41.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 28.3 m -140.33 158.53 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.37 28.71 29.5 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.136 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.5 t -69.91 140.45 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.607 0.718 . . . . 0.0 112.357 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.53 0.97 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 138' ' ' SER . 51.8 t -126.39 128.72 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.629 -0.785 . . . . 0.0 109.07 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -50.53 -36.12 32.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.313 . . . . 0.0 111.75 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.474 ' H ' HG12 ' A' ' 136' ' ' VAL . 24.4 m -93.4 6.31 48.58 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.417 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.5 t0 -120.31 26.51 9.17 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.67 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -106.9 139.58 27.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.042 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.4 tt -120.41 134.59 55.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.707 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.639 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -112.2 134.63 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.094 0.474 . . . . 0.0 111.843 -179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.732 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.3 mm? -129.73 135.02 47.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.607 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.72 136.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.701 ' CD1' HG22 ' A' ' 36' ' ' VAL . 4.1 mm -106.11 137.26 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.176 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.2 124.31 51.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.764 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -99.4 130.76 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 111.663 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -82.5 116.65 22.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -62.84 -22.81 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -58.89 -45.24 90.7 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.752 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.0 -40.47 80.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -65.01 -34.02 77.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.943 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -38.31 86.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.021 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.727 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -62.54 -46.06 90.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.74 83.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.99 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -59.59 -47.39 85.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.987 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -81.26 -35.15 31.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p30 42.43 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.549 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.55 144.88 35.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.71 138.29 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.6 115.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.21 -32.08 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.74 138.51 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.864 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.769 0.319 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.72 133.86 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -80.18 140.22 53.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.76 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.05 -169.79 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.322 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.04 158.69 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -94.02 156.18 16.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 92.41 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -101.0 98.99 9.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.9 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.785 0.326 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.469 ' HB ' ' CB ' ' A' ' 18' ' ' PHE . 3.2 p 56.01 52.24 10.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.032 0.444 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.31 86.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.91 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -68.94 -35.89 77.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.28 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' CB ' ' HB ' ' A' ' 15' ' ' THR . 3.1 t80 -60.54 -44.78 95.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -45.24 86.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 HG23 ' CE2' ' A' ' 23' ' ' PHE . 39.8 mm -63.54 -47.26 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.9 -33.58 74.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.2 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -56.07 -47.12 78.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.949 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.586 ' CE2' HG23 ' A' ' 20' ' ' ILE . 5.8 p90 -71.85 -47.12 55.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.054 0.455 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -57.92 -47.13 83.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.944 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -177.53 5.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.44 157.99 16.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -66.63 138.09 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.09 138.32 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.644 0.735 . . . . 0.0 111.819 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.56 44.36 0.06 OUTLIER Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.19 -38.86 60.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER 177.54 38.49 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.727 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.44 133.55 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 CA-C-N 113.846 -1.525 . . . . 0.0 112.393 -177.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.997 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.26 -61.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.203 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.429 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.8 p -149.02 146.22 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.287 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -113.95 138.03 50.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.802 0.334 . . . . 0.0 111.398 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 25.0 t -101.47 122.95 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.855 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.848 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -123.9 126.13 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.553 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.436 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.9 t -95.33 107.85 19.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.393 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.5 p -88.16 -20.02 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.756 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.71 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.9 -2.52 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 0.0 111.401 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.57 76.04 0.52 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.795 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -146.7 -42.15 0.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' A' ' 44' ' ' PRO . 12.4 mt -131.1 142.51 45.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.11 146.02 40.39 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.239 1.959 . . . . 0.0 112.102 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 37' ' ' ILE . 34.7 mt -56.34 148.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.897 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.01 159.51 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.051 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.18 119.76 35.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.025 0.441 . . . . 0.0 112.061 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.1 mt -95.54 137.49 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.997 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.58 158.76 43.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.04 141.81 36.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.655 -1.612 . . . . 0.0 110.695 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.5 m-20 -76.83 134.24 39.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.073 0.463 . . . . 0.0 111.351 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -64.27 -42.65 96.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.759 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -57.02 -38.66 73.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm-40 -68.5 -36.88 79.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.498 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG11 HD21 ' A' ' 155' ' ' LEU . 43.2 t -70.62 -41.66 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.006 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.06 -31.46 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.803 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -50.24 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.27 112.87 5.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -29.67 15.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.7 174.31 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.1 m 61.34 -168.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.995 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 92' ' ' LEU . 6.4 tp -101.34 144.04 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.627 ' HG2' HG22 ' A' ' 55' ' ' VAL . 12.6 mptt -65.89 -71.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.957 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 49' ' ' SER . 35.0 ttpt -149.22 121.19 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.041 0.448 . . . . 0.0 111.625 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 91' ' ' ILE . 10.6 p -107.53 139.88 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.707 0.765 . . . . 0.0 112.519 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.561 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.5 m-90 -100.59 139.05 36.83 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.99 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.4 127.01 55.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.679 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -113.57 145.36 41.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.47 -178.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.63 -175.71 39.01 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.779 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 28.4 mtm180 -74.97 -1.59 23.3 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t-20 -84.65 132.09 47.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.594 0.235 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.0 Cg_exo -68.52 -8.28 22.69 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.535 2.157 . . . . 0.0 111.669 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.84 -42.91 17.24 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.916 0.865 . . . . 0.0 108.693 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.68 138.2 1.46 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.66 179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -56.46 -19.24 14.3 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.984 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 52.8 t80 -130.21 126.39 37.26 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.036 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -101.49 137.62 39.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.434 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.665 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -124.59 -68.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.185 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 78' ' ' LEU . . . -168.3 -127.9 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.632 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 2.1 p30 -159.76 65.7 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 83' ' ' ARG . 35.2 mt -89.7 127.75 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -54.82 -24.92 25.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.238 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.779 ' NH1' HG23 ' B' ' 8' ' ' THR . 2.0 mmm180 -78.27 -48.23 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.04 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 88' ' ' HIS . 37.9 mt -72.84 152.25 41.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.904 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.0 p -95.71 164.53 12.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.29 -53.3 5.28 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.382 0.611 . . . . 0.0 109.757 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.76 81.1 1.64 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' A' ' 84' ' ' LEU . 10.3 t60 -60.0 -45.61 92.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.916 -176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.6 p90 -145.53 159.48 43.05 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.791 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.3 tt0 -135.99 141.39 44.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.472 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 65' ' ' VAL . 51.4 mt -118.15 129.91 73.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.809 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD12 HD13 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -111.5 140.94 45.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.003 0.43 . . . . 0.0 111.729 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.7 tm? -121.27 131.94 54.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.662 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 147.05 -162.99 28.66 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.627 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 62.7 105.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.931 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.51 -80.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.05 37.78 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -125.06 -173.85 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -120.11 150.36 40.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -132.6 145.3 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 130' ' ' ILE . 2.2 tp -112.8 127.01 56.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.219 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 90' ' ' GLN . 45.5 t30 -117.12 115.42 25.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.283 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.7 p30 -79.89 137.59 36.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.742 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 67' ' ' THR . 19.7 pt -146.44 40.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 157.84 16.17 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 120.957 0.408 . . . . 0.0 111.409 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -68.82 -34.77 76.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.61 -19.8 17.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.01 160.32 11.18 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.39 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.66 137.86 52.37 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -115.73 148.78 39.4 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.649 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.29 113.38 18.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 108.423 176.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 45.75 42.52 8.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.318 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.97 -3.37 87.03 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.626 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.51 118.54 36.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.052 0.426 . . . . 0.0 110.856 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.5 tptt -76.33 121.06 22.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.121 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -97.32 164.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.231 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 mt-10 -69.9 126.98 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 46.0 tttm -52.96 161.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.942 0.401 . . . . 0.0 110.634 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.05 34.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.312 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.36 145.08 40.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.225 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.729 ' HB3' HD23 ' A' ' 100' ' ' LEU . 11.0 m120 -86.11 130.01 34.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 28.6 mm-40 -129.48 146.77 51.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 119.32 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.198 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.797 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -52.93 156.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.396 0.617 . . . . 0.0 111.654 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.597 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.61 153.32 42.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.802 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.699 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.57 122.76 21.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.306 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.37 21.52 48.38 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.315 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.2 t70 -53.03 174.01 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.774 0.321 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.885 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.01 135.53 24.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 145' ' ' ILE . 7.2 mt -110.72 123.21 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.755 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.64 140.12 38.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.15 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.32 158.71 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.982 0.42 . . . . 0.0 112.129 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.85 36.36 13.72 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.0 t -80.13 140.36 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 111.917 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.79 -30.11 2.69 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 82.9 t -126.46 118.55 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.425 -0.887 . . . . 0.0 108.708 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -50.73 -35.68 32.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.33 6.73 47.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -125.52 29.3 6.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.637 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.13 139.36 29.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.59 134.43 55.01 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.543 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.71 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -111.25 132.49 54.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.078 0.466 . . . . 0.0 111.686 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 40.4 mt -125.01 150.22 46.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.377 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.885 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.4 t -117.5 140.24 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.784 0.326 . . . . 0.0 111.349 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 130' ' ' ILE . 13.1 mt -106.22 121.74 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.99 110.96 22.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.491 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -84.99 133.93 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.47 105.78 16.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.711 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -58.38 -30.73 67.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -59.26 -45.23 91.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.85 -41.79 83.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.034 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -62.57 -35.92 81.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -63.64 -40.35 96.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.54 -44.36 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.964 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.669 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -69.09 -39.63 78.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.028 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -48.07 77.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 -37.03 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p30 42.5 37.32 0.95 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.449 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -125.02 150.14 47.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.01 125.73 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -120.11 100.74 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.03 173.91 10.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 15.7 pt -79.23 130.62 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.049 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.743 0.306 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.434 ' O ' HG23 ' B' ' 4' ' ' ILE . 0.5 OUTLIER 42.67 93.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.617 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.504 ' H ' ' P ' ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.53 122.99 83.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.15 176.46 7.79 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.432 2.088 . . . . 0.0 112.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.779 HG23 ' NH1' ' A' ' 83' ' ' ARG . 0.6 OUTLIER -94.04 169.62 10.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 146.2 24.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.66 156.58 47.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t 60.63 85.34 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -140.98 -59.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -71.94 -38.54 69.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -59.05 -39.65 82.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.912 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 10.9 t80 -60.25 -39.25 86.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.694 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -31.9 72.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.82 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.63 -46.18 84.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.358 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -67.31 -23.95 65.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.61 -47.76 78.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.289 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.23 -22.64 61.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.012 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 62.43 169.26 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.949 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 132.83 53.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -91.8 107.27 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.07 138.35 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.635 0.731 . . . . 0.0 111.759 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.92 41.6 0.12 Allowed Glycine 0 C--N 1.313 -0.697 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.474 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.47 -47.35 56.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 177.92 40.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.691 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.5 mm -85.38 95.75 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.936 -1.483 . . . . 0.0 112.677 -177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 99' ' ' LEU . 3.1 t -45.58 -62.28 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.978 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.0 p -152.08 165.2 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.723 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -124.3 138.44 54.39 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.824 0.345 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.1 m -104.08 122.91 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.86 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -126.83 118.88 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.659 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.743 ' SG ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -79.92 102.31 9.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.169 179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 t -67.84 -20.65 65.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.269 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 142' ' ' SER . 73.2 p -79.74 -2.41 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.47 75.88 0.26 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.831 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -145.77 -42.99 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.743 HD12 ' SG ' ' A' ' 38' ' ' CYS . 4.5 mt -112.41 142.82 27.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.881 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.655 ' HD2' HG23 ' A' ' 43' ' ' ILE . 50.1 Cg_endo -71.35 135.18 26.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.223 1.948 . . . . 0.0 111.972 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.86 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -55.51 141.58 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.755 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.06 164.1 28.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.681 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HB3' HG21 ' A' ' 32' ' ' ILE . 4.5 m-20 -119.84 119.55 33.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.036 0.446 . . . . 0.0 111.986 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.3 mp -86.3 129.02 34.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.691 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.86 154.32 49.5 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -148.48 148.22 30.01 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.045 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 55' ' ' VAL . 19.3 m-20 -79.62 125.33 29.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.47 -44.98 97.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.162 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -40.98 87.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.143 0.497 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 47.9 mm-40 -68.42 -36.97 79.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.931 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.878 HG13 ' HG3' ' A' ' 63' ' ' LYS . 57.6 t -72.02 -40.88 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.097 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.6 tp -71.07 -29.97 65.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -49.96 10.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.66 133.29 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.975 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -110.47 -21.43 12.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -52.09 167.61 0.12 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.23 126.29 27.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 94' ' ' GLY . 1.3 tp 54.09 172.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.878 ' HG3' HG13 ' A' ' 55' ' ' VAL . 12.5 mmtp -132.09 -63.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.65 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.7 OUTLIER -134.44 124.35 25.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -124.64 138.92 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 112.071 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -103.65 139.07 39.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.774 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.87 126.22 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.042 0.449 . . . . 0.0 109.931 177.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 36' ' ' VAL . 2.0 m-85 -107.58 145.77 32.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.53 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 167.12 -175.1 42.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.848 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.3 mtp-105 -81.45 -4.82 56.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.86 137.18 38.12 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.325 . . . . 0.0 111.199 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.9 -5.97 16.96 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.779 2.319 . . . . 0.0 111.818 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -43.2 17.03 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 122.014 0.912 . . . . 0.0 108.621 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.36 137.61 4.67 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.514 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -56.34 -18.55 11.19 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.014 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 32.5 t80 -129.43 120.16 25.01 Favored 'General case' 0 C--N 1.338 0.078 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.811 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.26 112.14 23.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.743 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.727 ' CD2' HD13 ' A' ' 43' ' ' ILE . 60.9 mt -85.52 -79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.238 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.59 -108.33 0.21 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.39 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -166.54 46.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 111.258 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 HD12 ' A' ' 84' ' ' LEU . 7.0 mt -84.3 122.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.72 -29.64 53.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.117 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.561 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.794 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD12 HD12 ' A' ' 81' ' ' ILE . 24.5 mt -72.92 149.93 42.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.267 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 76.2 p -95.0 165.93 12.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.893 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.666 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.34 -53.65 4.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.383 0.611 . . . . 0.0 109.828 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.608 ' HB2' HD12 ' A' ' 104' ' ' ILE . 9.7 mttt -120.79 82.7 1.95 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.2 t60 -60.42 -46.2 90.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.817 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 10.2 p90 -148.51 158.65 44.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.278 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.695 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.1 tt0 -136.03 141.29 44.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.42 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.8 mp -114.23 127.26 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -113.25 145.15 41.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.13 0.491 . . . . 0.0 112.012 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 99' ' ' LEU . 17.8 tp -125.21 123.0 38.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 62' ' ' ILE . . . 129.73 119.94 2.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.617 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -177.3 -39.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.812 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -167.83 -42.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.807 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.04 39.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.509 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.64 -175.21 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.672 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -106.95 158.42 17.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.571 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.5 mt -133.06 143.56 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -112.59 122.99 49.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.88 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.765 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.2 t30 -114.94 115.72 27.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.059 0.457 . . . . 0.0 111.542 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.838 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.0 p30 -77.72 138.94 39.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.7 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.47 38.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.41 157.71 15.85 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.076 0.465 . . . . 0.0 111.533 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.0 m -69.07 -33.78 74.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.557 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -19.92 17.43 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.48 160.15 11.2 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.456 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.082 0.553 . . . . 0.0 109.535 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.54 148.36 38.07 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.18 113.56 18.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.372 177.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.4 m-80 44.29 43.34 5.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.43 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.41 -9.75 72.05 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.433 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.56 36.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.667 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 17.4 tptt -73.6 122.85 22.93 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.206 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.838 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.9 m -93.58 164.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.215 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.6 pm0 -69.89 124.06 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.583 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.7 tttm -51.87 161.29 0.58 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.04 0.448 . . . . 0.0 111.045 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.6 32.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.497 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.64 145.13 40.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.12 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.856 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.4 m120 -87.34 131.04 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.864 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' HD23 ' A' ' 100' ' ' LEU . 40.3 mm-40 -129.2 150.01 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.71 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.63 133.18 44.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.023 HD11 HG21 ' A' ' 145' ' ' ILE . 65.4 tp -64.74 155.5 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.51 0.672 . . . . 0.0 111.689 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.85 152.9 43.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.511 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.88 124.05 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.328 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.02 22.68 43.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.088 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 24.9 t70 -53.01 172.05 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.939 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.6 mt-10 -145.05 135.8 24.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 143' ' ' LEU . 15.6 mt -114.66 124.81 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.999 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.621 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.78 141.65 36.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG11 ' CD2' ' A' ' 88' ' ' HIS . 23.0 m -140.44 158.74 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.32 43.5 9.46 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.251 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.7 t -84.28 140.35 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.595 0.712 . . . . 0.0 112.336 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 144.2 -39.17 1.27 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 138' ' ' SER . 46.2 t -126.4 119.64 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 114.455 -0.872 . . . . 0.0 108.917 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.4 tt0 -50.39 -26.45 4.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.8 0.334 . . . . 0.0 111.455 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.562 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.45 6.49 47.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.7 25.48 5.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.19 138.75 31.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.17 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.61 134.57 52.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.157 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.2 t -109.96 150.36 28.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.676 0.751 . . . . 0.0 112.381 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.572 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -135.25 154.06 51.7 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.782 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.939 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -126.1 137.89 56.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.884 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.023 HG21 HD11 ' A' ' 124' ' ' LEU . 1.6 mm -106.32 120.91 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 120.837 0.351 . . . . 0.0 110.817 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.33 112.68 24.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.717 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -86.01 133.71 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.361 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -77.49 135.2 38.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.713 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -32.56 71.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -60.29 -46.0 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.988 0.423 . . . . 0.0 110.757 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -59.61 -43.97 93.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.033 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -45.86 87.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -47.17 86.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.74 -45.99 73.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.883 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.643 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -60.84 -35.89 77.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.823 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -42.84 92.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.73 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 159' ' ' LYS . 5.8 mm100 -84.78 -30.17 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.16 -91.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.658 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 157' ' ' GLN . 14.1 mttt -84.18 151.88 24.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.9 131.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -114.86 158.05 22.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -98.94 104.8 16.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.946 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.0 pt -84.59 133.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.876 0.369 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 19.0 tt -173.81 157.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.602 HG22 ' O2P' ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -74.41 111.65 13.8 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.8 161.08 42.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.547 HG21 ' HA3' ' A' ' 135' ' ' GLY . 25.4 m -81.85 144.65 30.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -86.68 174.6 8.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -93.27 144.87 24.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 131.96 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.859 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -71.81 0.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pm0 -63.82 -33.32 75.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.95 -39.46 94.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.673 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -60.21 -35.45 75.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.475 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 16' ' ' GLN . 34.6 mt -65.99 -33.3 75.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.672 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.6 mt -73.07 -35.61 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.667 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -42.15 82.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.451 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -67.1 -23.77 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.687 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.66 -47.41 79.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -31.08 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.79 159.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.01 120.95 12.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.51 102.8 15.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.95 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -82.01 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.709 0.766 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.5 68.53 0.07 OUTLIER Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -38.52 21.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-80 179.39 38.03 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.22 135.46 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.5 -177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.92 -60.41 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.925 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.597 ' SG ' HD12 ' A' ' 48' ' ' LEU . 11.9 p -150.15 147.42 27.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.24 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.443 HH11 HD11 ' A' ' 37' ' ' ILE . 3.1 ttm180 -113.95 132.8 55.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.25 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.1 m -95.08 122.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.7 mt -127.36 125.66 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.263 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HA ' HD23 ' A' ' 143' ' ' LEU . 5.4 t -89.4 109.84 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.491 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -82.6 -24.76 33.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.776 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.67 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.2 p -79.92 -2.71 44.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.712 0.291 . . . . 0.0 111.496 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 77.5 0.3 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.965 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -147.46 -39.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.008 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -126.44 141.69 40.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.7 Cg_endo -72.09 145.66 44.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.171 1.914 . . . . 0.0 112.139 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.8 mt -60.82 149.71 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.711 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -142.71 164.08 31.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.092 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.92 119.89 35.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 111.881 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.695 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.5 mt -97.65 137.21 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.13 158.78 43.89 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -178.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.94 141.98 25.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.845 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 m-20 -76.55 126.09 30.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.325 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.787 HD13 ' SG ' ' A' ' 154' ' ' CYS . 62.0 mt -64.65 -45.24 95.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.188 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -60.79 -39.44 88.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 0.0 110.634 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 33.5 mm-40 -68.48 -36.87 79.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.728 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 51' ' ' ASP . 57.8 t -71.43 -37.85 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.18 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.51 -27.82 64.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.393 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -93.44 -23.29 18.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.327 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.82 119.36 9.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.018 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.96 64.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -145.94 173.97 11.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -55.21 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.703 HD13 HD12 ' A' ' 92' ' ' LEU . 9.7 tp -123.91 156.96 31.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -107.5 -75.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.6 ttpt -121.68 133.89 54.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.42 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.643 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -131.96 139.16 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.245 0.545 . . . . 0.0 111.852 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.11 139.26 37.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.006 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.51 129.04 56.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -118.46 145.29 45.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.523 -178.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.63 -169.05 37.0 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.762 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.434 ' HG3' HD11 ' A' ' 78' ' ' LEU . 20.3 mtm180 -80.76 3.57 21.91 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.765 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.8 t-20 -84.76 132.56 45.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 0.0 111.134 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.19 -14.16 43.06 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.45 2.1 . . . . 0.0 111.637 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.78 -42.73 17.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.861 0.838 . . . . 0.0 108.909 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.42 139.02 1.14 Allowed 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.021 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.6 m-20 -56.3 -18.99 12.3 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.977 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.0 t80 -129.8 123.09 30.09 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 120.731 0.3 . . . . 0.0 111.083 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.07 107.9 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.5 pp -111.14 177.35 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.29 131.77 50.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.618 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -70.97 88.26 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.621 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.4 mt -106.33 135.08 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.06 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.27 -31.87 64.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.091 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.25 -49.26 57.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.189 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 81' ' ' ILE . 25.6 mt -74.54 151.21 39.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.321 . . . . 0.0 110.996 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 p -95.38 164.15 12.95 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.61 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.55 -52.63 4.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.424 0.631 . . . . 0.0 109.648 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.97 82.35 1.88 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -60.88 -46.13 91.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.761 -177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.7 p90 -143.46 160.0 41.37 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.907 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.97 142.33 44.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.462 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.645 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 67.6 mt -117.67 131.52 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.805 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.703 HD12 HD13 ' A' ' 62' ' ' ILE . 0.9 OUTLIER -118.93 140.21 50.37 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.049 0.452 . . . . 0.0 111.96 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.719 HD22 HG11 ' A' ' 33' ' ' VAL . 10.4 tp -125.19 122.9 38.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.237 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.07 -130.71 2.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.941 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.35 172.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.398 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 59.49 167.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.981 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.66 21.22 42.36 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.637 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -108.98 -177.15 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.828 0.346 . . . . 0.0 110.801 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.795 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -124.48 160.06 29.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.6 mt -125.84 141.01 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.099 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.69 122.24 47.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.386 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.5 t30 -113.95 115.69 28.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.978 0.418 . . . . 0.0 111.404 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.801 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.6 p30 -78.59 137.52 37.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.002 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -145.93 40.08 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.13 161.07 13.9 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.01 0.433 . . . . 0.0 111.712 -179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.485 HG22 ' HB3' ' B' ' 7' ' ' PRO . 88.6 m -69.05 -38.63 79.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.799 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -20.1 17.22 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.55 161.02 10.96 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.609 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.2 m -117.59 137.97 52.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.565 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.888 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.97 148.56 36.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.5 18.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.219 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 44.52 43.24 6.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.87 -10.86 68.65 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.514 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -104.61 118.5 36.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.055 0.427 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.888 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.5 tptm -73.5 131.11 41.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.228 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.801 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -102.79 165.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.193 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.5 tt0 -69.9 126.4 29.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.573 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.0 tttp -53.75 162.5 0.87 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.973 0.416 . . . . 0.0 110.619 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.32 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.111 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.53 145.07 40.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.109 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.685 ' HB3' HD22 ' A' ' 100' ' ' LEU . 24.8 m120 -88.75 130.71 35.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.968 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.846 ' O ' HD23 ' A' ' 100' ' ' LEU . 37.3 mm-40 -129.12 147.56 50.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.4 tm? -72.6 119.23 16.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.48 HD21 ' CG1' ' A' ' 147' ' ' ILE . 65.6 tp -54.68 157.79 2.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 111.537 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.438 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.31 153.25 42.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.26 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.705 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.31 122.41 20.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.458 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.62 23.01 54.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.138 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.7 t70 -57.41 173.86 0.24 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.911 0.386 . . . . 0.0 110.945 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.582 ' HG3' HG22 ' A' ' 144' ' ' VAL . 59.9 tt0 -145.13 135.61 24.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.041 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 145' ' ' ILE . 2.8 mp -109.24 127.37 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.62 139.01 40.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.29 37.41 15.02 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.15 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.3 t -77.58 140.39 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.671 0.748 . . . . 0.0 112.202 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' B' ' 8' ' ' THR . . . 143.82 -39.59 1.26 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.543 HG12 ' H ' ' A' ' 138' ' ' SER . 42.9 t -126.45 123.89 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.078 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -50.32 -29.59 10.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.808 0.337 . . . . 0.0 111.454 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.543 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.7 m -93.41 6.51 47.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.15 23.02 8.55 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.647 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -106.8 139.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.24 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 142' ' ' SER . 6.7 tt -124.4 134.65 53.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.478 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.702 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -110.92 129.12 55.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.177 0.513 . . . . 0.0 111.606 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 20.9 mt -122.53 136.78 54.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.677 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -110.85 140.17 31.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.331 . . . . 0.0 111.12 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.622 ' CD1' HD11 ' A' ' 130' ' ' ILE . 25.3 mt -105.97 136.39 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.82 111.78 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.705 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.86 128.65 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.482 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -75.87 134.82 40.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.829 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -74.03 -29.43 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.204 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -59.57 -45.64 91.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.441 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.1 t80 -63.06 -42.69 99.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.21 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -50.03 67.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.277 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -59.37 -36.94 76.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.108 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.787 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.0 t -68.0 -45.98 72.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.71 -35.94 77.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.797 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -61.54 -39.63 91.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.93 -36.99 15.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.834 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 44.44 -171.5 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.583 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.73 115.36 13.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.877 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG21 ' CG2' ' A' ' 163' ' ' ILE . 28.9 m -70.32 138.45 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -40.15 43.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -146.6 123.85 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.406 ' CG2' HG21 ' A' ' 160' ' ' VAL . 2.9 pt -93.67 130.46 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.825 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.555 ' O ' HG23 ' B' ' 4' ' ' ILE . 20.0 tt -130.4 114.82 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.67 119.3 57.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.714 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 106' ' ' THR . 86.8 Cg_endo -78.3 55.73 5.51 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.514 2.143 . . . . 0.0 112.552 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 135' ' ' GLY . 13.9 m 61.66 149.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.947 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.422 ' NE2' HG22 ' A' ' 136' ' ' VAL . 3.8 pt20 -56.47 175.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -88.29 132.03 34.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -116.86 130.13 56.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.86 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 p -106.84 -58.41 1.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.83 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -36.04 74.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.7 -36.95 85.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -45.02 77.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.789 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.8 mm -66.83 -35.0 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.075 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.05 -43.03 81.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.2 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -67.14 -23.87 65.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.403 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.57 -47.43 79.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.237 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -41.44 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.915 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -59.08 -66.62 0.48 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -83.8 130.99 34.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.955 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.13 124.8 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.07 138.36 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.713 0.768 . . . . 0.0 111.736 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 57.26 2.34 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.542 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.82 -43.42 94.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER -177.19 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.737 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -76.03 135.2 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 113.617 -1.629 . . . . 0.0 112.696 -177.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.79 -61.09 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.86 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.1 p -144.52 145.98 32.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.076 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.93 138.13 50.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 111.493 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 36' ' ' VAL . 11.9 p -105.33 122.69 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -129.39 118.44 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.514 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.0 t -79.98 115.22 19.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.369 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -82.57 -26.0 32.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.885 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 67.1 p -79.9 -2.24 42.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.722 0.296 . . . . 0.0 111.57 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.16 76.29 0.3 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.98 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -146.02 -43.76 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mt -114.13 141.3 26.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.1 Cg_endo -72.98 135.48 23.28 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.21 1.94 . . . . 0.0 112.198 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.75 HG12 HG23 ' A' ' 37' ' ' ILE . 35.0 mt -55.47 134.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.04 164.29 20.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.49 119.83 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.214 0.531 . . . . 0.0 111.733 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.629 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.6 mt -97.38 131.53 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.988 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.85 159.0 44.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -178.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.83 141.76 30.52 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.475 178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.804 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -82.75 147.16 28.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.157 0.503 . . . . 0.0 111.436 -179.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 mt -64.18 -45.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.069 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.8 t -56.53 -40.32 74.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.873 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.5 -36.8 79.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.444 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 51' ' ' ASP . 40.7 t -69.79 -41.8 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.2 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 159' ' ' LYS . 1.4 mp -71.03 -28.34 64.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -49.03 38.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.23 116.81 22.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.54 -20.03 8.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.297 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -106.12 -70.66 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.062 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 177.62 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.898 HD11 ' HB2' ' A' ' 92' ' ' LEU . 1.3 tt -75.02 147.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.977 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -81.81 -78.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.338 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 ttpt -143.56 139.41 29.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.814 0.34 . . . . 0.0 111.346 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG12 ' HG2' ' A' ' 90' ' ' GLN . 18.1 t -133.34 139.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.226 0.536 . . . . 0.0 112.007 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -103.42 139.08 39.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.99 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.93 130.24 56.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -120.05 145.27 47.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.49 -167.1 35.04 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.49 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -78.75 1.96 21.36 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.56 127.01 67.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.464 0.174 . . . . 0.0 110.948 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.9 Cg_exo -63.85 -14.33 42.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.317 2.012 . . . . 0.0 111.47 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -42.17 17.95 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.738 0.78 . . . . 0.0 108.925 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.09 138.61 1.07 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.592 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 t70 -56.35 -18.63 11.48 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.164 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' CE2' HG21 ' A' ' 43' ' ' ILE . 16.0 t80 -129.75 116.06 18.21 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 111.039 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -89.15 107.94 19.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.586 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD13 ' A' ' 84' ' ' LEU . 57.0 mt -71.87 -76.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.87 -98.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.465 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -162.89 53.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.334 . . . . 0.0 111.167 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.01 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -93.02 117.67 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -28.98 56.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.496 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -73.12 -47.88 40.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.157 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.01 HD12 HD13 ' A' ' 81' ' ' ILE . 16.1 mt -72.78 146.5 46.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.775 0.321 . . . . 0.0 110.948 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.2 p -94.29 163.52 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.723 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.55 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -41.43 -52.11 3.65 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.589 0.709 . . . . 0.0 110.007 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -121.34 81.37 1.78 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 10.9 t60 -61.21 -46.49 90.21 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.609 -177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.8 p90 -144.86 157.15 44.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.722 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.8 tt0 -136.15 138.92 42.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.27 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.5 mt -113.0 127.86 70.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.678 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.898 ' HB2' HD11 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -110.01 149.23 30.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.493 . . . . 0.0 111.836 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.673 HD12 HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -123.31 123.85 41.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.117 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -160.44 -174.21 29.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.716 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 61.74 18.51 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.636 0.255 . . . . 0.0 111.22 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 155' ' ' LEU . 0.6 OUTLIER 50.73 89.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.281 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.01 -65.42 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.661 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -56.38 134.13 53.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 111.109 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.815 HD21 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -109.95 153.38 24.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.764 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.0 mm? -133.17 145.29 50.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.943 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 124' ' ' LEU . 13.9 mt -112.73 122.91 49.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.596 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.8 t30 -115.62 115.72 26.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.059 0.457 . . . . 0.0 112.013 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.874 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.1 p30 -77.0 134.66 38.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.0 pt -142.0 39.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.6 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.62 159.7 14.79 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.956 0.408 . . . . 0.0 111.778 -178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.0 m -68.88 -37.97 79.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -19.77 17.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.6 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 122.71 162.97 11.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.432 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.4 m -117.35 137.85 52.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.894 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.11 148.36 35.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.578 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.19 113.43 18.3 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.302 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 16.4 m-80 42.75 44.1 3.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.527 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.65 -13.55 63.84 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.479 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -103.26 118.56 37.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.6 tptm -73.49 124.2 25.38 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.487 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.874 HG23 ' OD2' ' A' ' 103' ' ' ASP . 19.1 m -91.53 161.88 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.3 pt-20 -69.82 123.07 20.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.499 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 72.0 tttt -50.08 161.65 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.858 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.15 35.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.332 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.21 145.05 40.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.387 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.56 HD22 HD21 ' A' ' 92' ' ' LEU . 7.6 m120 -84.78 125.43 32.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.718 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.572 ' O ' HD13 ' A' ' 100' ' ' LEU . 36.0 mm-40 -129.54 147.16 51.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.9 tt -77.28 115.18 16.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.122 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.43 162.5 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 111.912 -179.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.507 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.93 153.41 42.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.421 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.37 119.92 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 110.543 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.39 56.89 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.434 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.578 ' OD2' HD13 ' A' ' 111' ' ' LEU . 12.7 t70 -60.55 -179.01 0.1 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.69 0.281 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.946 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.7 mt-10 -145.28 135.64 24.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 111.296 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.866 HG13 HD11 ' A' ' 145' ' ' ILE . 3.7 mt -113.72 127.72 70.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.496 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.579 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.46 141.09 36.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.028 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.28 158.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 43.52 8.71 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.026 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.494 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.3 t -84.35 140.42 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.663 0.744 . . . . 0.0 112.396 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.06 -38.81 0.83 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.42 123.15 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.166 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.4 -29.83 11.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.556 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.7 m -93.57 6.41 48.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -127.56 27.43 5.8 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.579 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -107.04 139.25 29.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.032 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.21 134.43 53.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.618 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.512 ' H ' HG21 ' A' ' 40' ' ' THR . 39.7 t -108.71 150.51 27.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.597 0.713 . . . . 0.0 112.145 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 77.4 mt -135.66 158.13 45.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.946 HG22 ' CG ' ' A' ' 129' ' ' GLU . 22.0 t -126.52 130.53 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.888 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.866 HD11 HG13 ' A' ' 130' ' ' ILE . 1.1 mp -105.64 120.8 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.29 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.29 112.17 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.586 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.515 ' CD1' HD22 ' A' ' 124' ' ' LEU . 5.2 mt -84.79 131.06 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.94 117.44 17.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.846 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.31 -33.69 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.036 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -59.95 -45.81 91.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -57.91 -42.73 85.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.084 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -34.86 74.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -61.13 -43.49 98.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -62.47 -45.91 90.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 96' ' ' ASP . 1.1 mm? -67.27 -36.01 80.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.965 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -62.52 -36.61 83.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -91.97 -36.51 13.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.983 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 p30 44.94 -172.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.593 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 56' ' ' LEU . 2.1 tttp -77.74 156.85 30.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 160' ' ' VAL . 27.7 m -101.63 121.05 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.88 -170.02 2.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 30.61 3.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.57 112.15 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.878 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p30 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.809 0.338 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 tt -165.59 139.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.76 124.76 77.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.28 139.22 34.65 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.503 2.135 . . . . 0.0 112.345 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.89 168.64 10.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -71.29 129.85 39.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -151.8 133.17 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.2 98.25 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.919 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.5 m -155.7 -50.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -64.58 -44.83 89.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -35.96 74.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -44.23 94.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -44.68 94.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -65.87 -35.0 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -57.14 -36.94 71.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.894 0.378 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -67.24 -23.9 65.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.751 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.53 79.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -36.15 82.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 60.1 84.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -99.12 139.75 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -84.4 103.61 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.94 138.34 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.631 0.729 . . . . 0.0 111.76 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.93 94.04 2.33 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.504 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -80.22 -34.06 37.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.953 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 178.61 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -74.02 133.91 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.742 -1.572 . . . . 0.0 112.465 -177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.998 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.74 -60.81 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.899 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.646 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.2 p -146.55 147.59 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.178 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.97 138.08 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' CE2' ' A' ' 68' ' ' PHE . 28.5 t -105.49 122.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.859 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -126.87 121.17 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.449 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' HD21 ' A' ' 141' ' ' LEU . 17.8 t -79.87 115.73 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.508 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -87.01 -25.05 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.742 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' H ' ' A' ' 142' ' ' SER . 30.4 p -79.89 -2.13 42.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.599 0.238 . . . . 0.0 111.441 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.36 76.99 0.26 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.897 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -147.26 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -122.17 142.08 35.93 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.0 Cg_endo -72.43 145.05 41.99 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.148 1.899 . . . . 0.0 112.228 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.859 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -56.61 147.35 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.49 161.38 35.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.198 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -118.63 119.74 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 111.707 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.4 mt -99.11 132.56 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.998 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.35 158.58 43.9 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -139.58 141.74 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.501 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -83.5 134.39 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.245 0.545 . . . . 0.0 111.331 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.5 -45.09 96.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.906 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.4 -39.18 86.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.0 110.585 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm100 -68.49 -36.81 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.579 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 51' ' ' ASP . 65.7 t -65.88 -48.21 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.801 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.05 -32.85 69.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -77.72 -42.55 33.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.14 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.95 120.16 10.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.975 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.34 70.21 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -145.58 171.4 14.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.2 p -71.13 -30.65 66.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 65' ' ' VAL . 9.3 tp -114.66 147.54 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.577 ' HD2' HG13 ' A' ' 55' ' ' VAL . 9.1 mmpt? -103.91 -66.66 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.5 ttpt -150.72 131.46 14.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.79 139.14 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.239 0.542 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.2 m-90 -102.81 139.44 38.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.15 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.38 128.88 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -118.35 145.34 45.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.477 -178.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.709 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 161.02 -166.59 35.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.644 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 16.4 mtm180 -84.34 5.42 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 18.4 t-20 -84.95 132.47 45.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 Cg_exo -65.72 -14.79 46.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.449 2.099 . . . . 0.0 111.462 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -43.31 16.96 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.854 0.835 . . . . 0.0 108.76 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.05 138.96 1.92 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.739 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.9 m-20 -56.35 -18.86 12.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.922 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.5 t80 -129.78 125.23 35.3 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 120.778 0.323 . . . . 0.0 111.257 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -103.28 112.84 25.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.614 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.709 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -119.29 72.87 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 48.26 -131.87 19.83 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.919 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.69 84.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.046 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -96.59 128.6 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -28.77 63.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.63 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -74.13 -27.76 61.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.059 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.971 HD12 HD13 ' A' ' 81' ' ' ILE . 17.5 mt -99.5 152.12 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.956 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.8 p -94.96 166.65 11.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.533 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.564 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.58 -53.85 5.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.353 0.597 . . . . 0.0 109.596 179.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.566 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.14 83.75 2.08 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -60.33 -46.27 90.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.507 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.8 p90 -144.59 160.27 41.43 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.171 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.78 141.32 44.77 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.196 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 65' ' ' VAL . 49.5 mt -117.3 132.18 67.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.027 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.93 151.59 27.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.087 0.47 . . . . 0.0 111.612 -179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.574 ' C ' HD13 ' A' ' 93' ' ' LEU . 2.6 tm? -125.05 122.9 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.461 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -99.91 165.44 19.87 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.711 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -58.66 -30.37 67.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.757 0.313 . . . . 0.0 111.05 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.07 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.95 29.7 8.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' C ' HD12 ' A' ' 99' ' ' LEU . 77.8 m-20 -133.73 -178.31 4.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.826 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.915 HD21 HG12 ' A' ' 33' ' ' VAL . 5.8 mp -132.23 160.11 37.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.6 mt -129.67 143.92 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -112.66 127.47 56.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.538 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.5 t30 -118.9 115.5 24.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 0.0 111.493 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.866 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -78.84 138.37 38.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -145.74 40.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.43 150.94 21.66 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.037 0.446 . . . . 0.0 111.798 -178.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.451 ' OG1' HG21 ' B' ' 5' ' ' TPO . 52.4 m -68.62 -31.56 70.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.769 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.14 -19.71 17.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.34 10.61 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.53 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.1 m -117.19 137.71 52.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.76 148.58 39.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.59 18.61 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.349 177.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 43.97 43.44 5.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.45 -12.55 64.65 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.485 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.42 118.53 36.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.082 0.468 . . . . 0.0 110.56 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.83 130.63 41.52 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.501 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.866 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.1 m -100.05 163.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.045 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 pm0 -69.98 124.69 24.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 26.9 tttt -50.99 161.01 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 111.012 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 34.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.401 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.37 145.16 40.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.343 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.8 ' HB3' HD22 ' A' ' 100' ' ' LEU . 14.6 m120 -85.49 128.55 34.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.34 147.53 51.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.705 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.4 tt -72.89 120.1 18.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.31 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -56.81 157.54 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.291 0.567 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.38 153.24 42.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.452 ' HG2' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 121.8 19.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.357 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.95 24.57 54.55 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.19 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.8 t70 -57.72 175.6 0.18 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.901 0.381 . . . . 0.0 110.902 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.6 mt-10 -145.07 135.55 24.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.035 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 145' ' ' ILE . 6.7 mt -113.14 128.19 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.383 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.651 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.19 138.88 40.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.805 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.26 158.41 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.35 21.46 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.936 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.0 t -75.07 140.43 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.661 0.743 . . . . 0.0 112.428 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.26 -37.8 0.85 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.38 123.26 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.499 -0.851 . . . . 0.0 108.96 178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -32.54 16.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.783 0.325 . . . . 0.0 111.585 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.461 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 3.6 t0 -125.86 29.47 5.91 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.651 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.8 mt -107.29 139.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 142' ' ' SER . 4.4 tt -124.4 134.41 53.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.577 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD23 ' A' ' 141' ' ' LEU . 45.7 t -112.71 150.27 31.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.481 0.658 . . . . 0.0 112.424 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HZ ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -134.1 148.5 51.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.14 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.6 t -114.04 135.5 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.046 HD11 HD11 ' A' ' 130' ' ' ILE . 27.9 mt -106.3 122.79 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.195 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 120.57 42.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.55 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.583 HG12 HD21 ' A' ' 124' ' ' LEU . 6.1 mt -84.59 134.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.826 0.346 . . . . 0.0 111.322 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -84.29 123.37 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.8 -17.97 62.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.206 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -57.44 -44.4 84.7 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.51 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.494 ' O ' HD23 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -58.7 -44.11 90.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.711 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -65.21 -33.93 77.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.85 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -46.31 71.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -59.89 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.01 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 151' ' ' PHE . 4.3 mm? -59.94 -39.1 84.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.803 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -78.5 -37.07 44.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 p30 42.43 44.03 3.31 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.488 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.27 114.01 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.73 131.9 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.18 -176.7 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.36 167.84 15.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.7 126.4 40.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.863 0.363 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -74.14 142.38 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' TPO . . . . . 0.632 ' O3P' HG22 ' B' ' 5' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -90.05 107.59 20.38 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.11 -169.08 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.444 2.096 . . . . 0.0 112.389 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -157.2 157.76 34.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.798 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -93.17 142.3 27.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -122.25 151.24 41.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . . . . . . . . . 16.2 m 60.43 179.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.894 179.988 . . . . . . . . 0 0 . 1 stop_ save_